Link to all CCASAnet Publications in PubMed
2775998
F2Y6PLUL
2025
1
padagogische-hochschule-bern-institut-vorschulstufe-und-primarstufe
50
date
desc
year
258
https://www.iedea.org/wp-content/plugins/zotpress/
%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3Afalse%2C%22meta%22%3A%7B%22request_last%22%3A0%2C%22request_next%22%3A0%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%223P95BNQ9%22%2C%22library%22%3A%7B%22id%22%3A2775998%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Ferreira%20et%20al.%22%2C%22parsedDate%22%3A%222025-08%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BFerreira%2C%20Isabella%20B.%20B.%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BMenezes%2C%20Rodrigo%20C.%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BAra%26%23xFA%3Bjo-Pereira%2C%20Mariana%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BRolla%2C%20Valeria%20C.%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BKritski%2C%20Afr%26%23xE2%3Bnio%20L.%26lt%3B%5C%2Fspan%26gt%3B%20et%20al.%26lt%3B%5C%2Fspan%26gt%3B%20%282025%29.%20Effects%20of%20missed%20anti-tuberculosis%20therapy%20doses%20on%20treatment%20outcome%3A%20a%20multi-center%20cohort%20study.%20%26lt%3Bi%26gt%3BLancet%20Regional%20Health.%20Americas%26lt%3B%5C%2Fi%26gt%3B%2C%20%26lt%3Bi%26gt%3B48%26lt%3B%5C%2Fi%26gt%3B%2C%20S.%20101162.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.lana.2025.101162%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.lana.2025.101162%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Effects%20of%20missed%20anti-tuberculosis%20therapy%20doses%20on%20treatment%20outcome%3A%20a%20multi-center%20cohort%20study%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Isabella%20B.%20B.%22%2C%22lastName%22%3A%22Ferreira%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rodrigo%20C.%22%2C%22lastName%22%3A%22Menezes%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mariana%22%2C%22lastName%22%3A%22Ara%5Cu00fajo-Pereira%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Valeria%20C.%22%2C%22lastName%22%3A%22Rolla%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Afr%5Cu00e2nio%20L.%22%2C%22lastName%22%3A%22Kritski%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marcelo%22%2C%22lastName%22%3A%22Cordeiro-Santos%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Timothy%20R.%22%2C%22lastName%22%3A%22Sterling%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Cody%22%2C%22lastName%22%3A%22Staats%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gustavo%22%2C%22lastName%22%3A%22Amorim%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anete%22%2C%22lastName%22%3A%22Trajman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bruno%20B.%22%2C%22lastName%22%3A%22Andrade%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22RePORT-Brazil%20Consortium%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20Tuberculosis%20%28TB%29%20remains%20a%20leading%20cause%20of%20infectious%20disease%20mortality%20globally.%20Although%20directly%20observed%20therapy%20%28DOT%29%20has%20been%20widely%20implemented%20to%20improve%20adherence%2C%20nonadherence%20continues%20to%20compromise%20treatment%20success%20rates%2C%20especially%20in%20real-world%20settings.%20Therefore%2C%20this%20study%20aims%20to%20assess%20the%20impact%20of%20missed%20doses%20on%20TB%20treatment%20outcomes.%5CnMETHODS%3A%20Prospective%20study%20that%20followed%20adults%20with%20drug-sensitive%20TB%20for%20two%20years%20after%20TB%20treatment%20initiation%20at%20five%20clinical%20centers%20of%20the%20RePORT-Brazil%20cohort%20between%20June%202015%20and%20June%202019.%20Participants%20not%20in%20DOT%20or%20followed%20for%20less%20than%2030%20days%20were%20excluded.%20Nonadherence%20was%20defined%20as%20the%20percentage%20of%20missed%20doses%20relative%20to%20the%20prescribed%20regimen%2C%20monitored%20daily%20through%20DOT.%20The%20primary%20composite%20outcome%20comprised%20treatment%20failure%2C%20disease%20recurrence%2C%20drug%20resistance%2C%20death%2C%20or%20loss%20to%20follow-up%20%28LTFU%29%20after%2030%20days%20of%20treatment.%20Associations%20were%20assessed%20with%20multivariable%20logistic%20regression.%5CnFINDINGS%3A%20Among%20the%20578%20participants%20analyzed%2C%20218%20%2837%5Cu00b77%25%29%20experienced%20unfavorable%20outcomes.%20Overall%2C%2023%25%20of%20participants%20missed%20more%20than%2010%25%20of%20prescribed%20doses%2C%20and%20this%20group%20had%20an%2081%5Cu00b72%25%20likelihood%20of%20experiencing%20unfavorable%20outcomes%2C%20compared%20to%20only%2021%5Cu00b76%25%20among%20those%20with%20complete%20adherence.%20A%20significant%20association%20was%20observed%20between%20the%20percentage%20of%20missed%20doses%20and%20unfavorable%20outcomes%20%28adjusted%20OR%3A%201%5Cu00b711%2C%2095%25%20CI%3A%201%5Cu00b707-1%5Cu00b714%2C%20p-value%20%26lt%3B%200%5Cu00b70001%29.%5CnINTERPRETATION%3A%20Even%20minor%20nonadherence%20in%20TB%20treatment%20was%20associated%20with%20an%20increased%20risk%20of%20unfavorable%20outcomes%2C%20highlighting%20the%20role%20of%20adherence%20in%20successful%20TB%20care.%5CnFUNDING%3A%20Funda%5Cu00e7%5Cu00e3o%20Oswaldo%20Cruz%2C%20Funda%5Cu00e7%5Cu00e3o%20Jos%5Cu00e9%20Silveira%2C%20Departamento%20de%20Ci%5Cu00eancia%20e%20Tecnologia%2C%20US%20National%20Institute%20of%20Allergy%20and%20Infectious%20Diseases.%22%2C%22date%22%3A%222025-08%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.lana.2025.101162%22%2C%22ISSN%22%3A%222667-193X%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22GXCKG69T%22%2C%22F2Y6PLUL%22%5D%2C%22dateModified%22%3A%222025-09-01T11%3A38%3A45Z%22%7D%7D%2C%7B%22key%22%3A%22NLELCWA7%22%2C%22library%22%3A%7B%22id%22%3A2775998%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Guerrero-Torres%20et%20al.%22%2C%22parsedDate%22%3A%222025-07-17%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BGuerrero-Torres%2C%20Lorena%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BBarbosa-Ram%26%23xED%3Brez%2C%20Bibiana%20Montserrat%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BBelaunzar%26%23xE1%3Bn-Zamudio%2C%20Pablo%20F.%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BAlegre-D%26%23xED%3Baz%2C%20Jes%26%23xFA%3Bs%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BRam%26%23xED%3Brez%2C%20Ra%26%23xFA%3Bl%26lt%3B%5C%2Fspan%26gt%3B%20et%20al.%26lt%3B%5C%2Fspan%26gt%3B%20%282025%29.%20Improving%20estimators%20of%20HIV%20mortality%20and%20retention%20in%20care%20by%20linking%20clinical%20cohort%20data%20with%20national%20registries%20in%20Mexico.%20%26lt%3Bi%26gt%3BBMC%20Public%20Health%26lt%3B%5C%2Fi%26gt%3B%2C%20%26lt%3Bi%26gt%3B25%26lt%3B%5C%2Fi%26gt%3B%20%281%29%2C%20S.%202489.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1186%5C%2Fs12889-025-23542-1%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1186%5C%2Fs12889-025-23542-1%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Improving%20estimators%20of%20HIV%20mortality%20and%20retention%20in%20care%20by%20linking%20clinical%20cohort%20data%20with%20national%20registries%20in%20Mexico%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lorena%22%2C%22lastName%22%3A%22Guerrero-Torres%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bibiana%20Montserrat%22%2C%22lastName%22%3A%22Barbosa-Ram%5Cu00edrez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Pablo%20F.%22%2C%22lastName%22%3A%22Belaunzar%5Cu00e1n-Zamudio%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jes%5Cu00fas%22%2C%22lastName%22%3A%22Alegre-D%5Cu00edaz%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ra%5Cu00fal%22%2C%22lastName%22%3A%22Ram%5Cu00edrez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Antonio%22%2C%22lastName%22%3A%22Rosa-Parra%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Juan%22%2C%22lastName%22%3A%22Sierra-Madero%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Brenda%22%2C%22lastName%22%3A%22Crabtree-Ram%5Cu00edrez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yanink%20Caro%22%2C%22lastName%22%3A%22Vega%22%7D%5D%2C%22abstractNote%22%3A%22INTRODUCTION%3A%20Loss%20to%20follow-up%20%28LTFU%29%20bias%20mortality%20estimates%20in%20cohort%20studies.%20This%20study%20aimed%20to%20estimate%20the%20corrected%20incidence%20of%20LTFU%2C%20retention%20in%20care%2C%20and%20mortality%20rates%20in%20people%20with%20HIV%20%28PWH%29%20in%20an%20HIV%5C%2FAIDS%20Clinic%20in%20Mexico%20City%2C%20by%20linking%20clinic%20and%20national%20registry%20data%2C%20and%20to%20identify%20characteristics%20associated%20with%20LTFU.%5CnMETHODS%3A%20We%20linked%20adult%20PWH%20who%20met%20lost%20to%20follow-up%20criteria%20while%20enrolled%20at%20a%20Mexico%20City%20clinic%20with%20the%20national%20death%20registry%2C%20a%20national%20administrative%20HIV%20database%20and%20a%20clinical%20national%20registry%20in%20May%202019%20and%20January%202021.%20We%20defined%20lost%20to%20follow-up%20as%20absence%20of%20a%20documented%20clinical%20contact%20in%20the%20previous%20180%20days.%20We%20estimated%20corrected%20LTFU%2C%20retention%20in%20care%2C%20mortality%20rates%2C%20and%20survival%2C%20and%20identified%20characteristics%20associated%20to%20LTFU.%5CnRESULTS%3A%20Among%202%2C826%20PWH%20followed%20by%20a%20median%20of%205.9%20years%20%28IQR%3A%201.9-7.1%29%2C%20804%20%2828.4%25%29%20were%20lost%20and%20149%20%285.3%25%29%20died.%20After%20the%20second%20linkage%2C%20of%20the%20804%20lost%2C%20257%20%2832%25%29%20died%2C%20175%20%2821.8%25%29%20transferred%2C%2040%20%284.9%25%29%20were%20retained%20in%20care%2C%20and%20332%20%2841.3%25%29%20remained%20LTFU.%20Post%20second%20linkage%2C%20the%20corrected%20cumulative%20proportion%20of%20LTFU%20slightly%20decreased%20%28n%5Cu2009%3D%5Cu2009764%2C%2027%25%29%2C%20but%20deaths%20substantially%20increased%20%28n%5Cu2009%3D%5Cu2009459%2C%2016.2%25%29.%20A%20subset%20of%20PWH%20transferred%20to%20other%20centres%20%28n%5Cu2009%3D%5Cu2009184%2C%206.5%25%29.%20The%20unadjusted%20LTFU%20rate%20decreased%20from%204.0%20to%202.9%20per%20100%20person-years%20%28PY%29%2C%20while%20mortality%20increased%20from%200.7%20to%201.7%20per%20100%20PY.%20Younger%20age%20%28aHR%201.5%2C%2095%25CI%201.38-1.63%20per%2010-year%20change%29%2C%20and%20lower%20education%20%28aHR%201.05%2C%2095%25CI%201.01-1.08%20per%20year%29%20were%20associated%20to%20a%20higher%20risk%20of%20LTFU.%5CnCONCLUSION%3A%20Datasets%20linkages%20revealed%20mortality%20rates%20three%20times%20higher%20than%20the%20original%20estimates%2C%20highlighting%20the%20limitations%20of%20relying%20in%20single-source%20data.%20At%20the%20individual%20level%2C%20identifying%20predictors%20of%20LTFU%20can%20help%20target%20interventions%20to%20improve%20retention%20and%20may%20reduce%20mortality.%20However%2C%20at%20the%20system-level%2C%20our%20study%20demonstrates%20the%20feasibility%20and%20value%20of%20cross-institutional%20data%20linkage%20in%20fragmented%20health%20systems.%20Key%20lessons%20include%20the%20importance%20of%20long-term%2C%20privacy-preserving%20data-sharing%20collaboration%20between%20institutions%20to%20improve%20patient%20tracking%20across%20institutions%2C%20mortality%20surveillance%20and%20care%20continuity.%22%2C%22date%22%3A%222025-07-17%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1186%5C%2Fs12889-025-23542-1%22%2C%22ISSN%22%3A%221471-2458%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22GXCKG69T%22%2C%22F2Y6PLUL%22%5D%2C%22dateModified%22%3A%222025-09-01T11%3A39%3A07Z%22%7D%7D%2C%7B%22key%22%3A%22C2TMM3CP%22%2C%22library%22%3A%7B%22id%22%3A2775998%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Fern%5Cu00e1ndez%20Villalobos%20et%20al.%22%2C%22parsedDate%22%3A%222025-07%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BFern%26%23xE1%3Bndez%20Villalobos%2C%20Nathalie%20Ver%26%23xF3%3Bnica%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BHelfenstein%2C%20Fabrice%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BKhol%2C%20Vohith%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BTwizere%2C%20Christella%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BSecco%2C%20Mayara%26lt%3B%5C%2Fspan%26gt%3B%20et%20al.%26lt%3B%5C%2Fspan%26gt%3B%20%282025%29.%20Scale%20of%20differentiated%20service%20delivery%20implementation%20in%20HIV%20care%20facilities%20in%20low-%20and%20middle-income%20countries%3A%20a%20global%20facility%20survey.%20%26lt%3Bi%26gt%3BJournal%20of%20the%20International%20AIDS%20Society%26lt%3B%5C%2Fi%26gt%3B%2C%20%26lt%3Bi%26gt%3B28%20Suppl%203%26lt%3B%5C%2Fi%26gt%3B%2C%20S.%20e26477.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1002%5C%2Fjia2.26477%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1002%5C%2Fjia2.26477%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Scale%20of%20differentiated%20service%20delivery%20implementation%20in%20HIV%20care%20facilities%20in%20low-%20and%20middle-income%20countries%3A%20a%20global%20facility%20survey%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nathalie%20Ver%5Cu00f3nica%22%2C%22lastName%22%3A%22Fern%5Cu00e1ndez%20Villalobos%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fabrice%22%2C%22lastName%22%3A%22Helfenstein%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vohith%22%2C%22lastName%22%3A%22Khol%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christella%22%2C%22lastName%22%3A%22Twizere%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mayara%22%2C%22lastName%22%3A%22Secco%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Barbara%22%2C%22lastName%22%3A%22Castelnuovo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jacqueline%22%2C%22lastName%22%3A%22Huwa%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Thierry%22%2C%22lastName%22%3A%22Tiendredbeogo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22C.%20William%22%2C%22lastName%22%3A%22Wester%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Siew%20Moy%22%2C%22lastName%22%3A%22Fong%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gad%22%2C%22lastName%22%3A%22Murenzi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yanink%22%2C%22lastName%22%3A%22Caro-Vega%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rita%20Elias%22%2C%22lastName%22%3A%22Lyamuya%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Idiovinio%22%2C%22lastName%22%3A%22Rafael%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Djimon%20Marcel%22%2C%22lastName%22%3A%22Zannou%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kathy%22%2C%22lastName%22%3A%22Petoumenos%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dominique%20Mahambou%22%2C%22lastName%22%3A%22Nsonde%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jorge%22%2C%22lastName%22%3A%22Pinto%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kara%22%2C%22lastName%22%3A%22Wools-Kaloustian%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Carolyn%20Bolton%22%2C%22lastName%22%3A%22Moore%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ounoo%20Elom%22%2C%22lastName%22%3A%22Takassi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sasisopin%22%2C%22lastName%22%3A%22Kiertiburanakul%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rogers%20Ajeh%22%2C%22lastName%22%3A%22Awoh%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shamim%20M.%22%2C%22lastName%22%3A%22Ali%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Geoffrey%22%2C%22lastName%22%3A%22Fatti%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Karen%22%2C%22lastName%22%3A%22Malateste%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Elizabeth%22%2C%22lastName%22%3A%22Zaniewski%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marie%22%2C%22lastName%22%3A%22Ballif%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22International%20epidemiology%20Databases%20to%20Evaluate%20AIDS%22%7D%5D%2C%22abstractNote%22%3A%22INTRODUCTION%3A%20In%202016%2C%20the%20World%20Health%20Organization%20recommended%20differentiated%20service%20delivery%20%28DSD%29%20as%20a%20client-centred%20approach%20to%20simplify%20HIV%20care%20in%20frequency%20and%20intensity%2C%20thus%20reducing%20the%20clinic%20visit%20burden%20on%20individuals%20and%20HIV%20programmes.%20We%20describe%20the%20scale%20of%20DSD%20implementation%20among%20HIV%20facilities%20in%20low-%20and%20middle-income%20countries%20%28LMICs%29%20in%20Latin%20America%2C%20Africa%20and%20the%20Asia-Pacific%20before%20the%20COVID-19%20pandemic.%5CnMETHODS%3A%20We%20analysed%20facility-level%20survey%20data%20from%20HIV%20care%20facilities%20participating%20in%20the%20International%20epidemiology%20Databases%20to%20Evaluate%20AIDS%20consortium%20in%202019.%20We%20used%20descriptive%20statistics%20to%20summarise%20the%20availability%20of%20DSD%2C%20multi-month%20dispensing%20%28MMD%29%20and%20DSD%20for%20HIV%20treatment%20models.%20We%20explored%20factors%20associated%20with%20DSD%20implementation%20using%20multivariable%20models.%5CnRESULTS%3A%20We%20included%20175%20facilities%20in%20the%20Asia-Pacific%20%28n%20%3D%2030%29%2C%20Latin%20America%20%28n%20%3D%208%29%2C%20Central%20Africa%20%28n%20%3D%2021%29%2C%20East%20Africa%20%28n%20%3D%2074%29%2C%20Southern%20Africa%20%28n%20%3D%2028%29%20and%20West%20Africa%20%28n%20%3D%2014%29.%20Overall%2C%20133%20facilities%20%2876%25%29%20reported%20implementing%20DSD.%20Of%20these%2C%2091%25%20offered%20DSD%20for%20HIV%20treatment%2C%2061%25%20for%20HIV%20testing%20and%2059%25%20for%20antiretroviral%20therapy%20%28ART%29%20initiation.%20The%20most%20common%20duration%20of%20ART%20refills%20for%20clinically%20stable%20clients%20was%203MMD%2C%20%2870%25%29%2C%20followed%20by%20monthly%20%2814%25%29%20and%206MMD%20%2810%25%29.%20Facility-based%20individual%20models%20were%20the%20most%20frequently%20available%20DSD%20for%20the%20HIV%20treatment%20model%20%2882%25%29%2C%20followed%20by%20client-managed%20group%20models%20%2860%25%29.%20Out-of-facility%20individual%20models%20were%20available%20at%2048%25%20of%20facilities.%20Facility-based%20individual%20models%20were%20particularly%20common%20among%20facilities%20in%20East%20%2892%25%29%20and%20Southern%20Africa%20%2896%25%29.%20Facilities%20in%20medium%20and%20high%20HIV%20prevalence%20countries%2C%20and%20those%20with%203MMD%2C%20were%20more%20likely%20to%20implement%20DSD.%5CnCONCLUSIONS%3A%20In%202019%2C%20DSD%20was%20available%20in%20most%20HIV%20care%20facilities%20globally%20but%20was%20not%20evenly%20implemented%20across%20regions%20and%20HIV%20services.%20Most%20offered%20facility-based%20DSD%20for%20HIV%20treatment%20models%20and%203MMD%20for%20clinically%20stable%20clients.%20Efforts%20to%20expand%20DSD%20for%20HIV%20testing%20and%20ART%20initiation%20and%20to%20offer%20longer%20MMD%20can%20improve%20long-term%20retention%20in%20care%20of%20people%20living%20with%20HIV%20in%20LMICs%2C%20while%20further%20alleviating%20the%20operational%20burden%20on%20healthcare%20services.%20These%20findings%20from%20the%20pre-COVID-19%20era%20underline%20the%20need%20for%20strengthening%20DSD%20in%20HIV%20care%2C%20which%20remains%20at%20the%20centre%20of%20current%20efforts%20towards%20client-centred%20care.%22%2C%22date%22%3A%222025-07%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1002%5C%2Fjia2.26477%22%2C%22ISSN%22%3A%221758-2652%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22GXCKG69T%22%2C%22ZVWK2Q45%22%2C%22D9WC3N3V%22%2C%22TCMBXKKM%22%2C%228IRGNQWZ%22%2C%22F2Y6PLUL%22%2C%22ZBJI578D%22%2C%22YAE5EUBI%22%2C%223FNU2D64%22%5D%2C%22dateModified%22%3A%222025-09-01T11%3A40%3A44Z%22%7D%7D%2C%7B%22key%22%3A%22KFLVZMKJ%22%2C%22library%22%3A%7B%22id%22%3A2775998%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Fonseca%20et%20al.%22%2C%22parsedDate%22%3A%222025-07%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BFonseca%2C%20Fernanda%20F.%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BRanadive%2C%20Paridhi%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BShepherd%2C%20Bryan%20E.%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BFerreira%2C%20Flavia%20G.%20F.%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BRodr%26%23xED%3Bguez%2C%20Maria%20F.%26lt%3B%5C%2Fspan%26gt%3B%20et%20al.%26lt%3B%5C%2Fspan%26gt%3B%20%282025%29.%20Persistent%20sex%20disparities%20in%20access%20to%20dolutegravir-based%20antiretroviral%20therapy%20in%20Latin%20America%20and%20the%20Caribbean%3A%20results%20from%20a%20retrospective%20observational%20study%20using%20data%20from%202017%20to%202022.%20%26lt%3Bi%26gt%3BJournal%20of%20the%20International%20AIDS%20Society%26lt%3B%5C%2Fi%26gt%3B%2C%20%26lt%3Bi%26gt%3B28%26lt%3B%5C%2Fi%26gt%3B%20%287%29%2C%20S.%20e26470.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1002%5C%2Fjia2.26470%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1002%5C%2Fjia2.26470%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Persistent%20sex%20disparities%20in%20access%20to%20dolutegravir-based%20antiretroviral%20therapy%20in%20Latin%20America%20and%20the%20Caribbean%3A%20results%20from%20a%20retrospective%20observational%20study%20using%20data%20from%202017%20to%202022%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fernanda%20F.%22%2C%22lastName%22%3A%22Fonseca%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Paridhi%22%2C%22lastName%22%3A%22Ranadive%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bryan%20E.%22%2C%22lastName%22%3A%22Shepherd%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Flavia%20G.%20F.%22%2C%22lastName%22%3A%22Ferreira%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Maria%20F.%22%2C%22lastName%22%3A%22Rodr%5Cu00edguez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Daisy%20M.%22%2C%22lastName%22%3A%22Machado%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vanessa%22%2C%22lastName%22%3A%22Rouzier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Diana%22%2C%22lastName%22%3A%22Varela%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fernanda%22%2C%22lastName%22%3A%22Maruri%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%22%2C%22lastName%22%3A%22Ribeiro%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Beatriz%22%2C%22lastName%22%3A%22Grinsztejn%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sandra%22%2C%22lastName%22%3A%22Wagner%20Cardoso%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Valdil%5Cu00e9a%20G.%22%2C%22lastName%22%3A%22Veloso%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jessica%20L.%22%2C%22lastName%22%3A%22Castilho%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Emilia%20M.%22%2C%22lastName%22%3A%22Jalil%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22CCASAnet%22%7D%5D%2C%22abstractNote%22%3A%22INTRODUCTION%3A%20Despite%20its%20reversal%20in%20July%202019%2C%20the%20World%20Health%20Organization%20warning%20issued%20in%20May%202018%20of%20potential%20teratogenicity%20associated%20with%20dolutegravir%20%28DTG%29%20may%20have%20produced%20persistent%20sex%20disparities%20in%20access%20to%20DTG.%20We%20compared%20DTG%20uptake%20of%20people%20with%20HIV%20%28PWH%29%20by%20sex%20in%20Latin%20America%20and%20the%20Caribbean%20%28LAC%29%20and%20its%20potential%20impact%20on%20virologic%20outcomes.%5CnMETHODS%3A%20We%20evaluated%20DTG%20initiation%20among%20antiretroviral%20therapy%20%28ART%29-na%5Cu00efve%20and%20-experienced%20cisgender%20PWH%20%5Cu226516%20years%20of%20age%20after%20DTG%20availability%20in%20Brazil%20%28February%5C%2F2017%29%2C%20Chile%20%28August%5C%2F2019%29%2C%20Haiti%20%28November%5C%2F2018%29%20and%20Honduras%20%28December%5C%2F2018%29.%20Time%20was%20divided%20into%20pre-%20%28before%20May%5C%2F2018%29%2C%20during-%20%28May%5C%2F2018-July%5C%2F2019%29%20and%20post-%20%28after%20July%5C%2F2019%29%20warning%20periods.%20We%20examined%20interactions%20of%20sex%2C%20age%20and%20calendar%20era%20with%20multivariable%20modified%20Poisson%20regression%20models%20and%20Cox%20proportional%20hazard%20models%20for%20the%20outcomes%20of%20DTG%20initiation%20among%20ART-na%5Cu00efve%20and%20ART-experienced%20PWH%2C%20respectively%2C%20and%20HIV%20RNA%20%26lt%3B50%20copies%5C%2Fml%20in%20the%20first%20year%20of%20therapy%20among%20ART-na%5Cu00efve%20PWH%2C%20adjusting%20for%20site%20and%20tuberculosis.%5CnRESULTS%3A%20Among%204622%20ART-na%5Cu00efve%20PWH%2C%203853%20%2883%25%29%20initiated%20DTG.%20ART-na%5Cu00efve%20females%20aged%2016-49%20years%20were%20less%20likely%20to%20initiate%20DTG%20compared%20to%20males%20of%20the%20same%20age%20both%20in%20the%20pre%5C%2Fduring-warning%20%28adjusted%20prevalence%20ratio%20%5BaPR%5D%3A%200.75%20%5B95%25%20confidence%20interval%20%2895%25%20CI%29%3A%200.71-0.80%5D%29%20and%20in%20the%20post-warning%20periods%20%28aPR%3A%200.97%20%5B95%25%20CI%3A%200.95-1.00%5D%29.%20Among%2016%2C154%20ART-experienced%20PWH%2C%209236%20%2857%25%29%20initiated%20DTG.%20ART-experienced%20females%2016-49%20years%20were%20less%20likely%20to%20initiate%20DTG%20compared%20to%20males%20of%20the%20same%20age%20in%20the%20pre%5C%2Fduring-warning%20%28adjusted%20hazard%20ratio%20%5BaHR%5D%3A%200.69%20%5B95%25%20CI%3A%200.66-0.73%5D%29%20and%20post-warning%20periods%20%28aHR%3A%200.79%20%5B95%25%20CI%3A%200.70-0.90%5D%29.%20This%20sex%20difference%20was%20not%20observed%20among%20older%20ART-experienced%20females%20and%20males%20pre%5C%2Fduring-warning%20%28aHR%3A%201.06%20%5B95%25%20CI%3A%200.99-1.14%5D%29.%20Compared%20to%20starting%20ART%20without%20DTG%2C%20DTG-based%20ART%20use%20was%20associated%20with%20a%20higher%20likelihood%20of%20HIV%20RNA%20suppression%20in%20the%20first%20year%20%28aPR%20%3D%201.10%20%5B95%25%20CI%3A%201.04-1.16%5D%29.%20In%20the%20post-warning%20period%2C%20females%20aged%2016-49%20years%20had%20a%20likelihood%20of%20viral%20suppression%20similar%20to%20males%20of%20the%20same%20age%20%28aPR%3A%201.03%20%5B95%25%20CI%3A%200.96-1.10%5D%29%2C%20which%20did%20not%20change%20after%20adjusting%20for%20DTG%20use%20%28aPR%3A%201.03%20%5B95%25%20CI%3A%200.97-1.11%5D%29.%5CnCONCLUSIONS%3A%20Despite%20the%20updated%20guidelines%20recommending%20DTG%20for%20all%20PWH%2C%20there%20are%20persistent%20sex%20disparities%20in%20the%20access%20to%20DTG%20in%20LAC%2C%20especially%20among%20females%20within%20the%20reproductive%20age.%22%2C%22date%22%3A%222025-07%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1002%5C%2Fjia2.26470%22%2C%22ISSN%22%3A%221758-2652%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22GXCKG69T%22%2C%22F2Y6PLUL%22%5D%2C%22dateModified%22%3A%222025-07-15T15%3A01%3A11Z%22%7D%7D%2C%7B%22key%22%3A%22S2RVPSG6%22%2C%22library%22%3A%7B%22id%22%3A2775998%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Castillo-Rozas%20et%20al.%22%2C%22parsedDate%22%3A%222025-05%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BCastillo-Rozas%2C%20Gabriel%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BFonseca%2C%20Fernanda%20F.%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BCastilho%2C%20Jessica%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BRebeiro%2C%20Peter%20F.%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BMachado%2C%20Daisy%20M.%26lt%3B%5C%2Fspan%26gt%3B%20et%20al.%26lt%3B%5C%2Fspan%26gt%3B%20%282025%29.%20ART%20to%20prevent%20vertical%20transmission%20in%20Latin%20America%3A%20where%20are%20we%20in%20the%20%26%23x201C%3BTreat-All%26%23x201D%3B%20era%3F%20%26lt%3Bi%26gt%3BJournal%20of%20the%20International%20AIDS%20Society%26lt%3B%5C%2Fi%26gt%3B%2C%20%26lt%3Bi%26gt%3B28%26lt%3B%5C%2Fi%26gt%3B%20%285%29%2C%20S.%20e26411.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1002%5C%2Fjia2.26411%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1002%5C%2Fjia2.26411%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22ART%20to%20prevent%20vertical%20transmission%20in%20Latin%20America%3A%20where%20are%20we%20in%20the%20%5C%22Treat-All%5C%22%20era%3F%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gabriel%22%2C%22lastName%22%3A%22Castillo-Rozas%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fernanda%20F.%22%2C%22lastName%22%3A%22Fonseca%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jessica%22%2C%22lastName%22%3A%22Castilho%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20F.%22%2C%22lastName%22%3A%22Rebeiro%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Daisy%20M.%22%2C%22lastName%22%3A%22Machado%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marco%20Tulio%22%2C%22lastName%22%3A%22Luque%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Emilia%20M.%22%2C%22lastName%22%3A%22Jalil%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fernando%22%2C%22lastName%22%3A%22Mejia%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ahra%22%2C%22lastName%22%3A%22Kim%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bryan%20E.%22%2C%22lastName%22%3A%22Shepherd%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Claudia%20P.%22%2C%22lastName%22%3A%22Cortes%22%7D%5D%2C%22abstractNote%22%3A%22INTRODUCTION%3A%20Antiretroviral%20therapy%20%28ART%29%20during%20pregnancy%20and%20at%20delivery%20has%20nearly%20eliminated%20vertical%20transmission%20%28VT%29%20in%20some%20settings%20but%20previously%20reported%20VT%20prevalence%20has%20been%20as%20high%20as%2015%25%20in%20Latin%20America%20and%20the%20Caribbean%20%28LAC%29.%20We%20evaluated%20VT%20in%20the%20Caribbean%2C%20Central%20and%20South%20America%20network%20for%20HIV%20epidemiology%20to%20further%20study%20the%20benefit%20of%20ART%20on%20VT%20in%20our%20region.%5CnMETHODS%3A%20We%20retrospectively%20collected%20data%20on%20cis-gender%20women%20%5Cu226515%20years%20of%20age%20enrolled%20in%20HIV%20clinics%20in%20Brazil%2C%20Chile%2C%20Honduras%20and%20Peru%20from%202003%20to%202018%20with%20%5Cu22651%20pregnancy%20resulting%20in%20a%20live%20birth%20after%20clinic%20entry%20to%20examine%20the%20association%20of%20ART%20use%20at%20the%20time%20of%20delivery%20and%20VT.%20We%20used%20propensity-score-matched%20logistic%20regression%20to%20examine%20the%20odds%20of%20VT%20by%20ART%20use.%20Matching%20weights%20incorporated%20site%2C%20HIV%20RNA%2C%20CD4%20cell%20count%2C%20maternal%20age%2C%20year%20and%20HIV%20diagnosis%20before%20or%20during%20pregnancy.%20We%20also%20examined%20the%20proportion%20of%20women%20who%20received%20ART%20during%20pregnancy%20before%20and%20after%20the%20treat-all%20era%2C%20as%20defined%20within%20each%20country.%5CnRESULTS%3A%20A%20total%20of%20623%20pregnant%20women%20with%20HIV%20contributed%20727%20live%20births.%20Of%20all%20births%2C%20613%20%2884.3%25%29%20infants%20had%20known%20HIV%20status%20and%20there%20were%2022%20%283.6%25%29%20VT%20events.%20Four%20of%20the%2022%20%2818%25%29%20were%20born%20to%20women%20on%20ART%20at%20delivery%2C%20compared%20to%20403%20of%20591%20%2868%25%29%20infants%20negative%20for%20HIV.%20In%20the%20propensity-score-matched%20model%2C%20ART%20use%20at%20delivery%20was%20associated%20with%2085%25%20decreased%20odds%20of%20VT%20%28odds%20ratio%20%3D%200.15%2C%2095%25%20confidence%20interval%200.04-0.58%29.%20In%20the%20pre-treat-all%20era%2C%2037%25%20%28181%5C%2F485%29%20of%20women%20received%20ART%20within%2030%20days%20of%20pregnancy%20diagnosis%2C%20compared%20to%2059%25%20%2875%5C%2F128%29%20during%20the%20treat-all%20era%20%28p%26lt%3B0.001%29.%20In%20the%20pre-treat-all%20era%2C%204.3%25%20%2821%5C%2F485%29%20of%20infants%20were%20born%20HIV%20positive%2C%20compared%20to%200.8%25%20%281%5C%2F128%29%20in%20the%20treat-all%20era%20%28p%20%3D%200.055%29.%5CnCONCLUSIONS%3A%20We%20found%20a%20low%20prevalence%20of%20VT%20in%20our%20cohort%2C%20especially%20in%20the%20treat-all%20era.%20ART%20use%20at%20delivery%20was%20strongly%20associated%20with%20a%20lower%20odd%20of%20VT.%20Despite%20improvements%2C%20access%20to%20ART%20during%20pregnancy%20remained%20far%20from%20universal.%20Therefore%2C%20new%20strategies%20to%20ensure%20its%20effective%20implementation%20in%20LAC%20are%20still%20warranted.%22%2C%22date%22%3A%222025-05%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1002%5C%2Fjia2.26411%22%2C%22ISSN%22%3A%221758-2652%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22GXCKG69T%22%2C%22F2Y6PLUL%22%5D%2C%22dateModified%22%3A%222025-05-19T11%3A27%3A27Z%22%7D%7D%2C%7B%22key%22%3A%22BS29FRDB%22%2C%22library%22%3A%7B%22id%22%3A2775998%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Patten%20et%20al.%22%2C%22parsedDate%22%3A%222025-04-04%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BPatten%2C%20Gabriela%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BMalateste%2C%20Karen%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BBolton%20Moore%2C%20Carolyn%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BSipambo%2C%20Nosisa%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BMokone%2C%20Limpho%26lt%3B%5C%2Fspan%26gt%3B%20et%20al.%26lt%3B%5C%2Fspan%26gt%3B%20%282025%29.%20Global%20Trends%20in%20CD4%20Measurement%20and%20Immunosuppression%20at%20ART%20Initiation%20Among%20Children%20With%20HIV.%20%26lt%3Bi%26gt%3BThe%20Pediatric%20Infectious%20Disease%20Journal%26lt%3B%5C%2Fi%26gt%3B.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1097%5C%2FINF.0000000000004819%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1097%5C%2FINF.0000000000004819%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Global%20Trends%20in%20CD4%20Measurement%20and%20Immunosuppression%20at%20ART%20Initiation%20Among%20Children%20With%20HIV%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gabriela%22%2C%22lastName%22%3A%22Patten%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Karen%22%2C%22lastName%22%3A%22Malateste%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Carolyn%22%2C%22lastName%22%3A%22Bolton%20Moore%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nosisa%22%2C%22lastName%22%3A%22Sipambo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Limpho%22%2C%22lastName%22%3A%22Mokone%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nanina%22%2C%22lastName%22%3A%22Anderegg%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kara%22%2C%22lastName%22%3A%22Wools-Kaloustian%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Denna%22%2C%22lastName%22%3A%22Michael%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Francesca%22%2C%22lastName%22%3A%22Odhiambo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Charles%22%2C%22lastName%22%3A%22Kasozi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sophie%22%2C%22lastName%22%3A%22Desmonde%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Madeleine%22%2C%22lastName%22%3A%22Amorissani-Folquet%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Val%5Cu00e9riane%22%2C%22lastName%22%3A%22Leroy%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dewi%22%2C%22lastName%22%3A%22Kumara%20Wati%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Revathy%22%2C%22lastName%22%3A%22Nallusamy%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Aarti%22%2C%22lastName%22%3A%22Kinikar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Du%20Tuan%22%2C%22lastName%22%3A%22Quy%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marcel%22%2C%22lastName%22%3A%22Yotebieng%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20Vanes%22%2C%22lastName%22%3A%22Ebasone%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Patricia%22%2C%22lastName%22%3A%22Lelo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jorge%22%2C%22lastName%22%3A%22Pinto%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vanessa%22%2C%22lastName%22%3A%22Rouzier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Daisy%20Maria%22%2C%22lastName%22%3A%22Machado%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nel%20Jason%22%2C%22lastName%22%3A%22Haw%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nathan%22%2C%22lastName%22%3A%22Ford%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22International%20epidemiology%20Databases%20to%20Evaluate%20AIDS%20collaboration%22%7D%5D%2C%22abstractNote%22%3A%22Eligibility%20for%20antiretroviral%20therapy%20is%20no%20longer%20based%20on%20immune%20criteria.%20In%20a%20global%20cohort%20of%2097%2C453%20children%2C%20between%202005%20and%202021%2C%20we%20observed%20large%20declines%20in%20CD4%20measurement%2C%20from%2051%25%20to%2012%25%20among%20%26lt%3B5%20seconds%2C%20and%20from%2074%25%20to%2020%25%20among%20those%205-14%20years%20of%20age.%20Lack%20of%20CD4%20testing%20may%20negatively%20affect%20clinical%20care%20and%20surveillance%20of%20severe%20immune%20suppression.%22%2C%22date%22%3A%222025-04-04%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1097%5C%2FINF.0000000000004819%22%2C%22ISSN%22%3A%221532-0987%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22GXCKG69T%22%2C%22369YB7BV%22%2C%22ZVWK2Q45%22%2C%22D9WC3N3V%22%2C%22TCMBXKKM%22%2C%228IRGNQWZ%22%2C%22F2Y6PLUL%22%2C%22ZBJI578D%22%2C%223FNU2D64%22%5D%2C%22dateModified%22%3A%222025-09-01T11%3A41%3A09Z%22%7D%7D%2C%7B%22key%22%3A%22CGJDXP9C%22%2C%22library%22%3A%7B%22id%22%3A2775998%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Embleton%20et%20al.%22%2C%22parsedDate%22%3A%222025-04%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BEmbleton%2C%20Lonnie%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BSudjaritruk%2C%20Tavitiya%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BMachado%2C%20Daisy%20Maria%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BChihota%2C%20Belinda%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BMusabyimana%2C%20Fran%26%23xE7%3Boise%26lt%3B%5C%2Fspan%26gt%3B%20et%20al.%26lt%3B%5C%2Fspan%26gt%3B%20%282025%29.%20Characterizing%20adolescent%20and%20youth-friendly%20HIV%20services%3A%20a%20cross-sectional%20assessment%20across%2016%20global%20sites.%20%26lt%3Bi%26gt%3BJournal%20of%20the%20International%20AIDS%20Society%26lt%3B%5C%2Fi%26gt%3B%2C%20%26lt%3Bi%26gt%3B28%26lt%3B%5C%2Fi%26gt%3B%20%284%29%2C%20S.%20e26437.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1002%5C%2Fjia2.26437%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1002%5C%2Fjia2.26437%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Characterizing%20adolescent%20and%20youth-friendly%20HIV%20services%3A%20a%20cross-sectional%20assessment%20across%2016%20global%20sites%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lonnie%22%2C%22lastName%22%3A%22Embleton%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tavitiya%22%2C%22lastName%22%3A%22Sudjaritruk%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Daisy%20Maria%22%2C%22lastName%22%3A%22Machado%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Belinda%22%2C%22lastName%22%3A%22Chihota%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fran%5Cu00e7oise%22%2C%22lastName%22%3A%22Musabyimana%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Julie%22%2C%22lastName%22%3A%22Jesson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Edith%22%2C%22lastName%22%3A%22Apondi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Thanyawee%22%2C%22lastName%22%3A%22Puthanakit%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marco%20Tulio%22%2C%22lastName%22%3A%22Luque%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicola%20Ellen%22%2C%22lastName%22%3A%22van%20Dongen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gad%22%2C%22lastName%22%3A%22Murenzi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Madeleine%22%2C%22lastName%22%3A%22Amorissani-Folquet%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Zachary%22%2C%22lastName%22%3A%22Kwena%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicole%22%2C%22lastName%22%3A%22Perreras%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vanessa%22%2C%22lastName%22%3A%22Rouzier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rita%22%2C%22lastName%22%3A%22Lyamuya%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kim%22%2C%22lastName%22%3A%22Anderson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Batya%22%2C%22lastName%22%3A%22Elul%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Val%5Cu00e9riane%22%2C%22lastName%22%3A%22Leroy%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Leslie%20A.%22%2C%22lastName%22%3A%22Enane%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Roxanne%22%2C%22lastName%22%3A%22Martin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kathryn%22%2C%22lastName%22%3A%22Lancaster%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Angela%20M.%22%2C%22lastName%22%3A%22Parcesepe%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rachel%22%2C%22lastName%22%3A%22Vreeman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22IeDEA%22%7D%5D%2C%22abstractNote%22%3A%22INTRODUCTION%3A%20Adolescent%20and%20youth-friendly%20health%20services%20%28AYFHS%29%20have%20been%20promoted%20as%20a%20best%20practice%20for%20adolescents%20and%20young%20people%20living%20with%20HIV%20%28AYLH%29.%20However%2C%20thorough%20descriptions%20of%20AYFHS%20for%20AYLH%20remain%20scarce.%20We%20sought%20to%20characterize%20adolescent-friendly%20HIV%20services%20in%20a%20global%20paediatric%20research%20consortium.%5CnMETHODS%3A%20Cross-sectional%20data%20were%20collected%20from%2016%20global%20sites%20in%20the%20Adolescent%20and%20Young%20Adult%20Network%20of%20IeDEA%20%28AYANI%29%20of%20the%20International%20epidemiology%20Databases%20to%20Evaluate%20AIDS%20consortium%20between%20August%202020%20and%20October%202022%20using%20a%20standardized%20site%20assessment%20tool%20that%20collected%20data%20on%20clinic%2C%20patient%20and%20provider%20characteristics%2C%20differentiated%20care%2C%20and%20transition%20to%20adult%20services%20processes.%20Descriptive%20analyses%20characterized%20the%20health%20services%20available%20across%20the%20participating%20sites%2C%20using%20frequencies%20and%20proportions%20for%20categorical%20variables%20and%20medians%20and%20interquartile%20range%20for%20continuous%20variables.%20Data%20were%20analysed%20using%20RStudio.%5CnRESULTS%3A%20Overall%2C%2013%20of%2016%20sites%20%2881%25%29%20reported%20having%20dedicated%20adolescent%20services%2C%20which%20most%20often%20consisted%20of%20dedicated%20clinic%20days%20%2862%25%2C%20n%20%3D%208%5C%2F13%29%2C%20primarily%20offered%20on%20weekdays.%20Across%20all%20sites%2C%20nurses%20and%20counsellors%20delivered%20services%20to%20adolescents.%20Over%20half%20of%20all%20clinics%20%2869%25%2C%20n%20%3D%2011%5C%2F16%29%20reported%20offering%20health%20education%20to%20adolescents%20to%20facilitate%20adolescent%20health%20literacy.%20Peer%20educators%20and%20navigators%20were%20involved%20in%20delivering%20services%20at%2062%25%20of%20sites%2C%20primarily%20in%20those%20with%20dedicated%20adolescent%20services%20%2869%25%2C%20n%20%3D%209%5C%2F13%29.%20There%20was%20limited%20integration%20of%20sexual%20and%20reproductive%20health%20services%20into%20HIV%20clinics%20for%20adolescents.%20With%2063%25%20of%20clinics%20conducting%20pregnancy%20screening%2C%2050%25%20providing%20family%20planning%20methods%20and%2038%25%20providing%20cervical%20cancer%20screening.%20Under%20half%20of%20all%20HIV%20clinics%20screened%20for%20physical%20abuse%20or%20violence%20%2844%25%2C%20n%20%3D%207%5C%2F16%29%20and%20sexual%20abuse%20or%20rape%20%2838%25%2C%20n%20%3D%206%5C%2F16%29.%20A%20low%20proportion%20of%20clinics%20screened%20for%20risk%20factors%20related%20to%20young%20key%20populations%2C%20including%20drug%20use%20%2856%25%2C%20n%20%3D%209%5C%2F16%29%2C%20homelessness%20%2838%25%2C%20n%20%3D%206%5C%2F16%29%20young%20men%20having%20sex%20with%20men%20%2831%25%2C%20n%20%3D%205%5C%2F16%29%20and%20transactional%20sex%20%2831%25%2C%20n%20%3D%205%5C%2F16%29.%20Mental%20health%20screening%20for%20concerns%20was%20variable.%5CnCONCLUSIONS%3A%20Findings%20suggest%20gaps%20in%20AYFHS%20for%20AYLH%20across%20the%20HIV%20clinics%20included%20in%20this%20analysis.%20There%20is%20a%20vital%20need%20to%20design%20health%20services%20for%20AYLH%20that%20are%20accessible%2C%20equitable%2C%20and%20effective%20and%20meet%20the%20global%20standards%20for%20delivering%20high-quality%20healthcare%20to%20adolescents.%22%2C%22date%22%3A%222025-04%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1002%5C%2Fjia2.26437%22%2C%22ISSN%22%3A%221758-2652%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22GXCKG69T%22%2C%22ZVWK2Q45%22%2C%22D9WC3N3V%22%2C%22TCMBXKKM%22%2C%228IRGNQWZ%22%2C%22F2Y6PLUL%22%2C%22ZBJI578D%22%2C%22YAE5EUBI%22%2C%223FNU2D64%22%5D%2C%22dateModified%22%3A%222025-08-05T13%3A54%3A37Z%22%7D%7D%2C%7B%22key%22%3A%22CNYLUXLS%22%2C%22library%22%3A%7B%22id%22%3A2775998%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Belaunzar%5Cu00e1n-Zamudio%20et%20al.%22%2C%22parsedDate%22%3A%222025-03%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BBelaunzar%26%23xE1%3Bn-Zamudio%2C%20Pablo%20F.%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BRebeiro%2C%20Peter%20F.%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BCaro-Vega%2C%20Yanink%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BCastilho%2C%20Jessica%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BCrabtree-Ram%26%23xED%3Brez%2C%20Brenda%20E.%26lt%3B%5C%2Fspan%26gt%3B%20et%20al.%26lt%3B%5C%2Fspan%26gt%3B%20%282025%29.%20Transitions%20through%20the%20HIV%20continuum%20of%20care%20in%20people%20enrolling%20in%20care%20with%20advanced%20HIV%20disease%20in%20Latin%20America.%20%26lt%3Bi%26gt%3BIJID%20Regions%26lt%3B%5C%2Fi%26gt%3B%2C%20%26lt%3Bi%26gt%3B14%26lt%3B%5C%2Fi%26gt%3B%2C%20S.%20100550.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.ijregi.2024.100550%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.ijregi.2024.100550%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Transitions%20through%20the%20HIV%20continuum%20of%20care%20in%20people%20enrolling%20in%20care%20with%20advanced%20HIV%20disease%20in%20Latin%20America%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Pablo%20F.%22%2C%22lastName%22%3A%22Belaunzar%5Cu00e1n-Zamudio%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20F.%22%2C%22lastName%22%3A%22Rebeiro%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yanink%22%2C%22lastName%22%3A%22Caro-Vega%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jessica%22%2C%22lastName%22%3A%22Castilho%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Brenda%20E.%22%2C%22lastName%22%3A%22Crabtree-Ram%5Cu00edrez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Carina%22%2C%22lastName%22%3A%22Cesar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Claudia%20P.%22%2C%22lastName%22%3A%22Cortes%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fernando%22%2C%22lastName%22%3A%22Mej%5Cu00eda%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marco%20Tulio%22%2C%22lastName%22%3A%22Luque%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vanessa%22%2C%22lastName%22%3A%22Rouzier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Guilherme%22%2C%22lastName%22%3A%22Calvet%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Catherine%20C.%22%2C%22lastName%22%3A%22McGowan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Juan%22%2C%22lastName%22%3A%22Sierra-Madero%22%7D%5D%2C%22abstractNote%22%3A%22OBJECTIVES%3A%20Advanced%20HIV%20disease%20%28AHD%29%20at%20HIV%20care%20enrollment%20is%20common%20in%20Latin%20America%20and%20may%20bias%20cross-sectional%20care%20continuum%20estimates.%20We%20therefore%20explored%20the%20impact%20of%20AHD%20on%20HIV%20care%20continuum%20outcomes%20using%20a%20longitudinal%20approach.%5CnMETHODS%3A%20We%20analyzed%20trajectories%20of%2026%2C174%20adult%20people%20with%20HIV%20enrolled%20at%20Caribbean%2C%20Central%20and%20South%20America%20network%20for%20HIV%20epidemiology%20%28CCASAnet%29%20sites%20%282003-2019%29%20using%20multi-state%20Cox%20regression%20across%20five%20stages%3A%20%28i%29%20enrolled%20without%20antiretroviral%20therapy%20%28no-ART%29%3B%20%28ii%29%20on%20ART%20without%20viral%20suppression%20%28viral%20load%20%5Cu2265200%20copies%5C%2Fm%3B%20ART%20%2B%20non-VS%29%3B%20%28iii%29%20on%20ART%20with%20viral%20suppression%20%28viral%20load%20%26lt%3B200%20copies%5C%2Fml%3B%20ART%20%2B%20VS%29%3B%20%28iv%29%20lost%20to%20follow-up%3B%20%28v%29%20death.%20We%20defined%20AHD%20as%20clusters%20of%20differentiation%204%2B%20count%20%26lt%3B200%20cells%5C%2F%5Cu00b5l%20and%5C%2For%20an%20AIDS-defining%20illness%20at%20enrollment.%5CnRESULTS%3A%20People%20with%20HIV%20with%20AHD%20had%20a%20shorter%20time%20with%20no-ART%2C%20a%20similar%20time%20ART%20%2B%20non-VS%2C%20but%20less%20time%20ART%20%2B%20VS%20before%202013%20than%20non-AHD.%20After%202013%2C%20time%20with%20no-ART%20decreased%20but%20the%205-year%20probability%20of%20transitioning%20from%20no-ART%20to%20ART%20%2B%20VS%20decreased%20in%20both%20groups.%20The%20time%20spent%20virally%20suppressed%20while%20in%20care%20was%20low%2C%20overall.%20Risk%20of%20loss%20to%20follow-up%20and%20death%20was%20persistently%20worse%20among%20adults%20with%20AHD.%5CnCONCLUSIONS%3A%20Using%20a%20longitudinal%20approach%20to%20assess%20the%20HIV%20continuum%20of%20care%20provided%20insight%20into%20limitations%20in%20HIV%20care%20provision%20in%20our%20region%20previously%20underexplained%20by%20cross-sectional%20assessments.%22%2C%22date%22%3A%222025-03%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.ijregi.2024.100550%22%2C%22ISSN%22%3A%222772-7076%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22GXCKG69T%22%2C%22F2Y6PLUL%22%5D%2C%22dateModified%22%3A%222025-03-10T15%3A58%3A18Z%22%7D%7D%2C%7B%22key%22%3A%225X94BPJX%22%2C%22library%22%3A%7B%22id%22%3A2775998%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Arriaga%20et%20al.%22%2C%22parsedDate%22%3A%222025-02-04%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BArriaga%2C%20Mar%26%23xED%3Ba%20B.%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BAmorim%2C%20Gustavo%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BFigueiredo%2C%20Marina%20C.%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BStaats%2C%20Cody%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BKritski%2C%20Afr%26%23xE2%3Bnio%20L.%26lt%3B%5C%2Fspan%26gt%3B%20et%20al.%26lt%3B%5C%2Fspan%26gt%3B%20%282025%29.%20Effect%20of%20Smoking%20on%20Longitudinal%20Interferon%20%26%23x3B3%3B%20Release%20Assay%20Results%20Among%20Close%20Contacts%20of%20People%20with%20Pulmonary%20Tuberculosis.%20%26lt%3Bi%26gt%3BThe%20Journal%20of%20Infectious%20Diseases%26lt%3B%5C%2Fi%26gt%3B%2C%20%26lt%3Bi%26gt%3B231%26lt%3B%5C%2Fi%26gt%3B%20%281%29%2C%20S.%20103%26%23x2013%3B108.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1093%5C%2Finfdis%5C%2Fjiae285%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1093%5C%2Finfdis%5C%2Fjiae285%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Effect%20of%20Smoking%20on%20Longitudinal%20Interferon%20%5Cu03b3%20Release%20Assay%20Results%20Among%20Close%20Contacts%20of%20People%20with%20Pulmonary%20Tuberculosis%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mar%5Cu00eda%20B.%22%2C%22lastName%22%3A%22Arriaga%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gustavo%22%2C%22lastName%22%3A%22Amorim%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marina%20C.%22%2C%22lastName%22%3A%22Figueiredo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Cody%22%2C%22lastName%22%3A%22Staats%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Afr%5Cu00e2nio%20L.%22%2C%22lastName%22%3A%22Kritski%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marcelo%22%2C%22lastName%22%3A%22Cordeiro-Santos%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Valeria%20C.%22%2C%22lastName%22%3A%22Rolla%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bruno%20B.%22%2C%22lastName%22%3A%22Andrade%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Timothy%20R.%22%2C%22lastName%22%3A%22Sterling%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22RePORT-Brazil%20consortium%22%7D%5D%2C%22abstractNote%22%3A%22Diagnosis%20of%20Mycobacterium%20tuberculosis%20infection%20in%20close%20contacts%20is%20critical%20for%20tuberculosis%20control.%20Smoking%20is%20a%20risk%20factor%20for%20M.%20tuberculosis%20infection%20and%20tuberculosis%20disease%20but%20its%20effect%20on%20longitudinal%20interferon%20%5Cu03b3%20release%20assay%20%28IGRA%29%20results%20remains%20unknown.%20We%20conducted%20a%20multisite%20prospective%20study%20in%20Brazil%20between%202015%20and%202019%2C%20among%20close%20contacts%20of%20adults%20with%20culture-confirmed%20pulmonary%20tuberculosis.%20IGRA%20was%20performed%20at%20baseline%2C%20at%20month%206%20if%20results%20were%20negative%20at%20baseline%2C%20and%20at%20months%2024-30%20after%20enrollment.%20IGRA%20results%20were%20categorized%20as%20IGRA%20positive%20%28maintained%20from%20baseline%20to%20the%20last%20visit%29%2C%20IGRA%20conversion%20%28from%20negative%20to%20positive%20at%20any%20time%29%2C%20IGRA%20reversion%20%28from%20positive%20to%20negative%20at%20any%20time%29%2C%20and%20IGRA%20negative%20%28maintained%20from%20baseline%20to%20the%20last%20visit%29.%20Associations%20between%20IGRA%20results%20and%20smoking%20status%20at%20baseline%20%28current%5C%2Fformer%20vs%20never%29%20in%20contacts%20were%20evaluated%20using%20propensity%20score-adjusted%20logistic%20regression%20models.%20Estimated%20propensity%20score%20was%20used%20as%20a%20covariate%20in%20models%2C%20which%20regressed%20the%20outcome%20%28IGRA%20positive%2C%20IGRA%20conversion%2C%20IGRA%20reversion%29%20on%20smoking%20status.%20Of%20430%20close%20contacts%2C%2089%20%2821%25%29%20were%20IGRA%20positive%2C%2030%20%287%25%29%20were%20converters%2C%2030%20%287%25%29%20were%20reverters%20and%2022%20were%20indeterminate.%20Smoking%20frequency%20was%2026%20%2829%25%29%20among%20IGRA-positive%20contacts%2C%207%20%2823%25%29%20in%20converters%2C%20and%203%20%2810%25%29%20in%20reverters.%20Smoking%20in%20contacts%20was%20associated%20with%20lower%20odds%20of%20IGRA%20reversion%20%28adjusted%20odds%20ratio%2C%200.16%20%5B95%25%20confidence%20interval%2C%20.03-.70%5D%29.%20We%20did%20not%20detect%20associations%20between%20smoking%20and%20IGRA%20positive%20or%20IGRA%20conversion.%20Our%20findings%20highlight%20the%20importance%20of%20smoking%20on%20longitudinal%20IGRA%20results.%20This%20has%20implications%20for%20clinical%20care%20and%20clinical%20trials%20in%20which%20IGRA%20status%20is%20monitored%20or%20used%20as%20an%20outcome.%22%2C%22date%22%3A%222025-02-04%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1093%5C%2Finfdis%5C%2Fjiae285%22%2C%22ISSN%22%3A%221537-6613%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22GXCKG69T%22%2C%22F2Y6PLUL%22%5D%2C%22dateModified%22%3A%222025-03-10T15%3A58%3A31Z%22%7D%7D%2C%7B%22key%22%3A%224H6RFYTE%22%2C%22library%22%3A%7B%22id%22%3A2775998%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Ford%20et%20al.%22%2C%22parsedDate%22%3A%222025-02%22%2C%22numChildren%22%3A7%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BFord%2C%20Nathan%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BKassanjee%2C%20Reshma%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BStelzle%2C%20Dominik%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BJarvis%2C%20Joseph%20N.%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BSued%2C%20Omar%26lt%3B%5C%2Fspan%26gt%3B%20et%20al.%26lt%3B%5C%2Fspan%26gt%3B%20%282025%29.%20Global%20prevalence%20of%20advanced%20HIV%20disease%20in%20healthcare%20settings%3A%20a%20rapid%20review.%20%26lt%3Bi%26gt%3BJournal%20of%20the%20International%20AIDS%20Society%26lt%3B%5C%2Fi%26gt%3B%2C%20%26lt%3Bi%26gt%3B28%26lt%3B%5C%2Fi%26gt%3B%20%282%29%2C%20S.%20e26415.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1002%5C%2Fjia2.26415%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1002%5C%2Fjia2.26415%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Global%20prevalence%20of%20advanced%20HIV%20disease%20in%20healthcare%20settings%3A%20a%20rapid%20review.%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nathan%22%2C%22lastName%22%3A%22Ford%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Reshma%22%2C%22lastName%22%3A%22Kassanjee%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dominik%22%2C%22lastName%22%3A%22Stelzle%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Joseph%20N.%22%2C%22lastName%22%3A%22Jarvis%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Omar%22%2C%22lastName%22%3A%22Sued%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Georges%22%2C%22lastName%22%3A%22Perrin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Meg%22%2C%22lastName%22%3A%22Doherty%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ajay%22%2C%22lastName%22%3A%22Rangaraj%22%7D%5D%2C%22abstractNote%22%3A%22INTRODUCTION%3A%20Recent%20studies%20have%20indicated%20a%20high%20enduring%20burden%20of%20advanced%20HIV%20disease%2C%20but%20estimates%20across%20regions%20and%20settings%20are%20lacking.%20The%20aim%20of%20this%20study%20was%20to%20estimate%20the%20prevalence%20of%20advanced%20HIV%20disease%20since%202015%20among%20those%20people%20with%20CD4%20measured%20in%20healthcare%20settings%2C%20disaggregated%20by%20age%20group%2C%20level%20of%20healthcare%20and%20region.%20METHODS%3A%20We%20searched%20MedLine%20via%20Pubmed%20and%20Hinari%20for%20studies%20that%20reported%20the%20proportion%20of%20individuals%20with%20advanced%20HIV%20disease%20%28defined%20as%20CD4%20cell%20count%20%26lt%3B200%20cells%5C%2Fmm%283%29%29%20in%20healthcare%20settings%20since%202015%3B%20this%20search%20was%20complemented%20by%20conference%20abstracts%20and%20data%20from%20the%20International%20epidemiology%20Databases%20to%20Evaluate%20AIDS%20Consortium%20%28IeDEA%29.%20We%20estimated%20pooled%20prevalence%20of%20advanced%20HIV%20disease%20using%20random-%20effects%20models%20and%20performed%20subgroup%20and%20sensitivity%20analyses%20to%20explore%20heterogeneity.%20RESULTS%3A%20We%20obtained%20data%20from%20117%20cohorts%2C%20representing%201%2C814%2C362%20individuals%20from%2052%20countries%20across%20all%20six%20World%20Health%20Organization%20regions.%20The%20majority%20of%20studies%20%28n%20%3D%2083%29%20were%20conducted%20among%20adults%20and%20recorded%20CD4%20cell%20count%20among%20treatment%20naive%20individuals%20at%20antiretroviral%20therapy%20start%20%28n%20%3D%2086%29.%20Studies%20included%20data%20reported%20up%20to%202023.%20The%20proportion%20of%20individuals%20with%20advanced%20HIV%20disease%20was%20higher%20in%20inpatient%20settings%20%2844.3%25%2C%2095%25%20CI%2039.1-49.6%25%29%20compared%20to%20outpatient%20settings%20%2833.5%25%2C%2095%25%20CI%2031.5-35.4%25%29.%20Prevalence%20was%20similar%20across%20age%20groups%2C%20time%20since%20HIV%20diagnosis%20and%20treatment%20status%2C%20and%20highest%20in%20West%20and%20Central%20Africa%2C%20South-East%20Asia%20and%20the%20Eastern%20Mediterranean%20region.%20DISCUSSION%3A%20This%20review%20finds%20that%20at%20least%20a%20third%20of%20people%20presenting%20to%20healthcare%20settings%20have%20advanced%20HIV%20disease%2C%20with%20no%20evidence%20that%20this%20has%20changed%20in%20recent%20years.%20Screening%20for%20advanced%20HIV%20remains%20important%20to%20be%20able%20to%20direct%20appropriate%20preventive%2C%20diagnostic%20and%20therapeutic%20interventions%20to%20prevent%20progression%20to%20severe%20illness%20and%20death.%20CONCLUSIONS%3A%20This%20review%20summarizes%20recent%20evidence%20of%20the%20continued%20high%20proportion%20of%20individuals%20who%20%28re%29present%20to%20care%20with%20advanced%20HIV%20disease.%20These%20findings%20underscore%20the%20urgent%20need%20to%20reinforce%20programme%20capacity%20to%20diagnose%2C%20prevent%20and%20treat%20advanced%20HIV%20disease%20as%20an%20essential%20pillar%20of%20the%20global%20AIDS%20response.%22%2C%22date%22%3A%222025%20Feb%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1002%5C%2Fjia2.26415%22%2C%22ISSN%22%3A%221758-2652%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22GXCKG69T%22%2C%22ZVWK2Q45%22%2C%22D9WC3N3V%22%2C%22TCMBXKKM%22%2C%228IRGNQWZ%22%2C%22F2Y6PLUL%22%2C%22ZBJI578D%22%2C%22YAE5EUBI%22%2C%223FNU2D64%22%5D%2C%22dateModified%22%3A%222025-07-08T08%3A12%3A21Z%22%7D%7D%2C%7B%22key%22%3A%22HT2U9YZV%22%2C%22library%22%3A%7B%22id%22%3A2775998%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Villalva-Serra%20et%20al.%22%2C%22parsedDate%22%3A%222025-01%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BVillalva-Serra%2C%20Klauss%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BBarreto-Duarte%2C%20Beatriz%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BRodrigues%2C%20Moreno%20M.%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BQueiroz%2C%20Artur%20T.%20L.%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BMartinez%2C%20Leonardo%26lt%3B%5C%2Fspan%26gt%3B%20et%20al.%26lt%3B%5C%2Fspan%26gt%3B%20%282025%29.%20Impact%20of%20strategic%20public%20health%20interventions%20to%20reduce%20tuberculosis%20incidence%20in%20Brazil%3A%20a%20Bayesian%20structural%20time-series%20scenario%20analysis.%20%26lt%3Bi%26gt%3BLancet%20Regional%20Health.%20Americas%26lt%3B%5C%2Fi%26gt%3B%2C%20%26lt%3Bi%26gt%3B41%26lt%3B%5C%2Fi%26gt%3B%2C%20S.%20100963.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.lana.2024.100963%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.lana.2024.100963%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Impact%20of%20strategic%20public%20health%20interventions%20to%20reduce%20tuberculosis%20incidence%20in%20Brazil%3A%20a%20Bayesian%20structural%20time-series%20scenario%20analysis%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Klauss%22%2C%22lastName%22%3A%22Villalva-Serra%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Beatriz%22%2C%22lastName%22%3A%22Barreto-Duarte%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Moreno%20M.%22%2C%22lastName%22%3A%22Rodrigues%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Artur%20T.%20L.%22%2C%22lastName%22%3A%22Queiroz%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Leonardo%22%2C%22lastName%22%3A%22Martinez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Julio%22%2C%22lastName%22%3A%22Croda%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Valeria%20C.%22%2C%22lastName%22%3A%22Rolla%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Afr%5Cu00e2nio%20L.%22%2C%22lastName%22%3A%22Kritski%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marcelo%22%2C%22lastName%22%3A%22Cordeiro-Santos%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Timothy%20R.%22%2C%22lastName%22%3A%22Sterling%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mariana%22%2C%22lastName%22%3A%22Ara%5Cu00fajo-Pereira%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bruno%20B.%22%2C%22lastName%22%3A%22Andrade%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20Despite%20government%20efforts%2C%20tuberculosis%20%28TB%29%20remains%20a%20major%20public%20health%20threat%20in%20Brazil.%20In%202023%2C%20TB%20incidence%20was%2039.8%20cases%20per%20100%2C000%20population%2C%20far%20above%20the%20WHO%26%23039%3Bs%20target%20of%206.7%20cases%20per%20100%2C000.%20Using%20national-level%20datasets%2C%20we%20investigated%20and%20forecasted%20the%20potential%20impact%20of%20proposed%20public%20health%20interventions%20aimed%20at%20reducing%20TB%20incidence%20in%20Brazil.%5CnMETHODS%3A%20Monthly%20TB%20surveillance%20data%20%28January%202018-December%202023%29%20were%20collected%20from%20Brazilian%20national%20reporting%20systems%3A%20SINAN-TB%20%28TB%20cases%29%2C%20SITE-TB%20%28TB%20drug%20resistance%29%2C%20and%20IL-TB%20%28preventive%20therapy%29.%20These%20data%20were%20used%20to%20create%20a%20multivariable%20Bayesian%20Structural%20Time-Series%20%28BSTS%29%20model%2C%20with%205000%20Monte-Carlo%20simulations%2C%20which%20identified%20key%20predictors%20of%20TB%20incidence%20and%20forecasted%20these%20rates%20from%202024%20to%202030%20under%20various%20scenarios.%5CnFINDINGS%3A%20Vulnerabilities%20including%20incarceration%2C%20TB-HIV%20coinfection%20and%20TB-diabetes%20mellitus%2C%20as%20well%20as%20coverages%20of%20directly%20observed%20therapy%20%28DOT%29%2C%20contact%20investigation%20and%20preventive%20treatment%20%28TPT%29%20completion%20rates%2C%20were%20identified%20as%20key%20predictors%20of%20TB%20incidence.%20Under%20current%20trends%2C%20we%20forecasted%20TB%20incidence%20in%20Brazil%20to%20be%2042.1%20%5B34.1-49.8%5D%20per%20100%2C000%20person-years%20by%202030%20%28mean%20%5B95%25%20prediction%20intervals%5D%29.%20A%20scenario%20considering%20decreases%20in%20TB%20cases%20among%20vulnerable%20populations%20resulted%20in%20an%20absolute%20reduction%20of%5Cu00a0-10.6%20%5B-9.4%20to%5Cu00a0-12.0%5D%20in%20projected%20TB%20incidence.%20Additional%20reductions%20were%20seen%20with%20increased%20coverage%20of%20DOT%2C%20TPT%20adherence%2C%20and%20contact%20investigation%20rates%20%28-14.4%20%5B-13%20to%5Cu00a0-16.2%5D%29%2C%20and%20by%20combining%20these%20with%20efforts%20to%20reduce%20TB%20cases%20among%20vulnerable%20populations%20%28-23.6%20%5B-26.3%20to%5Cu00a0-41.4%5D%29%2C%20potentially%20lowering%20incidence%20to%2018.5%20%5B7.8-28.4%5D%20per%20100%2C000%2C%20though%20still%20above%20WHO%20targets.%5CnINTERPRETATION%3A%20Our%20findings%20demonstrate%20that%20interventions%20focused%20on%20enhancing%20health%20policies%20focused%20on%20decreasing%20TB%20cases%20among%20vulnerable%20populations%2C%20such%20as%20individuals%20with%20TB-HIV%20coinfection%2C%20incarcerated%20populations%2C%20and%20those%20with%20TB-diabetes%20comorbidity%2C%20along%20with%20improvements%20in%20health%20management%20indicators%20such%20as%20DOT%20implementation%2C%20contact%20investigation%20coverage%2C%20and%20TPT%20completion%20rates%2C%20are%20effective%20in%20reducing%20TB%20incidence%20nationwide.%5CnFUNDING%3A%20Oswaldo%20Cruz%20Foundation.%22%2C%22date%22%3A%222025-01%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.lana.2024.100963%22%2C%22ISSN%22%3A%222667-193X%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22GXCKG69T%22%2C%22F2Y6PLUL%22%5D%2C%22dateModified%22%3A%222025-05-19T11%3A23%3A33Z%22%7D%7D%5D%7D
Ferreira, Isabella B. B.; Menezes, Rodrigo C.; Araújo-Pereira, Mariana; Rolla, Valeria C.; Kritski, Afrânio L. et al. (2025). Effects of missed anti-tuberculosis therapy doses on treatment outcome: a multi-center cohort study. Lancet Regional Health. Americas, 48, S. 101162. http://doi.org/10.1016/j.lana.2025.101162.
Guerrero-Torres, Lorena; Barbosa-Ramírez, Bibiana Montserrat; Belaunzarán-Zamudio, Pablo F.; Alegre-Díaz, Jesús; Ramírez, Raúl et al. (2025). Improving estimators of HIV mortality and retention in care by linking clinical cohort data with national registries in Mexico. BMC Public Health, 25 (1), S. 2489. http://doi.org/10.1186/s12889-025-23542-1.
Fernández Villalobos, Nathalie Verónica; Helfenstein, Fabrice; Khol, Vohith; Twizere, Christella; Secco, Mayara et al. (2025). Scale of differentiated service delivery implementation in HIV care facilities in low- and middle-income countries: a global facility survey. Journal of the International AIDS Society, 28 Suppl 3, S. e26477. http://doi.org/10.1002/jia2.26477.
Fonseca, Fernanda F.; Ranadive, Paridhi; Shepherd, Bryan E.; Ferreira, Flavia G. F.; Rodríguez, Maria F. et al. (2025). Persistent sex disparities in access to dolutegravir-based antiretroviral therapy in Latin America and the Caribbean: results from a retrospective observational study using data from 2017 to 2022. Journal of the International AIDS Society, 28 (7), S. e26470. http://doi.org/10.1002/jia2.26470.
Castillo-Rozas, Gabriel; Fonseca, Fernanda F.; Castilho, Jessica; Rebeiro, Peter F.; Machado, Daisy M. et al. (2025). ART to prevent vertical transmission in Latin America: where are we in the “Treat-All” era? Journal of the International AIDS Society, 28 (5), S. e26411. http://doi.org/10.1002/jia2.26411.
Patten, Gabriela; Malateste, Karen; Bolton Moore, Carolyn; Sipambo, Nosisa; Mokone, Limpho et al. (2025). Global Trends in CD4 Measurement and Immunosuppression at ART Initiation Among Children With HIV. The Pediatric Infectious Disease Journal. http://doi.org/10.1097/INF.0000000000004819.
Embleton, Lonnie; Sudjaritruk, Tavitiya; Machado, Daisy Maria; Chihota, Belinda; Musabyimana, Françoise et al. (2025). Characterizing adolescent and youth-friendly HIV services: a cross-sectional assessment across 16 global sites. Journal of the International AIDS Society, 28 (4), S. e26437. http://doi.org/10.1002/jia2.26437.
Belaunzarán-Zamudio, Pablo F.; Rebeiro, Peter F.; Caro-Vega, Yanink; Castilho, Jessica; Crabtree-Ramírez, Brenda E. et al. (2025). Transitions through the HIV continuum of care in people enrolling in care with advanced HIV disease in Latin America. IJID Regions, 14, S. 100550. http://doi.org/10.1016/j.ijregi.2024.100550.
Arriaga, María B.; Amorim, Gustavo; Figueiredo, Marina C.; Staats, Cody; Kritski, Afrânio L. et al. (2025). Effect of Smoking on Longitudinal Interferon γ Release Assay Results Among Close Contacts of People with Pulmonary Tuberculosis. The Journal of Infectious Diseases, 231 (1), S. 103–108. http://doi.org/10.1093/infdis/jiae285.
Ford, Nathan; Kassanjee, Reshma; Stelzle, Dominik; Jarvis, Joseph N.; Sued, Omar et al. (2025). Global prevalence of advanced HIV disease in healthcare settings: a rapid review. Journal of the International AIDS Society, 28 (2), S. e26415. http://doi.org/10.1002/jia2.26415.
Villalva-Serra, Klauss; Barreto-Duarte, Beatriz; Rodrigues, Moreno M.; Queiroz, Artur T. L.; Martinez, Leonardo et al. (2025). Impact of strategic public health interventions to reduce tuberculosis incidence in Brazil: a Bayesian structural time-series scenario analysis. Lancet Regional Health. Americas, 41, S. 100963. http://doi.org/10.1016/j.lana.2024.100963.
2775998
F2Y6PLUL
2024
1
padagogische-hochschule-bern-institut-vorschulstufe-und-primarstufe
50
date
desc
year
258
https://www.iedea.org/wp-content/plugins/zotpress/
%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3Afalse%2C%22meta%22%3A%7B%22request_last%22%3A0%2C%22request_next%22%3A0%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%22W6R4THL2%22%2C%22library%22%3A%7B%22id%22%3A2775998%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Ridolfi%20et%20al.%22%2C%22parsedDate%22%3A%222024-12-16%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BRidolfi%2C%20Felipe%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BAmorim%2C%20Gustavo%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BHaas%2C%20David%20W.%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BArriaga%2C%20Maria%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BStaats%2C%20Cody%26lt%3B%5C%2Fspan%26gt%3B%20et%20al.%26lt%3B%5C%2Fspan%26gt%3B%20%282024%29.%20Pharmacogenomic%20associations%20with%20HIV-1%20virologic%20suppression%20in%20TB%5C%2FHIV%20patients.%20%26lt%3Bi%26gt%3BResearch%20Square%26lt%3B%5C%2Fi%26gt%3B%2C%20S.%20rs.3.rs-5418156.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.21203%5C%2Frs.3.rs-5418156%5C%2Fv1%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.21203%5C%2Frs.3.rs-5418156%5C%2Fv1%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Pharmacogenomic%20associations%20with%20HIV-1%20virologic%20suppression%20in%20TB%5C%2FHIV%20patients%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Felipe%22%2C%22lastName%22%3A%22Ridolfi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gustavo%22%2C%22lastName%22%3A%22Amorim%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22David%20W.%22%2C%22lastName%22%3A%22Haas%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Maria%22%2C%22lastName%22%3A%22Arriaga%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Cody%22%2C%22lastName%22%3A%22Staats%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marcelo%22%2C%22lastName%22%3A%22Cordeiro-Santos%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Afr%5Cu00e2nio%20L.%22%2C%22lastName%22%3A%22Kritski%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marina%20C.%22%2C%22lastName%22%3A%22Figueiredo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bruno%20B.%22%2C%22lastName%22%3A%22Andrade%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Timothy%20R.%22%2C%22lastName%22%3A%22Sterling%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Valeria%20C.%22%2C%22lastName%22%3A%22Rolla%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22Regional%20Prospective%20Observational%20Research%20in%20Tuberculosis%20Brazil%20consortium%20%28RePORT-Brazil%29%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20Human%20genetic%20variants%20can%20affect%20TB%20and%20HIV%20drug%20metabolism%2C%20which%20may%20lead%20to%20toxicity%20or%20treatment%20failure.%20We%20evaluated%20associations%20between%20genetic%20variants%20of%20antiretroviral%20therapy%20%28ART%29%20and%20HIV-1%20outcomes%20among%20TB%5C%2FHIV%20patients.%5CnMETHODS%3A%20We%20included%20RePORT-Brazil%20participants%20with%20TB%5C%2FHIV%20who%20initiated%20standard%20TB%20treatment%20%5B2%20months%20of%20isoniazid%5C%2Frifampicin%20%28or%20rifabutin%29%5C%2Fpyrazinamide%5C%2Fethambutol%2C%20then%204%20months%20or%20more%20of%20isoniazid%5C%2Frifampicin%20%28or%20rifabutin%29%5D%2C%20and%20ART.%20The%20endpoint%20was%20HIV-1%20virologic%20suppression%20%28defined%20as%20%26lt%3B1%2C000%20HIV-1%20RNA%20copies%5C%2FmL%2C%20for%20primary%20analysis%2C%20and%20%26lt%3B50%20HIV-1%20RNA%20copies%5C%2FmL%2C%20for%20secondary%20analysis%29%20after%20at%20least%202%20weeks%20of%20ART.%20We%20compared%20non-nucleoside%20reverse%20transcriptase%20inhibitor%20%28NNRTI%29-based%20and%20integrase%20strand%20transfer%20inhibitor%20%28INSTI%29-based%20ART%20regimens.%20We%20genotyped%20CYP2B6%20%28rs3745274%2C%20rs28399499%2C%20rs4803419%3B%20affects%20efavirenz%20metabolism%29%20and%20UGT1A1%20%28rs887829%3B%20affects%20dolutegravir%20and%20raltegravir%20metabolism%29%3B%20all%20have%20defined%20normal%2C%20intermediate%2C%20and%20slow%20genotypes.%20Genotyping%20was%20performed%20by%20MassARRAY%20iPLEX%20Gold.%20We%20compared%20outcome%20proportions%20%28Fisher%26%23039%3Bs%20test%29%20and%20time-to-virologic%20suppression%20%28survival%20analysis%2C%20Wilcoxon-Gehan%20test%29.%5CnRESULTS%3A%20Among%20194%20TB%5C%2FHIV%20participants%20included%2C%20efavirenz%20was%20the%20most%20frequent%20NNRTI%20%28%5Bn%3D76%5D%2C%20one%20participant%20received%20etravirine%29%2C%20and%20raltegravir%20was%20the%20most%20frequent%20INSTI%20%28n%3D88%29.%20The%20overall%20virologic%20suppression%20was%20suboptimal%2C%20with%2032%25%20%28n%3D62%29%20of%20participants%20not%20achieving%20HIV-1%20virologic%20suppression.%20Among%20them%2C%2036%25%20%28n%3D28%29%20used%20efavirenz-based%20ART%20and%20were%20more%20likely%20to%20be%20CYP2B6%20normal%20metabolizers%20%28n%3D8%2C%2044%25%29%3B%20and%2030%25%20%28n%3D30%29%20used%20INSTI-based%20ART%20and%20the%20UGT1A1%20normal%20genotype%20was%20also%20the%20most%20common%20%28n%3D13%2C%2050%25%29.%20The%20median%20time%20to%20virologic%20suppression%20for%20efavirenz-based%20ART%20was%20184%20days%20%2895%25%20Confidence%20Interval%20%28CI%29160-207%29%2C%20and%20for%20INSTI-based%20ART%2C%20188%20days%20%2895%25%20CI%20144-231%29%20%28p%3D0.84%29.%20No%20significant%20associations%20were%20found%20comparing%20the%20proportions%20and%20time%20to%20virologic%20suppression%20among%20CYP2B6%20and%20UGT1A1genotypes.%5CnCONCLUSIONS%3A%20In%20this%20observational%20cohort%20of%20patients%20treated%20for%20TB%5C%2FHIV%2C%20the%20proportion%20of%20participants%20achieving%20virologic%20suppression%20was%20low%2C%20and%20genetic%20variants%20affecting%20ART%20metabolism%20were%20not%20significantly%20associated%20with%20the%20likelihood%20of%20virologic%20suppression.%22%2C%22date%22%3A%222024-12-16%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.21203%5C%2Frs.3.rs-5418156%5C%2Fv1%22%2C%22ISSN%22%3A%222693-5015%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22GXCKG69T%22%2C%22F2Y6PLUL%22%5D%2C%22dateModified%22%3A%222025-03-10T14%3A58%3A57Z%22%7D%7D%2C%7B%22key%22%3A%22Y3FGNBTA%22%2C%22library%22%3A%7B%22id%22%3A2775998%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Mendelsohn%20et%20al.%22%2C%22parsedDate%22%3A%222024-12-16%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BMendelsohn%2C%20Simon%20C.%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BAndrade%2C%20Bruno%20B.%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BMbandi%2C%20Stanley%20Kimbung%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BAndrade%2C%20Alice%20M.%20S.%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BMuwanga%2C%20Vanessa%20M.%26lt%3B%5C%2Fspan%26gt%3B%20et%20al.%26lt%3B%5C%2Fspan%26gt%3B%20%282024%29.%20Transcriptomic%20Signatures%20of%20Progression%20to%20Tuberculosis%20Disease%20Among%20Close%20Contacts%20in%20Brazil.%20%26lt%3Bi%26gt%3BThe%20Journal%20of%20Infectious%20Diseases%26lt%3B%5C%2Fi%26gt%3B%2C%20%26lt%3Bi%26gt%3B230%26lt%3B%5C%2Fi%26gt%3B%20%286%29%2C%20S.%20e1355%26%23x2013%3Be1365.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1093%5C%2Finfdis%5C%2Fjiae237%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1093%5C%2Finfdis%5C%2Fjiae237%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Transcriptomic%20Signatures%20of%20Progression%20to%20Tuberculosis%20Disease%20Among%20Close%20Contacts%20in%20Brazil%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Simon%20C.%22%2C%22lastName%22%3A%22Mendelsohn%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bruno%20B.%22%2C%22lastName%22%3A%22Andrade%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Stanley%20Kimbung%22%2C%22lastName%22%3A%22Mbandi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alice%20M.%20S.%22%2C%22lastName%22%3A%22Andrade%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vanessa%20M.%22%2C%22lastName%22%3A%22Muwanga%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marina%20C.%22%2C%22lastName%22%3A%22Figueiredo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mzwandile%22%2C%22lastName%22%3A%22Erasmus%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Valeria%20C.%22%2C%22lastName%22%3A%22Rolla%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Prisca%20K.%22%2C%22lastName%22%3A%22Thami%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marcelo%22%2C%22lastName%22%3A%22Cordeiro-Santos%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Adam%22%2C%22lastName%22%3A%22Penn-Nicholson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Afranio%20L.%22%2C%22lastName%22%3A%22Kritski%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mark%22%2C%22lastName%22%3A%22Hatherill%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Timothy%20R.%22%2C%22lastName%22%3A%22Sterling%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Thomas%20J.%22%2C%22lastName%22%3A%22Scriba%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22RePORT%5Cu2013South%20Africa%20and%20RePORT%5Cu2013Brazil%20Consortia%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20Approximately%205%25%20of%20people%20infected%20with%20Mycobacterium%20tuberculosis%20progress%20to%20tuberculosis%20%28TB%29%20disease%20without%20preventive%20therapy.%20There%20is%20a%20need%20for%20a%20prognostic%20test%20to%20identify%20those%20at%20highest%20risk%20of%20incident%20TB%20so%20that%20therapy%20can%20be%20targeted.%20We%20evaluated%20host%20blood%20transcriptomic%20signatures%20for%20progression%20to%20TB%20disease.%5CnMETHODS%3A%20Close%20contacts%20%28%5Cu22654%20hours%20of%20exposure%20per%20week%29%20of%20adult%20patients%20with%20culture-confirmed%20pulmonary%20TB%20were%20enrolled%20in%20Brazil.%20Investigation%20for%20incident%2C%20microbiologically%20confirmed%2C%20or%20clinically%20diagnosed%20pulmonary%20or%20extrapulmonary%20TB%20disease%20through%2024%20months%20of%20follow-up%20was%20symptom%20triggered.%20Twenty%20previously%20validated%20blood%20TB%20transcriptomic%20signatures%20were%20measured%20at%20baseline%20by%20real-time%20quantitative%20polymerase%20chain%20reaction.%20Prognostic%20performance%20for%20incident%20TB%20was%20tested%20by%20receiver%20operating%20characteristic%20curve%20analysis%20at%206%2C%209%2C%2012%2C%20and%2024%20months%20of%20follow-up.%5CnRESULTS%3A%20Between%20June%202015%20and%20June%202019%2C%201854%20close%20contacts%20were%20enrolled.%20Twenty-five%20progressed%20to%20incident%20TB%2C%20of%20whom%2013%20had%20microbiologically%20confirmed%20disease.%20Baseline%20transcriptomic%20signature%20scores%20were%20measured%20in%201789%20close%20contacts.%20Prognostic%20performance%20for%20all%20signatures%20was%20best%20within%206%20months%20of%20diagnosis.%20Seven%20signatures%20%28Gliddon4%2C%20Suliman4%2C%20Roe3%2C%20Roe1%2C%20Penn-Nicholson6%2C%20Francisco2%2C%20and%20Rajan5%29%20met%20the%20minimum%20World%20Health%20Organization%20target%20product%20profile%20for%20a%20prognostic%20test%20through%206%20months%20and%203%20signatures%20%28Gliddon4%2C%20Rajan5%2C%20and%20Duffy9%29%20through%209%20months.%20None%20met%20the%20target%20product%20profile%20threshold%20through%20%5Cu226512%20months%20of%20follow-up.%5CnCONCLUSIONS%3A%20Blood%20transcriptomic%20signatures%20may%20be%20useful%20for%20predicting%20TB%20risk%20within%209%20months%20of%20measurement%20among%20TB-exposed%20contacts%20to%20target%20preventive%20therapy%20administration.%22%2C%22date%22%3A%222024-12-16%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1093%5C%2Finfdis%5C%2Fjiae237%22%2C%22ISSN%22%3A%221537-6613%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22GXCKG69T%22%2C%22F2Y6PLUL%22%5D%2C%22dateModified%22%3A%222025-03-10T14%3A59%3A19Z%22%7D%7D%2C%7B%22key%22%3A%22TM7MDYIK%22%2C%22library%22%3A%7B%22id%22%3A2775998%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Espejo-Ortiz%20et%20al.%22%2C%22parsedDate%22%3A%222024-12%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BEspejo-Ortiz%2C%20Cristian%20E.%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BSierra-Barajas%2C%20Nancy%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BSilva-Casarrubias%2C%20Angelina%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BGuerrero-Torres%2C%20Lorena%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BCaro-Vega%2C%20Yanink%26lt%3B%5C%2Fspan%26gt%3B%20et%20al.%26lt%3B%5C%2Fspan%26gt%3B%20%282024%29.%20A%20cascade%20of%20care%20for%20diabetes%20in%20people%20living%20with%20HIV%20in%20a%20tertiary%20care%20center%20in%20Mexico%20City.%20%26lt%3Bi%26gt%3BHIV%20Research%20%26amp%3B%20Clinical%20Practice%26lt%3B%5C%2Fi%26gt%3B%2C%20%26lt%3Bi%26gt%3B25%26lt%3B%5C%2Fi%26gt%3B%20%281%29%2C%20S.%202411481.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1080%5C%2F25787489.2024.2411481%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1080%5C%2F25787489.2024.2411481%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22A%20cascade%20of%20care%20for%20diabetes%20in%20people%20living%20with%20HIV%20in%20a%20tertiary%20care%20center%20in%20Mexico%20City%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Cristian%20E.%22%2C%22lastName%22%3A%22Espejo-Ortiz%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nancy%22%2C%22lastName%22%3A%22Sierra-Barajas%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Angelina%22%2C%22lastName%22%3A%22Silva-Casarrubias%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lorena%22%2C%22lastName%22%3A%22Guerrero-Torres%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yanink%22%2C%22lastName%22%3A%22Caro-Vega%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yamile%20G.%22%2C%22lastName%22%3A%22Serrano-Pinto%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alvaro%22%2C%22lastName%22%3A%22Lopez-I%5Cu00f1iguez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Juan%20G.%22%2C%22lastName%22%3A%22Sierra-Madero%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Brenda%20E.%22%2C%22lastName%22%3A%22Crabtree-Ram%5Cu00edrez%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20Diabetes%20affects%204.5%25%20of%20people%20living%20with%20HIV%20in%20Mexico.%20This%20study%20aims%20to%20describe%20the%20diabetes%20cascade%20of%20care%20%28DMC%29%20in%20people%20with%20HIV%20in%20a%20tertiary%20center%20in%20Mexico%20City.%5CnMETHODS%3A%20We%20conducted%20a%20single-center%20review%20of%20people%20with%20HIV%20aged%20over%2018%2C%20using%20medical%20records%20of%20active%20people%20enrolled%20at%20the%20Instituto%20Nacional%20de%20Ciencias%20M%5Cu00e9dicas%20y%20Nutrici%5Cu00f3n%20Salvador%20Zubir%5Cu00e1n%20%28INCMNSZ%29%20HIV%20Clinic%20%28HIVC%29.%20Our%20analysis%20focused%20on%20their%20last%20visit%20to%20describe%20the%20DMC%2C%20aiming%20to%20identify%20gaps%20in%20control%20goals.%20We%20included%20people%20who%20had%20a%20consultation%20within%20the%2012%5Cu2009months%20preceding%20May%202020.%5CnRESULTS%3A%20Out%20of%20the%202072%20active%20people%2C%20medical%20records%20were%20available%20for%202050%20%2898.9%25%29.%20Among%20these%2C%20326%20people%20%2815.9%25%29%20had%20fasting%20glucose%20%28FG%29%20abnormalities%2C%20of%20which%20133%20%2840.7%25%29%20had%20diabetes.%20The%20prevalence%20of%20diabetes%20among%20people%20with%20HIV%20was%20of%206.4%25%20%28133%5C%2F2050%29.%20Regarding%20the%20DMC%2C%20the%20following%20proportions%20of%20people%20achieved%20control%20goals%3A%20133%5C%2F133%20%28100%25%29%20received%20medical%20care%20in%20the%20last%2012%5Cu2009months%2C%20123%5C%2F123%20%28100%25%29%20had%20blood%20pressure%20%28BP%29%20%26lt%3B140%5C%2F90%5Cu2009mmHg%2C%2073%5C%2F132%20%2855.3%25%29%20had%20LDL%20cholesterol%20%28c-LDL%29%20%26lt%3B100%5Cu2009mg%5C%2Fdl%2C%2063%5C%2F132%20%2847.7%25%29%20had%20FG%20%26lt%3B130%5Cu2009mg%5C%2Fdl%2C%2050%5C%2F116%20%2843.1%25%29%20had%20glycosylated%20hemoglobin%20%28HbA1c%29%20%26lt%3B7%25.%20ABC%20goals%20%28HbA1c%20%26lt%3B7%25%2C%20c-LDL%20%26lt%3B100%5Cu2009mg%5C%2Fdl%2C%20BP%20%26lt%3B140%5C%2F90%5Cu2009mmHg%29%20were%20met%20in%2028%5C%2F109%20%2825.6%25%29%20people.%20126%5C%2F133%20%2894%25%29%20people%20with%20HIV%20achieved%20HIV-viral%20load%20%26lt%3B50%20copies%5C%2FmL.%5CnCONCLUSIONS%3A%20Despite%20the%20high%20rate%20of%20viral%20suppression%20among%20people%20with%20HIV%20and%20diabetes%2C%20significant%20challenges%20remain%20in%20achieving%20comprehensive%20diabetes%20control.%20These%20findings%20highlight%20the%20need%20for%20targeted%20interventions%20to%20improve%20metabolic%20outcomes%20and%20the%20overall%20management%20of%20diabetes%20in%20people%20with%20HIV.%22%2C%22date%22%3A%222024-12%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1080%5C%2F25787489.2024.2411481%22%2C%22ISSN%22%3A%222578-7470%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22GXCKG69T%22%2C%22F2Y6PLUL%22%5D%2C%22dateModified%22%3A%222024-11-06T09%3A34%3A32Z%22%7D%7D%2C%7B%22key%22%3A%227GP8K3Y5%22%2C%22library%22%3A%7B%22id%22%3A2775998%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22de%20Waal%20et%20al.%22%2C%22parsedDate%22%3A%222024-11-06%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3Bde%20Waal%2C%20Rene%26%23xE9%3B%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BWools-Kaloustian%2C%20Kara%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BBrazier%2C%20Ellen%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BAlthoff%2C%20Keri%20N.%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BJaquet%2C%20Antoine%26lt%3B%5C%2Fspan%26gt%3B%20et%20al.%26lt%3B%5C%2Fspan%26gt%3B%20%282024%29.%20Global%20trends%20in%20CD4%20count%20measurement%20and%20distribution%20at%20first%20antiretroviral%20treatment%20initiation.%20%26lt%3Bi%26gt%3BClinical%20Infectious%20Diseases%3A%20An%20Official%20Publication%20of%20the%20Infectious%20Diseases%20Society%20of%20America%26lt%3B%5C%2Fi%26gt%3B%2C%20S.%20ciae548.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1093%5C%2Fcid%5C%2Fciae548%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1093%5C%2Fcid%5C%2Fciae548%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Global%20trends%20in%20CD4%20count%20measurement%20and%20distribution%20at%20first%20antiretroviral%20treatment%20initiation%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rene%5Cu00e9%22%2C%22lastName%22%3A%22de%20Waal%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kara%22%2C%22lastName%22%3A%22Wools-Kaloustian%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ellen%22%2C%22lastName%22%3A%22Brazier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Keri%20N.%22%2C%22lastName%22%3A%22Althoff%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Antoine%22%2C%22lastName%22%3A%22Jaquet%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Stephany%20N.%22%2C%22lastName%22%3A%22Duda%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nagalingeswaran%22%2C%22lastName%22%3A%22Kumarasamy%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Theodora%22%2C%22lastName%22%3A%22Savory%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Helen%22%2C%22lastName%22%3A%22Byakwaga%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gad%22%2C%22lastName%22%3A%22Murenzi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Amy%22%2C%22lastName%22%3A%22Justice%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Didier%20K.%22%2C%22lastName%22%3A%22Ekouevi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Carina%22%2C%22lastName%22%3A%22Cesar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mark%20K.%20U.%22%2C%22lastName%22%3A%22Pasayan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Agness%22%2C%22lastName%22%3A%22Thawani%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Charles%22%2C%22lastName%22%3A%22Kasozi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Pelagie%22%2C%22lastName%22%3A%22Babakazo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Maile%22%2C%22lastName%22%3A%22Karris%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eugene%22%2C%22lastName%22%3A%22Messou%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Claudia%20P.%22%2C%22lastName%22%3A%22Cortes%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Cordelia%22%2C%22lastName%22%3A%22Kunzekwenyika%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jun%20Yong%22%2C%22lastName%22%3A%22Choi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Noela%20C.%22%2C%22lastName%22%3A%22Owarwo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Annabelle%22%2C%22lastName%22%3A%22Niyongabo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vincent%20C.%22%2C%22lastName%22%3A%22Marconi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Oliver%22%2C%22lastName%22%3A%22Ezechi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jessica%20L.%22%2C%22lastName%22%3A%22Castilho%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kathy%22%2C%22lastName%22%3A%22Petoumenos%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Leigh%22%2C%22lastName%22%3A%22Johnson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nathan%22%2C%22lastName%22%3A%22Ford%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Reshma%22%2C%22lastName%22%3A%22Kassanjee%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20While%20people%20with%20HIV%20%28PWH%29%20start%20antiretroviral%20treatment%20%28ART%29%20regardless%20of%20CD4%20count%2C%20CD4%20measurement%20remains%20crucial%20for%20detecting%20advanced%20HIV%20disease%20and%20evaluating%20ART%20programmes.%20We%20explored%20CD4%20measurement%20%28proportion%20of%20PWH%20with%20a%20CD4%20result%20available%29%20and%20prevalence%20of%20CD4%20%26lt%3B200%20cells%5C%2F%5Cu00b5L%20at%20ART%20initiation%20within%20the%20International%20epidemiology%20Databases%20to%20Evaluate%20AIDS%20%28IeDEA%29%20global%20collaboration.%5CnMETHODS%3A%20We%20included%20PWH%20at%20participating%20ART%20programmes%20who%20first%20initiated%20ART%20at%20age%2015-80%20years%20during%202005-2019.%20We%20described%20proportions%20of%20PWH%20%28i%29%20with%20CD4%20%28measured%20within%206%20months%20before%20to%202%20weeks%20after%20ART%20initiation%29%3B%20and%20%28ii%29%20among%20those%20with%20a%20CD4%2C%20with%20CD4%20%26lt%3B200%3B%20by%20year%20of%20ART%20initiation%20and%20region.%5CnRESULTS%3A%20We%20included%201%2C355%2C104%20PWH%20from%2042%20countries%20in%207%20regions%3B%2063%25%20were%20female.%20Median%20%28interquartile%20range%29%20age%20at%20ART%20initiation%20was%2037%20%2831-44%29%20in%20men%20and%2032%20%2826-39%29%20in%20women.%20CD4%20measurement%20initially%20increased%2C%20or%20remained%20stable%20over%20time%20until%20around%202013%2C%20but%20then%20declined%20to%20low%20levels%20in%20some%20regions%20%28Southern%20Africa%2C%20except%20South%20Africa%3A%20from%2054%20to%2013%25%3B%20East%20Africa%2085%20to%2031%25%3B%20Central%20Africa%2072%20to%2020%25%3B%20West%20Africa%3A%2091%20to%2053%25%3B%20and%20Latin%20America%3A%2087%20to%2056%25%29.%20Prevalence%20of%20CD4%26lt%3B200%20declined%20over%20time%20in%20all%20regions%2C%20but%20plateaued%20after%202015%20at%20%5Cu226530%25.%5CnCONCLUSIONS%3A%20CD4%20measurement%20has%20declined%20sharply%20in%20recent%20years%2C%20especially%20in%20sub-Saharan%20Africa.%20Among%20those%20with%20a%20CD4%2C%20the%20prevalence%20of%20CD4%20%26lt%3B200%20remains%20concerningly%20high.%20Scaling%20up%20CD4%20testing%20and%20securing%20adequate%20funding%20are%20urgent%20priorities.%22%2C%22date%22%3A%222024-11-06%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1093%5C%2Fcid%5C%2Fciae548%22%2C%22ISSN%22%3A%221537-6591%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22GXCKG69T%22%2C%22ZVWK2Q45%22%2C%22D9WC3N3V%22%2C%22TCMBXKKM%22%2C%228IRGNQWZ%22%2C%22F2Y6PLUL%22%2C%22ZBJI578D%22%2C%22YAE5EUBI%22%2C%223FNU2D64%22%5D%2C%22dateModified%22%3A%222025-04-14T13%3A33%3A07Z%22%7D%7D%2C%7B%22key%22%3A%22BPPML97E%22%2C%22library%22%3A%7B%22id%22%3A2775998%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Castilho%20et%20al.%22%2C%22parsedDate%22%3A%222024-11%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BCastilho%2C%20Jessica%20L.%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BFonseca%2C%20Fernanda%20F.%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BKim%2C%20Ahra%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BJalil%2C%20Emilia%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BTu%2C%20Shengxin%26lt%3B%5C%2Fspan%26gt%3B%20et%20al.%26lt%3B%5C%2Fspan%26gt%3B%20%282024%29.%20Prenatal%20syphilis%20and%20adverse%20pregnancy%20outcomes%20in%20women%20with%20HIV%20receiving%20ART%20in%20Brazil%3A%20a%20population-based%20study.%20%26lt%3Bi%26gt%3BLancet%20Regional%20Health.%20Americas%26lt%3B%5C%2Fi%26gt%3B%2C%20%26lt%3Bi%26gt%3B39%26lt%3B%5C%2Fi%26gt%3B%2C%20S.%20100894.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.lana.2024.100894%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.lana.2024.100894%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Prenatal%20syphilis%20and%20adverse%20pregnancy%20outcomes%20in%20women%20with%20HIV%20receiving%20ART%20in%20Brazil%3A%20a%20population-based%20study%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jessica%20L.%22%2C%22lastName%22%3A%22Castilho%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fernanda%20F.%22%2C%22lastName%22%3A%22Fonseca%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ahra%22%2C%22lastName%22%3A%22Kim%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Emilia%22%2C%22lastName%22%3A%22Jalil%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shengxin%22%2C%22lastName%22%3A%22Tu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Andr%5Cu00e9a%20M.%20B.%22%2C%22lastName%22%3A%22Beber%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Adele%20S.%22%2C%22lastName%22%3A%22Benzaken%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Valdil%5Cu00e9a%20G.%22%2C%22lastName%22%3A%22Veloso%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Beatriz%22%2C%22lastName%22%3A%22Grinsztejn%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bryan%20E.%22%2C%22lastName%22%3A%22Shepherd%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ang%5Cu00e9lica%20E.%20B.%22%2C%22lastName%22%3A%22Miranda%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22National%20Cohort%20Study%20of%20Dolutegravir%20and%20Pregnancy%20Outcomes%20in%20Brazil%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20We%20aimed%20to%20examine%20factors%20associated%20with%20prenatal%20syphilis%2C%20including%20prenatal%20care%2C%20and%20pregnancy%20outcomes%20of%20pregnant%20women%20with%20HIV%20in%20Brazil.%5CnMETHODS%3A%20Retrospective%20data%20were%20gathered%20from%20a%20national%20cohort%20of%20Brazilian%20women%20with%20HIV%20on%20antiretroviral%20therapy%20who%20became%20pregnant%20between%20January%202015%20and%20May%202018.%20Prenatal%20syphilis%20was%20defined%20by%20clinical%20diagnoses%20with%20treatment%20or%20any%20positive%20syphilis%20laboratory%20result%20between%2030%20days%20before%20conception%20and%20pregnancy%20conclusion.%20Multivariable%20logistic%20regression%20models%20examined%20factors%20associated%20with%20prenatal%20syphilis%20risk%20and%20adverse%20pregnancy%20outcomes%20%28including%20stillbirth%2C%20abortion%2C%20preterm%20delivery%2C%20small%20for%20gestational%20age%2C%20and%20congenital%20abnormalities%29.%20Receipt%20of%20recommended%20prenatal%20syphilis%20screening%20and%20adequacy%20of%20prenatal%20care%20were%20also%20evaluated.%5CnFINDINGS%3A%20Among%202169%20women%2C%20166%20%287.77%25%20%5B95%25%20CI%3A%206.5-8.8%25%5D%29%20had%20prenatal%20syphilis%2C%20of%20whom%20151%20%2891%25%29%20had%20documented%20treatment.%20Prevalence%20of%20prenatal%20syphilis%20was%20higher%20among%20women%20of%20Black%5C%2FPardo%5C%2FIndigenous%20race%20%2813.7%5C%2F7.7%5C%2F8.3%25%20vs.%205.8%25%20in%20White%20women%29%2C%20those%20of%20younger%20age%20%28median%20age%2025.9%20years%20vs.%2027.6%20in%20total%20cohort%29%20and%20those%20with%20crack%5C%2Fcocaine%20use%20during%5C%2Fbefore%20pregnancy%20%2820%25%29.%20Of%201042%5C%2F2169%20women%20with%20prenatal%20care%20and%20screening%20data%2C%20475%20%2846%25%29%20received%20inadequate%20prenatal%20care%20and%20only%20301%20%2829%25%29%20received%20the%20recommended%20antenatal%20syphilis%20screening.%20Prenatal%20syphilis%20was%20not%20associated%20with%20adverse%20pregnancy%20outcomes%20%28aOR%200.91%20%5B0.64-1.30%5D%29.%5CnINTERPRETATION%3A%20Prenatal%20syphilis%20was%20prevalent%20in%20this%20cohort%20of%20pregnant%20women%20with%20HIV.%20Prenatal%20syphilis%20was%20not%20associated%20with%20adverse%20pregnancy%20outcomes.%20Attention%20to%20syphilis%20prevention%20and%20treatment%20is%20especially%20needed%20in%20marginalised%20women.%5CnFUNDING%3A%20Brazilian%20Ministry%20of%20Health%20and%20United%20States%26%23039%3B%20National%20Institutes%20of%20Health.%22%2C%22date%22%3A%222024-11%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.lana.2024.100894%22%2C%22ISSN%22%3A%222667-193X%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22GXCKG69T%22%2C%22F2Y6PLUL%22%5D%2C%22dateModified%22%3A%222025-03-11T12%3A04%3A06Z%22%7D%7D%2C%7B%22key%22%3A%226VI4Q44U%22%2C%22library%22%3A%7B%22id%22%3A2775998%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Barreto-Duarte%20et%20al.%22%2C%22parsedDate%22%3A%222024-11%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BBarreto-Duarte%2C%20Beatriz%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BVillalva-Serra%2C%20Klauss%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BCampos%2C%20Vanessa%20M.%20S.%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BCordeiro-Santos%2C%20Marcelo%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BKritski%2C%20Afr%26%23xE2%3Bnio%20L.%26lt%3B%5C%2Fspan%26gt%3B%20et%20al.%26lt%3B%5C%2Fspan%26gt%3B%20%282024%29.%20Nationwide%20economic%20analysis%20of%20pulmonary%20tuberculosis%20in%20the%20Brazilian%20healthcare%20system%20over%20seven%20years%20%282015-2022%29%3A%20a%20population-based%20study.%20%26lt%3Bi%26gt%3BLancet%20Regional%20Health.%20Americas%26lt%3B%5C%2Fi%26gt%3B%2C%20%26lt%3Bi%26gt%3B39%26lt%3B%5C%2Fi%26gt%3B%2C%20S.%20100905.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.lana.2024.100905%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.lana.2024.100905%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Nationwide%20economic%20analysis%20of%20pulmonary%20tuberculosis%20in%20the%20Brazilian%20healthcare%20system%20over%20seven%20years%20%282015-2022%29%3A%20a%20population-based%20study%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Beatriz%22%2C%22lastName%22%3A%22Barreto-Duarte%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Klauss%22%2C%22lastName%22%3A%22Villalva-Serra%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vanessa%20M.%20S.%22%2C%22lastName%22%3A%22Campos%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marcelo%22%2C%22lastName%22%3A%22Cordeiro-Santos%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Afr%5Cu00e2nio%20L.%22%2C%22lastName%22%3A%22Kritski%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mariana%22%2C%22lastName%22%3A%22Ara%5Cu00fajo-Pereira%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Moreno%20M.%22%2C%22lastName%22%3A%22Rodrigues%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bruno%20B.%22%2C%22lastName%22%3A%22Andrade%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20Tuberculosis%20%28TB%29%20remains%20a%20global%20challenge%20and%20disproportionately%20affecting%20vulnerable%20populations.%20This%20study%20analyses%20the%20economic%20burden%20of%20pulmonary%20TB%20in%20Brazil%2C%20focusing%20on%20direct%20healthcare%20costs.%20It%20also%20evaluates%20the%20cost-effectiveness%20of%20the%20Directly%20Observed%20Treatment%20%28DOT%29%20strategy%20and%20the%20economic%20effort%20required%20to%20achieve%20a%2090%25%20probability%20of%20cure.%5CnMETHODS%3A%20A%20nationwide%20retrospective%20study%20utilized%20data%20from%20the%20Brazilian%20Information%20System%20for%20Notifiable%20Diseases%20%28SINAN%29%20between%202015%20and%202022.%20The%20cost%20per%20pulmonary%20TB%20case%20was%20estimated%2C%20encompassing%20expenses%20related%20to%20healthcare%20professionals%2C%20medication%2C%20laboratory%20exams%2C%20and%20the%20duration%20of%20treatment%20reported%20in%20SINAN.%20The%20population%20was%20stratified%20based%20on%20the%20presence%20of%20social%20vulnerabilities%20or%20a%20history%20of%20previous%20anti-TB%20treatment.%20Number%20Needed%20to%20Treat%20%28NNT%29%20analyses%20assessed%20the%20effectiveness%20of%20DOT%20implementation.%20Additionally%2C%20the%20study%20calculated%20the%20cost%20needed%20to%20achieve%20a%2090%25%20probability%20of%20cure%20through%20binomial%20regression%20models.%5CnFINDINGS%3A%20The%20total%20direct%20cost%20for%20pulmonary%20TB%20in%20Brazil%20during%20the%20seven%20years%20exceeded%20%241.3%20billion%2C%20with%20retreatment%20cases%20accounting%20for%20%2423.5%20million.%20The%20lowest%20NNT%20of%20DOT%20were%20homeless%20%283.0%29%2C%20people%20who%20use%20drugs%20%283.72%29%2C%20and%20retreatment%20%284.56%29%20subpopulations.%20These%20groups%20also%20presented%20the%20highest%20cost%20to%20achieve%20a%2090%25%20probability%20of%20cure.%5CnINTERPRETATION%3A%20This%20study%20highlights%20the%20economic%20impact%20of%20pulmonary%20TB%20on%20the%20Brazilian%20healthcare%20system.%20It%20underscores%20the%20effectiveness%20of%20DOT%20across%20various%20patient%20groups%2C%20regardless%20of%20their%20vulnerabilities%20or%20previous%20anti-TB%20treatment%20history.%20NNT%20analyses%20highlighted%20retreatment%2C%20homeless%2C%20and%20people%20who%20use%20drugs%20subpopulations%20as%20the%20most%20effective%20for%20DOT%20implementation.%5CnFUNDING%3A%20Intramural%20Research%20Program-Oswaldo%20Cruz%20Foundation.%22%2C%22date%22%3A%222024-11%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.lana.2024.100905%22%2C%22ISSN%22%3A%222667-193X%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22GXCKG69T%22%2C%22F2Y6PLUL%22%5D%2C%22dateModified%22%3A%222025-03-11T11%3A59%3A32Z%22%7D%7D%2C%7B%22key%22%3A%22BTHF7ARY%22%2C%22library%22%3A%7B%22id%22%3A2775998%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Amorim%20et%20al.%22%2C%22parsedDate%22%3A%222024-10-15%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BAmorim%2C%20Gustavo%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BJaworski%2C%20James%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BYang%2C%20Jing%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BCordeiro-Santos%2C%20Marcelo%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BKritski%2C%20Afr%26%23xE2%3Bnio%20L.%26lt%3B%5C%2Fspan%26gt%3B%20et%20al.%26lt%3B%5C%2Fspan%26gt%3B%20%282024%29.%20Pharmacogenetics%20of%20tuberculosis%20treatment%20toxicity%20and%20effectiveness%20in%20a%20large%20Brazilian%20cohort.%20%26lt%3Bi%26gt%3BPharmacogenetics%20and%20Genomics%26lt%3B%5C%2Fi%26gt%3B.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1097%5C%2FFPC.0000000000000552%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1097%5C%2FFPC.0000000000000552%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Pharmacogenetics%20of%20tuberculosis%20treatment%20toxicity%20and%20effectiveness%20in%20a%20large%20Brazilian%20cohort%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gustavo%22%2C%22lastName%22%3A%22Amorim%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22James%22%2C%22lastName%22%3A%22Jaworski%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jing%22%2C%22lastName%22%3A%22Yang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marcelo%22%2C%22lastName%22%3A%22Cordeiro-Santos%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Afr%5Cu00e2nio%20L.%22%2C%22lastName%22%3A%22Kritski%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marina%20C.%22%2C%22lastName%22%3A%22Figueiredo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Megan%22%2C%22lastName%22%3A%22Turner%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bruno%20B.%22%2C%22lastName%22%3A%22Andrade%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Digna%20R.%22%2C%22lastName%22%3A%22Velez%20Edwards%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Adalberto%20R.%22%2C%22lastName%22%3A%22Santos%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Valeria%20C.%22%2C%22lastName%22%3A%22Rolla%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Timothy%20R.%22%2C%22lastName%22%3A%22Sterling%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22David%20W.%22%2C%22lastName%22%3A%22Haas%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22Regional%20Prospective%20Observational%20Research%20in%20Tuberculosis%20%28RePORT%29-Brazil%20network%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20Genetic%20polymorphisms%20have%20been%20associated%20with%20risk%20of%20antituberculosis%20treatment%20toxicity.%20We%20characterized%20associations%20with%20adverse%20events%20and%20treatment%20failure%5C%2Frecurrence%20among%20adults%20treated%20for%20tuberculosis%20in%20Brazil.%5CnMETHODS%3A%20Participants%20were%20followed%20in%20Regional%20Prospective%20Observational%20Research%20in%20Tuberculosis%20%28RePORT%29-Brazil.%20We%20included%20persons%20with%20culture-confirmed%20drug-susceptible%20pulmonary%20tuberculosis%20who%20started%20treatment%20between%202015%20and%202019%2C%20and%20who%20were%20eligible%20for%20pharmacogenetics.%20Treatment%20included%202%20months%20of%20isoniazid%2C%20rifampin%20or%20rifabutin%2C%20pyrazinamide%2C%20and%20ethambutol%2C%20then%204%20months%20of%20isoniazid%20and%20rifampin%20or%20rifabutin%2C%20with%2024-month%20follow-up.%20Analyses%20included%2043%20polymorphisms%20in%2020%20genes%20related%20to%20antituberculosis%20drug%20hepatotoxicity%20or%20pharmacokinetics.%20Whole%20exome%20sequencing%20was%20done%20in%20a%20case-control%20toxicity%20subset.%5CnRESULTS%3A%20Among%20903%20participants%20in%20multivariable%20genetic%20association%20analyses%2C%20NAT2%20slow%20acetylator%20status%20was%20associated%20with%20increased%20risk%20of%20treatment-related%20grade%202%20or%20greater%20adverse%20events%2C%20including%20hepatotoxicity.%20Treatment%20failure%5C%2Frecurrence%20was%20more%20likely%20among%20NAT2%20rapid%20acetylators%2C%20but%20not%20statistically%20significant%20at%20the%205%25%20level.%20A%20GSTM1%20polymorphism%20%28rs412543%29%20was%20associated%20with%20increased%20risk%20of%20treatment-related%20adverse%20events%2C%20including%20hepatotoxicity.%20SLCO1B1%20polymorphisms%20were%20associated%20with%20increased%20risk%20of%20treatment-related%20hepatoxicity%20and%20treatment%20failure%5C%2Frecurrence.%20Polymorphisms%20in%20NR1%5C%2F2%20were%20associated%20with%20decreased%20risk%20of%20adverse%20events%20and%20increased%20risk%20of%20failure%5C%2Frecurrence.%20In%20whole%20exome%20sequencing%2C%20hepatotoxicity%20was%20associated%20with%20a%20polymorphism%20in%20VTI1A%2C%20and%20the%20genes%20METTL17%20and%20PRSS57%2C%20but%20none%20achieved%20genome-wide%20significance.%5CnCONCLUSION%3A%20In%20a%20clinical%20cohort%20representing%20three%20regions%20of%20Brazil%2C%20NAT2%20acetylator%20status%20was%20associated%20with%20risk%20for%20treatment-related%20adverse%20events.%20Additional%20significant%20polymorphisms%20merit%20investigation%20in%20larger%20study%20populations%2C%20particularly%20regarding%20risk%20of%20treatment%20failure%5C%2Frecurrence.%22%2C%22date%22%3A%222024-10-15%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1097%5C%2FFPC.0000000000000552%22%2C%22ISSN%22%3A%221744-6880%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22GXCKG69T%22%2C%22F2Y6PLUL%22%5D%2C%22dateModified%22%3A%222024-11-06T09%3A26%3A47Z%22%7D%7D%2C%7B%22key%22%3A%224HQSQPK4%22%2C%22library%22%3A%7B%22id%22%3A2775998%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Parcesepe%20et%20al.%22%2C%22parsedDate%22%3A%222024-10%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BParcesepe%2C%20Angela%20M.%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BStockton%2C%20Melissa%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BBernard%2C%20Charlotte%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BKanguya%2C%20Tukiya%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BKwobah%2C%20Edith%20Kamaru%26lt%3B%5C%2Fspan%26gt%3B%20et%20al.%26lt%3B%5C%2Fspan%26gt%3B%20%282024%29.%20Prevalence%20and%20co-occurrence%20of%20symptoms%20of%20mental%20and%20substance%20use%20disorders%20among%20people%20with%20HIV%20age%2040%20and%20older%20in%20low-%20and%20middle-income%20countries%3A%20a%20cross-sectional%20study.%20%26lt%3Bi%26gt%3BJournal%20of%20the%20International%20AIDS%20Society%26lt%3B%5C%2Fi%26gt%3B%2C%20%26lt%3Bi%26gt%3B27%26lt%3B%5C%2Fi%26gt%3B%20%2810%29%2C%20S.%20e26359.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1002%5C%2Fjia2.26359%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1002%5C%2Fjia2.26359%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Prevalence%20and%20co-occurrence%20of%20symptoms%20of%20mental%20and%20substance%20use%20disorders%20among%20people%20with%20HIV%20age%2040%20and%20older%20in%20low-%20and%20middle-income%20countries%3A%20a%20cross-sectional%20study%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Angela%20M.%22%2C%22lastName%22%3A%22Parcesepe%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Melissa%22%2C%22lastName%22%3A%22Stockton%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Charlotte%22%2C%22lastName%22%3A%22Bernard%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tukiya%22%2C%22lastName%22%3A%22Kanguya%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Edith%20Kamaru%22%2C%22lastName%22%3A%22Kwobah%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alvaro%22%2C%22lastName%22%3A%22Lopez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gad%22%2C%22lastName%22%3A%22Murenzi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jeremy%22%2C%22lastName%22%3A%22Ross%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Albert%22%2C%22lastName%22%3A%22Minga%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fernanda%22%2C%22lastName%22%3A%22Maruri%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mpho%22%2C%22lastName%22%3A%22Tlali%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Suzanne%22%2C%22lastName%22%3A%22Goodrich%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hugo%22%2C%22lastName%22%3A%22Perazzo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fran%5Cu00e7oise%22%2C%22lastName%22%3A%22Musabyimana%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Smita%22%2C%22lastName%22%3A%22Nimkar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kathryn%22%2C%22lastName%22%3A%22Lancaster%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22IeDEA%22%2C%22lastName%22%3A%22Consortium%22%7D%5D%2C%22abstractNote%22%3A%22INTRODUCTION%3A%20Due%20to%20the%20increased%20effectiveness%20of%20and%20access%20to%20antiretroviral%20therapy%20%28ART%29%2C%20people%20with%20HIV%20%28PWH%29%20are%20living%20longer.%20As%20a%20result%2C%20the%20population%20of%20older%20PWH%20has%20increased.%20Mental%20and%20substance%20use%20disorders%20%28MSDs%29%20are%20common%20and%20frequently%20co-occurring%20among%20PWH%20and%20are%20associated%20with%20poor%20HIV%20care%20outcomes.%20Research%20into%20the%20prevalence%20and%20co-occurrence%20of%20MSDs%20among%20ageing%20PWH%20remains%20limited%2C%20particularly%20in%20low-%20and%20middle-income%20countries%20%28LMICs%29.%5CnMETHODS%3A%20We%20analysed%20data%20collected%20between%202020%20and%202022%20from%20the%20International%20epidemiology%20Databases%20to%20Evaluate%20AIDS%20%28IeDEA%29%20Sentinel%20Research%20Network%20cohort%20of%20PWH%20aged%2040%20years%20or%20older%20on%20ART%20at%2011%20HIV%20clinics%20in%20Brazil%2C%20C%5Cu00f4te%20d%26%23039%3BIvoire%2C%20India%2C%20Kenya%2C%20Mexico%2C%20Uganda%2C%20Rwanda%2C%20Togo%2C%20Vietnam%2C%20Zambia%20and%20Zimbabwe.%20We%20estimated%20the%20prevalence%20and%20co-occurrence%20of%20unhealthy%20alcohol%20use%20%28AUDIT-C%20%5Cu22653%20for%20women%2C%20%5Cu22654%20for%20men%29%2C%20unhealthy%20drug%20use%20%28ASSIST%20%26gt%3B3%20for%20cannabis%2C%20cocaine%2C%20amphetamines%2C%20inhalants%2C%20sedatives%2C%20hallucinogens%20and%5C%2For%20opioids%29%2C%20and%20moderate%20to%20severe%20symptoms%20of%20depression%20%28PHQ-9%20%5Cu226510%29%2C%20anxiety%20%28GAD-7%20%5Cu226510%29%20and%20post-traumatic%20stress%20disorder%20%28PTSD%29%20%28PCL-5%20%5Cu226533%29.%20Psychiatric%20multimorbidity%20was%20defined%20as%20having%20symptoms%20of%20two%20or%20more%20disorders%20assessed.%20Log%20binomial%20models%20assessed%20the%20association%20between%20socio-demographic%20and%20HIV%20care%20characteristics%20and%20symptoms%20of%20anxiety%2C%20depression%2C%20PTSD%20or%20unhealthy%20substance%20use.%5CnRESULTS%3A%20Of%202821%20participants%2C%20the%20prevalence%20of%20unhealthy%20alcohol%20and%20drug%20use%20was%2021%25%20and%205%25%2C%20respectively.%20The%20prevalence%20of%20moderate%20to%20severe%20symptoms%20of%20depression%2C%20anxiety%20and%20PTSD%20was%2014%25%2C%209%25%20and%206%25%2C%20respectively.%20Overall%2C%20the%20prevalence%20of%20psychiatric%20multimorbidity%20was%2011%25.%20Among%20those%20with%20symptoms%20of%20at%20least%20one%20mental%20health%20or%20substance%20use%20outcome%20assessed%20%28n%20%3D%201036%29%2C%20the%20prevalence%20of%20psychiatric%20multimorbidity%20was%2031%25.%20In%20binomial%20models%2C%20the%20prevalence%20of%20symptoms%20of%20depression%20and%20anxiety%20was%20higher%2C%20while%20the%20prevalence%20of%20unhealthy%20alcohol%20and%20drug%20use%20was%20lower%20among%20women%20than%20men.%5CnCONCLUSIONS%3A%20Unhealthy%20alcohol%20use%20and%20symptoms%20of%20depression%20were%20most%20commonly%20reported%2C%20among%20this%20cohort%20of%20PWH%20aged%2040%20or%20older%20across%2011%20LMICs.%20Integration%20of%20MSD%20screening%20and%20treatment%20into%20HIV%20care%20should%20be%20prioritized.%20The%20effectiveness%20and%20implementation%20of%20transdiagnostic%20or%20multi-focus%20mental%20health%20treatment%20approaches%20in%20HIV%20care%20settings%20should%20be%20examined.%22%2C%22date%22%3A%222024-10%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1002%5C%2Fjia2.26359%22%2C%22ISSN%22%3A%221758-2652%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22GXCKG69T%22%2C%22ZVWK2Q45%22%2C%22D9WC3N3V%22%2C%22TCMBXKKM%22%2C%228IRGNQWZ%22%2C%22F2Y6PLUL%22%2C%22ZBJI578D%22%2C%22YAE5EUBI%22%2C%223FNU2D64%22%5D%2C%22dateModified%22%3A%222025-03-10T15%3A35%3A37Z%22%7D%7D%2C%7B%22key%22%3A%22CTS44ZKW%22%2C%22library%22%3A%7B%22id%22%3A2775998%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Kuniholm%20et%20al.%22%2C%22parsedDate%22%3A%222024-09-12%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BKuniholm%2C%20Mark%20H.%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BMurenzi%2C%20Gad%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BShumbusho%2C%20Fabienne%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BBrazier%2C%20Ellen%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BPlaisy%2C%20Marie%20K.%26lt%3B%5C%2Fspan%26gt%3B%20et%20al.%26lt%3B%5C%2Fspan%26gt%3B%20%282024%29.%20Association%20of%20cardiovascular%20disease%20risk%20with%20liver%20steatosis%20and%20fibrosis%20in%20people%20living%20with%20hiv%20in%20low-%20and%20middle-income%20countries.%20%26lt%3Bi%26gt%3BAIDS%20%28London%2C%20England%29%26lt%3B%5C%2Fi%26gt%3B.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1097%5C%2FQAD.0000000000004012%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1097%5C%2FQAD.0000000000004012%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Association%20of%20cardiovascular%20disease%20risk%20with%20liver%20steatosis%20and%20fibrosis%20in%20people%20living%20with%20hiv%20in%20low-%20and%20middle-income%20countries%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mark%20H.%22%2C%22lastName%22%3A%22Kuniholm%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gad%22%2C%22lastName%22%3A%22Murenzi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fabienne%22%2C%22lastName%22%3A%22Shumbusho%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ellen%22%2C%22lastName%22%3A%22Brazier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marie%20K.%22%2C%22lastName%22%3A%22Plaisy%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ephrem%22%2C%22lastName%22%3A%22Mensah%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gilles%22%2C%22lastName%22%3A%22Wandeler%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Carlotta%22%2C%22lastName%22%3A%22Riebensahm%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Belinda%20V.%22%2C%22lastName%22%3A%22Chihota%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Niharika%22%2C%22lastName%22%3A%22Samala%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lameck%22%2C%22lastName%22%3A%22Diero%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Aggrey%20S.%22%2C%22lastName%22%3A%22Semeere%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Thida%22%2C%22lastName%22%3A%22Chanyachukul%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rohidas%22%2C%22lastName%22%3A%22Borse%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dung%20T.%20H.%22%2C%22lastName%22%3A%22Nguyen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hugo%22%2C%22lastName%22%3A%22Perazzo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alvaro%22%2C%22lastName%22%3A%22Lopez-Iniguez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jessica%20L.%22%2C%22lastName%22%3A%22Castilho%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fernanda%22%2C%22lastName%22%3A%22Maruri%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Antoine%22%2C%22lastName%22%3A%22Jaquet%22%7D%5D%2C%22abstractNote%22%3A%22OBJECTIVE%3A%20To%20understand%20the%20relationship%20between%20cardiovascular%20disease%20%28CVD%29%20risk%20and%20liver%20steatosis%20and%20fibrosis%20among%20people%20living%20with%20HIV%20%28PLWH%29%20%5Cu226540%5Cu200ayears%20on%20antiretroviral%20therapy%20%28ART%29%20in%20low-%20and%20middle-income%20countries%20%28LMIC%29.%5CnDESIGN%3A%20We%20used%20cross-sectional%20behavioral%20and%20clinical%20data%20collected%20during%20study%20enrollment%20visits%20in%202020-2022%20for%20the%20Sentinel%20Research%20Network%20of%20International%20epidemiology%20Databases%20to%20Evaluate%20AIDS%20%28SRN%20of%20IeDEA%29.%5CnMETHODS%3A%20Ten-year%20CVD%20risk%20was%20calculated%20using%202019%20World%20Health%20Organization%20non-laboratory%20and%20laboratory%20models.%20Transient%20elastography%20%28TE%29%20was%20used%20to%20assess%20liver%20disease.%20Presence%20of%20steatosis%20and%20significant%20fibrosis%20were%20defined%20by%20Controlled%20Attenuation%20Parameter%20%28CAP%29%20%5Cu2265248%5Cu200adB%5C%2Fm%20and%20liver%20stiffness%20measurement%20%28LSM%29%20%5Cu22657.1%5Cu200akPa%2C%20respectively.%20Participants%20with%20viral%20hepatitis%2C%20hazardous%20alcohol%20consumption%20and%20unsuppressed%20HIV%20viral%20load%20were%20excluded%20from%20the%20analysis.%20Logistic%20regression%20was%20used%20to%20estimate%20odds%20ratios%2C%20adjusting%20for%20study%20site%2C%20CD4%5Cu200aT%20cell%20count%2C%20stavudine%20and%20didanosine%20exposure%2C%20and%20in%20models%20stratified%20by%20sex%20and%20geographic%20region.%5CnRESULTS%3A%20There%20were%201%2C750%20participants%20from%20nine%20LMIC.%20Median%20CVD%20risk%20was%203%25%20for%20both%20non-laboratory%20and%20laboratory-based%20models.%20Adjusted%20odds%20ratios%20%28ORs%29%20for%20steatosis%20and%20significant%20fibrosis%20associated%20with%20laboratory%20CVD%20risk%20%28%5Cu226510%25%20vs.%20%26lt%3B5%25%29%20were%20OR%5Cu200a%3D%5Cu200a1.83%20%2895%25%20confidence%20interval%3A%28CI%29%5Cu200a%3D%5Cu200a1.21-2.76%3B%20P%5Cu200a%3D%5Cu200a0.004%29%20and%20OR%5Cu200a%3D%5Cu200a1.62%20%2895%25%20CI%5Cu200a%3D%5Cu200a0.85-3.07%3B%20P%5Cu200a%3D%5Cu200a0.14%29%2C%20respectively.%20Associations%20of%20CVD%20risk%20with%20steatosis%20were%20stronger%20in%20males%20and%20among%20participants%20at%20study%20sites%20outside%20Africa.%5CnCONCLUSIONS%3A%20Higher%20CVD%20risk%20was%20associated%20with%20steatosis%20but%20not%20with%20significant%20fibrosis%20in%20PLWH%20in%20our%20LMIC%20cohort.%22%2C%22date%22%3A%222024-09-12%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1097%5C%2FQAD.0000000000004012%22%2C%22ISSN%22%3A%221473-5571%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22GXCKG69T%22%2C%22ZVWK2Q45%22%2C%22D9WC3N3V%22%2C%22TCMBXKKM%22%2C%228IRGNQWZ%22%2C%22F2Y6PLUL%22%2C%22ZBJI578D%22%2C%223FNU2D64%22%5D%2C%22dateModified%22%3A%222025-07-15T14%3A52%3A36Z%22%7D%7D%2C%7B%22key%22%3A%22DH7Q539B%22%2C%22library%22%3A%7B%22id%22%3A2775998%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Zaniewski%20et%20al.%22%2C%22parsedDate%22%3A%222024-09-05%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BZaniewski%2C%20Elizabeth%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BSkrivankova%2C%20Veronika%20Whitesell%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BBrazier%2C%20Ellen%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BAvihingsanon%2C%20Anchalee%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BCardoso%2C%20Sandra%20Wagner%26lt%3B%5C%2Fspan%26gt%3B%20et%20al.%26lt%3B%5C%2Fspan%26gt%3B%20%282024%29.%20Transition%20to%20dolutegravir-based%20ART%20in%2035%20low-%20and%20middle-income%20countries%3A%20a%20global%20survey%20of%20HIV%20care%20clinics.%20%26lt%3Bi%26gt%3BAIDS%20%28London%2C%20England%29%26lt%3B%5C%2Fi%26gt%3B.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1097%5C%2FQAD.0000000000004007%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1097%5C%2FQAD.0000000000004007%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Transition%20to%20dolutegravir-based%20ART%20in%2035%20low-%20and%20middle-income%20countries%3A%20a%20global%20survey%20of%20HIV%20care%20clinics%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Elizabeth%22%2C%22lastName%22%3A%22Zaniewski%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Veronika%20Whitesell%22%2C%22lastName%22%3A%22Skrivankova%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ellen%22%2C%22lastName%22%3A%22Brazier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anchalee%22%2C%22lastName%22%3A%22Avihingsanon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sandra%20Wagner%22%2C%22lastName%22%3A%22Cardoso%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Carina%22%2C%22lastName%22%3A%22Cesar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Henri%22%2C%22lastName%22%3A%22Chenal%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Brenda%20E.%22%2C%22lastName%22%3A%22Crabtree-Ram%5Cu00edrez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rossana%20A.%22%2C%22lastName%22%3A%22Ditangco%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20Vanes%22%2C%22lastName%22%3A%22Ebasone%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Brian%22%2C%22lastName%22%3A%22Eley%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jonathan%20George%22%2C%22lastName%22%3A%22Euvrard%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Geoffrey%22%2C%22lastName%22%3A%22Fatti%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jacqueline%20Madalitso%22%2C%22lastName%22%3A%22Huwa%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Patricia%22%2C%22lastName%22%3A%22Lelo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Daisy%20Maria%22%2C%22lastName%22%3A%22Machado%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eugene%20Kouassi%22%2C%22lastName%22%3A%22Messou%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Albert%20Kla%22%2C%22lastName%22%3A%22Minga%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Joseph%22%2C%22lastName%22%3A%22Muleebwa%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sanjay%22%2C%22lastName%22%3A%22Mundhe%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gad%22%2C%22lastName%22%3A%22Murenzi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Winnie%20R.%22%2C%22lastName%22%3A%22Muyindike%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dominique%20Mahambou%22%2C%22lastName%22%3A%22Nsonde%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sarah%20M.%22%2C%22lastName%22%3A%22Obatsa%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Joseph%22%2C%22lastName%22%3A%22Odhiambo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hans%20Walter%22%2C%22lastName%22%3A%22Prozesky%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Supattra%22%2C%22lastName%22%3A%22Rungmaitree%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Aggrey%20Semwendero%22%2C%22lastName%22%3A%22Semeere%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Moussa%22%2C%22lastName%22%3A%22Seydi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nosisa%22%2C%22lastName%22%3A%22Sipambo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tavitiya%22%2C%22lastName%22%3A%22Sudjaritruk%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Karl-G%5Cu00fcnter%22%2C%22lastName%22%3A%22Technau%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Thierry%22%2C%22lastName%22%3A%22Tiendrebeogo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christelle%22%2C%22lastName%22%3A%22Twizere%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marie%22%2C%22lastName%22%3A%22Ballif%22%7D%5D%2C%22abstractNote%22%3A%22OBJECTIVE%3A%20We%20studied%20the%20transition%20to%20dolutegravir-containing%20antiretroviral%20therapy%20%28ART%29%20at%20HIV%20treatment%20clinics%20within%20the%20International%20epidemiology%20Databases%20to%20Evaluate%20AIDS%20%28IeDEA%29.%5CnDESIGN%3A%20Site-level%20survey%20conducted%20in%202020-2021%20among%20HIV%20clinics%20in%20low-%20and%20middle-income%20countries%20%28LMICs%29.%5CnMETHODS%3A%20We%20assessed%20the%20status%20of%20dolutegravir%20rollout%20and%20viral%20load%20and%20drug%20resistance%20testing%20practices%20for%20patients%20on%20ART%20switching%20to%20dolutegravir-based%20regimens.%20We%20used%20generalized%20estimating%20equations%20to%20assess%20associations%20between%20clinic%20rollout%20of%20both%20first-%20and%20second-line%20dolutegravir-based%20ART%20regimens%20%28dual%20rollout%29%20and%20site-level%20factors.%5CnRESULTS%3A%20Of%20179%20surveyed%20clinics%2C%20175%20%2898%25%29%20participated%3B%20137%20%2878%25%29%20from%20Africa%2C%2030%20%2817%25%29%20from%20the%20Asia-Pacific%2C%20and%208%20%285%25%29%20from%20Latin%20America.%20Most%20clinics%20%2880%25%29%20were%20in%20low-%20or%20lower-middle-income%20countries%2C%20and%20there%20were%20a%20mix%20of%20primary-%2C%20secondary-%20and%20tertiary-level%20clinics.%20Ninety%20percent%20reported%20rollout%20of%20first-line%20dolutegravir%2C%2059%25%20of%20second-line%2C%2094%25%20of%20first-%20or%20second-line%20and%2055%25%20of%20dual%20rollout.%20The%20adjusted%20odds%20of%20dual%20rollout%20were%20higher%20among%20tertiary-level%20%28aOR%204.00%3B%2095%25%20CI%201.39%20to%2011.47%29%20and%20secondary-level%20clinics%20%28aOR%203.66%3B%2095%25%20CI%202.19%20to%206.11%29%20than%20in%20primary-level%20clinics.%20Over%20half%20%2859%25%29%20of%20clinics%20that%20introduced%20first-%20or%20second-line%20dolutegravir-based%20ART%20required%20recent%20viral%20load%20testing%20before%20switching%20to%20dolutegravir%2C%20and%2015%25%20performed%20genotypic%20resistance%20testing%20at%20switch.%5CnCONCLUSIONS%3A%20Dolutegravir-based%20ART%20was%20rolled%20out%20at%20nearly%20all%20IeDEA%20clinics%20in%20LMICs%2C%20yet%20many%20switched%20patients%20to%20dolutegravir%20without%20recent%20viral%20load%20testing%20and%20drug%20resistance%20testing%20was%20rarely%20performed.%20Without%20such%20testing%2C%20drug%20resistance%20among%20patient%20switching%20to%20dolutegravir%20may%20go%20undetected.%22%2C%22date%22%3A%222024-09-05%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1097%5C%2FQAD.0000000000004007%22%2C%22ISSN%22%3A%221473-5571%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22GXCKG69T%22%2C%22ZVWK2Q45%22%2C%22D9WC3N3V%22%2C%22TCMBXKKM%22%2C%228IRGNQWZ%22%2C%22F2Y6PLUL%22%2C%22ZBJI578D%22%2C%22YAE5EUBI%22%2C%223FNU2D64%22%5D%2C%22dateModified%22%3A%222025-03-10T15%3A22%3A41Z%22%7D%7D%2C%7B%22key%22%3A%22XY975M2U%22%2C%22library%22%3A%7B%22id%22%3A2775998%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Egger%20et%20al.%22%2C%22parsedDate%22%3A%222024-08-21%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BEgger%2C%20Matthias%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BSauermann%2C%20Mamatha%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BLoosli%2C%20Tom%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BHossmann%2C%20Stefanie%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BRiedo%2C%20Selma%26lt%3B%5C%2Fspan%26gt%3B%20et%20al.%26lt%3B%5C%2Fspan%26gt%3B%20%282024%29.%20HIV-1%20subtype-specific%20drug%20resistance%20on%20dolutegravir-based%20antiretroviral%20therapy%3A%20protocol%20for%20a%20multicentre%20study%20%28DTG%20RESIST%29.%20%26lt%3Bi%26gt%3BBMJ%20Open%26lt%3B%5C%2Fi%26gt%3B%2C%20%26lt%3Bi%26gt%3B14%26lt%3B%5C%2Fi%26gt%3B%20%288%29%2C%20S.%20e085819.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1136%5C%2Fbmjopen-2024-085819%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1136%5C%2Fbmjopen-2024-085819%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22HIV-1%20subtype-specific%20drug%20resistance%20on%20dolutegravir-based%20antiretroviral%20therapy%3A%20protocol%20for%20a%20multicentre%20study%20%28DTG%20RESIST%29%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Matthias%22%2C%22lastName%22%3A%22Egger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mamatha%22%2C%22lastName%22%3A%22Sauermann%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tom%22%2C%22lastName%22%3A%22Loosli%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Stefanie%22%2C%22lastName%22%3A%22Hossmann%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Selma%22%2C%22lastName%22%3A%22Riedo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Niko%22%2C%22lastName%22%3A%22Beerenwinkel%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Antoine%22%2C%22lastName%22%3A%22Jaquet%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Albert%22%2C%22lastName%22%3A%22Minga%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jeremy%22%2C%22lastName%22%3A%22Ross%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jennifer%22%2C%22lastName%22%3A%22Giandhari%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Roger%20D.%22%2C%22lastName%22%3A%22Kouyos%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Richard%22%2C%22lastName%22%3A%22Lessells%22%7D%5D%2C%22abstractNote%22%3A%22INTRODUCTION%3A%20HIV%20drug%20resistance%20poses%20a%20challenge%20to%20the%20United%20Nation%26%23039%3Bs%20goal%20of%20ending%20the%20HIV%5C%2FAIDS%20epidemic.%20The%20integrase%20strand%20transfer%20inhibitor%20%28InSTI%29%20dolutegravir%2C%20which%20has%20a%20higher%20resistance%20barrier%2C%20was%20endorsed%20by%20the%20WHO%20in%202019%20for%20first-line%2C%20second-line%20and%20third-line%20antiretroviral%20therapy%20%28ART%29.%20This%20multiplicity%20of%20roles%20of%20dolutegravir%20in%20ART%20may%20facilitate%20the%20emergence%20of%20dolutegravir%20resistance.%5CnMETHODS%20AND%20ANALYSIS%3A%20Nested%20within%20the%20International%20epidemiology%20Databases%20to%20Evaluate%20AIDS%20%28IeDEA%29%2C%20DTG%20RESIST%20is%20a%20multicentre%20study%20of%20adults%20and%20adolescents%20living%20with%20HIV%20in%20sub-Saharan%20Africa%2C%20Asia%2C%20and%20South%20and%20Central%20America%20who%20experienced%20virological%20failure%20on%20dolutegravir-based%20ART.%20At%20the%20time%20of%20virological%20failure%2C%20whole%20blood%20will%20be%20collected%20and%20processed%20to%20prepare%20plasma%20or%20dried%20blood%20spots.%20Laboratories%20in%20Durban%2C%20Mexico%20City%20and%20Bangkok%20will%20perform%20genotyping.%20Analyses%20will%20focus%20on%20%281%29%20individuals%20who%20experienced%20virological%20failure%20on%20dolutegravir%20and%20%282%29%20those%20who%20started%20or%20switched%20to%20such%20a%20regimen%20and%20were%20at%20risk%20of%20virological%20failure.%20For%20population%20%281%29%2C%20the%20outcome%20will%20be%20any%20InSTI%20drug%20resistance%20mutations%2C%20and%20for%20population%20%282%29%20virological%20failure%20is%20defined%20as%20a%20viral%20load%20%26gt%3B1000%20copies%5C%2FmL.%20Phenotypic%20testing%20will%20focus%20on%20non-B%20subtype%20viruses%20with%20major%20InSTI%20resistance%20mutations.%20Bayesian%20evolutionary%20models%20will%20explore%20and%20predict%20treatment%20failure%20genotypes.%20The%20study%20will%20have%20intermediate%20statistical%20power%20to%20detect%20differences%20in%20resistance%20mutation%20prevalence%20between%20major%20HIV-1%20subtypes%3B%20ample%20power%20to%20identify%20risk%20factors%20for%20virological%20failure%20and%20limited%20power%20for%20analysing%20factors%20associated%20with%20individual%20InSTI%20drug%20resistance%20mutations.%5CnETHICS%20AND%20DISSEMINATION%3A%20The%20research%20protocol%20was%20approved%20by%20the%20Biomedical%20Research%20Ethics%20Committee%20at%20the%20University%20of%20KwaZulu-Natal%2C%20South%20Africa%20and%20the%20Ethics%20Committee%20of%20the%20Canton%20of%20Bern%2C%20Switzerland.%20All%20sites%20participate%20in%20International%20epidemiology%20Databases%20to%20Evaluate%20AIDS%20and%20have%20obtained%20ethics%20approval%20from%20their%20local%20ethics%20committee%20to%20collect%20additional%20data.%5CnTRIAL%20REGISTRATION%20NUMBER%3A%20NCT06285110.%22%2C%22date%22%3A%222024-08-21%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1136%5C%2Fbmjopen-2024-085819%22%2C%22ISSN%22%3A%222044-6055%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22GXCKG69T%22%2C%22D9WC3N3V%22%2C%22TCMBXKKM%22%2C%228IRGNQWZ%22%2C%22F2Y6PLUL%22%2C%22ZBJI578D%22%2C%223FNU2D64%22%5D%2C%22dateModified%22%3A%222025-03-06T12%3A15%3A24Z%22%7D%7D%2C%7B%22key%22%3A%22BIDVG29V%22%2C%22library%22%3A%7B%22id%22%3A2775998%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Barreto-Duarte%20et%20al.%22%2C%22parsedDate%22%3A%222024-08%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BBarreto-Duarte%2C%20Beatriz%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BVillalva-Serra%2C%20Klauss%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BMiguez-Pinto%2C%20Jo%26%23xE3%3Bo%20P.%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BAra%26%23xFA%3Bjo-Pereira%2C%20Mariana%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BCampos%2C%20Vanessa%20M.%20S.%26lt%3B%5C%2Fspan%26gt%3B%20et%20al.%26lt%3B%5C%2Fspan%26gt%3B%20%282024%29.%20Retreatment%20and%20Anti-tuberculosis%20Therapy%20Outcomes%20in%20Brazil%20Between%202015%20and%202022%3A%20A%20Nationwide%20Study.%20%26lt%3Bi%26gt%3BOpen%20Forum%20Infectious%20Diseases%26lt%3B%5C%2Fi%26gt%3B%2C%20%26lt%3Bi%26gt%3B11%26lt%3B%5C%2Fi%26gt%3B%20%288%29%2C%20S.%20ofae416.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1093%5C%2Fofid%5C%2Fofae416%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1093%5C%2Fofid%5C%2Fofae416%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Retreatment%20and%20Anti-tuberculosis%20Therapy%20Outcomes%20in%20Brazil%20Between%202015%20and%202022%3A%20A%20Nationwide%20Study%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Beatriz%22%2C%22lastName%22%3A%22Barreto-Duarte%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Klauss%22%2C%22lastName%22%3A%22Villalva-Serra%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jo%5Cu00e3o%20P.%22%2C%22lastName%22%3A%22Miguez-Pinto%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mariana%22%2C%22lastName%22%3A%22Ara%5Cu00fajo-Pereira%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vanessa%20M.%20S.%22%2C%22lastName%22%3A%22Campos%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gabriela%22%2C%22lastName%22%3A%22Rosier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bet%5Cu00e2nia%20M.%20F.%22%2C%22lastName%22%3A%22Nogueira%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Artur%20T.%20L.%22%2C%22lastName%22%3A%22Queiroz%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Valeria%20C.%22%2C%22lastName%22%3A%22Rolla%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marcelo%22%2C%22lastName%22%3A%22Cordeiro-Santos%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Afr%5Cu00e2nio%20L.%22%2C%22lastName%22%3A%22Kritski%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Leonardo%22%2C%22lastName%22%3A%22Martinez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20F.%22%2C%22lastName%22%3A%22Rebeiro%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Timothy%20R.%22%2C%22lastName%22%3A%22Sterling%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Moreno%20M.%22%2C%22lastName%22%3A%22Rodrigues%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bruno%20B.%22%2C%22lastName%22%3A%22Andrade%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20Adherence%20to%20anti-tuberculosis%20treatment%20%28ATT%29%20in%20Brazil%20remains%20a%20challenge%20in%20achieving%20the%20goals%20set%20by%20the%20World%20Health%20Organization%20%28WHO%29.%20Patients%20who%20are%20lost%20to%20follow-up%20during%20treatment%20pose%20a%20significant%20public%20health%20problem.%20This%20study%20aimed%20to%20investigate%20the%20factors%20associated%20with%20unfavorable%20ATT%20outcomes%20among%20those%20undergoing%20retreatment%20in%20Brazil.%5CnMETHODS%3A%20We%20conducted%20an%20observational%20study%20of%20patients%20aged%20%5Cu226518%20years%20with%20tuberculosis%20%28TB%29%20reported%20to%20the%20Brazilian%20National%20Notifiable%20Disease%20Information%20System%20between%202015%20and%202022.%20Clinical%20and%20epidemiologic%20variables%20were%20compared%20between%20the%20study%20groups%20%28new%20cases%20and%20retreatment%29.%20Regression%20models%20identified%20variables%20associated%20with%20unfavorable%20outcomes.%5CnRESULTS%3A%20Among%20743%20823%20reported%20TB%20cases%20in%20the%20study%20period%2C%20555%20632%20cases%20were%20eligible%2C%20consisting%20of%20462%20061%20new%20cases%20and%2093%20571%20undergoing%20retreatments%20%2844%20642%20recurrent%20and%2048%20929%20retreatments%20after%20loss%20to%20follow-up%20%5BRLTFU%5D%29.%20RLTFU%20%28odds%20ratio%20%5BOR%5D%2C%203.96%20%5B95%25%20confidence%20interval%20%7BCI%7D%2C%203.83-4.1%5D%29%20was%20a%20significant%20risk%20factor%20for%20any%20type%20of%20unfavorable%20ATT.%20Furthermore%2C%20RLTFU%20%28OR%2C%204.93%20%5B95%25%20CI%2C%204.76-5.11%5D%29%20was%20the%20main%20risk%20factor%20for%20subsequent%20LTFU.%20For%20death%2C%20aside%20from%20advanced%20age%2C%20living%20with%20HIV%20%28OR%2C%206.28%20%5B95%25%20CI%2C%206.03-6.54%5D%29%20was%20the%20top%20risk%20factor.%5CnCONCLUSIONS%3A%20Retreatment%20is%20a%20substantial%20risk%20factor%20for%20unfavorable%20ATT%20outcomes%2C%20especially%20after%20LTFU.%20The%20rates%20of%20treatment%20success%20in%20RLTFU%20are%20distant%20from%20the%20WHO%20End%20TB%20Strategy%20targets%20throughout%20Brazil.%20These%20findings%20underscore%20the%20need%20for%20targeted%20interventions%20to%20improve%20treatment%20adherence%20and%20outcomes%20in%20persons%20who%20experience%20RLTFU.%22%2C%22date%22%3A%222024-08%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1093%5C%2Fofid%5C%2Fofae416%22%2C%22ISSN%22%3A%222328-8957%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22GXCKG69T%22%2C%22F2Y6PLUL%22%5D%2C%22dateModified%22%3A%222024-09-02T06%3A49%3A52Z%22%7D%7D%2C%7B%22key%22%3A%22Y7K3REIE%22%2C%22library%22%3A%7B%22id%22%3A2775998%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Lotspeich%20et%20al.%22%2C%22parsedDate%22%3A%222024-06%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BLotspeich%2C%20Sarah%20C.%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BAmorim%2C%20Gustavo%20G.%20C.%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BShaw%2C%20Pamela%20A.%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BTao%2C%20Ran%26lt%3B%5C%2Fspan%26gt%3B%20%26amp%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BShepherd%2C%20Bryan%20E.%26lt%3B%5C%2Fspan%26gt%3B%20%282024%29.%20Optimal%20multiwave%20validation%20of%20secondary%20use%20data%20with%20outcome%20and%20exposure%20misclassification.%20%26lt%3Bi%26gt%3BThe%20Canadian%20Journal%20of%20Statistics%20%3D%20Revue%20Canadienne%20De%20Statistique%26lt%3B%5C%2Fi%26gt%3B%2C%20%26lt%3Bi%26gt%3B52%26lt%3B%5C%2Fi%26gt%3B%20%282%29%2C%20S.%20532%26%23x2013%3B554.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1002%5C%2Fcjs.11772%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1002%5C%2Fcjs.11772%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Optimal%20multiwave%20validation%20of%20secondary%20use%20data%20with%20outcome%20and%20exposure%20misclassification%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sarah%20C.%22%2C%22lastName%22%3A%22Lotspeich%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gustavo%20G.%20C.%22%2C%22lastName%22%3A%22Amorim%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Pamela%20A.%22%2C%22lastName%22%3A%22Shaw%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ran%22%2C%22lastName%22%3A%22Tao%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bryan%20E.%22%2C%22lastName%22%3A%22Shepherd%22%7D%5D%2C%22abstractNote%22%3A%22Observational%20databases%20provide%20unprecedented%20opportunities%20for%20secondary%20use%20in%20biomedical%20research.%20However%2C%20these%20data%20can%20be%20error-prone%20and%20must%20be%20validated%20before%20use.%20It%20is%20usually%20unrealistic%20to%20validate%20the%20whole%20database%20because%20of%20resource%20constraints.%20A%20cost-effective%20alternative%20is%20a%20two-phase%20design%20that%20validates%20a%20subset%20of%20records%20enriched%20for%20information%20about%20a%20particular%20research%20question.%20We%20consider%20odds%20ratio%20estimation%20under%20differential%20outcome%20and%20exposure%20misclassification%20and%20propose%20optimal%20designs%20that%20minimize%20the%20variance%20of%20the%20maximum%20likelihood%20estimator.%20Our%20adaptive%20grid%20search%20algorithm%20can%20locate%20the%20optimal%20design%20in%20a%20computationally%20feasible%20manner.%20Because%20the%20optimal%20design%20relies%20on%20unknown%20parameters%2C%20we%20introduce%20a%20multiwave%20strategy%20to%20approximate%20the%20optimal%20design.%20We%20demonstrate%20the%20proposed%20design%26%23039%3Bs%20efficiency%20gains%20through%20simulations%20and%20two%20large%20observational%20studies.%22%2C%22date%22%3A%222024-06%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1002%5C%2Fcjs.11772%22%2C%22ISSN%22%3A%220319-5724%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22GXCKG69T%22%2C%22F2Y6PLUL%22%5D%2C%22dateModified%22%3A%222024-12-16T10%3A09%3A57Z%22%7D%7D%2C%7B%22key%22%3A%22YRXXW78T%22%2C%22library%22%3A%7B%22id%22%3A2775998%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Gorsline%20et%20al.%22%2C%22parsedDate%22%3A%222024-06%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BGorsline%2C%20Chelsea%20A.%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BLotspeich%2C%20Sarah%20C.%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BBelaunzar%26%23xE1%3Bn-Zamudio%2C%20Pablo%20F.%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BMejia%2C%20Fernando%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BCortes%2C%20Claudia%20P.%26lt%3B%5C%2Fspan%26gt%3B%20et%20al.%26lt%3B%5C%2Fspan%26gt%3B%20%282024%29.%20The%20impact%20of%20earthquakes%20in%20Latin%20America%20on%20the%20continuity%20of%20HIV%20care%3A%20A%20retrospective%20observational%20cohort%20study.%20%26lt%3Bi%26gt%3BPublic%20Health%20in%20Practice%20%28Oxford%2C%20England%29%26lt%3B%5C%2Fi%26gt%3B%2C%20%26lt%3Bi%26gt%3B7%26lt%3B%5C%2Fi%26gt%3B%2C%20S.%20100479.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.puhip.2024.100479%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.puhip.2024.100479%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22The%20impact%20of%20earthquakes%20in%20Latin%20America%20on%20the%20continuity%20of%20HIV%20care%3A%20A%20retrospective%20observational%20cohort%20study%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Chelsea%20A.%22%2C%22lastName%22%3A%22Gorsline%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sarah%20C.%22%2C%22lastName%22%3A%22Lotspeich%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Pablo%20F.%22%2C%22lastName%22%3A%22Belaunzar%5Cu00e1n-Zamudio%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fernando%22%2C%22lastName%22%3A%22Mejia%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Claudia%20P.%22%2C%22lastName%22%3A%22Cortes%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Brenda%22%2C%22lastName%22%3A%22Crabtree-Ram%5Cu00edrez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Damocles%20Patrice%22%2C%22lastName%22%3A%22Severe%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vanessa%22%2C%22lastName%22%3A%22Rouzier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Catherine%20C.%22%2C%22lastName%22%3A%22McGowan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20F.%22%2C%22lastName%22%3A%22Rebeiro%22%7D%5D%2C%22abstractNote%22%3A%22OBJECTIVES%3A%20As%20earthquakes%20occur%20frequently%20in%20Latin%20America%20and%20can%20cause%20significant%20disruptions%20in%20HIV%20care%2C%20we%20sought%20to%20analyze%20patterns%20of%20HIV%20care%20for%20adults%20at%20Latin%20American%20clinical%20sites%20experiencing%20a%20significant%20earthquake%20within%20the%20past%20two%20decades.%5CnSTUDY%20DESIGN%3A%20Retrospective%20clinical%20cohort%20study.%5CnMETHODS%3A%20Adults%20receiving%20HIV%20care%20at%20sites%20experiencing%20at%20least%20a%20%26quot%3Bmoderate%20intensity%26quot%3B%20%28Modified%20Mercalli%20scale%29%20earthquake%20in%20the%20Caribbean%2C%20Central%20and%20South%20America%20network%20for%20HIV%20epidemiology%20%28CCASAnet%29%20contributed%20data%20from%202003%20to%202017.%20Interrupted%20Time%20Series%20models%20were%20fit%20with%20discontinuities%20at%20site-specific%20earthquake%20dates%20%28Sept.%2016%2C%202015%20in%20Chile%3B%20Apr.%2018%2C%202014%20and%20Sept.%2019%2C%202017%20in%20Mexico%3B%20and%20Aug.%2015%2C%202007%20in%20Peru%29%20to%20assess%20clinical%20visit%2C%20CD4%20measure%2C%20viral%20load%20lab%2C%20and%20ART%20initiation%20rates%203-%20and%206-months%20after%20versus%20before%20earthquakes.%5CnRESULTS%3A%20Comparing%20post-to%20pre-earthquake%20periods%2C%20there%20was%20a%20sharp%20drop%20in%20median%20visit%20%28incidence%20rate%20ratio%20%5BIRR%5D%5Cu00a0%3D%5Cu00a00.79%2C%2095%25%20confidence%20interval%20%5BCI%5D%3A%200.68-0.91%29%20and%20viral%20load%20lab%20%28IRR%5Cu00a0%3D%5Cu00a00.78%2C%2095%25%20CI%3A%200.62-0.99%29%20rates%20per%20week%2C%20using%20a%203-month%20window.%20CD4%20measurement%20rates%20also%20decreased%20%28IRR%5Cu00a0%3D%5Cu00a00.43%3B%2095%25%20CI%3A%200.37-0.51%29%2C%20though%20only%20using%20a%206-month%20window.%5CnCONCLUSIONS%3A%20Given%20that%20earthquakes%20occur%20frequently%20in%20Latin%20America%2C%20disaster%20preparedness%20plans%20must%20be%20more%20broadly%20implemented%20to%20avoid%20disruptions%20in%20HIV%20care%20and%20attendant%20poor%20outcomes.%22%2C%22date%22%3A%222024-06%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.puhip.2024.100479%22%2C%22ISSN%22%3A%222666-5352%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22GXCKG69T%22%2C%22F2Y6PLUL%22%5D%2C%22dateModified%22%3A%222024-04-12T12%3A43%3A54Z%22%7D%7D%2C%7B%22key%22%3A%229RZS3LVI%22%2C%22library%22%3A%7B%22id%22%3A2775998%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Rodrigues%20et%20al.%22%2C%22parsedDate%22%3A%222024-05-23%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BRodrigues%2C%20Moreno%20M.%20S.%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BBarreto-Duarte%2C%20Beatriz%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BVinhaes%2C%20Caian%20L.%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BAra%26%23xFA%3Bjo-Pereira%2C%20Mariana%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BFukutani%2C%20Eduardo%20R.%26lt%3B%5C%2Fspan%26gt%3B%20et%20al.%26lt%3B%5C%2Fspan%26gt%3B%20%282024%29.%20Machine%20learning%20algorithms%20using%20national%20registry%20data%20to%20predict%20loss%20to%20follow-up%20during%20tuberculosis%20treatment.%20%26lt%3Bi%26gt%3BBMC%20Public%20Health%26lt%3B%5C%2Fi%26gt%3B%2C%20%26lt%3Bi%26gt%3B24%26lt%3B%5C%2Fi%26gt%3B%20%281%29%2C%20S.%201385.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1186%5C%2Fs12889-024-18815-0%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1186%5C%2Fs12889-024-18815-0%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Machine%20learning%20algorithms%20using%20national%20registry%20data%20to%20predict%20loss%20to%20follow-up%20during%20tuberculosis%20treatment%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Moreno%20M.%20S.%22%2C%22lastName%22%3A%22Rodrigues%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Beatriz%22%2C%22lastName%22%3A%22Barreto-Duarte%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Caian%20L.%22%2C%22lastName%22%3A%22Vinhaes%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mariana%22%2C%22lastName%22%3A%22Ara%5Cu00fajo-Pereira%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eduardo%20R.%22%2C%22lastName%22%3A%22Fukutani%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Keityane%20Bone%22%2C%22lastName%22%3A%22Bergamaschi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Afr%5Cu00e2nio%22%2C%22lastName%22%3A%22Kristki%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marcelo%22%2C%22lastName%22%3A%22Cordeiro-Santos%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Valeria%20C.%22%2C%22lastName%22%3A%22Rolla%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Timothy%20R.%22%2C%22lastName%22%3A%22Sterling%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Artur%20T.%20L.%22%2C%22lastName%22%3A%22Queiroz%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bruno%20B.%22%2C%22lastName%22%3A%22Andrade%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20Identifying%20patients%20at%20increased%20risk%20of%20loss%20to%20follow-up%20%28LTFU%29%20is%20key%20to%20developing%20strategies%20to%20optimize%20the%20clinical%20management%20of%20tuberculosis%20%28TB%29.%20The%20use%20of%20national%20registry%20data%20in%20prediction%20models%20may%20be%20a%20useful%20tool%20to%20inform%20healthcare%20workers%20about%20risk%20of%20LTFU.%20Here%20we%20developed%20a%20score%20to%20predict%20the%20risk%20of%20LTFU%20during%20anti-TB%20treatment%20%28ATT%29%20in%20a%20nationwide%20cohort%20of%20cases%20using%20clinical%20data%20reported%20to%20the%20Brazilian%20Notifiable%20Disease%20Information%20System%20%28SINAN%29.%5CnMETHODS%3A%20We%20performed%20a%20retrospective%20study%20of%20all%20TB%20cases%20reported%20to%20SINAN%20between%202015%20and%202022%3B%20excluding%20children%20%28%26lt%3B%5Cu200918%20years-old%29%2C%20vulnerable%20groups%20or%20drug-resistant%20TB.%20For%20the%20score%2C%20data%20before%20treatment%20initiation%20were%20used.%20We%20trained%20and%20internally%20validated%20three%20different%20prediction%20scoring%20systems%2C%20based%20on%20Logistic%20Regression%2C%20Random%20Forest%2C%20and%20Light%20Gradient%20Boosting.%20Before%20applying%20our%20models%20we%20splitted%20our%20data%20into%20training%20%28~%5Cu200980%25%20data%29%20and%20test%20%28~%5Cu200920%25%29%20sets%2C%20and%20then%20compared%20the%20model%20metrics%20using%20the%20test%20data%20set.%5CnRESULTS%3A%20Of%20the%20243%2C726%20cases%20included%2C%2041%2C373%20experienced%20LTFU%20whereas%20202%2C353%20were%20successfully%20treated.%20The%20groups%20were%20different%20with%20regards%20to%20several%20clinical%20and%20sociodemographic%20characteristics.%20The%20directly%20observed%20treatment%20%28DOT%29%20was%20unbalanced%20between%20the%20groups%20with%20lower%20prevalence%20in%20those%20who%20were%20LTFU.%20Three%20models%20were%20developed%20to%20predict%20LTFU%20using%208%20features%20%28prior%20TB%2C%20drug%20use%2C%20age%2C%20sex%2C%20HIV%20infection%20and%20schooling%20level%29%20with%20different%20score%20composition%20approaches.%20Those%20prediction%20scoring%20systems%20exhibited%20an%20area%20under%20the%20curve%20%28AUC%29%20ranging%20between%200.71%20and%200.72.%20The%20Light%20Gradient%20Boosting%20technique%20resulted%20in%20the%20best%20prediction%20performance%2C%20weighting%20specificity%20and%20sensitivity.%20A%20user-friendly%20web%20calculator%20app%20was%20developed%20%28%20https%3A%5C%2F%5C%2Ftbprediction.herokuapp.com%5C%2F%20%29%20to%20facilitate%20implementation.%5CnCONCLUSIONS%3A%20Our%20nationwide%20risk%20score%20predicts%20the%20risk%20of%20LTFU%20during%20ATT%20in%20Brazilian%20adults%20prior%20to%20treatment%20commencement%20utilizing%20schooling%20level%2C%20sex%2C%20age%2C%20prior%20TB%20status%2C%20and%20substance%20use%20%28drug%2C%20alcohol%2C%20and%5C%2For%20tobacco%29.%20This%20is%20a%20potential%20tool%20to%20assist%20in%20decision-making%20strategies%20to%20guide%20resource%20allocation%2C%20DOT%20indications%2C%20and%20improve%20TB%20treatment%20adherence.%22%2C%22date%22%3A%222024-05-23%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1186%5C%2Fs12889-024-18815-0%22%2C%22ISSN%22%3A%221471-2458%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22GXCKG69T%22%2C%22F2Y6PLUL%22%5D%2C%22dateModified%22%3A%222024-07-25T14%3A40%3A21Z%22%7D%7D%2C%7B%22key%22%3A%22EDIV7L8F%22%2C%22library%22%3A%7B%22id%22%3A2775998%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Kebede%20et%20al.%22%2C%22parsedDate%22%3A%222024-04-01%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BKebede%2C%20Samuel%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BBrazier%2C%20Ellen%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BFreeman%2C%20Aimee%20M.%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BMuwonge%2C%20Timothy%20R.%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BChoi%2C%20Jun%20Yong%26lt%3B%5C%2Fspan%26gt%3B%20et%20al.%26lt%3B%5C%2Fspan%26gt%3B%20%282024%29.%20Preexposure%20prophylaxis%20availability%20among%20health%20facilities%20participating%20in%20the%20global%20International%20epidemiology%20Databases%20to%20Evaluate%20AIDS%20%28IeDEA%29%20consortium.%20%26lt%3Bi%26gt%3BAIDS%20%28London%2C%20England%29%26lt%3B%5C%2Fi%26gt%3B%2C%20%26lt%3Bi%26gt%3B38%26lt%3B%5C%2Fi%26gt%3B%20%285%29%2C%20S.%20751%26%23x2013%3B756.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1097%5C%2FQAD.0000000000003824%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1097%5C%2FQAD.0000000000003824%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Preexposure%20prophylaxis%20availability%20among%20health%20facilities%20participating%20in%20the%20global%20International%20epidemiology%20Databases%20to%20Evaluate%20AIDS%20%28IeDEA%29%20consortium%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Samuel%22%2C%22lastName%22%3A%22Kebede%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ellen%22%2C%22lastName%22%3A%22Brazier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Aimee%20M.%22%2C%22lastName%22%3A%22Freeman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Timothy%20R.%22%2C%22lastName%22%3A%22Muwonge%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jun%20Yong%22%2C%22lastName%22%3A%22Choi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Renee%22%2C%22lastName%22%3A%22de%20Waal%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Armel%22%2C%22lastName%22%3A%22Poda%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Carina%22%2C%22lastName%22%3A%22Cesar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Athanase%22%2C%22lastName%22%3A%22Munyaneza%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Charles%22%2C%22lastName%22%3A%22Kasozi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mark%20Kristoffer%20U.%22%2C%22lastName%22%3A%22Pasayan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Keri%20N.%22%2C%22lastName%22%3A%22Althoff%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alisho%22%2C%22lastName%22%3A%22Shongo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicola%22%2C%22lastName%22%3A%22Low%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Didier%22%2C%22lastName%22%3A%22Ekouevi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Valdil%5Cu00e9a%20G.%22%2C%22lastName%22%3A%22Veloso%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jonathan%22%2C%22lastName%22%3A%22Ross%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22International%20Epidemiology%20Databases%20to%20Evaluate%20AIDS%20%28IeDEA%29%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20While%20recognized%20as%20a%20key%20HIV%20prevention%20strategy%2C%20preexposure%20prophylaxis%20%28PrEP%29%20availability%20and%20accessibility%20are%20not%20well%20documented%20globally.%20We%20aimed%20to%20describe%20PrEP%20drug%20registration%20status%20and%20the%20availability%20of%20PrEP%20services%20across%20HIV%20care%20sites%20participating%20in%20the%20International%20epidemiology%20Databases%20to%20Evaluate%20AIDS%20%28IeDEA%29%20research%20consortium.%5CnMETHODS%3A%20We%20used%20country-level%20PrEP%20drug%20registration%20status%20from%20the%20AIDS%20Vaccine%20Advocacy%20Coalition%20and%20data%20from%20IeDEA%20surveys%20conducted%20in%202014%2C%202017%20and%202020%20among%20participating%20HIV%20clinics%20in%20seven%20global%20regions.%20We%20used%20descriptive%20statistics%20to%20assess%20PrEP%20availability%20across%20IeDEA%20sites%20serving%20adult%20patients%20in%202020%20and%20examined%20trends%20in%20PrEP%20availability%20among%20sites%20that%20responded%20to%20all%20three%20surveys.%5CnRESULTS%3A%20Of%20199%20sites%20that%20completed%20the%202020%20survey%2C%20PrEP%20was%20available%20in%20161%20%2881%25%29.%20PrEP%20availability%20was%20highest%20at%20sites%20in%20North%20America%20%2829%5C%2F30%3B%2097%25%29%20and%20East%20Africa%20%2870%5C%2F74%3B%2095%25%29%20and%20lowest%20at%20sites%20in%20Central%20%2810%5C%2F20%3B%2050%25%29%20and%20West%20Africa%20%281%5C%2F6%3B%2017%25%29.%20PrEP%20availability%20was%20higher%20among%20sites%20in%20countries%20where%20PrEP%20was%20officially%20registered%20%28146%5C%2F161%3B%2091%25%29%20than%20where%20it%20was%20not%20%2814%5C%2F32%3B%2044%25%29.%20Availability%20was%20higher%20at%20health%20centers%20%28109%5C%2F120%3B%2090%25%29%20and%20district%20hospitals%20%2814%5C%2F16%3B%2088%25%29%20compared%20to%20regional%5C%2Fteaching%20hospitals%20%2836%5C%2F63%29.%20Among%20the%2094%20sites%20that%20responded%20to%20all%20three%20surveys%2C%20PrEP%20availability%20increased%20from%2047%25%20in%202014%20to%2060%25%20in%202017%20and%2076%25%20in%202020.%5CnCONCLUSION%3A%20PrEP%20availability%20has%20substantially%20increased%20since%202014%20and%20is%20now%20available%20at%20most%20IeDEA%20sites.%20However%2C%20PrEP%20service%20provision%20varies%20markedly%20across%20global%20regions.%22%2C%22date%22%3A%222024-04-01%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1097%5C%2FQAD.0000000000003824%22%2C%22ISSN%22%3A%221473-5571%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22GXCKG69T%22%2C%22ZVWK2Q45%22%2C%22D9WC3N3V%22%2C%22TCMBXKKM%22%2C%228IRGNQWZ%22%2C%22F2Y6PLUL%22%2C%22ZBJI578D%22%2C%22YAE5EUBI%22%2C%223FNU2D64%22%5D%2C%22dateModified%22%3A%222025-03-06T12%3A15%3A22Z%22%7D%7D%2C%7B%22key%22%3A%22GNS9IMDT%22%2C%22library%22%3A%7B%22id%22%3A2775998%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Plaisy%20et%20al.%22%2C%22parsedDate%22%3A%222024-04%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BPlaisy%2C%20Marie%20Kerbie%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BMinga%2C%20Albert%20K.%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BWandeler%2C%20Gilles%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BMurenzi%2C%20Gad%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BSamala%2C%20Niharika%26lt%3B%5C%2Fspan%26gt%3B%20et%20al.%26lt%3B%5C%2Fspan%26gt%3B%20%282024%29.%20Metabolic%20causes%20of%20liver%20disease%20among%20adults%20living%20with%20HIV%20from%20low-%20and%20middle-income%20countries%3A%20a%20cross-sectional%20study.%20%26lt%3Bi%26gt%3BJournal%20of%20the%20International%20AIDS%20Society%26lt%3B%5C%2Fi%26gt%3B%2C%20%26lt%3Bi%26gt%3B27%26lt%3B%5C%2Fi%26gt%3B%20%284%29%2C%20S.%20e26238.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1002%5C%2Fjia2.26238%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1002%5C%2Fjia2.26238%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Metabolic%20causes%20of%20liver%20disease%20among%20adults%20living%20with%20HIV%20from%20low-%20and%20middle-income%20countries%3A%20a%20cross-sectional%20study%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marie%20Kerbie%22%2C%22lastName%22%3A%22Plaisy%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Albert%20K.%22%2C%22lastName%22%3A%22Minga%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gilles%22%2C%22lastName%22%3A%22Wandeler%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gad%22%2C%22lastName%22%3A%22Murenzi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Niharika%22%2C%22lastName%22%3A%22Samala%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jeremy%22%2C%22lastName%22%3A%22Ross%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alvaro%22%2C%22lastName%22%3A%22Lopez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ephrem%22%2C%22lastName%22%3A%22Mensah%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ren%5Cu00e9e%22%2C%22lastName%22%3A%22de%20Waal%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mark%20H.%22%2C%22lastName%22%3A%22Kuniholm%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lameck%22%2C%22lastName%22%3A%22Diero%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sonali%22%2C%22lastName%22%3A%22Salvi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rodrigo%22%2C%22lastName%22%3A%22Moreira%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alain%22%2C%22lastName%22%3A%22Attia%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ardele%22%2C%22lastName%22%3A%22Mandiriri%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fabienne%22%2C%22lastName%22%3A%22Shumbusho%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Suzanne%22%2C%22lastName%22%3A%22Goodrich%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dhanushi%22%2C%22lastName%22%3A%22Rupasinghe%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Paola%22%2C%22lastName%22%3A%22Alarcon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fernanda%22%2C%22lastName%22%3A%22Maruri%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hugo%22%2C%22lastName%22%3A%22Perrazo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Antoine%22%2C%22lastName%22%3A%22Jaquet%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22Sentinel%20Research%20Network%20of%20the%20International%20epidemiology%20Databases%20to%20Evaluate%20AIDS%22%7D%5D%2C%22abstractNote%22%3A%22INTRODUCTION%3A%20Liver%20disease%20is%20a%20leading%20cause%20of%20morbidity%20and%20mortality%20among%20persons%20living%20with%20HIV%20%28PLHIV%29.%20While%20chronic%20viral%20hepatitis%20has%20been%20extensively%20studied%20in%20low-%20and%20middle-income%20countries%20%28LMICs%29%2C%20there%20is%20limited%20information%20about%20the%20burden%20of%20metabolic%20disorders%20on%20liver%20disease%20in%20PLHIV.%5CnMETHODS%3A%20We%20conducted%20a%20cross-sectional%20analysis%20of%20baseline%20data%20collected%20between%20October%202020%20and%20July%202022%20from%20the%20IeDEA-Sentinel%20Research%20Network%2C%20a%20prospective%20cohort%20enrolling%20PLHIV%20%5Cu226540%20years%20on%20antiretroviral%20treatment%20%28ART%29%20for%20%5Cu22656%20months%20from%20eight%20clinics%20in%20Asia%2C%20Americas%2C%20and%20central%2C%20East%2C%20southern%20and%20West%20Africa.%20Clinical%20assessments%2C%20laboratory%20testing%20on%20fasting%20blood%20samples%20and%20liver%20stiffness%20measurement%20%28LSM%29%5C%2Fcontrolled%20attenuation%20parameter%20%28CAP%29%20by%20vibration-controlled%20transient%20elastography%20were%20performed.%20Multivariable%20logistic%20regression%20models%20assessed%20factors%20associated%20with%20liver%20fibrosis%20%28LSM%20%5Cu22657.1%20kPa%29%20and%20steatosis%20%28CAP%20%5Cu2265248%20dB%5C%2Fm%29.%20Population%20attributable%20fraction%20%28PAF%29%20of%20each%20variable%20associated%20with%20significant%20liver%20fibrosis%20was%20estimated%20using%20Levin%26%23039%3Bs%20formula.%5CnRESULTS%3A%20Overall%2C%202120%20PLHIV%20%2856%25%20female%2C%20median%20age%2050%20%5Binterquartile%20range%3A%2045-56%5D%20years%29%20were%20included.%20The%20prevalence%20of%20obesity%20was%2019%25%2C%2012%25%20had%20type%202%20diabetes%20mellitus%20%28T2DM%29%2C%2029%25%20had%20hypertension%20and%2053%25%20had%20dyslipidaemia.%20The%20overall%20prevalence%20of%20liver%20fibrosis%20and%20steatosis%20was%207.6%25%20%2895%25%20confidence%20interval%20%5BCI%5D%206.1-8.4%29%20and%2028.4%25%20%2895%25%20CI%2026.5-30.7%29%2C%20respectively%2C%20with%20regional%20variability.%20Male%20sex%20at%20birth%20%28odds%20ratio%20%5BOR%5D%201.62%2C%20CI%201.10-2.40%29%2C%20overweight%5C%2Fobesity%20%28OR%20%3D%202.50%2C%2095%25%20CI%201.69-3.75%29%2C%20T2DM%20%28OR%202.26%2C%2095%25%20CI%201.46-3.47%29%20and%20prolonged%20exposure%20to%20didanosine%20%28OR%203.13%2C%2095%25%20CI%201.46-6.49%29%20were%20associated%20with%20liver%20fibrosis.%20Overweight%5C%2Fobesity%20and%20T2DM%20accounted%20for%2042%25%20and%2011%25%20of%20the%20PAF%20for%20liver%20fibrosis%2C%20while%20HBsAg%20and%20anti-HCV%20accounted%20for%203%25%20and%201%25%2C%20respectively.%20Factors%20associated%20with%20steatosis%20included%20overweight%5C%2Fobesity%20%28OR%204.25%2C%2095%25%20CI%203.29-5.51%29%2C%20T2DM%20%28OR%202.06%2C%2095%25%20CI%201.47-2.88%29%2C%20prolonged%20exposure%20to%20stavudine%20%28OR%201.69%2C%2095%25%20CI%201.27-2.26%29%20and%20dyslipidaemia%20%28OR%201.68%2C%2095%25%20CI%201.31-2.16%29.%5CnCONCLUSIONS%3A%20Metabolic%20disorders%20were%20significant%20risk%20factors%20for%20liver%20disease%20among%20PLHIV%20in%20LMICs.%20Early%20recognition%20of%20metabolic%20disorders%20risk%20factors%20might%20be%20helpful%20to%20guide%20clinical%20and%20lifestyle%20interventions.%20Further%20prospective%20studies%20are%20needed%20to%20determine%20the%20causative%20natures%20of%20these%20findings.%22%2C%22date%22%3A%222024-04%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1002%5C%2Fjia2.26238%22%2C%22ISSN%22%3A%221758-2652%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22GXCKG69T%22%2C%22ZVWK2Q45%22%2C%22D9WC3N3V%22%2C%22TCMBXKKM%22%2C%228IRGNQWZ%22%2C%22F2Y6PLUL%22%2C%22ZBJI578D%22%2C%223FNU2D64%22%5D%2C%22dateModified%22%3A%222025-03-17T13%3A02%3A12Z%22%7D%7D%2C%7B%22key%22%3A%22L9HJN877%22%2C%22library%22%3A%7B%22id%22%3A2775998%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Baker%20et%20al.%22%2C%22parsedDate%22%3A%222024-03-27%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BBaker%2C%20Paul%20J.%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BBohrer%2C%20Andrea%20C.%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BCastro%2C%20Ehydel%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BAmaral%2C%20Eduardo%20P.%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BSnow-Smith%2C%20Maryonne%26lt%3B%5C%2Fspan%26gt%3B%20et%20al.%26lt%3B%5C%2Fspan%26gt%3B%20%282024%29.%20The%20inflammatory%20microenvironment%20of%20the%20lung%20at%20the%20time%20of%20infection%20governs%20innate%20control%20of%20SARS-CoV-2%20replication.%20%26lt%3Bi%26gt%3BbioRxiv%3A%20The%20Preprint%20Server%20for%20Biology%26lt%3B%5C%2Fi%26gt%3B%2C%20S.%202024.03.27.586885.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1101%5C%2F2024.03.27.586885%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1101%5C%2F2024.03.27.586885%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22The%20inflammatory%20microenvironment%20of%20the%20lung%20at%20the%20time%20of%20infection%20governs%20innate%20control%20of%20SARS-CoV-2%20replication%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Paul%20J.%22%2C%22lastName%22%3A%22Baker%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Andrea%20C.%22%2C%22lastName%22%3A%22Bohrer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ehydel%22%2C%22lastName%22%3A%22Castro%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eduardo%20P.%22%2C%22lastName%22%3A%22Amaral%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Maryonne%22%2C%22lastName%22%3A%22Snow-Smith%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Flor%22%2C%22lastName%22%3A%22Torres-Ju%5Cu00e1rez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sydnee%20T.%22%2C%22lastName%22%3A%22Gould%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Artur%20T.%20L.%22%2C%22lastName%22%3A%22Queiroz%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eduardo%20R.%22%2C%22lastName%22%3A%22Fukutani%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Cassandra%20M.%22%2C%22lastName%22%3A%22Jordan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jaspal%20S.%22%2C%22lastName%22%3A%22Khillan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kyoungin%22%2C%22lastName%22%3A%22Cho%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Daniel%20L.%22%2C%22lastName%22%3A%22Barber%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bruno%20B.%22%2C%22lastName%22%3A%22Andrade%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Reed%20F.%22%2C%22lastName%22%3A%22Johnson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kerry%20L.%22%2C%22lastName%22%3A%22Hilligan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Katrin%20D.%22%2C%22lastName%22%3A%22Mayer-Barber%22%7D%5D%2C%22abstractNote%22%3A%22SARS-CoV-2%20infection%20leads%20to%20vastly%20divergent%20clinical%20outcomes%20ranging%20from%20asymptomatic%20infection%20to%20fatal%20disease.%20Co-morbidities%2C%20sex%2C%20age%2C%20host%20genetics%20and%20vaccine%20status%20are%20known%20to%20affect%20disease%20severity.%20Yet%2C%20how%20the%20inflammatory%20milieu%20of%20the%20lung%20at%20the%20time%20of%20SARS-CoV-2%20exposure%20impacts%20the%20control%20of%20viral%20replication%20remains%20poorly%20understood.%20We%20demonstrate%20here%20that%20immune%20events%20in%20the%20mouse%20lung%20closely%20preceding%20SARS-CoV-2%20infection%20significantly%20impact%20viral%20control%20and%20we%20identify%20key%20innate%20immune%20pathways%20required%20to%20limit%20viral%20replication.%20A%20diverse%20set%20of%20pulmonary%20inflammatory%20stimuli%2C%20including%20resolved%20antecedent%20respiratory%20infections%20with%20S.%20aureus%20or%20influenza%2C%20ongoing%20pulmonary%20M.%20tuberculosis%20infection%2C%20ovalbumin%5C%2Falum-induced%20asthma%20or%20airway%20administration%20of%20defined%20TLR%20ligands%20and%20recombinant%20cytokines%2C%20all%20establish%20an%20antiviral%20state%20in%20the%20lung%20that%20restricts%20SARS-CoV-2%20replication%20upon%20infection.%20In%20addition%20to%20antiviral%20type%20I%20interferons%2C%20the%20broadly%20inducible%20inflammatory%20cytokines%20TNF%5Cu03b1%20and%20IL-1%20precondition%20the%20lung%20for%20enhanced%20viral%20control.%20Collectively%2C%20our%20work%20shows%20that%20SARS-CoV-2%20may%20benefit%20from%20an%20immunologically%20quiescent%20lung%20microenvironment%20and%20suggests%20that%20heterogeneity%20in%20pulmonary%20inflammation%20that%20precedes%20or%20accompanies%20SARS-CoV-2%20exposure%20may%20be%20a%20significant%20factor%20contributing%20to%20the%20population-wide%20variability%20in%20COVID-19%20disease%20outcomes.%22%2C%22date%22%3A%222024-03-27%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1101%5C%2F2024.03.27.586885%22%2C%22ISSN%22%3A%22%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22GXCKG69T%22%2C%22F2Y6PLUL%22%5D%2C%22dateModified%22%3A%222024-04-12T12%3A32%3A24Z%22%7D%7D%2C%7B%22key%22%3A%22Y9257EJM%22%2C%22library%22%3A%7B%22id%22%3A2775998%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Vinhaes%20et%20al.%22%2C%22parsedDate%22%3A%222024-03-15%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BVinhaes%2C%20Caian%20L.%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BFukutani%2C%20Eduardo%20R.%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BSantana%2C%20Gabriel%20C.%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BArriaga%2C%20Mar%26%23xED%3Ba%20B.%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BBarreto-Duarte%2C%20Beatriz%26lt%3B%5C%2Fspan%26gt%3B%20et%20al.%26lt%3B%5C%2Fspan%26gt%3B%20%282024%29.%20An%20integrative%20multi-omics%20approach%20to%20characterize%20interactions%20between%20tuberculosis%20and%20diabetes%20mellitus.%20%26lt%3Bi%26gt%3BiScience%26lt%3B%5C%2Fi%26gt%3B%2C%20%26lt%3Bi%26gt%3B27%26lt%3B%5C%2Fi%26gt%3B%20%283%29%2C%20S.%20109135.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.isci.2024.109135%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.isci.2024.109135%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22An%20integrative%20multi-omics%20approach%20to%20characterize%20interactions%20between%20tuberculosis%20and%20diabetes%20mellitus%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Caian%20L.%22%2C%22lastName%22%3A%22Vinhaes%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eduardo%20R.%22%2C%22lastName%22%3A%22Fukutani%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gabriel%20C.%22%2C%22lastName%22%3A%22Santana%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mar%5Cu00eda%20B.%22%2C%22lastName%22%3A%22Arriaga%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Beatriz%22%2C%22lastName%22%3A%22Barreto-Duarte%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mariana%22%2C%22lastName%22%3A%22Ara%5Cu00fajo-Pereira%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mateus%22%2C%22lastName%22%3A%22Maggitti-Bezerril%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alice%20M.%20S.%22%2C%22lastName%22%3A%22Andrade%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marina%20C.%22%2C%22lastName%22%3A%22Figueiredo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ginger%20L.%22%2C%22lastName%22%3A%22Milne%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Valeria%20C.%22%2C%22lastName%22%3A%22Rolla%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Afr%5Cu00e2nio%20L.%22%2C%22lastName%22%3A%22Kristki%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marcelo%22%2C%22lastName%22%3A%22Cordeiro-Santos%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Timothy%20R.%22%2C%22lastName%22%3A%22Sterling%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bruno%20B.%22%2C%22lastName%22%3A%22Andrade%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Artur%20T.%20L.%22%2C%22lastName%22%3A%22Queiroz%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22RePORT%20Brazil%20Consortium%22%7D%5D%2C%22abstractNote%22%3A%22Tuberculosis-diabetes%20mellitus%20%28TB-DM%29%20is%20linked%20to%20a%20distinct%20inflammatory%20profile%2C%20which%20can%20be%20assessed%20using%20multi-omics%20analyses.%20Here%2C%20a%20machine%20learning%20algorithm%20was%20applied%20to%20multi-platform%20data%2C%20including%20cytokines%20and%20gene%20expression%20in%20peripheral%20blood%20and%20eicosanoids%20in%20urine%2C%20in%20a%20Brazilian%20multi-center%20TB%20cohort.%20There%20were%20four%20clinical%20groups%3A%20TB-DM%28n%5Cu00a0%3D%2024%29%2C%20TB%20only%28n%5Cu00a0%3D%2028%29%2C%20DM%28HbA1c%20%5Cu2265%206.5%25%29%20only%28n%5Cu00a0%3D%2011%29%2C%20and%20a%20control%20group%20of%20close%20TB%20contacts%20who%20did%20not%20have%20TB%20or%20DM%28n%5Cu00a0%3D%2013%29.%20After%5Cu00a0cross-validation%2C%20baseline%20expression%20or%20abundance%20of%20MMP-28%2C%20LTE-4%2C%2011-dTxB2%2C%20PGDM%2C%20FBXO6%2C%20SECTM1%2C%20and%20LINCO2009%20differentiated%20the%20four%20patient%20groups.%20A%20distinct%20multi-omic-derived%2C%20dimensionally%20reduced%2C%20signature%20was%20associated%20with%20TB%2C%20regardless%20of%20glycemic%20status.%20SECTM1%20and%20FBXO6%20mRNA%20levels%20were%20positively%20correlated%20with%20sputum%20acid-fast%20bacilli%20grade%20in%20TB-DM.%20Values%20of%20the%20biomarkers%20decreased%20during%20the%20course%20of%20anti-TB%20therapy.%20Our%20study%20identified%20several%20markers%20associated%20with%20the%20pathophysiology%20of%20TB-DM%20that%20could%20be%20evaluated%20in%20future%20mechanistic%20investigations.%22%2C%22date%22%3A%222024-03-15%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.isci.2024.109135%22%2C%22ISSN%22%3A%222589-0042%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22GXCKG69T%22%2C%22F2Y6PLUL%22%5D%2C%22dateModified%22%3A%222024-04-12T12%3A38%3A01Z%22%7D%7D%2C%7B%22key%22%3A%22784IN2BU%22%2C%22library%22%3A%7B%22id%22%3A2775998%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Ridolfi%20et%20al.%22%2C%22parsedDate%22%3A%222024-03-14%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BRidolfi%2C%20Felipe%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BAmorim%2C%20Gustavo%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BPeetluk%2C%20Lauren%20S.%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BHaas%2C%20David%20W.%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BStaats%2C%20Cody%26lt%3B%5C%2Fspan%26gt%3B%20et%20al.%26lt%3B%5C%2Fspan%26gt%3B%20%282024%29.%20Prediction%20Models%20for%20Adverse%20Drug%20Reactions%20During%20Tuberculosis%20Treatment%20in%20Brazil.%20%26lt%3Bi%26gt%3BThe%20Journal%20of%20Infectious%20Diseases%26lt%3B%5C%2Fi%26gt%3B%2C%20%26lt%3Bi%26gt%3B229%26lt%3B%5C%2Fi%26gt%3B%20%283%29%2C%20S.%20813%26%23x2013%3B823.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1093%5C%2Finfdis%5C%2Fjiae025%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1093%5C%2Finfdis%5C%2Fjiae025%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Prediction%20Models%20for%20Adverse%20Drug%20Reactions%20During%20Tuberculosis%20Treatment%20in%20Brazil%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Felipe%22%2C%22lastName%22%3A%22Ridolfi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gustavo%22%2C%22lastName%22%3A%22Amorim%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lauren%20S.%22%2C%22lastName%22%3A%22Peetluk%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22David%20W.%22%2C%22lastName%22%3A%22Haas%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Cody%22%2C%22lastName%22%3A%22Staats%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mariana%22%2C%22lastName%22%3A%22Ara%5Cu00fajo-Pereira%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marcelo%22%2C%22lastName%22%3A%22Cordeiro-Santos%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Afr%5Cu00e2nio%20L.%22%2C%22lastName%22%3A%22Kritski%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marina%20C.%22%2C%22lastName%22%3A%22Figueiredo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bruno%20B.%22%2C%22lastName%22%3A%22Andrade%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Valeria%20C.%22%2C%22lastName%22%3A%22Rolla%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Timothy%20R.%22%2C%22lastName%22%3A%22Sterling%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22Regional%20Prospective%20Observational%20Research%20in%20Tuberculosis%20%28RePORT%29%5Cu2013Brazil%20Consortium%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20Tuberculosis%20%28TB%29%20treatment-related%20adverse%20drug%20reactions%20%28TB-ADRs%29%20can%20negatively%20affect%20adherence%20and%20treatment%20success%20rates.%5CnMETHODS%3A%20We%20developed%20prediction%20models%20for%20TB-ADRs%2C%20considering%20participants%20with%20drug-susceptible%20pulmonary%20TB%20who%20initiated%20standard%20TB%20therapy.%20TB-ADRs%20were%20determined%20by%20the%20physician%20attending%20the%20participant%2C%20assessing%20causality%20to%20TB%20drugs%2C%20the%20affected%20organ%20system%2C%20and%20grade.%20Potential%20baseline%20predictors%20of%20TB-ADR%20included%20concomitant%20medication%20%28CM%29%20use%2C%20human%20immunodeficiency%20virus%20%28HIV%29%20status%2C%20glycated%20hemoglobin%20%28HbA1c%29%2C%20age%2C%20body%20mass%20index%20%28BMI%29%2C%20sex%2C%20substance%20use%2C%20and%20TB%20drug%20metabolism%20variables%20%28NAT2%20acetylator%20profiles%29.%20The%20models%20were%20developed%20through%20bootstrapped%20backward%20selection.%20Cox%20regression%20was%20used%20to%20evaluate%20TB-ADR%20risk.%5CnRESULTS%3A%20There%20were%20156%20TB-ADRs%20among%20102%20of%20the%20945%20%2811%25%29%20participants%20included.%20Most%20TB-ADRs%20were%20hepatic%20%28n%20%3D%2082%20%5B53%25%5D%29%2C%20of%20moderate%20severity%20%28grade%202%3B%20n%20%3D%20121%20%5B78%25%5D%29%2C%20and%20occurred%20in%20NAT2%20slow%20acetylators%20%28n%20%3D%2062%20%5B61%25%5D%29.%20The%20main%20prediction%20model%20included%20CM%20use%2C%20HbA1c%2C%20alcohol%20use%2C%20HIV%20seropositivity%2C%20BMI%2C%20and%20age%2C%20with%20robust%20performance%20%28c-statistic%20%3D%200.79%20%5B95%25%20confidence%20interval%20%7BCI%7D%2C%20.74-.83%29%20and%20fit%20%28optimism-corrected%20slope%20and%20intercept%20of%20-0.09%20and%200.94%2C%20respectively%29.%20An%20alternative%20model%20replacing%20BMI%20with%20NAT2%20had%20similar%20performance.%20HIV%20seropositivity%20%28hazard%20ratio%20%5BHR%5D%2C%202.68%20%5B95%25%20CI%2C%201.75-4.09%5D%29%20and%20CM%20use%20%28HR%2C%205.26%20%5B95%25%20CI%2C%202.63-10.52%5D%29%20increased%20TB-ADR%20risk.%5CnCONCLUSIONS%3A%20The%20models%2C%20with%20clinical%20variables%20and%20with%20NAT2%2C%20were%20highly%20predictive%20of%20TB-ADRs.%22%2C%22date%22%3A%222024-03-14%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1093%5C%2Finfdis%5C%2Fjiae025%22%2C%22ISSN%22%3A%221537-6613%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22GXCKG69T%22%2C%22F2Y6PLUL%22%5D%2C%22dateModified%22%3A%222024-04-12T12%3A38%3A59Z%22%7D%7D%2C%7B%22key%22%3A%22EKX688G4%22%2C%22library%22%3A%7B%22id%22%3A2775998%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Brazier%20et%20al.%22%2C%22parsedDate%22%3A%222024-03%22%2C%22numChildren%22%3A3%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BBrazier%2C%20Ellen%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BTymejczyk%2C%20Olga%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BWools-Kaloustian%2C%20Kara%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BJiamsakul%2C%20Awachana%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BTorres%2C%20Marco%20Tulio%20Luque%26lt%3B%5C%2Fspan%26gt%3B%20et%20al.%26lt%3B%5C%2Fspan%26gt%3B%20%282024%29.%20Long-term%20HIV%20care%20outcomes%20under%20universal%20HIV%20treatment%20guidelines%3A%20A%20retrospective%20cohort%20study%20in%2025%20countries.%20%26lt%3Bi%26gt%3BPLoS%20Medicine%26lt%3B%5C%2Fi%26gt%3B%2C%20%26lt%3Bi%26gt%3B21%26lt%3B%5C%2Fi%26gt%3B%20%283%29%2C%20S.%20e1004367.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1371%5C%2Fjournal.pmed.1004367%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1371%5C%2Fjournal.pmed.1004367%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Long-term%20HIV%20care%20outcomes%20under%20universal%20HIV%20treatment%20guidelines%3A%20A%20retrospective%20cohort%20study%20in%2025%20countries%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ellen%22%2C%22lastName%22%3A%22Brazier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Olga%22%2C%22lastName%22%3A%22Tymejczyk%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kara%22%2C%22lastName%22%3A%22Wools-Kaloustian%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Awachana%22%2C%22lastName%22%3A%22Jiamsakul%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marco%20Tulio%20Luque%22%2C%22lastName%22%3A%22Torres%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jennifer%20S.%22%2C%22lastName%22%3A%22Lee%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lisa%22%2C%22lastName%22%3A%22Abuogi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vohith%22%2C%22lastName%22%3A%22Khol%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fernando%22%2C%22lastName%22%3A%22Mej%5Cu00eda%20Cordero%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Keri%20N.%22%2C%22lastName%22%3A%22Althoff%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Matthew%20G.%22%2C%22lastName%22%3A%22Law%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Denis%22%2C%22lastName%22%3A%22Nash%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22International%20epidemiology%20Databases%20to%20Evaluate%20AIDS%20%28IeDEA%29%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20While%20national%20adoption%20of%20universal%20HIV%20treatment%20guidelines%20has%20led%20to%20improved%2C%20timely%20uptake%20of%20antiretroviral%20therapy%20%28ART%29%2C%20longer-term%20care%20outcomes%20are%20understudied.%20There%20is%20little%20data%20from%20real-world%20service%20delivery%20settings%20on%20patient%20attrition%2C%20viral%20load%20%28VL%29%20monitoring%2C%20and%20viral%20suppression%20%28VS%29%20at%2024%20and%2036%20months%20after%20HIV%20treatment%20initiation.%5CnMETHODS%20AND%20FINDINGS%3A%20For%20this%20retrospective%20cohort%20analysis%2C%20we%20used%20observational%20data%20from%2025%20countries%20in%20the%20International%20epidemiology%20Databases%20to%20Evaluate%20AIDS%20%28IeDEA%29%20consortium%26%23039%3Bs%20Asia-Pacific%2C%20Central%20Africa%2C%20East%20Africa%2C%20Central%5C%2FSouth%20America%2C%20and%20North%20America%20regions%20for%20patients%20who%20were%20ART%20na%5Cu00efve%20and%20aged%20%5Cu226515%20years%20at%20care%20enrollment%20between%2024%20months%20before%20and%2012%20months%20after%20national%20adoption%20of%20universal%20treatment%20guidelines%2C%20occurring%202012%20to%202018.%20We%20estimated%20crude%20cumulative%20incidence%20of%20loss-to-clinic%20%28CI-LTC%29%20at%2012%2C%2024%2C%20and%2036%20months%20after%20enrollment%20among%20patients%20enrolling%20in%20care%20before%20and%20after%20guideline%20adoption%20using%20competing%20risks%20regression.%20Guideline%20change-associated%20hazard%20ratios%20of%20LTC%20at%20each%20time%20point%20after%20enrollment%20were%20estimated%20via%20cause-specific%20Cox%20proportional%20hazards%20regression%20models.%20Modified%20Poisson%20regression%20was%20used%20to%20estimate%20relative%20risks%20of%20retention%2C%20VL%20monitoring%2C%20and%20VS%20at%2012%2C%2024%2C%20and%2036%20months%20after%20ART%20initiation.%20There%20were%2066%2C963%20patients%20enrolling%20in%20HIV%20care%20at%20109%20clinics%20with%20%5Cu226512%20months%20of%20follow-up%20time%20after%20enrollment%20%2846%2C484%20%5B69.4%25%5D%20enrolling%20before%20guideline%20adoption%20and%2020%2C479%20%5B30.6%25%5D%20enrolling%20afterwards%29.%20More%20than%20half%20%2854.9%25%29%20were%20females%2C%20and%20median%20age%20was%2034%20years%20%28interquartile%20range%20%5BIQR%5D%3A%2027%20to%2043%29.%20Mean%20follow-up%20time%20was%2051%20months%20%28standard%20deviation%3A%2017%20months%3B%20range%3A%2012%2C%20110%20months%29.%20Among%20patients%20enrolling%20before%20guideline%20adoption%2C%20crude%20CI-LTC%20was%2023.8%25%20%2895%25%20confidence%20interval%20%5B95%25%20CI%5D%2023.4%2C%2024.2%29%20at%2012%20months%2C%2031.0%25%20%2895%25%20CI%20%5B30.6%2C%2031.5%5D%29%20at%2024%20months%2C%20and%2037.2%25%20%2895%25%20%5BCI%2036.8%2C%2037.7%5D%29%20at%2036%20months%20after%20enrollment.%20Adjusting%20for%20sex%2C%20age%20group%2C%20enrollment%20CD4%2C%20clinic%20location%20and%20type%2C%20and%20country%20income%20level%2C%20enrolling%20in%20care%20and%20initiating%20ART%20after%20guideline%20adoption%20was%20associated%20with%20increased%20hazard%20of%20LTC%20at%2012%20months%20%28adjusted%20hazard%20ratio%20%5BaHR%5D%201.25%20%5B95%25%20CI%201.08%2C%201.44%5D%3B%20p%20%3D%200.003%29%3B%2024%20months%20%28aHR%201.38%20%5B95%25%20CI%201.19%2C%201.59%5D%3B%20p%20%26lt%3B%20.001%29%3B%20and%2036%20months%20%28aHR%201.34%20%5B95%25%20CI%201.18%2C%201.53%5D%2C%20p%20%26lt%3B%20.001%29%20compared%20with%20enrollment%20before%20guideline%20adoption%2C%20with%20no%20before-after%20differences%20among%20patients%20with%20no%20record%20of%20ART%20initiation%20by%20end%20of%20follow-up.%20Among%20patients%20retained%20after%20ART%20initiation%2C%20VL%20monitoring%20was%20low%2C%20with%20marginal%20improvements%20associated%20with%20guideline%20adoption%20only%20at%2012%20months%20after%20ART%20initiation.%20Among%20those%20with%20VL%20monitoring%2C%20VS%20was%20high%20at%20each%20time%20point%20among%20patients%20enrolling%20before%20guideline%20adoption%20%2886.0%25%20to%2088.8%25%29%20and%20afterwards%20%2886.2%25%20to%2090.3%25%29%2C%20with%20no%20substantive%20difference%20associated%20with%20guideline%20adoption.%20Study%20limitations%20include%20lags%20in%20and%20potential%20underascertainment%20of%20care%20outcomes%20in%20real-world%20service%20delivery%20data%20and%20potential%20lack%20of%20generalizability%20beyond%20IeDEA%20sites%20and%20regions%20included%20in%20this%20analysis.%5CnCONCLUSIONS%3A%20In%20this%20study%2C%20adoption%20of%20universal%20HIV%20treatment%20guidelines%20was%20associated%20with%20lower%20retention%20after%20ART%20initiation%20out%20to%2036%20months%20of%20follow-up%2C%20with%20little%20change%20in%20VL%20monitoring%20or%20VS%20among%20retained%20patients.%20Monitoring%20long-term%20HIV%20care%20outcomes%20remains%20critical%20to%20identify%20and%20address%20causes%20of%20attrition%20and%20gaps%20in%20HIV%20care%20quality.%22%2C%22date%22%3A%222024-03%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1371%5C%2Fjournal.pmed.1004367%22%2C%22ISSN%22%3A%221549-1676%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22GXCKG69T%22%2C%22ZVWK2Q45%22%2C%22D9WC3N3V%22%2C%22TCMBXKKM%22%2C%228IRGNQWZ%22%2C%22F2Y6PLUL%22%2C%22ZBJI578D%22%2C%22YAE5EUBI%22%5D%2C%22dateModified%22%3A%222025-03-06T12%3A15%3A31Z%22%7D%7D%2C%7B%22key%22%3A%22GZJ6K5A9%22%2C%22library%22%3A%7B%22id%22%3A2775998%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Castillo-Rozas%20et%20al.%22%2C%22parsedDate%22%3A%222024-03%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BCastillo-Rozas%2C%20Gabriel%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BTu%2C%20Shengxin%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BLuz%2C%20Paula%20Mendes%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BMejia%2C%20Fernando%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BSierra-Madero%2C%20Juan%26lt%3B%5C%2Fspan%26gt%3B%20et%20al.%26lt%3B%5C%2Fspan%26gt%3B%20%282024%29.%20Clinical%20outcomes%20and%20risk%20factors%20for%20immune%20recovery%20and%20all-cause%20mortality%20in%20Latin%20Americans%20living%20with%20HIV%20with%20virological%20success%3A%20a%20retrospective%20cohort%20study.%20%26lt%3Bi%26gt%3BJournal%20of%20the%20International%20AIDS%20Society%26lt%3B%5C%2Fi%26gt%3B%2C%20%26lt%3Bi%26gt%3B27%26lt%3B%5C%2Fi%26gt%3B%20%283%29%2C%20S.%20e26214.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1002%5C%2Fjia2.26214%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1002%5C%2Fjia2.26214%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Clinical%20outcomes%20and%20risk%20factors%20for%20immune%20recovery%20and%20all-cause%20mortality%20in%20Latin%20Americans%20living%20with%20HIV%20with%20virological%20success%3A%20a%20retrospective%20cohort%20study%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gabriel%22%2C%22lastName%22%3A%22Castillo-Rozas%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shengxin%22%2C%22lastName%22%3A%22Tu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Paula%20Mendes%22%2C%22lastName%22%3A%22Luz%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fernando%22%2C%22lastName%22%3A%22Mejia%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Juan%22%2C%22lastName%22%3A%22Sierra-Madero%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vanessa%22%2C%22lastName%22%3A%22Rouzier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bryan%20E.%22%2C%22lastName%22%3A%22Shepherd%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Claudia%20P.%22%2C%22lastName%22%3A%22Cortes%22%7D%5D%2C%22abstractNote%22%3A%22INTRODUCTION%3A%20Immune%20reconstitution%20following%20antiretroviral%20therapy%20%28ART%29%20initiation%20is%20crucial%20to%20prevent%20AIDS%20and%20non-AIDS-related%20comorbidities.%20Patients%20with%20suppressed%20viraemia%20who%20fail%20to%20restore%20cellular%20immunity%20are%20exposed%20to%20an%20increased%20risk%20of%20morbidity%20and%20mortality%20during%20long-term%20follow-up%2C%20although%20the%20underlying%20mechanisms%20remain%20poorly%20understood.%20We%20aim%20to%20describe%20clinical%20outcomes%20and%20factors%20associated%20with%20the%20worse%20immune%20recovery%20and%20all-cause%20mortality%20in%20people%20living%20with%20HIV%20%28PLWH%29%20from%20Latin%20America%20following%20ART%20initiation.%5CnMETHODS%3A%20Retrospective%20cohort%20study%20using%20the%20CCASAnet%20database%3A%20PLWH%20%5Cu226518%20years%20of%20age%20at%20ART%20initiation%20using%20a%20three%20drug-based%20combination%20therapy%20and%20with%20medical%20follow-up%20for%20%5Cu226524%20months%20after%20ART%20initiation%20and%20undetectable%20viral%20load%20were%20included.%20Patients%20were%20divided%20into%20four%20immune%20recovery%20groups%20based%20on%20rounded%20quartiles%20of%20increase%20in%20CD4%20T-cell%20count%20at%202%20years%20of%20treatment%20%28%26lt%3B150%2C%20%5B150%2C%20250%29%2C%20%5B250%2C%20350%5D%20and%20%26gt%3B350%20cells%5C%2Fmm3%20%29.%20Primary%20outcomes%20included%20all-cause%20mortality%2C%20AIDS-defining%20events%20and%20non-communicable%20diseases%20that%20occurred%20%26gt%3B2%20years%20after%20ART%20initiation.%20Factors%20associated%20with%20an%20increase%20in%20CD4%20T-cell%20count%20at%202%20years%20of%20treatment%20were%20evaluated%20using%20a%20cumulative%20probability%20model%20with%20a%20logit%20link.%5CnRESULTS%3A%20In%20our%20cohort%20of%204496%20Latin%20American%20PLWH%2C%20we%20found%20that%20patients%20with%20the%20lowest%20CD4%20increase%20%28%26lt%3B150%29%20had%20the%20lowest%20survival%20probability%20at%2010%20years%20of%20follow-up.%20Lower%20increase%20in%20CD4%20count%20following%20therapy%20initiation%20%28and%20remarkably%20not%20a%20lower%20baseline%20CD4%20T-cell%20count%29%20and%20older%20age%20were%20risk%20factors%20for%20all-cause%20mortality.%20We%20also%20found%20that%20older%20age%2C%20male%20sex%20and%20higher%20baseline%20CD4%20T-cell%20count%20were%20associated%20with%20lower%20CD4%20count%20increase%20following%20therapy%20initiation.%5CnCONCLUSIONS%3A%20Our%20study%20shows%20that%20PLWH%20with%20lower%20increases%20in%20CD4%20count%20have%20lower%20survival%20probabilities.%20CD4%20increase%20during%20follow-up%20might%20be%20a%20better%20predictor%20of%20mortality%20in%20undetectable%20PLWH%20than%20baseline%20CD4%20count.%20Therefore%2C%20it%20should%20be%20included%20as%20a%20routine%20clinical%20variable%20to%20assess%20immune%20recovery%20and%20overall%20survival.%22%2C%22date%22%3A%222024-03%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1002%5C%2Fjia2.26214%22%2C%22ISSN%22%3A%221758-2652%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22GXCKG69T%22%2C%22F2Y6PLUL%22%5D%2C%22dateModified%22%3A%222024-04-12T12%3A35%3A56Z%22%7D%7D%2C%7B%22key%22%3A%22VH2UK4RU%22%2C%22library%22%3A%7B%22id%22%3A2775998%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Davidovi%5Cu0107%20et%20al.%22%2C%22parsedDate%22%3A%222024-02-01%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BDavidovi%26%23x107%3B%2C%20Ma%26%23x161%3Ba%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BAsangbeh%2C%20Serra%20Lem%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BTaghavi%2C%20Katayoun%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BDhokotera%2C%20Tafadzwa%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BJaquet%2C%20Antoine%26lt%3B%5C%2Fspan%26gt%3B%20et%20al.%26lt%3B%5C%2Fspan%26gt%3B%20%282024%29.%20Facility-Based%20Indicators%20to%20Manage%20and%20Scale%20Up%20Cervical%20Cancer%20Prevention%20and%20Care%20Services%20for%20Women%20Living%20With%20HIV%20in%20Sub-Saharan%20Africa%3A%20a%20Three-Round%20Online%20Delphi%20Consensus%20Method.%20%26lt%3Bi%26gt%3BJournal%20of%20Acquired%20Immune%20Deficiency%20Syndromes%20%281999%29%26lt%3B%5C%2Fi%26gt%3B%2C%20%26lt%3Bi%26gt%3B95%26lt%3B%5C%2Fi%26gt%3B%20%282%29%2C%20S.%20170%26%23x2013%3B178.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1097%5C%2FQAI.0000000000003343%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1097%5C%2FQAI.0000000000003343%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Facility-Based%20Indicators%20to%20Manage%20and%20Scale%20Up%20Cervical%20Cancer%20Prevention%20and%20Care%20Services%20for%20Women%20Living%20With%20HIV%20in%20Sub-Saharan%20Africa%3A%20a%20Three-Round%20Online%20Delphi%20Consensus%20Method%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ma%5Cu0161a%22%2C%22lastName%22%3A%22Davidovi%5Cu0107%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Serra%20Lem%22%2C%22lastName%22%3A%22Asangbeh%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Katayoun%22%2C%22lastName%22%3A%22Taghavi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tafadzwa%22%2C%22lastName%22%3A%22Dhokotera%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Antoine%22%2C%22lastName%22%3A%22Jaquet%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Beverly%22%2C%22lastName%22%3A%22Musick%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Cari%22%2C%22lastName%22%3A%22Van%20Schalkwyk%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22David%22%2C%22lastName%22%3A%22Schwappach%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eliane%22%2C%22lastName%22%3A%22Rohner%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gad%22%2C%22lastName%22%3A%22Murenzi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kara%22%2C%22lastName%22%3A%22Wools-Kaloustian%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kathryn%22%2C%22lastName%22%3A%22Anastos%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Orang%27o%20Elkanah%22%2C%22lastName%22%3A%22Omenge%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Simon%20Pierre%22%2C%22lastName%22%3A%22Boni%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Stephany%20N.%22%2C%22lastName%22%3A%22Duda%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Per%22%2C%22lastName%22%3A%22von%20Groote%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Julia%22%2C%22lastName%22%3A%22Bohlius%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22International%20Epidemiology%20Databases%20to%20Evaluate%20AIDS%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20Of%20women%20with%20cervical%20cancer%20%28CC%29%20and%20HIV%2C%2085%25%20live%20in%20sub-Saharan%20Africa%2C%20where%2021%25%20of%20all%20CC%20cases%20are%20attributable%20to%20HIV%20infection.%20We%20aimed%20to%20generate%20internationally%20acceptable%20facility-based%20indicators%20to%20monitor%20and%20guide%20scale%20up%20of%20CC%20prevention%20and%20care%20services%20offered%20on-site%20or%20off-site%20by%20HIV%20clinics.%5CnMETHODS%3A%20We%20reviewed%20the%20literature%20and%20extracted%20relevant%20indicators%2C%20grouping%20them%20into%20domains%20along%20the%20CC%20control%20continuum.%20From%20February%202021%20to%20March%202022%2C%20we%20conducted%20a%20three-round%2C%20online%20Delphi%20process%20to%20reach%20consensus%20on%20indicators.%20We%20invited%20106%20experts%20to%20participate.%20Through%20an%20anonymous%2C%20iterative%20process%2C%20participants%20adapted%20the%20indicators%20to%20their%20context%20%28round%201%29%2C%20then%20rated%20them%20for%205%20criteria%20on%20a%205-point%20Likert-type%20scale%20%28rounds%202%20and%203%29%20and%20then%20ranked%20their%20importance%20%28round%203%29.%5CnRESULTS%3A%20We%20reviewed%2039%20policies%20from%2021%20African%20countries%20and%207%20from%20international%20organizations%3B%2072%20experts%20from%2015%20sub-Saharan%20Africa%20countries%20or%20international%20organizations%20participated%20in%20our%20Delphi%20process.%20Response%20rates%20were%2034%25%20in%20round%201%2C%2040%25%20in%20round%202%2C%20and%2044%25%20in%20round%203.%20Experts%20reached%20consensus%20for%2017%20indicators%20in%20the%20following%20domains%3A%20primary%20prevention%20%28human%20papillomavirus%20prevention%2C%20n%20%3D%202%29%2C%20secondary%20prevention%20%28screening%2C%20triage%2C%20treatment%20of%20precancerous%20lesions%2C%20n%20%3D%2011%29%2C%20tertiary%20prevention%20%28CC%20diagnosis%20and%20care%2C%20n%20%3D%202%29%2C%20and%20long-term%20impact%20of%20the%20program%20and%20linkage%20to%20HIV%20service%20%28n%20%3D%202%29.%5CnCONCLUSION%3A%20We%20recommend%20that%20HIV%20clinics%20that%20offer%20CC%20control%20services%20in%20sub-Saharan%20Africa%20implement%20the%2017%20indicators%20stepwise%20and%20adapt%20them%20to%20context%20to%20improve%20monitoring%20along%20the%20CC%20control%20cascade.%22%2C%22date%22%3A%222024-02-01%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1097%5C%2FQAI.0000000000003343%22%2C%22ISSN%22%3A%221944-7884%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22GXCKG69T%22%2C%22ZVWK2Q45%22%2C%22D9WC3N3V%22%2C%22TCMBXKKM%22%2C%228IRGNQWZ%22%2C%22F2Y6PLUL%22%2C%22ZBJI578D%22%2C%22YAE5EUBI%22%2C%223FNU2D64%22%5D%2C%22dateModified%22%3A%222025-03-06T12%3A15%3A29Z%22%7D%7D%2C%7B%22key%22%3A%223K3AFYPR%22%2C%22library%22%3A%7B%22id%22%3A2775998%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Lancaster%20et%20al.%22%2C%22parsedDate%22%3A%222024-02%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BLancaster%2C%20Kathryn%20E.%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BStockton%2C%20Melissa%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BRemch%2C%20Molly%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BWester%2C%20C.%20William%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BNash%2C%20Denis%26lt%3B%5C%2Fspan%26gt%3B%20et%20al.%26lt%3B%5C%2Fspan%26gt%3B%20%282024%29.%20Availability%20of%20substance%20use%20screening%20and%20treatment%20within%20HIV%20clinical%20sites%20across%20seven%20geographic%20regions%20within%20the%20IeDEA%20consortium.%20%26lt%3Bi%26gt%3BThe%20International%20Journal%20on%20Drug%20Policy%26lt%3B%5C%2Fi%26gt%3B%2C%20%26lt%3Bi%26gt%3B124%26lt%3B%5C%2Fi%26gt%3B%2C%20S.%20104309.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.drugpo.2023.104309%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.drugpo.2023.104309%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Availability%20of%20substance%20use%20screening%20and%20treatment%20within%20HIV%20clinical%20sites%20across%20seven%20geographic%20regions%20within%20the%20IeDEA%20consortium%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kathryn%20E.%22%2C%22lastName%22%3A%22Lancaster%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Melissa%22%2C%22lastName%22%3A%22Stockton%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Molly%22%2C%22lastName%22%3A%22Remch%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22C.%20William%22%2C%22lastName%22%3A%22Wester%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Denis%22%2C%22lastName%22%3A%22Nash%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ellen%22%2C%22lastName%22%3A%22Brazier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Adebola%22%2C%22lastName%22%3A%22Adedimeji%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Robert%22%2C%22lastName%22%3A%22Finlayson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Aimee%22%2C%22lastName%22%3A%22Freeman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Breanna%22%2C%22lastName%22%3A%22Hogan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Charles%22%2C%22lastName%22%3A%22Kasozi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Edith%20Kamaru%22%2C%22lastName%22%3A%22Kwobah%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jayne%20Lewis%22%2C%22lastName%22%3A%22Kulzer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tuti%22%2C%22lastName%22%3A%22Merati%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Judiacel%22%2C%22lastName%22%3A%22Tine%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Armel%22%2C%22lastName%22%3A%22Poda%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Regina%22%2C%22lastName%22%3A%22Succi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christelle%22%2C%22lastName%22%3A%22Twizere%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mpho%22%2C%22lastName%22%3A%22Tlali%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Per%20von%22%2C%22lastName%22%3A%22Groote%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22E.%20Jennifer%22%2C%22lastName%22%3A%22Edelman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Angela%20M.%22%2C%22lastName%22%3A%22Parcesepe%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22IeDEA%20Consortium%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20Overwhelming%20evidence%20highlights%20the%20negative%20impact%20of%20substance%20use%20on%20HIV%20care%20and%20treatment%20outcomes.%20Yet%2C%20the%20extent%20to%20which%20alcohol%20use%20disorder%20%28AUD%29%20and%20other%20substance%20use%20disorders%20%28SUD%29%20services%20have%20been%20integrated%20within%20HIV%20clinical%20settings%20is%20limited.%20We%20describe%20AUD%5C%2FSUD%20screening%20and%20treatment%20availability%20in%20HIV%20clinical%20sites%20participating%20in%20the%20International%20epidemiology%20Databases%20to%20Evaluate%20AIDS%20%28IeDEA%29%20consortium.%5CnMETHODS%3A%20In%202020%2C%20223%20IeDEA%20HIV%20clinical%20sites%20from%2041%20countries%20across%20seven%20geographic%20regions%20completed%20a%20survey%20on%20capacity%20and%20practices%20related%20to%20management%20of%20AUD%5C%2F%20SUD.%20Sites%20provided%20information%20on%20AUD%20and%20other%20SUD%20screening%20and%20treatment%20practices.%5CnRESULTS%3A%20Sites%20were%20from%20low-income%20countries%20%2823%25%29%2C%20lower-middle-income%20countries%20%2838%25%29%2C%20upper-middle%20income%20countries%20%2817%25%29%20and%20high-income%20counties%20%2823%25%29.%20AUD%20and%20SUD%20screening%20using%20validated%20instruments%20were%20reported%20at%2032%25%20%28n%3D71%20located%20in%2012%20countries%29%20and%2012%25%20%28n%3D27%20located%20in%206%20countries%29%20of%20the%20223%20sites%20from%2041%20countries%2C%20respectively.%20The%20North%20American%20region%20had%20the%20highest%20proportion%20of%20clinics%20that%20reported%20AUD%20screening%20%2876%25%29%2C%20followed%20by%20East%20Africa%20%2846%25%29%3B%20none%20of%20the%20sites%20in%20West%20or%20Central%20Africa%20reported%20AUD%20screening.%2031%25%20%28n%3D69%29%20reported%20both%20AUD%20screening%20and%20counseling%2C%20brief%20intervention%2C%20psychotherapy%2C%20or%20Screening%2C%20Brief%20Intervention%2C%20and%20Referral%20to%20Treatment%3B%208%25%20%28n%3D18%29%20reported%20AUD%20screening%20and%20detox%20hospitalization%3B%20and%2010%25%20%28n%3D24%29%20reported%20both%20AUD%20screening%20and%20medication.%20While%20the%20proportion%20of%20clinics%20providing%20treatment%20for%20SUD%20was%20lower%20than%20those%20treating%20AUD%2C%20the%20prevalence%20estimates%20of%20treatment%20availability%20were%20similar.%5CnCONCLUSIONS%3A%20Availability%20of%20screening%20and%20treatment%20for%20AUD%5C%2FSUD%20in%20HIV%20care%20settings%20is%20limited%2C%20leaving%20a%20substantial%20gap%20for%20integration%20into%20ongoing%20HIV%20care.%20A%20critical%20understanding%20is%20needed%20of%20the%20multilevel%20implementation%20factors%20or%20feasible%20implementation%20strategies%20for%20integrating%20screening%20and%20treatment%20of%20AUD%5C%2FSUD%20into%20HIV%20care%20settings%2C%20particularly%20for%20resource-constrained%20regions.%22%2C%22date%22%3A%222024-02%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.drugpo.2023.104309%22%2C%22ISSN%22%3A%221873-4758%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22GXCKG69T%22%2C%22ZVWK2Q45%22%2C%22D9WC3N3V%22%2C%22TCMBXKKM%22%2C%228IRGNQWZ%22%2C%22F2Y6PLUL%22%2C%22ZBJI578D%22%2C%22YAE5EUBI%22%2C%223FNU2D64%22%5D%2C%22dateModified%22%3A%222025-03-06T12%3A15%3A21Z%22%7D%7D%2C%7B%22key%22%3A%222Y4PZUCX%22%2C%22library%22%3A%7B%22id%22%3A2775998%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Rocha%20et%20al.%22%2C%22parsedDate%22%3A%222024-01-19%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BRocha%2C%20Eduardo%20Fukutani%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BVinhaes%2C%20Caian%20Leal%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BAra%26%23xFA%3Bjo-Pereira%2C%20Mariana%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BMota%2C%20Tiago%20Feitosa%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BGupte%2C%20Akshay%20N.%26lt%3B%5C%2Fspan%26gt%3B%20et%20al.%26lt%3B%5C%2Fspan%26gt%3B%20%282024%29.%20The%20sound%20of%20silent%20RNA%20in%20tuberculosis%20and%20the%20lncRNA%20role%20on%20infection.%20%26lt%3Bi%26gt%3BiScience%26lt%3B%5C%2Fi%26gt%3B%2C%20%26lt%3Bi%26gt%3B27%26lt%3B%5C%2Fi%26gt%3B%20%281%29%2C%20S.%20108662.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.isci.2023.108662%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.isci.2023.108662%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22The%20sound%20of%20silent%20RNA%20in%20tuberculosis%20and%20the%20lncRNA%20role%20on%20infection%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eduardo%20Fukutani%22%2C%22lastName%22%3A%22Rocha%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Caian%20Leal%22%2C%22lastName%22%3A%22Vinhaes%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mariana%22%2C%22lastName%22%3A%22Ara%5Cu00fajo-Pereira%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tiago%20Feitosa%22%2C%22lastName%22%3A%22Mota%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Akshay%20N.%22%2C%22lastName%22%3A%22Gupte%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nathella%20Pavan%22%2C%22lastName%22%3A%22Kumar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Maria%20Belen%22%2C%22lastName%22%3A%22Arriaga%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Timothy%20R.%22%2C%22lastName%22%3A%22Sterling%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Subash%22%2C%22lastName%22%3A%22Babu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sanjay%22%2C%22lastName%22%3A%22Gaikwad%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rajesh%22%2C%22lastName%22%3A%22Karyakarte%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vidya%22%2C%22lastName%22%3A%22Mave%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vandana%22%2C%22lastName%22%3A%22Kulkarni%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mandar%22%2C%22lastName%22%3A%22Paradkar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vijay%22%2C%22lastName%22%3A%22Viswanathan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hardy%22%2C%22lastName%22%3A%22Kornfeld%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Amita%22%2C%22lastName%22%3A%22Gupta%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bruno%20Bezerril%22%2C%22lastName%22%3A%22Andrade%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Artur%20Trancoso%20Lopo%20de%22%2C%22lastName%22%3A%22Queiroz%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22RePORT%20Brazil%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22RePORT%20India%20Consortia%22%7D%5D%2C%22abstractNote%22%3A%22Tuberculosis%20%28TB%29%20is%20one%20of%20the%20leading%20causes%20of%20death%20worldwide%2C%20and%20Diabetes%20Mellitus%20is%20one%20of%20the%20major%20comorbidities%20%28TB%5C%2FDM%29%20associated%20with%20the%20disease.%20A%20total%20of%20103%20differentially%20expressed%20ncRNAs%20have%20been%20identified%20in%20the%20TB%20and%20TB%5C%2FDM%20comparisons.%20A%20machine%20learning%20algorithm%20was%20employed%20to%20identify%20the%20most%20informative%20lncRNAs%3A%20ADM-DT%2C%20LINC02009%2C%20LINC02471%2C%20SOX2-OT%2C%20and%20GK-AS1.%20These%20lncRNAs%20presented%20substantial%20accuracy%20in%20classifying%20TB%20from%20HC%20%28AUCs%20%26gt%3B0.85%29%20and%20TB%5C%2FDM%20from%20HC%20%28AUCs%20%26gt%3B0.90%29%20in%20the%20other%20three%20countries.%20Genes%20with%20significant%20correlations%20with%20the%20five%20lncRNAs%20enriched%20common%20pathways%20in%20Brazil%20and%20India%20for%20both%20TB%20and%20TB%5C%2FDM.%20This%20suggests%20that%20lncRNAs%20play%20an%20important%20role%20in%20the%20regulation%20of%20genes%20related%20to%20the%20TB%20immune%20response.%22%2C%22date%22%3A%222024-01-19%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.isci.2023.108662%22%2C%22ISSN%22%3A%222589-0042%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22GXCKG69T%22%2C%22F2Y6PLUL%22%5D%2C%22dateModified%22%3A%222024-02-06T15%3A09%3A55Z%22%7D%7D%2C%7B%22key%22%3A%22JUI8ZCRG%22%2C%22library%22%3A%7B%22id%22%3A2775998%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Enane%20et%20al.%22%2C%22parsedDate%22%3A%222024-01-09%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BEnane%2C%20Leslie%20A.%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BDuda%2C%20Stephany%20N.%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BChanyachukul%2C%20Thida%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BBolton-Moore%2C%20Carolyn%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BNavuluri%2C%20Neelima%26lt%3B%5C%2Fspan%26gt%3B%20et%20al.%26lt%3B%5C%2Fspan%26gt%3B%20%282024%29.%20The%20Tuberculosis%20Sentinel%20Research%20Network%20%28TB-SRN%29%20of%20the%20International%20epidemiology%20Databases%20to%20Evaluate%20AIDS%20%28IeDEA%29%3A%20protocol%20for%20a%20prospective%20cohort%20study%20in%20Africa%2C%20Southeast%20Asia%20and%20Latin%20America.%20%26lt%3Bi%26gt%3BBMJ%20Open%26lt%3B%5C%2Fi%26gt%3B%2C%20%26lt%3Bi%26gt%3B14%26lt%3B%5C%2Fi%26gt%3B%20%281%29%2C%20S.%20e079138.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1136%5C%2Fbmjopen-2023-079138%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1136%5C%2Fbmjopen-2023-079138%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22The%20Tuberculosis%20Sentinel%20Research%20Network%20%28TB-SRN%29%20of%20the%20International%20epidemiology%20Databases%20to%20Evaluate%20AIDS%20%28IeDEA%29%3A%20protocol%20for%20a%20prospective%20cohort%20study%20in%20Africa%2C%20Southeast%20Asia%20and%20Latin%20America%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Leslie%20A.%22%2C%22lastName%22%3A%22Enane%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Stephany%20N.%22%2C%22lastName%22%3A%22Duda%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Thida%22%2C%22lastName%22%3A%22Chanyachukul%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Carolyn%22%2C%22lastName%22%3A%22Bolton-Moore%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Neelima%22%2C%22lastName%22%3A%22Navuluri%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eug%5Cu00e8ne%22%2C%22lastName%22%3A%22Messou%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nana%22%2C%22lastName%22%3A%22Mbonze%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22LaQuita%20R.%22%2C%22lastName%22%3A%22McDade%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marina%20Cruvinel%22%2C%22lastName%22%3A%22Figueiredo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jeremy%22%2C%22lastName%22%3A%22Ross%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Denise%22%2C%22lastName%22%3A%22Evans%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lameck%22%2C%22lastName%22%3A%22Diero%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Robert%22%2C%22lastName%22%3A%22Akpata%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Natalia%22%2C%22lastName%22%3A%22Zotova%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Aimee%22%2C%22lastName%22%3A%22Freeman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marie%20Flore%22%2C%22lastName%22%3A%22Pierre%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dhanushi%22%2C%22lastName%22%3A%22Rupasinghe%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marie%22%2C%22lastName%22%3A%22Ballif%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Helen%22%2C%22lastName%22%3A%22Byakwaga%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nathalie%22%2C%22lastName%22%3A%22de%20Castro%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Martine%22%2C%22lastName%22%3A%22Tabala%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Timothy%20R.%22%2C%22lastName%22%3A%22Sterling%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Annette%20H.%22%2C%22lastName%22%3A%22Sohn%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lukas%22%2C%22lastName%22%3A%22Fenner%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kara%22%2C%22lastName%22%3A%22Wools-Kaloustian%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Armel%22%2C%22lastName%22%3A%22Poda%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marcel%22%2C%22lastName%22%3A%22Yotebieng%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Robin%22%2C%22lastName%22%3A%22Huebner%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Olivier%22%2C%22lastName%22%3A%22Marcy%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22International%20epidemiology%20Databases%20to%20Evaluate%20AIDS%22%7D%5D%2C%22abstractNote%22%3A%22INTRODUCTION%3A%20Tuberculosis%20%28TB%29%20is%20a%20leading%20infectious%20cause%20of%20death%20globally.%20It%20is%20the%20most%20common%20opportunistic%20infection%20in%20people%20living%20with%20HIV%2C%20and%20the%20most%20common%20cause%20of%20their%20morbidity%20and%20mortality.%20Following%20TB%20treatment%2C%20surviving%20individuals%20may%20be%20at%20risk%20for%20post-TB%20lung%20disease.%20The%20TB%20Sentinel%20Research%20Network%20%28TB-SRN%29%20provides%20a%20platform%20for%20coordinated%20observational%20TB%20research%20within%20the%20International%20epidemiology%20Databases%20to%20Evaluate%20AIDS%20%28IeDEA%29%20consortium.%5CnMETHODS%20AND%20ANALYSIS%3A%20This%20prospective%2C%20observational%20cohort%20study%20will%20assess%20treatment%20and%20post-treatment%20outcomes%20of%20pulmonary%20TB%20%28microbiologically%20confirmed%20or%20clinically%20diagnosed%29%20among%202600%20people%20aged%20%5Cu226515%20years%2C%20with%20and%20without%20HIV%20coinfection%2C%20consecutively%20enrolled%20at%2016%20sites%20in%2011%20countries%2C%20across%206%20of%20IeDEA%26%23039%3Bs%20global%20regions.%20Data%20regarding%20clinical%20and%20sociodemographic%20factors%2C%20mental%20health%2C%20health-related%20quality%20of%20life%2C%20pulmonary%20function%2C%20and%20laboratory%20and%20radiographic%20findings%20will%20be%20collected%20using%20standardised%20questionnaires%20and%20data%20collection%20tools%2C%20beginning%20from%20the%20initiation%20of%20TB%20treatment%20and%20through%2012%20months%20after%20the%20end%20of%20treatment.%20Data%20will%20be%20aggregated%20for%20proposed%20analyses.%5CnETHICS%20AND%20DISSEMINATION%3A%20Ethics%20approval%20was%20obtained%20at%20all%20implementing%20study%20sites%2C%20including%20the%20Vanderbilt%20University%20Medical%20Center%20Human%20Research%20Protections%20Programme.%20Participants%20will%20provide%20informed%20consent%3B%20for%20minors%2C%20this%20includes%20both%20adolescent%20assent%20and%20the%20consent%20of%20their%20parent%20or%20primary%20caregiver.%20Protections%20for%20vulnerable%20groups%20are%20included%2C%20in%20alignment%20with%20local%20standards%20and%20considerations%20at%20sites.%20Procedures%20for%20requesting%20use%20and%20analysis%20of%20TB-SRN%20data%20are%20publicly%20available.%20Findings%20from%20TB-SRN%20analyses%20will%20be%20shared%20with%20national%20TB%20programmes%20to%20inform%20TB%20programming%20and%20policy%2C%20and%20disseminated%20at%20regional%20and%20global%20conferences%20and%20other%20venues.%22%2C%22date%22%3A%222024-01-09%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1136%5C%2Fbmjopen-2023-079138%22%2C%22ISSN%22%3A%222044-6055%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22GXCKG69T%22%2C%22ZVWK2Q45%22%2C%22D9WC3N3V%22%2C%22TCMBXKKM%22%2C%228IRGNQWZ%22%2C%22F2Y6PLUL%22%2C%22ZBJI578D%22%2C%22YAE5EUBI%22%2C%223FNU2D64%22%5D%2C%22dateModified%22%3A%222024-02-06T15%3A01%3A41Z%22%7D%7D%2C%7B%22key%22%3A%22Z5INAYF8%22%2C%22library%22%3A%7B%22id%22%3A2775998%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Ara%5Cu00fajo-Pereira%20et%20al.%22%2C%22parsedDate%22%3A%222024-01%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BAra%26%23xFA%3Bjo-Pereira%2C%20Mariana%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BArriaga%2C%20Mar%26%23xED%3Ba%20B.%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BCarvalho%2C%20Anna%20Cristina%20C.%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BSpener-Gomes%2C%20Renata%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BSchmaltz%2C%20Carolina%20A.%20S.%26lt%3B%5C%2Fspan%26gt%3B%20et%20al.%26lt%3B%5C%2Fspan%26gt%3B%20%282024%29.%20Isoniazid%20Monoresistance%20and%20Antituberculosis%20Treatment%20Outcome%20in%20Persons%20With%20Pulmonary%20Tuberculosis%20in%20Brazil.%20%26lt%3Bi%26gt%3BOpen%20Forum%20Infectious%20Diseases%26lt%3B%5C%2Fi%26gt%3B%2C%20%26lt%3Bi%26gt%3B11%26lt%3B%5C%2Fi%26gt%3B%20%281%29%2C%20S.%20ofad691.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1093%5C%2Fofid%5C%2Fofad691%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1093%5C%2Fofid%5C%2Fofad691%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Isoniazid%20Monoresistance%20and%20Antituberculosis%20Treatment%20Outcome%20in%20Persons%20With%20Pulmonary%20Tuberculosis%20in%20Brazil%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mariana%22%2C%22lastName%22%3A%22Ara%5Cu00fajo-Pereira%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mar%5Cu00eda%20B.%22%2C%22lastName%22%3A%22Arriaga%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anna%20Cristina%20C.%22%2C%22lastName%22%3A%22Carvalho%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Renata%22%2C%22lastName%22%3A%22Spener-Gomes%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Carolina%20A.%20S.%22%2C%22lastName%22%3A%22Schmaltz%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bet%5Cu00e2nia%20M.%20F.%22%2C%22lastName%22%3A%22Nogueira%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marina%20C.%22%2C%22lastName%22%3A%22Figueiredo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Megan%20M.%22%2C%22lastName%22%3A%22Turner%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marcelo%22%2C%22lastName%22%3A%22Cordeiro-Santos%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Valeria%20C.%22%2C%22lastName%22%3A%22Rolla%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Timothy%20R.%22%2C%22lastName%22%3A%22Sterling%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bruno%20B.%22%2C%22lastName%22%3A%22Andrade%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Afr%5Cu00e2nio%20L.%22%2C%22lastName%22%3A%22Kritski%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22Regional%20Prospective%20Observational%20Research%20for%20Tuberculosis%20%28RePORT%29-Brazil%20Consortium%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20The%20high%20burden%20of%20drug-resistant%20tuberculosis%20%28TB%29%20is%20a%20problem%20to%20achieve%20the%20goals%20of%20the%20End%20TB%20Strategy%20by%202035.%20Whether%20isoniazid%20monoresistance%20%28Hr%29%20affects%20anti-TB%20treatment%20%28ATT%29%20outcomes%20remains%20unknown%20in%20high-burden%20countries.%5CnMETHODS%3A%20We%20evaluated%20determinants%20of%20ATT%20outcome%20among%20pulmonary%20TB%20cases%20reported%20to%20the%20National%20Notifiable%20Disease%20Information%20System%20%28SINAN%29%20between%20June%202015%20and%20June%202019%2C%20according%20to%20drug%20sensitivity%20testing%20%28DST%29%20results.%20Binomial%20logistic%20regression%20models%20were%20employed%20to%20evaluate%20whether%20Hr%20was%20associated%20with%20an%20unfavorable%20ATT%20outcome%3A%20death%20or%20failure%2C%20compared%20to%20cure%20or%20treatment%20completion.%5CnRESULTS%3A%20Among%2060%20804%20TB%20cases%20reported%20in%20SINAN%2C%2021%20197%20%2834.9%25%29%20were%20included%20in%20the%20study.%20In%20this%20database%2C%20the%20frequency%20of%20unfavorable%20outcomes%20was%20significantly%20higher%20in%20those%20with%20Hr%20in%20contrast%20to%20isoniazid-sensitive%20persons%20with%20pulmonary%20TB%20%289.1%25%20vs%203.05%25%3B%20P%20%26lt%3B%20.001%29.%20Using%20a%20binomial%20logistic%20regression%20model%2C%20Hr%20was%20independently%20associated%20with%20unfavorable%20outcomes%20%28odds%20ratio%2C%203.34%20%5B95%25%20confidence%20interval%2C%202.06-5.40%5D%3B%20P%20%26lt%3B%20.001%29.%5CnCONCLUSIONS%3A%20Hr%20detected%20prior%20to%20ATT%20was%20predictive%20of%20unfavorable%20outcomes%20at%20the%20national%20level%20in%20Brazil.%20Our%20data%20reinforce%20the%20need%20for%20high-TB-burden%20countries%20to%20prioritize%20DST%20to%20detect%20Hr.%20Effective%20treatment%20regimens%20for%20Hr-TB%20are%20needed%20to%20improve%20outcomes.%22%2C%22date%22%3A%222024-01%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1093%5C%2Fofid%5C%2Fofad691%22%2C%22ISSN%22%3A%222328-8957%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22GXCKG69T%22%2C%22F2Y6PLUL%22%5D%2C%22dateModified%22%3A%222025-03-11T11%3A53%3A27Z%22%7D%7D%2C%7B%22key%22%3A%22497K6SDZ%22%2C%22library%22%3A%7B%22id%22%3A2775998%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Cumming%20et%20al.%22%2C%22parsedDate%22%3A%222024%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BCumming%2C%20Bridgette%20M.%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BAddicott%2C%20Kelvin%20W.%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BMaruri%2C%20Fernanda%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BPillay%2C%20Vanessa%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BAsmal%2C%20Rukaya%26lt%3B%5C%2Fspan%26gt%3B%20et%20al.%26lt%3B%5C%2Fspan%26gt%3B%20%282024%29.%20Longitudinal%20mitochondrial%20bioenergetic%20signatures%20of%20blood%20monocytes%20and%20lymphocytes%20improve%20during%20treatment%20of%20drug-susceptible%20pulmonary%20tuberculosis%20patients%20Monocyte%5C%2Flymphocyte%20bioenergetic%20signatures%20post-TB%20treatment.%20%26lt%3Bi%26gt%3BFrontiers%20in%20Immunology%26lt%3B%5C%2Fi%26gt%3B%2C%20%26lt%3Bi%26gt%3B15%26lt%3B%5C%2Fi%26gt%3B%2C%20S.%201465448.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.3389%5C%2Ffimmu.2024.1465448%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.3389%5C%2Ffimmu.2024.1465448%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Longitudinal%20mitochondrial%20bioenergetic%20signatures%20of%20blood%20monocytes%20and%20lymphocytes%20improve%20during%20treatment%20of%20drug-susceptible%20pulmonary%20tuberculosis%20patients%20Monocyte%5C%2Flymphocyte%20bioenergetic%20signatures%20post-TB%20treatment%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bridgette%20M.%22%2C%22lastName%22%3A%22Cumming%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kelvin%20W.%22%2C%22lastName%22%3A%22Addicott%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fernanda%22%2C%22lastName%22%3A%22Maruri%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vanessa%22%2C%22lastName%22%3A%22Pillay%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rukaya%22%2C%22lastName%22%3A%22Asmal%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sashen%22%2C%22lastName%22%3A%22Moodley%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Beatriz%22%2C%22lastName%22%3A%22Barreto-Durate%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mariana%22%2C%22lastName%22%3A%22Ara%5Cu00fajo-Pereira%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Matilda%22%2C%22lastName%22%3A%22Mazibuko%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Zoey%22%2C%22lastName%22%3A%22Mhlane%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nikiwe%22%2C%22lastName%22%3A%22Mbatha%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Khadija%22%2C%22lastName%22%3A%22Khan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Senamile%22%2C%22lastName%22%3A%22Makhari%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Farina%22%2C%22lastName%22%3A%22Karim%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lauren%22%2C%22lastName%22%3A%22Peetluk%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alexander%20S.%22%2C%22lastName%22%3A%22Pym%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mahomed%20Yunus%20S.%22%2C%22lastName%22%3A%22Moosa%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yuri%20F.%22%2C%22lastName%22%3A%22van%20der%20Heijden%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Timothy%20S.%22%2C%22lastName%22%3A%22Sterling%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bruno%20B.%22%2C%22lastName%22%3A%22Andrade%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alasdair%22%2C%22lastName%22%3A%22Leslie%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Adrie%20J.%20C.%22%2C%22lastName%22%3A%22Steyn%22%7D%5D%2C%22abstractNote%22%3A%22The%20impact%20of%20human%20pulmonary%20tuberculosis%20%28TB%29%20on%20the%20bioenergetic%20metabolism%20of%20circulating%20immune%20cells%20remains%20elusive%2C%20as%20does%20the%20resolution%20of%20these%20effects%20with%20TB%20treatment.%20In%20this%20study%2C%20the%20rates%20of%20oxidative%20phosphorylation%20%28OXPHOS%29%20and%20glycolysis%20in%20circulating%20lymphocytes%20and%20monocytes%20of%20patients%20with%20drug-susceptible%20TB%20at%20diagnosis%2C%202%20months%2C%20and%206%20months%20during%20treatment%2C%20and%2012%20months%20after%20diagnosis%20were%20investigated%20using%20extracellular%20flux%20analysis.%20At%20diagnosis%2C%20the%20bioenergetic%20parameters%20of%20both%20blood%20lymphocytes%20and%20monocytes%20of%20TB%20patients%20were%20severely%20impaired%20in%20comparison%20to%20non-TB%20and%20non-HIV-infected%20controls.%20However%2C%20most%20bioenergetic%20parameters%20were%20not%20affected%20by%20HIV%20status%20or%20glycemic%20index.%20Treatment%20of%20TB%20patients%20restored%20the%20%25%20spare%20respiratory%20capacity%20%28%25SRC%29%20of%20the%20circulating%20lymphocytes%20to%20that%20observed%20in%20non-TB%20and%20non-HIV%20infected%20controls%20by%2012%20months.%20Treatment%20also%20improved%20the%20maximal%20respiration%20of%20circulating%20lymphocytes%20and%20the%20%25SRC%20of%20circulating%20monocytes%20of%20the%20TB%20patients.%20Notably%2C%20the%20differential%20correlation%20of%20the%20clinical%20and%20bioenergetic%20parameters%20of%20the%20monocytes%20and%20lymphocytes%20from%20the%20controls%20and%20TB%20patients%20at%20baseline%20and%20month%2012%20was%20consistent%20with%20improved%20metabolic%20health%20and%20resolution%20of%20inflammation%20following%20successful%20TB%20treatment.%20Network%20analysis%20of%20the%20bioenergetic%20parameters%20of%20circulating%20immune%20cells%20with%20serum%20cytokine%20levels%20indicated%20a%20highly%20coordinated%20immune%20response%20at%20month%206.%20These%20findings%20underscore%20the%20importance%20of%20metabolic%20health%20in%20combating%20TB%2C%20supporting%20the%20need%20for%20further%20investigation%20of%20the%20bioenergetic%20immunometabolism%20associated%20with%20TB%20infection%20for%20novel%20therapeutic%20approaches%20aimed%20at%20bolstering%20cellular%20energetics%20to%20enhance%20immune%20responses%20and%20expedite%20recovery%20in%20TB%20patients.%22%2C%22date%22%3A%222024%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.3389%5C%2Ffimmu.2024.1465448%22%2C%22ISSN%22%3A%221664-3224%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22GXCKG69T%22%2C%22F2Y6PLUL%22%5D%2C%22dateModified%22%3A%222024-12-16T10%3A10%3A39Z%22%7D%7D%2C%7B%22key%22%3A%2255IDC9HU%22%2C%22library%22%3A%7B%22id%22%3A2775998%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Tian%20et%20al.%22%2C%22parsedDate%22%3A%222024%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BTian%2C%20Yuqi%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BLi%2C%20Chun%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BTu%2C%20Shengxin%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BJames%2C%20Nathan%20T.%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BHarrell%2C%20Frank%20E.%26lt%3B%5C%2Fspan%26gt%3B%20et%20al.%26lt%3B%5C%2Fspan%26gt%3B%20%282024%29.%20Addressing%20Multiple%20Detection%20Limits%20with%20Semiparametric%20Cumulative%20Probability%20Models.%20%26lt%3Bi%26gt%3BJournal%20of%20the%20American%20Statistical%20Association%26lt%3B%5C%2Fi%26gt%3B%2C%20%26lt%3Bi%26gt%3B119%26lt%3B%5C%2Fi%26gt%3B%20%28546%29%2C%20S.%20864%26%23x2013%3B874.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1080%5C%2F01621459.2024.2315667%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1080%5C%2F01621459.2024.2315667%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Addressing%20Multiple%20Detection%20Limits%20with%20Semiparametric%20Cumulative%20Probability%20Models%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yuqi%22%2C%22lastName%22%3A%22Tian%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Chun%22%2C%22lastName%22%3A%22Li%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shengxin%22%2C%22lastName%22%3A%22Tu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nathan%20T.%22%2C%22lastName%22%3A%22James%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Frank%20E.%22%2C%22lastName%22%3A%22Harrell%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bryan%20E.%22%2C%22lastName%22%3A%22Shepherd%22%7D%5D%2C%22abstractNote%22%3A%22Detection%20limits%20%28DLs%29%2C%20where%20a%20variable%20cannot%20be%20measured%20outside%20of%20a%20certain%20range%2C%20are%20common%20in%20research.%20DLs%20may%20vary%20across%20study%20sites%20or%20over%20time.%20Most%20approaches%20to%20handling%20DLs%20in%20response%20variables%20implicitly%20make%20strong%20parametric%20assumptions%20on%20the%20distribution%20of%20data%20outside%20DLs.%20We%20propose%20a%20new%20approach%20to%20deal%20with%20multiple%20DLs%20based%20on%20a%20widely%20used%20ordinal%20regression%20model%2C%20the%20cumulative%20probability%20model%20%28CPM%29.%20The%20CPM%20is%20a%20rank-based%2C%20semiparametric%20linear%20transformation%20model%20that%20can%20handle%20mixed%20distributions%20of%20continuous%20and%20discrete%20outcome%20variables.%20These%20features%20are%20key%20for%20analyzing%20data%20with%20DLs%20because%20while%20observations%20inside%20DLs%20are%20continuous%2C%20those%20outside%20DLs%20are%20censored%20and%20generally%20put%20into%20discrete%20categories.%20With%20a%20single%20lower%20DL%2C%20CPMs%20assign%20values%20below%20the%20DL%20as%20having%20the%20lowest%20rank.%20With%20multiple%20DLs%2C%20the%20CPM%20likelihood%20can%20be%20modified%20to%20appropriately%20distribute%20probability%20mass.%20We%20demonstrate%20the%20use%20of%20CPMs%20with%20DLs%20via%20simulations%20and%20a%20data%20example.%20This%20work%20is%20motivated%20by%20a%20study%20investigating%20factors%20associated%20with%20HIV%20viral%20load%206%20months%20after%20starting%20antiretroviral%20therapy%20in%20Latin%20America%3B%2056%25%20of%20observations%20are%20below%20lower%20DLs%20that%20vary%20across%20study%20sites%20and%20over%20time.%22%2C%22date%22%3A%222024%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1080%5C%2F01621459.2024.2315667%22%2C%22ISSN%22%3A%220162-1459%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22GXCKG69T%22%2C%22F2Y6PLUL%22%5D%2C%22dateModified%22%3A%222024-11-06T09%3A27%3A52Z%22%7D%7D%2C%7B%22key%22%3A%22MS8AYKAK%22%2C%22library%22%3A%7B%22id%22%3A2775998%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Passos%20et%20al.%22%2C%22parsedDate%22%3A%222024%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BPassos%2C%20Beatriz%20B.%20S.%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BAra%26%23xFA%3Bjo-Pereira%2C%20Mariana%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BVinhaes%2C%20Caian%20L.%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BAmaral%2C%20Eduardo%20P.%26lt%3B%5C%2Fspan%26gt%3B%20%26amp%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BAndrade%2C%20Bruno%20B.%26lt%3B%5C%2Fspan%26gt%3B%20%282024%29.%20The%20role%20of%20ESAT-6%20in%20tuberculosis%20immunopathology.%20%26lt%3Bi%26gt%3BFrontiers%20in%20Immunology%26lt%3B%5C%2Fi%26gt%3B%2C%20%26lt%3Bi%26gt%3B15%26lt%3B%5C%2Fi%26gt%3B%2C%20S.%201383098.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.3389%5C%2Ffimmu.2024.1383098%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.3389%5C%2Ffimmu.2024.1383098%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22The%20role%20of%20ESAT-6%20in%20tuberculosis%20immunopathology%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Beatriz%20B.%20S.%22%2C%22lastName%22%3A%22Passos%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mariana%22%2C%22lastName%22%3A%22Ara%5Cu00fajo-Pereira%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Caian%20L.%22%2C%22lastName%22%3A%22Vinhaes%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eduardo%20P.%22%2C%22lastName%22%3A%22Amaral%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bruno%20B.%22%2C%22lastName%22%3A%22Andrade%22%7D%5D%2C%22abstractNote%22%3A%22Despite%20major%20global%20efforts%20to%20eliminate%20tuberculosis%2C%20which%20is%20caused%20by%20Mycobacterium%20tuberculosis%20%28Mtb%29%2C%20this%20disease%20remains%20as%20a%20major%20plague%20of%20humanity.%20Several%20factors%20associated%20with%20the%20host%20and%20Mtb%20interaction%20favor%20the%20infection%20establishment%20and%5C%2For%20determine%20disease%20progression.%20The%20Early%20Secreted%20Antigenic%20Target%206%20kDa%20%28ESAT-6%29%20is%20one%20of%20the%20most%20important%20and%20well-studied%20mycobacterial%20virulence%20factors.%20This%20molecule%20has%20been%20described%20to%20play%20an%20important%20role%20in%20the%20development%20of%20tuberculosis-associated%20pathology%20by%20subverting%20crucial%20components%20of%20the%20host%20immune%20responses.%20This%20review%20highlights%20the%20main%20effector%20mechanisms%20by%20which%20ESAT-6%20modulates%20the%20immune%20system%2C%20directly%20impacting%20cell%20fate%20and%20disease%20progression.%22%2C%22date%22%3A%222024%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.3389%5C%2Ffimmu.2024.1383098%22%2C%22ISSN%22%3A%221664-3224%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22GXCKG69T%22%2C%22F2Y6PLUL%22%5D%2C%22dateModified%22%3A%222024-07-25T14%3A41%3A28Z%22%7D%7D%5D%7D
Ridolfi, Felipe; Amorim, Gustavo; Haas, David W.; Arriaga, Maria; Staats, Cody et al. (2024). Pharmacogenomic associations with HIV-1 virologic suppression in TB/HIV patients. Research Square, S. rs.3.rs-5418156. http://doi.org/10.21203/rs.3.rs-5418156/v1.
Mendelsohn, Simon C.; Andrade, Bruno B.; Mbandi, Stanley Kimbung; Andrade, Alice M. S.; Muwanga, Vanessa M. et al. (2024). Transcriptomic Signatures of Progression to Tuberculosis Disease Among Close Contacts in Brazil. The Journal of Infectious Diseases, 230 (6), S. e1355–e1365. http://doi.org/10.1093/infdis/jiae237.
Espejo-Ortiz, Cristian E.; Sierra-Barajas, Nancy; Silva-Casarrubias, Angelina; Guerrero-Torres, Lorena; Caro-Vega, Yanink et al. (2024). A cascade of care for diabetes in people living with HIV in a tertiary care center in Mexico City. HIV Research & Clinical Practice, 25 (1), S. 2411481. http://doi.org/10.1080/25787489.2024.2411481.
de Waal, Reneé; Wools-Kaloustian, Kara; Brazier, Ellen; Althoff, Keri N.; Jaquet, Antoine et al. (2024). Global trends in CD4 count measurement and distribution at first antiretroviral treatment initiation. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America, S. ciae548. http://doi.org/10.1093/cid/ciae548.
Castilho, Jessica L.; Fonseca, Fernanda F.; Kim, Ahra; Jalil, Emilia; Tu, Shengxin et al. (2024). Prenatal syphilis and adverse pregnancy outcomes in women with HIV receiving ART in Brazil: a population-based study. Lancet Regional Health. Americas, 39, S. 100894. http://doi.org/10.1016/j.lana.2024.100894.
Barreto-Duarte, Beatriz; Villalva-Serra, Klauss; Campos, Vanessa M. S.; Cordeiro-Santos, Marcelo; Kritski, Afrânio L. et al. (2024). Nationwide economic analysis of pulmonary tuberculosis in the Brazilian healthcare system over seven years (2015-2022): a population-based study. Lancet Regional Health. Americas, 39, S. 100905. http://doi.org/10.1016/j.lana.2024.100905.
Amorim, Gustavo; Jaworski, James; Yang, Jing; Cordeiro-Santos, Marcelo; Kritski, Afrânio L. et al. (2024). Pharmacogenetics of tuberculosis treatment toxicity and effectiveness in a large Brazilian cohort. Pharmacogenetics and Genomics. http://doi.org/10.1097/FPC.0000000000000552.
Parcesepe, Angela M.; Stockton, Melissa; Bernard, Charlotte; Kanguya, Tukiya; Kwobah, Edith Kamaru et al. (2024). Prevalence and co-occurrence of symptoms of mental and substance use disorders among people with HIV age 40 and older in low- and middle-income countries: a cross-sectional study. Journal of the International AIDS Society, 27 (10), S. e26359. http://doi.org/10.1002/jia2.26359.
Kuniholm, Mark H.; Murenzi, Gad; Shumbusho, Fabienne; Brazier, Ellen; Plaisy, Marie K. et al. (2024). Association of cardiovascular disease risk with liver steatosis and fibrosis in people living with hiv in low- and middle-income countries. AIDS (London, England). http://doi.org/10.1097/QAD.0000000000004012.
Zaniewski, Elizabeth; Skrivankova, Veronika Whitesell; Brazier, Ellen; Avihingsanon, Anchalee; Cardoso, Sandra Wagner et al. (2024). Transition to dolutegravir-based ART in 35 low- and middle-income countries: a global survey of HIV care clinics. AIDS (London, England). http://doi.org/10.1097/QAD.0000000000004007.
Egger, Matthias; Sauermann, Mamatha; Loosli, Tom; Hossmann, Stefanie; Riedo, Selma et al. (2024). HIV-1 subtype-specific drug resistance on dolutegravir-based antiretroviral therapy: protocol for a multicentre study (DTG RESIST). BMJ Open, 14 (8), S. e085819. http://doi.org/10.1136/bmjopen-2024-085819.
Barreto-Duarte, Beatriz; Villalva-Serra, Klauss; Miguez-Pinto, João P.; Araújo-Pereira, Mariana; Campos, Vanessa M. S. et al. (2024). Retreatment and Anti-tuberculosis Therapy Outcomes in Brazil Between 2015 and 2022: A Nationwide Study. Open Forum Infectious Diseases, 11 (8), S. ofae416. http://doi.org/10.1093/ofid/ofae416.
Lotspeich, Sarah C.; Amorim, Gustavo G. C.; Shaw, Pamela A.; Tao, Ran & Shepherd, Bryan E. (2024). Optimal multiwave validation of secondary use data with outcome and exposure misclassification. The Canadian Journal of Statistics = Revue Canadienne De Statistique, 52 (2), S. 532–554. http://doi.org/10.1002/cjs.11772.
Gorsline, Chelsea A.; Lotspeich, Sarah C.; Belaunzarán-Zamudio, Pablo F.; Mejia, Fernando; Cortes, Claudia P. et al. (2024). The impact of earthquakes in Latin America on the continuity of HIV care: A retrospective observational cohort study. Public Health in Practice (Oxford, England), 7, S. 100479. http://doi.org/10.1016/j.puhip.2024.100479.
Rodrigues, Moreno M. S.; Barreto-Duarte, Beatriz; Vinhaes, Caian L.; Araújo-Pereira, Mariana; Fukutani, Eduardo R. et al. (2024). Machine learning algorithms using national registry data to predict loss to follow-up during tuberculosis treatment. BMC Public Health, 24 (1), S. 1385. http://doi.org/10.1186/s12889-024-18815-0.
Kebede, Samuel; Brazier, Ellen; Freeman, Aimee M.; Muwonge, Timothy R.; Choi, Jun Yong et al. (2024). Preexposure prophylaxis availability among health facilities participating in the global International epidemiology Databases to Evaluate AIDS (IeDEA) consortium. AIDS (London, England), 38 (5), S. 751–756. http://doi.org/10.1097/QAD.0000000000003824.
Plaisy, Marie Kerbie; Minga, Albert K.; Wandeler, Gilles; Murenzi, Gad; Samala, Niharika et al. (2024). Metabolic causes of liver disease among adults living with HIV from low- and middle-income countries: a cross-sectional study. Journal of the International AIDS Society, 27 (4), S. e26238. http://doi.org/10.1002/jia2.26238.
Baker, Paul J.; Bohrer, Andrea C.; Castro, Ehydel; Amaral, Eduardo P.; Snow-Smith, Maryonne et al. (2024). The inflammatory microenvironment of the lung at the time of infection governs innate control of SARS-CoV-2 replication. bioRxiv: The Preprint Server for Biology, S. 2024.03.27.586885. http://doi.org/10.1101/2024.03.27.586885.
Vinhaes, Caian L.; Fukutani, Eduardo R.; Santana, Gabriel C.; Arriaga, María B.; Barreto-Duarte, Beatriz et al. (2024). An integrative multi-omics approach to characterize interactions between tuberculosis and diabetes mellitus. iScience, 27 (3), S. 109135. http://doi.org/10.1016/j.isci.2024.109135.
Ridolfi, Felipe; Amorim, Gustavo; Peetluk, Lauren S.; Haas, David W.; Staats, Cody et al. (2024). Prediction Models for Adverse Drug Reactions During Tuberculosis Treatment in Brazil. The Journal of Infectious Diseases, 229 (3), S. 813–823. http://doi.org/10.1093/infdis/jiae025.
Brazier, Ellen; Tymejczyk, Olga; Wools-Kaloustian, Kara; Jiamsakul, Awachana; Torres, Marco Tulio Luque et al. (2024). Long-term HIV care outcomes under universal HIV treatment guidelines: A retrospective cohort study in 25 countries. PLoS Medicine, 21 (3), S. e1004367. http://doi.org/10.1371/journal.pmed.1004367.
Castillo-Rozas, Gabriel; Tu, Shengxin; Luz, Paula Mendes; Mejia, Fernando; Sierra-Madero, Juan et al. (2024). Clinical outcomes and risk factors for immune recovery and all-cause mortality in Latin Americans living with HIV with virological success: a retrospective cohort study. Journal of the International AIDS Society, 27 (3), S. e26214. http://doi.org/10.1002/jia2.26214.
Davidović, Maša; Asangbeh, Serra Lem; Taghavi, Katayoun; Dhokotera, Tafadzwa; Jaquet, Antoine et al. (2024). Facility-Based Indicators to Manage and Scale Up Cervical Cancer Prevention and Care Services for Women Living With HIV in Sub-Saharan Africa: a Three-Round Online Delphi Consensus Method. Journal of Acquired Immune Deficiency Syndromes (1999), 95 (2), S. 170–178. http://doi.org/10.1097/QAI.0000000000003343.
Lancaster, Kathryn E.; Stockton, Melissa; Remch, Molly; Wester, C. William; Nash, Denis et al. (2024). Availability of substance use screening and treatment within HIV clinical sites across seven geographic regions within the IeDEA consortium. The International Journal on Drug Policy, 124, S. 104309. http://doi.org/10.1016/j.drugpo.2023.104309.
Rocha, Eduardo Fukutani; Vinhaes, Caian Leal; Araújo-Pereira, Mariana; Mota, Tiago Feitosa; Gupte, Akshay N. et al. (2024). The sound of silent RNA in tuberculosis and the lncRNA role on infection. iScience, 27 (1), S. 108662. http://doi.org/10.1016/j.isci.2023.108662.
Enane, Leslie A.; Duda, Stephany N.; Chanyachukul, Thida; Bolton-Moore, Carolyn; Navuluri, Neelima et al. (2024). The Tuberculosis Sentinel Research Network (TB-SRN) of the International epidemiology Databases to Evaluate AIDS (IeDEA): protocol for a prospective cohort study in Africa, Southeast Asia and Latin America. BMJ Open, 14 (1), S. e079138. http://doi.org/10.1136/bmjopen-2023-079138.
Araújo-Pereira, Mariana; Arriaga, María B.; Carvalho, Anna Cristina C.; Spener-Gomes, Renata; Schmaltz, Carolina A. S. et al. (2024). Isoniazid Monoresistance and Antituberculosis Treatment Outcome in Persons With Pulmonary Tuberculosis in Brazil. Open Forum Infectious Diseases, 11 (1), S. ofad691. http://doi.org/10.1093/ofid/ofad691.
Cumming, Bridgette M.; Addicott, Kelvin W.; Maruri, Fernanda; Pillay, Vanessa; Asmal, Rukaya et al. (2024). Longitudinal mitochondrial bioenergetic signatures of blood monocytes and lymphocytes improve during treatment of drug-susceptible pulmonary tuberculosis patients Monocyte/lymphocyte bioenergetic signatures post-TB treatment. Frontiers in Immunology, 15, S. 1465448. http://doi.org/10.3389/fimmu.2024.1465448.
Tian, Yuqi; Li, Chun; Tu, Shengxin; James, Nathan T.; Harrell, Frank E. et al. (2024). Addressing Multiple Detection Limits with Semiparametric Cumulative Probability Models. Journal of the American Statistical Association, 119 (546), S. 864–874. http://doi.org/10.1080/01621459.2024.2315667.
Passos, Beatriz B. S.; Araújo-Pereira, Mariana; Vinhaes, Caian L.; Amaral, Eduardo P. & Andrade, Bruno B. (2024). The role of ESAT-6 in tuberculosis immunopathology. Frontiers in Immunology, 15, S. 1383098. http://doi.org/10.3389/fimmu.2024.1383098.
2775998
F2Y6PLUL
2023
1
padagogische-hochschule-bern-institut-vorschulstufe-und-primarstufe
50
date
desc
year
258
https://www.iedea.org/wp-content/plugins/zotpress/
%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3Afalse%2C%22meta%22%3A%7B%22request_last%22%3A0%2C%22request_next%22%3A0%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%227SWCRYX4%22%2C%22library%22%3A%7B%22id%22%3A2775998%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Rodrigues%20et%20al.%22%2C%22parsedDate%22%3A%222023-12-11%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BRodrigues%2C%20Moreno%20M.%20S.%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BBarreto-Duarte%2C%20Beatriz%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BVinhaes%2C%20Caian%20L.%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BAra%26%23xFA%3Bjo-Pereira%2C%20Mariana%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BFukutani%2C%20Eduardo%20R.%26lt%3B%5C%2Fspan%26gt%3B%20et%20al.%26lt%3B%5C%2Fspan%26gt%3B%20%282023%29.%20Machine%20learning%20algorithms%20using%20national%20registry%20data%20to%20predict%20loss%20to%20follow-%20up%20during%20tuberculosis%20treatment.%20%26lt%3Bi%26gt%3BResearch%20Square%26lt%3B%5C%2Fi%26gt%3B%2C%20S.%20rs.3.rs-3706875.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.21203%5C%2Frs.3.rs-3706875%5C%2Fv1%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.21203%5C%2Frs.3.rs-3706875%5C%2Fv1%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Machine%20learning%20algorithms%20using%20national%20registry%20data%20to%20predict%20loss%20to%20follow-%20up%20during%20tuberculosis%20treatment%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Moreno%20M.%20S.%22%2C%22lastName%22%3A%22Rodrigues%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Beatriz%22%2C%22lastName%22%3A%22Barreto-Duarte%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Caian%20L.%22%2C%22lastName%22%3A%22Vinhaes%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mariana%22%2C%22lastName%22%3A%22Ara%5Cu00fajo-Pereira%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eduardo%20R.%22%2C%22lastName%22%3A%22Fukutani%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Keityane%20Bone%22%2C%22lastName%22%3A%22Bergamaschi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Afr%5Cu00e2nio%22%2C%22lastName%22%3A%22Kristki%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marcelo%22%2C%22lastName%22%3A%22Cordeiro-Santos%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Valeria%20C.%22%2C%22lastName%22%3A%22Rolla%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Timothy%20R.%22%2C%22lastName%22%3A%22Sterling%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Artur%20T.%20L.%22%2C%22lastName%22%3A%22Queiroz%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bruno%20B.%22%2C%22lastName%22%3A%22Andrade%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20Identifying%20patients%20at%20increased%20risk%20of%20loss%20to%20follow-up%20%28LTFU%29%20is%20key%20to%20developing%20strategies%20to%20optimize%20the%20clinical%20management%20of%20tuberculosis%20%28TB%29.%20The%20use%20of%20national%20registry%20data%20in%20prediction%20models%20may%20be%20a%20useful%20tool%20to%20inform%20healthcare%20workers%20about%20risk%20of%20LTFU.%20Here%20we%20developed%20a%20score%20to%20predict%20the%20risk%20of%20LTFU%20during%20anti-TB%20treatment%20%28ATT%29%20in%20a%20nationwide%20cohort%20of%20cases%20using%20clinical%20data%20reported%20to%20the%20Brazilian%20Notifiable%20Disease%20Information%20System%20%28SINAN%29.%5CnMETHODS%3A%20We%20performed%20a%20retrospective%20study%20of%20all%20TB%20cases%20reported%20to%20SINAN%20between%202015-2022%3B%20excluding%20children%20%28%26lt%3B18%20years-old%29%2C%20vulnerable%20groups%20or%20drug-resistant%20TB.%20For%20the%20score%2C%20data%20before%20treatment%20initiation%20were%20used.%20We%20trained%20and%20internally%20validated%20three%20different%20prediction%20scoring%20systems%2C%20based%20on%20Logistic%20Regression%2C%20Random%20Forest%2C%20and%20Light%20Gradient%20Boosting.%20Before%20applying%20our%20models%20we%20split%20our%20data%20into%20train%20%28~80%25%20data%29%20and%20test%20%28~20%25%29%2C%20and%20then%20we%20compare%20model%20metrics%20using%20a%20test%20data%20set.%5CnRESULTS%3A%20Of%20the%20243%2C726%20cases%20included%2C%2041%2C373%20experienced%20LTFU%20whereas%20202%2C353%20were%20successfully%20treated%20and%20cured.%20The%20groups%20were%20different%20with%20regards%20to%20several%20clinical%20and%20sociodemographic%20characteristics.%20The%20directly%20observed%20treatment%20%28DOT%29%20was%20unbalanced%20between%20the%20groups%20with%20lower%20prevalence%20in%20those%20who%20were%20LTFU.%20Three%20models%20were%20developed%20to%20predict%20LTFU%20using%208%20features%20%28prior%20TB%2C%20drug%20use%2C%20age%2C%20sex%2C%20HIV%20infection%20and%20schooling%20level%29%20with%20different%20score%20composition%20approaches.%20Those%20prediction%20scoring%20system%20exhibited%20an%20area%20under%20the%20curve%20%28AUC%29%20ranging%20between%200.71%20and%200.72.%20The%20Light%20Gradient%20Boosting%20technique%20resulted%20in%20the%20best%20prediction%20performance%2C%20weighting%20specificity%2C%20and%20sensibility.%20A%20user-friendly%20web%20calculator%20app%20was%20created%20%28https%3A%5C%2F%5C%2Ftbprediction.herokuapp.com%5C%2F%29%20to%20facilitate%20implementation.%5CnCONCLUSIONS%3A%20Our%20nationwide%20risk%20score%20predicts%20the%20risk%20of%20LTFU%20during%20ATT%20in%20Brazilian%20adults%20prior%20to%20treatment%20commencement.%20This%20is%20a%20potential%20tool%20to%20assist%20in%20decision-making%20strategies%20to%20guide%20resource%20allocation%2C%20DOT%20indications%2C%20and%20improve%20TB%20treatment%20adherence.%22%2C%22date%22%3A%222023-12-11%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.21203%5C%2Frs.3.rs-3706875%5C%2Fv1%22%2C%22ISSN%22%3A%22%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22GXCKG69T%22%2C%22F2Y6PLUL%22%5D%2C%22dateModified%22%3A%222024-01-12T13%3A02%3A52Z%22%7D%7D%2C%7B%22key%22%3A%22CUA4BYIU%22%2C%22library%22%3A%7B%22id%22%3A2775998%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Grinsztejn%20et%20al.%22%2C%22parsedDate%22%3A%222023-12-01%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BGrinsztejn%2C%20Eduarda%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BCardoso%2C%20Sandra%20Wagner%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BVelasque%2C%20Luciane%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BHoagland%2C%20Brenda%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BDos%20Santos%2C%20Desiree%20Gomes%26lt%3B%5C%2Fspan%26gt%3B%20et%20al.%26lt%3B%5C%2Fspan%26gt%3B%20%282023%29.%20Impact%20of%20Latent%20M.%20tuberculosis%20Infection%20Treatment%20on%20Time%20to%20CD4%5C%2FCD8%20Recovery%20in%20Acute%2C%20Recent%2C%20and%20Chronic%20HIV%20Infection.%20%26lt%3Bi%26gt%3BJournal%20of%20Acquired%20Immune%20Deficiency%20Syndromes%20%281999%29%26lt%3B%5C%2Fi%26gt%3B%2C%20%26lt%3Bi%26gt%3B94%26lt%3B%5C%2Fi%26gt%3B%20%284%29%2C%20S.%20355%26%23x2013%3B363.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1097%5C%2FQAI.0000000000003284%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1097%5C%2FQAI.0000000000003284%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Impact%20of%20Latent%20M.%20tuberculosis%20Infection%20Treatment%20on%20Time%20to%20CD4%5C%2FCD8%20Recovery%20in%20Acute%2C%20Recent%2C%20and%20Chronic%20HIV%20Infection%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eduarda%22%2C%22lastName%22%3A%22Grinsztejn%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sandra%20Wagner%22%2C%22lastName%22%3A%22Cardoso%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Luciane%22%2C%22lastName%22%3A%22Velasque%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Brenda%22%2C%22lastName%22%3A%22Hoagland%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Desiree%20Gomes%22%2C%22lastName%22%3A%22Dos%20Santos%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Carolina%22%2C%22lastName%22%3A%22Coutinho%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Simone%20da%20Costa%22%2C%22lastName%22%3A%22Cruz%20Silva%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sandro%20Coutinho%22%2C%22lastName%22%3A%22Nazer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ana%20Cristina%20Garcia%22%2C%22lastName%22%3A%22Ferreira%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jessica%22%2C%22lastName%22%3A%22Castilho%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Beatriz%22%2C%22lastName%22%3A%22Grinsztejn%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Valdilea%20G.%22%2C%22lastName%22%3A%22Veloso%22%7D%5D%2C%22abstractNote%22%3A%22INTRODUCTION%3A%20In%20people%20living%20with%20HIV%2C%20active%20and%20latent%20tuberculosis%20%28TB%29%20coinfections%20are%20associated%20with%20immune%20activation%20that%20correlate%20with%20HIV%20progression%20and%20mortality.%20We%20investigated%20the%20effect%20of%20initiating%20antiretroviral%20therapy%20%28ART%29%20during%20acute%20%28AHI%29%2C%20recent%20%28RHI%29%2C%20or%20chronic%20HIV%20infection%20%28CHI%29%20on%20CD4%5C%2FCD8%20ratio%20normalization%20and%20associated%20factors%2C%20the%20impact%20of%20latent%20TB%20infection%20treatment%2C%20and%20prior%5C%2Fconcomitant%20TB%20diagnosis%20at%20the%20time%20of%20ART%20initiation.%5CnMETHODS%3A%20We%20included%20sex%20with%20men%20and%20transgender%20women%20individuals%20initiating%20ART%20with%20AHI%2C%20RHI%20and%20CHI%20between%202013%20and%202019%2C%20from%20a%20prospective%20cohort%20in%20Brazil.%20We%20compared%20time%20from%20ART%20initiation%20to%20the%20first%20normal%20CD4%5C%2FCD8%20ratio%20%28CD4%5C%2FCD8%20%5Cu22651%29%20using%20Kaplan-Meier%20curves%20and%20multivariable%20Cox%20proportional%20hazards%20models.%20Sociodemographic%20and%20clinical%20variables%20were%20explored.%20Variables%20with%20P%20-values%20%26lt%3B0.20%20in%20univariable%20analyses%20were%20included%20in%20multivariable%20analyses.%5CnRESULTS%3A%20Five%20hundred%20fifty%20participants%20were%20included%2C%2011.8%25%20classified%20as%20AHI%20and%206.4%25%20as%20RHI%2C%2046.7%25%20with%20CHI-CD4%20cell%20counts%20%5Cu2265350%20cells%5C%2Fmm%203%20and%2035.1%25%20with%20CHI-CD4%20cell%20counts%20%26lt%3B350%20cells%5C%2Fmm%203%20.%20Time%20to%20normalization%20was%20shortest%20among%20AHI%20patients%2C%20followed%20by%20RHI%20and%20CHI%20individuals%20with%20higher%20baseline%20CD4.%20In%20the%20multivariable%20model%2C%20AHI%20was%20associated%20with%20a%20six-fold%20increased%20likelihood%20of%20achieving%20a%20CD4%5C%2FCD8%20ratio%20%5Cu22651%20%28hazard%20ratio%20%5BHR%5D%3A%206.03%3B%2095%25%20confidence%20interval%20%5BCI%5D%3A%203.70%20to%209.82%3B%20P%20%26lt%3B%200.001%29%2C%20RHI%20with%20HR%3A%204.47%20%2895%25%20CI%3A%202.57%20to%207.76%3B%20P%20%26lt%3B%200.001%29%2C%20and%20CHI%20CD4%20%5Cu2265350%20cells%5C%2Fmm%203%20with%20HR%3A%201.87%20%2895%25%20CI%3A%201.24%20to%202.84%3B%20P%20%3D%200.003%29.%20Latent%20TB%20infection%20treatment%20was%20significantly%20associated%20with%20a%20higher%20likelihood%20of%20the%20outcome%20%28HR%3A%201.79%3B%2095%25%20CI%3A%201.22%20to%202.62%3B%20P%20%3D%200.003%29.%20Previous%20history%20or%20concomitant%20active%20TB%20at%20ART%20initiation%20was%20associated%20with%20a%20lower%20likelihood%20of%20the%20outcome%20%28HR%3A%200.41%3B%2095%25%20CI%3A%200.16%20to%201.02%3B%20P%20%3D%200.054%29.%5CnCONCLUSIONS%3A%20Initiating%20ART%20early%20during%20AHI%20may%20offer%20an%20opportunity%20to%20mitigate%20immune%20damage.%20Efforts%20to%20implement%20HIV%20diagnosis%20and%20ART%20initiation%20during%20AHI%20are%20critical%20to%20amplify%20ART%20benefits.%22%2C%22date%22%3A%222023-12-01%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1097%5C%2FQAI.0000000000003284%22%2C%22ISSN%22%3A%221944-7884%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22GXCKG69T%22%2C%22F2Y6PLUL%22%5D%2C%22dateModified%22%3A%222024-01-12T13%3A25%3A20Z%22%7D%7D%2C%7B%22key%22%3A%22C8REYNX4%22%2C%22library%22%3A%7B%22id%22%3A2775998%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Meireles%20et%20al.%22%2C%22parsedDate%22%3A%222023-12%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BMeireles%2C%20Glaucia%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BNobre%2C%20Aline%20A.%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BCardoso%2C%20Sandra%20W.%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BVelasque%2C%20Luciane%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BVeloso%2C%20Valdilea%20G.%26lt%3B%5C%2Fspan%26gt%3B%20et%20al.%26lt%3B%5C%2Fspan%26gt%3B%20%282023%29.%20Real-world%20effectiveness%20of%20WHO%20recommended%20first-line%20antiretroviral%20therapies%3A%20a%20cohort%20study%20from%20a%20middle-income%20country.%20%26lt%3Bi%26gt%3BAIDS%20Care%26lt%3B%5C%2Fi%26gt%3B%2C%20%26lt%3Bi%26gt%3B35%26lt%3B%5C%2Fi%26gt%3B%20%2812%29%2C%20S.%201891%26%23x2013%3B1903.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1080%5C%2F09540121.2023.2190954%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1080%5C%2F09540121.2023.2190954%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Real-world%20effectiveness%20of%20WHO%20recommended%20first-line%20antiretroviral%20therapies%3A%20a%20cohort%20study%20from%20a%20middle-income%20country%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Glaucia%22%2C%22lastName%22%3A%22Meireles%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Aline%20A.%22%2C%22lastName%22%3A%22Nobre%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sandra%20W.%22%2C%22lastName%22%3A%22Cardoso%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Luciane%22%2C%22lastName%22%3A%22Velasque%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Valdilea%20G.%22%2C%22lastName%22%3A%22Veloso%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Beatriz%22%2C%22lastName%22%3A%22Grinsztejn%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Paula%20M.%22%2C%22lastName%22%3A%22Luz%22%7D%5D%2C%22abstractNote%22%3A%22We%20estimate%20the%20effectiveness%20of%20antiretroviral%20therapy%20%28ART%29%20among%20individuals%20receiving%20HIV%20care%20in%20Rio%20de%20Janeiro%2C%20Brazil.%20Adults%20%2818y%2B%29%20initiating%20ART%20between%20Jan%5C%2F2008%20and%20Dec%5C%2F2018%20%28follow-up%20through%20Dec%5C%2F2020%29%20were%20included.%20First-line%20ART%20%28two%20nucleoside%20reverse%20transcriptase%20inhibitors%20plus%20one%20antiretroviral%20from%20another%20class%29%20was%20categorized%20into%20four%20categories%3A%20non-nucleoside%20reverse%20transcriptase%20inhibitor%5C%2FNNRTI-based%2C%20protease%20inhibitor%5C%2FPI-based%2C%20integrase%20strand%20transfer%20inhibitor%5C%2FINSTI-based%2C%20and%20single-tablet%20regimen%20%28STR%2C%20Tenofovir%20300mg%5Cu2009%2B%5Cu2009Lamivudine%20300mg%5Cu2009%2B%5Cu2009Efavirenz%20600mg%29.%20Effectiveness%20%28viral%20load%20%5Cu226450%20copies%5C%2F%5Cu00b5L%29%20was%20evaluated%20at%206%283-9%29%20and%2012%289-15%29%20months%20from%20ART%20initiation.%20Bayesian%20logistic%20regression%20models%20were%20used%20to%20quantify%20the%20association%20between%20exposure%20and%20outcomes%20while%20accounting%20for%20missing%20data.%20Overall%2C%201863%2857%25%29%2C%20652%2819.9%25%29%2C%20412%2812.6%25%29%2C%20and%20342%2810.5%25%29%20individuals%20used%2C%20respectively%2C%20NNRTI-based%2C%20PI-based%2C%20INSTI-based%20regimens%2C%20and%20STR.%20Compared%20to%20NNRTIs%2C%20the%20odds%20of%20viral%20suppression%20with%20INSTI-based%20regimens%20was%2076%25%20higher%20%28adjusted%20OR%3A1.76%2C%2095%25CI%3A1.23-2.51%29%20at%20six%20months%20but%20no%20higher%20at%2012%20months.%20Older%20age%2C%20higher%20education%2C%20CD4%20count%20%5Cu2265500%20cells%5C%2Fmm3%20and%20viral%20load%20%26lt%3B100%2C000%20copies%5C%2F%5Cu00b5L%20at%20ART%20initiation%20increased%20the%20odds%20of%20viral%20suppression.%20Viral%20suppression%20at%20six%20months%20was%20the%20strongest%20predictor%20of%20viral%20suppression%20at%2012%20months.%20These%20results%20highlight%20population%20groups%20that%20could%20benefit%20from%20close%20monitoring%20during%20the%20first%20year%20of%20ART.%22%2C%22date%22%3A%222023-12%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1080%5C%2F09540121.2023.2190954%22%2C%22ISSN%22%3A%221360-0451%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22GXCKG69T%22%2C%22F2Y6PLUL%22%5D%2C%22dateModified%22%3A%222023-12-01T10%3A43%3A00Z%22%7D%7D%2C%7B%22key%22%3A%22XACIV894%22%2C%22library%22%3A%7B%22id%22%3A2775998%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Eden%20et%20al.%22%2C%22parsedDate%22%3A%222023-09-27%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BEden%2C%20Svetlana%20K.%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BLi%2C%20Chun%26lt%3B%5C%2Fspan%26gt%3B%20%26amp%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BShepherd%2C%20Bryan%20E.%26lt%3B%5C%2Fspan%26gt%3B%20%282023%29.%20Spearman-like%20correlation%20measure%20adjusting%20for%20covariates%20in%20bivariate%20survival%20data.%20%26lt%3Bi%26gt%3BBiometrical%20Journal.%20Biometrische%20Zeitschrift%26lt%3B%5C%2Fi%26gt%3B%2C%20S.%20e2200137.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1002%5C%2Fbimj.202200137%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1002%5C%2Fbimj.202200137%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Spearman-like%20correlation%20measure%20adjusting%20for%20covariates%20in%20bivariate%20survival%20data%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Svetlana%20K.%22%2C%22lastName%22%3A%22Eden%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Chun%22%2C%22lastName%22%3A%22Li%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bryan%20E.%22%2C%22lastName%22%3A%22Shepherd%22%7D%5D%2C%22abstractNote%22%3A%22We%20propose%20an%20extension%20of%20Spearman%26%23039%3Bs%20correlation%20for%20censored%20continuous%20and%20discrete%20data%20that%20permits%20covariate%20adjustment.%20Previously%20proposed%20nonparametric%20and%20semiparametric%20Spearman%26%23039%3Bs%20correlation%20estimators%20require%20either%20nonparametric%20estimation%20of%20the%20bivariate%20survival%20surface%20or%20parametric%20assumptions%20about%20the%20dependence%20structure.%20In%20practice%2C%20nonparametric%20estimation%20of%20the%20bivariate%20survival%20surface%20is%20difficult%2C%20and%20parametric%20assumptions%20about%20the%20correlation%20structure%20may%20not%20be%20satisfied.%20Therefore%2C%20we%20propose%20a%20method%20that%20requires%20neither%20and%20uses%20only%20the%20marginal%20survival%20distributions.%20Our%20method%20estimates%20the%20correlation%20of%20probability-scale%20residuals%2C%20which%20has%20been%20shown%20to%20equal%20Spearman%26%23039%3Bs%20correlation%20when%20there%20is%20no%20censoring.%20Because%20this%20method%20relies%20only%20on%20marginal%20distributions%2C%20it%20tends%20to%20be%20less%20variable%20than%20the%20previously%20suggested%20nonparametric%20estimators%2C%20and%20the%20confidence%20intervals%20are%20easily%20constructed.%20Although%20under%20censoring%2C%20it%20is%20biased%20for%20Spearman%26%23039%3Bs%20correlation%20as%20our%20simulations%20show%2C%20it%20performs%20well%20under%20moderate%20censoring%2C%20with%20a%20smaller%20mean%20squared%20error%20than%20nonparametric%20approaches.%20We%20also%20extend%20it%20to%20partial%20%28adjusted%29%2C%20conditional%2C%20and%20partial-conditional%20correlation%2C%20which%20makes%20it%20particularly%20relevant%20for%20practical%20applications.%20We%20apply%20our%20method%20to%20estimate%20the%20correlation%20between%20time%20to%20viral%20failure%20and%20time%20to%20regimen%20change%20in%20a%20multisite%20cohort%20of%20persons%20living%20with%20HIV%20in%20Latin%5Cu00a0America.%22%2C%22date%22%3A%222023-09-27%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1002%5C%2Fbimj.202200137%22%2C%22ISSN%22%3A%221521-4036%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22GXCKG69T%22%2C%22F2Y6PLUL%22%5D%2C%22dateModified%22%3A%222023-10-10T11%3A47%3A18Z%22%7D%7D%2C%7B%22key%22%3A%22W2HVK3BT%22%2C%22library%22%3A%7B%22id%22%3A2775998%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Bocage%20et%20al.%22%2C%22parsedDate%22%3A%222023-08%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BBocage%2C%20A.%20E.%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BCoelho%2C%20L.%20E.%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BLake%2C%20J.%20E.%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BClark%2C%20J.%20L.%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BTorres%2C%20T.%20S.%26lt%3B%5C%2Fspan%26gt%3B%20et%20al.%26lt%3B%5C%2Fspan%26gt%3B%20%282023%29.%20The%20Impact%20of%20COVID-19%20on%20HIV%20Care%20in%20Rio%20de%20Janeiro%2C%20Brazil%202019-2021%3A%20Disparities%20by%20Age%20and%20Gender.%20%26lt%3Bi%26gt%3BAIDS%20Behav%26lt%3B%5C%2Fi%26gt%3B%2C%20%26lt%3Bi%26gt%3B27%26lt%3B%5C%2Fi%26gt%3B%20%288%29%2C%20S.%202629%26%23x2013%3B2641.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1007%5C%2Fs10461-023-03988-3%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1007%5C%2Fs10461-023-03988-3%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22The%20Impact%20of%20COVID-19%20on%20HIV%20Care%20in%20Rio%20de%20Janeiro%2C%20Brazil%202019-2021%3A%20Disparities%20by%20Age%20and%20Gender%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22A.%20E.%22%2C%22lastName%22%3A%22Bocage%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22L.%20E.%22%2C%22lastName%22%3A%22Coelho%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J.%20E.%22%2C%22lastName%22%3A%22Lake%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J.%20L.%22%2C%22lastName%22%3A%22Clark%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22T.%20S.%22%2C%22lastName%22%3A%22Torres%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22E.%20M.%22%2C%22lastName%22%3A%22Jalil%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22S.%20W.%22%2C%22lastName%22%3A%22Cardoso%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22R.%20I.%22%2C%22lastName%22%3A%22Moreira%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22V.%20G.%22%2C%22lastName%22%3A%22Veloso%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22B.%22%2C%22lastName%22%3A%22Grinsztejn%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22P.%20M.%22%2C%22lastName%22%3A%22Luz%22%7D%5D%2C%22abstractNote%22%3A%22We%20evaluated%20COVID-19%26%23039%3Bs%20impact%20on%20HIV%20care%20indicators%20among%20INI%5C%2FFIOCRUZ%26%23039%3Bs%20HIV%20Clinical%20Cohort%20in%20Rio%20de%20Janeiro%2C%20Brazil%3A%20%281%29%20Adequate%20care%20visits%3A%20two%20visits%20%26gt%3B%5C%2F%3D%2090%20days%20apart%3B%20%282%29%20Adequate%20viral%20load%20monitoring%3A%20%26gt%3B%5C%2F%3D%202%20viral%20load%20results%20%26gt%3B%5C%2F%3D%2090%20days%20apart%3B%20%283%29%20Consistent%20viral%20suppression%3A%20all%20viral%20loads%20%26lt%3B%2040%20copies%5C%2FmL%3B%20and%20%284%29%20ART%20medication%20possession%20ratio%20%28MPR%29%20%26gt%3B%5C%2F%3D%2095%25.%20Chi-square%20tests%20compared%20the%20fraction%20of%20participants%20meeting%20each%20indicator%20per%20period%3A%20pre-pandemic%20%283%5C%2F1%5C%2F2019-2%5C%2F29%5C%2F2020%29%20and%20post-pandemic%20%283%5C%2F1%5C%2F2020-2%5C%2F28%5C%2F2021%29.%20Logistic%20regression%20models%20were%20used%20to%20assess%20disparities%20in%20adequate%20care%20visits.%20Among%20906%20participants%2C%20care%20visits%20and%20viral%20load%20monitoring%20decreased%20pre-pandemic%20to%20post-pandemic%3A%2077.0-55.1%25%20and%2036.6-11.6%25%20%28both%20p%20%26lt%3B%200.001%29%2C%20respectively.%20The%20optimal%20MPR%20rate%20improved%20from%2025.5%20to%2040.0%25%20%28p%20%26lt%3B%200.001%29.%20Post-pandemic%20period%20%28aOR%200.33%2C%20CI%200.28-0.40%29%2C%20transgender%20women%20%28aOR%200.34%2C%20CI%200.22-0.53%29%2C%20and%20those%20aged%2018-24%20years%20%28aOR%200.67%2C%20CI%200.45-0.97%29%20had%20lower%20odds%20of%20adequate%20care%20visits.%20COVID-19%20disrupted%20care%20access%20disproportionately%20for%20transgender%20women%20and%20younger%20participants.%22%2C%22date%22%3A%22Aug%202023%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1007%5C%2Fs10461-023-03988-3%22%2C%22ISSN%22%3A%221573-3254%20%28Electronic%29%201090-7165%20%28Print%29%201090-7165%20%28Linking%29%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22GXCKG69T%22%2C%22F2Y6PLUL%22%5D%2C%22dateModified%22%3A%222023-08-20T14%3A49%3A28Z%22%7D%7D%2C%7B%22key%22%3A%22K22SKTEE%22%2C%22library%22%3A%7B%22id%22%3A2775998%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Parcesepe%20et%20al.%22%2C%22parsedDate%22%3A%222023-08%22%2C%22numChildren%22%3A10%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BParcesepe%2C%20Angela%20M.%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BStockton%2C%20Melissa%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BRemch%2C%20Molly%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BWester%2C%20C.%20William%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BBernard%2C%20Charlotte%26lt%3B%5C%2Fspan%26gt%3B%20et%20al.%26lt%3B%5C%2Fspan%26gt%3B%20%282023%29.%20Availability%20of%20screening%20and%20treatment%20for%20common%20mental%20disorders%20in%20HIV%20clinic%20settings%3A%20data%20from%20the%20global%20International%20epidemiology%20Databases%20to%20Evaluate%20AIDS%20%28IeDEA%29%20Consortium%2C%202016-2017%20and%202020.%20%26lt%3Bi%26gt%3BJournal%20of%20the%20International%20AIDS%20Society%26lt%3B%5C%2Fi%26gt%3B%2C%20%26lt%3Bi%26gt%3B26%26lt%3B%5C%2Fi%26gt%3B%20%288%29%2C%20S.%20e26147.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1002%5C%2Fjia2.26147%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1002%5C%2Fjia2.26147%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Availability%20of%20screening%20and%20treatment%20for%20common%20mental%20disorders%20in%20HIV%20clinic%20settings%3A%20data%20from%20the%20global%20International%20epidemiology%20Databases%20to%20Evaluate%20AIDS%20%28IeDEA%29%20Consortium%2C%202016-2017%20and%202020%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Angela%20M.%22%2C%22lastName%22%3A%22Parcesepe%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Melissa%22%2C%22lastName%22%3A%22Stockton%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Molly%22%2C%22lastName%22%3A%22Remch%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22C.%20William%22%2C%22lastName%22%3A%22Wester%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Charlotte%22%2C%22lastName%22%3A%22Bernard%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jeremy%22%2C%22lastName%22%3A%22Ross%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Andreas%20D.%22%2C%22lastName%22%3A%22Haas%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rogers%22%2C%22lastName%22%3A%22Ajeh%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Keri%20N.%22%2C%22lastName%22%3A%22Althoff%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Leslie%22%2C%22lastName%22%3A%22Enane%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22William%22%2C%22lastName%22%3A%22Pape%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Albert%22%2C%22lastName%22%3A%22Minga%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Edith%22%2C%22lastName%22%3A%22Kwobah%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mpho%22%2C%22lastName%22%3A%22Tlali%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Junko%22%2C%22lastName%22%3A%22Tanuma%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dominique%22%2C%22lastName%22%3A%22Nsonde%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Aimee%22%2C%22lastName%22%3A%22Freeman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Stephany%20N.%22%2C%22lastName%22%3A%22Duda%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Denis%22%2C%22lastName%22%3A%22Nash%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kathryn%22%2C%22lastName%22%3A%22Lancaster%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22IeDEA%20Consortium%22%7D%5D%2C%22abstractNote%22%3A%22INTRODUCTION%3A%20Common%20mental%20disorders%20%28CMDs%29%20are%20highly%20prevalent%20among%20people%20with%20HIV.%20Integrating%20mental%20healthcare%20into%20HIV%20care%20may%20improve%20mental%20health%20and%20HIV%20treatment%20outcomes.%20We%20describe%20the%20reported%20availability%20of%20screening%20and%20treatment%20for%20depression%2C%20anxiety%20and%20post-traumatic%20stress%20disorder%20%28PTSD%29%20at%20global%20HIV%20treatment%20centres%20participating%20in%20the%20International%20epidemiology%20Databases%20to%20Evaluate%20AIDS%20%28IeDEA%29%20Consortium%20in%202020%20and%20changes%20in%20availability%20at%20sites%20in%20low-%20or%20middle-income%20countries%20%28LMICs%29%20between%202016%5C%2F2017%20and%202020.%5CnMETHODS%3A%20In%202020%2C%20238%20sites%20contributing%20individual-level%20data%20to%20the%20IeDEA%20Consortium%20and%20in%202016%5C%2F2017%20a%20stratified%20random%20sample%20of%20IeDEA%20sites%20in%20LMICs%20were%20eligible%20to%20participate%20in%20site%20surveys%20on%20the%20availability%20of%20screening%20and%20treatment%20for%20CMDs.%20We%20assessed%20trends%20over%20time%20for%2068%20sites%20across%2027%20LMICs%20that%20participated%20in%20both%20surveys.%5CnRESULTS%3A%20Among%20the%20238%20sites%20eligible%20to%20participate%20in%20the%202020%20site%20survey%2C%20227%20%2895%25%29%20participated%2C%20and%20mental%20health%20screening%20and%20treatment%20data%20were%20available%20for%20223%20%2898%25%29%20sites%20across%2041%20countries.%20A%20total%20of%2095%20sites%20across%2029%20LMICs%20completed%20the%202016%5C%2F2017%20survey.%20In%202020%2C%2068%25%20of%20sites%20were%20in%20urban%20settings%2C%20and%2077%25%20were%20in%20LMICs.%20Overall%2C%2050%25%2C%2014%25%20and%2012%25%20of%20sites%20reported%20screening%20with%20a%20validated%20instrument%20for%20depression%2C%20anxiety%20and%20PTSD%2C%20respectively.%20Screening%20plus%20treatment%20in%20the%20form%20of%20counselling%20was%20available%20for%20depression%2C%20anxiety%20and%20PTSD%20at%2046%25%2C%2013%25%20and%2011%25%20of%20sites%2C%20respectively.%20Screening%20plus%20treatment%20in%20the%20form%20of%20medication%20was%20available%20for%20depression%2C%20anxiety%20and%20PTSD%20at%2036%25%2C%2011%25%20and%208%25%20of%20sites%2C%20respectively.%20Among%20sites%20that%20participated%20in%20both%20surveys%2C%20screening%20for%20depression%20was%20more%20commonly%20available%20in%202020%20than%202016%5C%2F2017%20%2875%25%20vs.%2059%25%2C%20respectively%2C%20p%20%3D%200.048%29.%5CnCONCLUSIONS%3A%20Reported%20availability%20of%20screening%20for%20depression%20increased%20among%20this%20group%20of%20IeDEA%20sites%20in%20LMICs%20between%202016%5C%2F2017%20and%202020.%20However%2C%20substantial%20gaps%20persist%20in%20the%20availability%20of%20mental%20healthcare%20at%20HIV%20treatment%20sites%20across%20global%20settings%2C%20particularly%20in%20resource-constrained%20settings.%20Implementation%20of%20sustainable%20strategies%20to%20integrate%20mental%20health%20services%20into%20HIV%20care%20is%20needed.%22%2C%22date%22%3A%222023-08%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1002%5C%2Fjia2.26147%22%2C%22ISSN%22%3A%221758-2652%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22GXCKG69T%22%2C%22ZVWK2Q45%22%2C%22D9WC3N3V%22%2C%22TCMBXKKM%22%2C%228IRGNQWZ%22%2C%22F2Y6PLUL%22%2C%22ZBJI578D%22%2C%22YAE5EUBI%22%2C%223FNU2D64%22%5D%2C%22dateModified%22%3A%222024-01-12T13%3A25%3A38Z%22%7D%7D%2C%7B%22key%22%3A%22RHAAX2AX%22%2C%22library%22%3A%7B%22id%22%3A2775998%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Person%20et%20al.%22%2C%22parsedDate%22%3A%222023-06-16%22%2C%22numChildren%22%3A4%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BPerson%2C%20Anna%20K.%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BCrabtree-Ramirez%2C%20Brenda%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BKim%2C%20Ahra%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BVeloso%2C%20Valdil%26%23xE9%3Ba%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BMaruri%2C%20Fernanda%26lt%3B%5C%2Fspan%26gt%3B%20et%20al.%26lt%3B%5C%2Fspan%26gt%3B%20%282023%29.%20Cryptococcal%20Meningitis%20and%20Clinical%20Outcomes%20in%20Persons%20With%20Human%20Immunodeficiency%20Virus%3A%20A%20Global%20View.%20%26lt%3Bi%26gt%3BClinical%20Infectious%20Diseases%3A%20An%20Official%20Publication%20of%20the%20Infectious%20Diseases%20Society%20of%20America%26lt%3B%5C%2Fi%26gt%3B%2C%20%26lt%3Bi%26gt%3B76%26lt%3B%5C%2Fi%26gt%3B%20%2812%29%2C%20S.%202116%26%23x2013%3B2125.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1093%5C%2Fcid%5C%2Fciad076%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1093%5C%2Fcid%5C%2Fciad076%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Cryptococcal%20Meningitis%20and%20Clinical%20Outcomes%20in%20Persons%20With%20Human%20Immunodeficiency%20Virus%3A%20A%20Global%20View%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anna%20K.%22%2C%22lastName%22%3A%22Person%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Brenda%22%2C%22lastName%22%3A%22Crabtree-Ramirez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ahra%22%2C%22lastName%22%3A%22Kim%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Valdil%5Cu00e9a%22%2C%22lastName%22%3A%22Veloso%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fernanda%22%2C%22lastName%22%3A%22Maruri%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gilles%22%2C%22lastName%22%3A%22Wandeler%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Matthew%22%2C%22lastName%22%3A%22Fox%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Richard%22%2C%22lastName%22%3A%22Moore%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M.%22%2C%22lastName%22%3A%22John%20Gill%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Darma%22%2C%22lastName%22%3A%22Imran%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kinh%22%2C%22lastName%22%3A%22Van%20Nguyen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Elizabeth%22%2C%22lastName%22%3A%22Nalitya%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Winnie%22%2C%22lastName%22%3A%22Muyindike%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bryan%20E.%22%2C%22lastName%22%3A%22Shepherd%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Catherine%20C.%22%2C%22lastName%22%3A%22McGowan%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20Cryptococcal%20meningitis%20%28CM%29%20is%20a%20major%20cause%20of%20morbidity%20and%20mortality%20in%20persons%20with%20human%20immunodeficiency%20virus%20%28HIV%3B%20PWH%29.%20Little%20is%20known%20about%20CM%20outcomes%20and%20availability%20of%20diagnostic%20and%20treatment%20modalities%20globally.%5CnMETHODS%3A%20In%20this%20retrospective%20cohort%20study%2C%20we%20investigated%20CM%20incidence%20and%20all-cause%20mortality%20in%20PWH%20in%20the%20International%20Epidemiology%20Databases%20to%20Evaluate%20AIDS%20cohort%20from%201996%20to%202017.%20We%20estimated%20incidence%20using%20quasi-Poisson%20models%20adjusted%20for%20sex%2C%20age%2C%20calendar%20year%2C%20CD4%20cell%20count%20%28CD4%29%2C%20and%20antiretroviral%20therapy%20%28ART%29%20status.%20Mortality%20after%20CM%20diagnosis%20was%20examined%20using%20multivariable%20Cox%20models.%20A%20site%20survey%20from%202017%20assessed%20availability%20of%20CM%20diagnostic%20and%20treatment%20modalities.%5CnRESULTS%3A%20Among%20518%20852%20PWH%2C%20there%20were%203857%20cases%20of%20CM%20with%20an%20estimated%20incidence%20of%201.54%20per%201000%20person-years.%20Mortality%20over%20a%20median%20of%202.6%20years%20of%20post-CM%20diagnosis%20follow-up%20was%2031.6%25%2C%20with%2029%25%20lost%20to%20follow-up.%20In%20total%2C%202478%20%2864%25%29%20were%20diagnosed%20with%20CM%20after%20ART%20start%20with%20a%20median%20of%20253%20days%20from%20ART%20start%20to%20CM%20diagnosis.%20Older%20age%20%28hazard%20%5BHR%5D%2C%201.31%20for%2050%20vs%2035%20years%29%2C%20lower%20CD4%20%28HR%2C%201.15%20for%20200%20vs%20350%20cells%5C%2Fmm3%29%2C%20and%20earlier%20year%20of%20CM%20diagnosis%20%28HR%2C%200.51%20for%202015%20vs%202000%29%20were%20associated%20with%20higher%20mortality.%20Of%2089%20sites%2C%2034%25%20reported%20access%20to%20amphotericin%20B%3B%2012%25%20had%20access%20to%20flucytosine.%5CnCONCLUSIONS%3A%20Mortality%20after%20CM%20diagnosis%20was%20high.%20A%20substantial%20portion%20of%20CM%20cases%20occurred%20after%20ART%20start%2C%20though%20incidence%20and%20mortality%20may%20be%20higher%20than%20reported%20due%20to%20ascertainment%20bias.%20Many%20sites%20lacked%20access%20to%20recommended%20CM%20treatment.%22%2C%22date%22%3A%222023-06-16%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1093%5C%2Fcid%5C%2Fciad076%22%2C%22ISSN%22%3A%221537-6591%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22GXCKG69T%22%2C%22D9WC3N3V%22%2C%22TCMBXKKM%22%2C%228IRGNQWZ%22%2C%22F2Y6PLUL%22%2C%22ZBJI578D%22%2C%22YAE5EUBI%22%5D%2C%22dateModified%22%3A%222025-03-06T12%3A15%3A39Z%22%7D%7D%2C%7B%22key%22%3A%223C9UBUIJ%22%2C%22library%22%3A%7B%22id%22%3A2775998%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Ara%5Cu00fajo-Pereira%20et%20al.%22%2C%22parsedDate%22%3A%222023-06%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BAra%26%23xFA%3Bjo-Pereira%2C%20Mariana%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BNogueira%2C%20Bet%26%23xE2%3Bnia%20M.%20F.%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BSpener-Gomes%2C%20Renata%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BCarvalho%2C%20Anna%20C.%20C.%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BSant%26%23x2019%3BAnna%2C%20Fl%26%23xE1%3Bvia%20Marinho%26lt%3B%5C%2Fspan%26gt%3B%20et%20al.%26lt%3B%5C%2Fspan%26gt%3B%20%282023%29.%20Anemia%20and%20anti-tuberculosis%20treatment%20outcome%20in%20persons%20with%20pulmonary%20tuberculosis%3A%20A%20multi-center%20prospective%20cohort%20study.%20%26lt%3Bi%26gt%3BJournal%20of%20Infection%20and%20Public%20Health%26lt%3B%5C%2Fi%26gt%3B%2C%20%26lt%3Bi%26gt%3B16%26lt%3B%5C%2Fi%26gt%3B%20%286%29%2C%20S.%20974%26%23x2013%3B980.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.jiph.2023.04.009%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.jiph.2023.04.009%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Anemia%20and%20anti-tuberculosis%20treatment%20outcome%20in%20persons%20with%20pulmonary%20tuberculosis%3A%20A%20multi-center%20prospective%20cohort%20study%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mariana%22%2C%22lastName%22%3A%22Ara%5Cu00fajo-Pereira%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bet%5Cu00e2nia%20M.%20F.%22%2C%22lastName%22%3A%22Nogueira%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Renata%22%2C%22lastName%22%3A%22Spener-Gomes%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anna%20C.%20C.%22%2C%22lastName%22%3A%22Carvalho%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fl%5Cu00e1via%20Marinho%22%2C%22lastName%22%3A%22Sant%27Anna%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marina%20C.%22%2C%22lastName%22%3A%22Figueiredo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Megan%20M.%22%2C%22lastName%22%3A%22Turner%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Afr%5Cu00e2nio%20L.%22%2C%22lastName%22%3A%22Kritski%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marcelo%22%2C%22lastName%22%3A%22Cordeiro-Santos%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Valeria%20C.%22%2C%22lastName%22%3A%22Rolla%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Timothy%20R.%22%2C%22lastName%22%3A%22Sterling%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bruno%20B.%22%2C%22lastName%22%3A%22Andrade%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22RePORT-Brazil%20Consortium%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20Tuberculosis%20%28TB%29%20remains%20a%20major%20plague%20of%20humanity.%20People%20with%20TB%20%28PWTB%29%20are%20commonly%20anemic.%20Here%2C%20we%20assessed%20whether%20the%20severity%20of%20anemia%20in%20PWTB%20prior%20to%20anti-TB%20treatment%20%28ATT%29%20was%20a%20risk%20factor%20for%20an%20unfavorable%20outcome.%5CnMETHODS%3A%20Patients%20%5Cu2265%5Cu00a018%20years%20old%20with%20culture-confirmed%20drug-susceptible%20pulmonary%20TB%20enrolled%20between%202015%20and%202019%20in%20a%20multi-center%20Brazilian%20cohort%20were%20followed%20for%20up%20to%2024%20months%20and%20classified%20according%20to%20anemia%20severity%20%28mild%2C%20moderate%2C%20and%20severe%29%2C%20based%20on%20hemoglobin%20levels.%20A%20multinomial%20logistic%20regression%20model%20was%20employed%20to%20assess%20whether%20anemia%20was%20associated%20with%20unfavorable%20outcome%20%28death%2C%20failure%2C%20loss%20to%20follow-up%2C%20regimen%20modification%20or%20relapse%29%2C%20compared%20to%20treatment%20success%20%28cure%20or%20treatment%20completion%29.%5CnRESULTS%3A%20Among%20786%20participants%20who%20met%20inclusion%20criteria%2C%20441%20%2856%20%25%29%20were%20anemic%20at%20baseline.%20Patients%20with%20moderate%5C%2Fsevere%20anemia%20were%20more%20HIV-seropositive%2C%20as%20well%20as%20more%20symptomatic%20and%20had%20higher%20frequencies%20of%20unfavorable%20outcomes%20compared%20to%20the%20other%20groups.%20Moderate%5C%2Fsevere%20anemia%20%28adjusted%20OR%20%5BaOR%5D%3A%207.80%2C%2095%20%25CI%3A1.34-45.4%2C%20p%5Cu00a0%3D%5Cu00a00.022%29%20was%20associated%20with%20death%20independent%20of%20sex%2C%20age%2C%20BMI%2C%20HIV%20and%20glycemic%20status.%5CnCONCLUSION%3A%20Moderate%5C%2Fsevere%20anemia%20prior%20to%20ATT%20was%20a%20significant%20risk%20factor%20for%20death.%20Such%20patients%20should%20be%20closely%20monitored%20given%20the%20high%20risk%20of%20unfavorable%20ATT%20outcomes.%22%2C%22date%22%3A%222023-06%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.jiph.2023.04.009%22%2C%22ISSN%22%3A%221876-035X%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22GXCKG69T%22%2C%22F2Y6PLUL%22%5D%2C%22dateModified%22%3A%222025-03-11T11%3A04%3A15Z%22%7D%7D%2C%7B%22key%22%3A%225NYZBK8G%22%2C%22library%22%3A%7B%22id%22%3A2775998%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Queiroz%20et%20al.%22%2C%22parsedDate%22%3A%222023-05-12%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BQueiroz%2C%20Artur%20T.%20L.%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BVinhaes%2C%20Caian%20L.%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BFukutani%2C%20Eduardo%20R.%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BGupte%2C%20Akshay%20N.%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BKumar%2C%20Nathella%20Pavan%26lt%3B%5C%2Fspan%26gt%3B%20et%20al.%26lt%3B%5C%2Fspan%26gt%3B%20%282023%29.%20A%20multi-center%2C%20prospective%20cohort%20study%20of%20whole%20blood%20gene%20expression%20in%20the%20tuberculosis-diabetes%20interaction.%20%26lt%3Bi%26gt%3BScientific%20Reports%26lt%3B%5C%2Fi%26gt%3B%2C%20%26lt%3Bi%26gt%3B13%26lt%3B%5C%2Fi%26gt%3B%20%281%29%2C%20S.%207769.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1038%5C%2Fs41598-023-34847-9%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1038%5C%2Fs41598-023-34847-9%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22A%20multi-center%2C%20prospective%20cohort%20study%20of%20whole%20blood%20gene%20expression%20in%20the%20tuberculosis-diabetes%20interaction%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Artur%20T.%20L.%22%2C%22lastName%22%3A%22Queiroz%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Caian%20L.%22%2C%22lastName%22%3A%22Vinhaes%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eduardo%20R.%22%2C%22lastName%22%3A%22Fukutani%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Akshay%20N.%22%2C%22lastName%22%3A%22Gupte%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nathella%20Pavan%22%2C%22lastName%22%3A%22Kumar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kiyoshi%20F.%22%2C%22lastName%22%3A%22Fukutani%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mar%5Cu00eda%20B.%22%2C%22lastName%22%3A%22Arriaga%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Timothy%20R.%22%2C%22lastName%22%3A%22Sterling%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Subash%22%2C%22lastName%22%3A%22Babu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sanjay%22%2C%22lastName%22%3A%22Gaikwad%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rajesh%22%2C%22lastName%22%3A%22Karyakarte%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vidya%22%2C%22lastName%22%3A%22Mave%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mandar%22%2C%22lastName%22%3A%22Paradhkar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vijay%22%2C%22lastName%22%3A%22Viswanathan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Amita%22%2C%22lastName%22%3A%22Gupta%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bruno%20B.%22%2C%22lastName%22%3A%22Andrade%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hardy%22%2C%22lastName%22%3A%22Kornfeld%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22RePORT%20Brazil%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22RePORT%20India%20Consortia%22%7D%5D%2C%22abstractNote%22%3A%22Diabetes%20mellitus%20%28DM%29%20increases%20tuberculosis%20%28TB%29%20severity.%20We%20compared%20blood%20gene%20expression%20in%20adults%20with%20pulmonary%20TB%2C%20with%20or%20without%20diabetes%20mellitus%20%28DM%29%20from%20sites%20in%20Brazil%20and%20India.%20RNA%20sequencing%20%28RNAseq%29%20performed%20at%20baseline%20and%20during%20TB%20treatment.%20Publicly%20available%20baseline%20RNAseq%20data%20from%20South%20Africa%20and%20Romania%20reported%20by%20the%20TANDEM%20Consortium%20were%20also%20analyzed.%20Across%20the%20sites%2C%20differentially%20expressed%20genes%20varied%20for%20each%20condition%20%28DM%2C%20TB%2C%20and%20TBDM%29%20and%20no%20pattern%20classified%20any%20one%20group%20across%20all%20sites.%20A%20concise%20signature%20of%20TB%20disease%20was%20identified%20but%20this%20was%20expressed%20equally%20in%20TB%20and%20TBDM.%20Pathway%20enrichment%20analysis%20failed%20to%20distinguish%20TB%20from%20TBDM%2C%20although%20there%20was%20a%20trend%20for%20greater%20neutrophil%20and%20innate%20immune%20pathway%20activation%20in%20TBDM%20participants.%20Pathways%20associated%20with%20insulin%20resistance%2C%20metabolic%20dysfunction%2C%20diabetic%20complications%2C%20and%20chromosomal%20instability%20were%20positively%20correlated%20with%20glycohemoglobin.%20The%20immune%20response%20to%20pulmonary%20TB%20as%20reflected%20by%20whole%20blood%20gene%20expression%20is%20substantially%20similar%20with%20or%20without%20comorbid%20DM.%20Gene%20expression%20pathways%20associated%20with%20the%20microvascular%20and%20macrovascular%20complications%20of%20DM%20are%20upregulated%20during%20TB%2C%20supporting%20a%20syndemic%20interaction%20between%20these%20coprevalent%20diseases.%22%2C%22date%22%3A%222023-05-12%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1038%5C%2Fs41598-023-34847-9%22%2C%22ISSN%22%3A%222045-2322%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22GXCKG69T%22%2C%22F2Y6PLUL%22%5D%2C%22dateModified%22%3A%222024-01-12T13%3A25%3A46Z%22%7D%7D%2C%7B%22key%22%3A%22SF5ZU36U%22%2C%22library%22%3A%7B%22id%22%3A2775998%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Vreeman%20et%20al.%22%2C%22parsedDate%22%3A%222023-03-13%22%2C%22numChildren%22%3A14%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BVreeman%2C%20R.%20C.%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BYiannoutsos%2C%20C.%20T.%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BYusoff%2C%20N.%20K.%20N.%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BWester%2C%20C.%20W.%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BEdmonds%2C%20A.%26lt%3B%5C%2Fspan%26gt%3B%20et%20al.%26lt%3B%5C%2Fspan%26gt%3B%20%282023%29.%20Global%20HIV%20prevention%2C%20care%20and%20treatment%20services%20for%20children%3A%20a%20cross-sectional%20survey%20from%20the%20International%20Epidemiology%20Databases%20to%20Evaluate%20AIDS%20%28IeDEA%29%20consortium.%20%26lt%3Bi%26gt%3BBMJ%20Open%26lt%3B%5C%2Fi%26gt%3B%2C%20%26lt%3Bi%26gt%3B13%26lt%3B%5C%2Fi%26gt%3B%20%283%29%2C%20S.%20e069399.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1136%5C%2Fbmjopen-2022-069399%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1136%5C%2Fbmjopen-2022-069399%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Global%20HIV%20prevention%2C%20care%20and%20treatment%20services%20for%20children%3A%20a%20cross-sectional%20survey%20from%20the%20International%20Epidemiology%20Databases%20to%20Evaluate%20AIDS%20%28IeDEA%29%20consortium%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22R.%20C.%22%2C%22lastName%22%3A%22Vreeman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22C.%20T.%22%2C%22lastName%22%3A%22Yiannoutsos%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22N.%20K.%20N.%22%2C%22lastName%22%3A%22Yusoff%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22C.%20W.%22%2C%22lastName%22%3A%22Wester%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22A.%22%2C%22lastName%22%3A%22Edmonds%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22S.%22%2C%22lastName%22%3A%22Ofner%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M.%20A.%22%2C%22lastName%22%3A%22Davies%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22V.%22%2C%22lastName%22%3A%22Leroy%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22P.%22%2C%22lastName%22%3A%22Lumbiganon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22R.%20C.%22%2C%22lastName%22%3A%22de%20Menezes%20Succi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22C.%22%2C%22lastName%22%3A%22Twizere%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22S.%22%2C%22lastName%22%3A%22Brown%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22C.%22%2C%22lastName%22%3A%22Bolton-Moore%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22O.%20E.%22%2C%22lastName%22%3A%22Takassi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M.%22%2C%22lastName%22%3A%22Scanlon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22R.%22%2C%22lastName%22%3A%22Martin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22K.%22%2C%22lastName%22%3A%22Wools-Kaloustian%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22%22%2C%22lastName%22%3A%22IeDea%22%7D%5D%2C%22abstractNote%22%3A%22OBJECTIVES%3A%20To%20assess%20access%20children%20with%20HIV%20have%20to%20comprehensive%20HIV%20care%20services%2C%20to%20longitudinally%20evaluate%20the%20implementation%20and%20scale-up%20of%20services%2C%20and%20to%20use%20site%20services%20and%20clinical%20cohort%20data%20to%20explore%20whether%20access%20to%20these%20services%20influences%20retention%20in%20care.%20METHODS%3A%20A%20cross-sectional%20standardised%20survey%20was%20completed%20in%202014-2015%20by%20sites%20providing%20paediatric%20HIV%20care%20across%20regions%20of%20the%20International%20Epidemiology%20Databases%20to%20Evaluate%20AIDS%20%28IeDEA%29%20consortium.%20We%20developed%20a%20comprehensiveness%20score%20based%20on%20the%20WHO%26%23039%3Bs%20nine%20categories%20of%20essential%20services%20to%20categorise%20sites%20as%20%26%23039%3Blow%26%23039%3B%20%280-5%29%2C%20%26%23039%3Bmedium%26%23039%3B%2C%20%286-7%29%20or%20%26%23039%3Bhigh%26%23039%3B%20%288-9%29.%20When%20available%2C%20comprehensiveness%20scores%20were%20compared%20with%20scores%20from%20a%202009%20survey.%20We%20used%20patient-level%20data%20with%20site%20services%20to%20investigate%20the%20relationship%20between%20the%20comprehensiveness%20of%20services%20and%20retention.%20RESULTS%3A%20Survey%20data%20from%20174%20IeDEA%20sites%20in%2032%20countries%20were%20analysed.%20Of%20the%20WHO%20essential%20services%2C%20sites%20were%20most%20likely%20to%20offer%20antiretroviral%20therapy%20%28ART%29%20provision%20and%20counselling%20%28n%3D173%3B%2099%25%29%2C%20co-trimoxazole%20prophylaxis%20%28168%3B%2097%25%29%2C%20prevention%20of%20perinatal%20transmission%20services%20%28167%3B%2096%25%29%2C%20outreach%20for%20patient%20engagement%20and%20follow-up%20%28166%3B%2095%25%29%2C%20CD4%20cell%20count%20testing%20%28126%3B%2088%25%29%2C%20tuberculosis%20screening%20%28151%3B%2087%25%29%20and%20select%20immunisation%20services%20%28126%3B%2072%25%29.%20Sites%20were%20less%20likely%20to%20offer%20nutrition%5C%2Ffood%20support%20%2897%3B%2056%25%29%2C%20viral%20load%20testing%20%2899%3B%2069%25%29%20and%20HIV%20counselling%20and%20testing%20%2869%3B%2040%25%29.%2010%25%20of%20sites%20rated%20%26%23039%3Blow%26%23039%3B%2C%2059%25%20%26%23039%3Bmedium%26%23039%3B%20and%2031%25%20%26%23039%3Bhigh%26%23039%3B%20in%20the%20comprehensiveness%20score.%20The%20mean%20comprehensiveness%20of%20services%20score%20increased%20significantly%20from%205.6%20in%202009%20to%207.3%20in%202014%20%28p%26lt%3B0.001%3B%20n%3D30%29.%20Patient-level%20analysis%20of%20lost%20to%20follow-up%20after%20ART%20initiation%20estimated%20the%20hazard%20was%20highest%20in%20sites%20rated%20%26%23039%3Blow%26%23039%3B%20and%20lowest%20in%20sites%20rated%20%26%23039%3Bhigh%26%23039%3B.%20CONCLUSION%3A%20This%20global%20assessment%20suggests%20the%20potential%20care%20impact%20of%20scaling-up%20and%20sustaining%20comprehensive%20paediatric%20HIV%20services.%20Meeting%20recommendations%20for%20comprehensive%20HIV%20services%20should%20remain%20a%20global%20priority.%22%2C%22date%22%3A%22Mar%2013%202023%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1136%5C%2Fbmjopen-2022-069399%22%2C%22ISSN%22%3A%222044-6055%20%28Electronic%29%202044-6055%20%28Linking%29%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22GXCKG69T%22%2C%22ZVWK2Q45%22%2C%22D9WC3N3V%22%2C%22TCMBXKKM%22%2C%228IRGNQWZ%22%2C%22F2Y6PLUL%22%2C%22ZBJI578D%22%2C%22YAE5EUBI%22%2C%223FNU2D64%22%5D%2C%22dateModified%22%3A%222025-03-20T13%3A07%3A42Z%22%7D%7D%2C%7B%22key%22%3A%22EBWEB6MV%22%2C%22library%22%3A%7B%22id%22%3A2775998%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Ridolfi%20et%20al.%22%2C%22parsedDate%22%3A%222023-02-08%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BRidolfi%2C%20F.%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BPeetluk%2C%20L.%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BAmorim%2C%20G.%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BTurner%2C%20M.%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BFigueiredo%2C%20M.%26lt%3B%5C%2Fspan%26gt%3B%20et%20al.%26lt%3B%5C%2Fspan%26gt%3B%20%282023%29.%20Tuberculosis%20Treatment%20Outcomes%20in%20Brazil%3A%20Different%20Predictors%20for%20Each%20Type%20of%20Unsuccessful%20Outcome.%20%26lt%3Bi%26gt%3BClin%20Infect%20Dis%26lt%3B%5C%2Fi%26gt%3B%2C%20%26lt%3Bi%26gt%3B76%26lt%3B%5C%2Fi%26gt%3B%20%283%29%2C%20S.%20e930%26%23x2013%3Be937.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1093%5C%2Fcid%5C%2Fciac541%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1093%5C%2Fcid%5C%2Fciac541%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Tuberculosis%20Treatment%20Outcomes%20in%20Brazil%3A%20Different%20Predictors%20for%20Each%20Type%20of%20Unsuccessful%20Outcome%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22F.%22%2C%22lastName%22%3A%22Ridolfi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22L.%22%2C%22lastName%22%3A%22Peetluk%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22G.%22%2C%22lastName%22%3A%22Amorim%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M.%22%2C%22lastName%22%3A%22Turner%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M.%22%2C%22lastName%22%3A%22Figueiredo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M.%22%2C%22lastName%22%3A%22Cordeiro-Santos%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22S.%22%2C%22lastName%22%3A%22Cavalcante%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22A.%22%2C%22lastName%22%3A%22Kritski%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22B.%22%2C%22lastName%22%3A%22Durovni%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22B.%22%2C%22lastName%22%3A%22Andrade%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22T.%20R.%22%2C%22lastName%22%3A%22Sterling%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22V.%22%2C%22lastName%22%3A%22Rolla%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Consortium%22%2C%22lastName%22%3A%22Regional%20Prospective%20Observational%20Research%20in%20Tuberculosis%20-Brazil%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20Successful%20tuberculosis%20%28TB%29%20treatment%20is%20necessary%20for%20disease%20control.%20The%20World%20Health%20Organization%20%28WHO%29%20has%20a%20target%20TB%20treatment%20success%20rate%20of%20%26gt%3B%5C%2F%3D90%25.%20We%20assessed%20whether%20the%20different%20types%20of%20unfavorable%20TB%20treatment%20outcome%20had%20different%20predictors.%20METHODS%3A%20Using%20data%20from%20Regional%20Prospective%20Observational%20Research%20for%20Tuberculosis-Brazil%2C%20we%20evaluated%20biological%20and%20behavioral%20factors%20associated%20with%20each%20component%20of%20unsuccessful%20TB%20outcomes%2C%20recently%20updated%20by%20WHO%20%28death%2C%20loss%20to%20follow-up%20%5BLTFU%5D%2C%20and%20treatment%20failure%29.%20We%20included%20culture-confirmed%2C%20drug-susceptible%2C%20pulmonary%20TB%20participants%20receiving%20standard%20treatment%20in%202015-2019.%20Multinomial%20logistic%20regression%20models%20with%20inverse%20probability%20weighting%20were%20used%20to%20evaluate%20the%20distinct%20determinants%20of%20each%20unsuccessful%20outcome.%20RESULTS%3A%20Of%20915%20participants%20included%2C%20727%20%2879%25%29%20were%20successfully%20treated%2C%20118%20%2813%25%29%20were%20LTFU%2C%2044%20%285%25%29%20had%20treatment%20failure%2C%20and%2026%20%283%25%29%20died.%20LTFU%20was%20associated%20with%20current%20drug-use%20%28adjusted%20odds%20ratio%20%5BaOR%5D%20%3D%205.3%3B%2095%25%20confidence%20interval%20%5BCI%5D%2C%203.0-9.4%29%2C%20current%20tobacco%20use%20%28aOR%20%3D%202.9%3B%2095%25%20CI%2C%201.7-4.9%29%2C%20and%20being%20a%20person%20with%20HIV%20%28PWH%29%20%28aOR%20%3D%202.0%3B%2095%25%20CI%2C%201.1-3.5%29.%20Treatment%20failure%20was%20associated%20with%20PWH%20%28aOR%20%3D%202.7%3B%2095%25%20CI%2C%201.2-6.2%29%20and%20having%20diabetes%20%28aOR%20%3D%202.2%3B%2095%25%20CI%2C%201.1-4.4%29.%20Death%20was%20associated%20with%20anemia%20%28aOR%20%3D%205.3%3B%2095%25%20CI%2C%201.4-19.7%29%2C%20diabetes%20%28aOR%20%3D%203.1%3B%2095%25%20CI%2C%201.4-6.7%29%2C%20and%20PWH%20%28aOR%20%3D%203.9%3B%2095%25%20CI%2C%201.3-11.4%29.%20Direct%20observed%20therapy%20was%20protective%20for%20treatment%20failure%20%28aOR%20%3D%200.5%3B%2095%25%20CI%2C%20.3-.9%29%20and%20death%20%28aOR%20%3D%200.5%3B%2095%25%20CI%2C%20.2-1.0%29.%20CONCLUSIONS%3A%20The%20treatment%20success%20rate%20was%20below%20the%20WHO%20target.%20Behavioral%20factors%20were%20most%20associated%20with%20LTFU%2C%20whereas%20clinical%20comorbidities%20were%20correlated%20with%20treatment%20failure%20and%20death.%20Because%20determinants%20of%20unsuccessful%20outcomes%20are%20distinct%2C%20different%20intervention%20strategies%20may%20be%20needed%20to%20improve%20TB%20outcomes.%22%2C%22date%22%3A%22Feb%208%202023%22%2C%22language%22%3A%22en%22%2C%22DOI%22%3A%2210.1093%5C%2Fcid%5C%2Fciac541%22%2C%22ISSN%22%3A%221537-6591%20%28Electronic%29%201058-4838%20%28Print%29%201058-4838%20%28Linking%29%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22GXCKG69T%22%2C%22F2Y6PLUL%22%5D%2C%22dateModified%22%3A%222023-08-20T14%3A06%3A01Z%22%7D%7D%2C%7B%22key%22%3A%22DQZY2PUS%22%2C%22library%22%3A%7B%22id%22%3A2775998%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Ross%20et%20al.%22%2C%22parsedDate%22%3A%222023-01-06%22%2C%22numChildren%22%3A16%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BRoss%2C%20J.%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BBrazier%2C%20E.%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BFatti%2C%20G.%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BJaquet%2C%20A.%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BTanon%2C%20A.%26lt%3B%5C%2Fspan%26gt%3B%20et%20al.%26lt%3B%5C%2Fspan%26gt%3B%20%282023%29.%20Same-Day%20Antiretroviral%20Therapy%20Initiation%20as%20a%20Predictor%20of%20Loss%20to%20Follow-up%20and%20Viral%20Suppression%20Among%20People%20With%20Human%20Immunodeficiency%20Virus%20in%20Sub-Saharan%20Africa.%20%26lt%3Bi%26gt%3BClin%20Infect%20Dis%26lt%3B%5C%2Fi%26gt%3B%2C%20%26lt%3Bi%26gt%3B76%26lt%3B%5C%2Fi%26gt%3B%20%281%29%2C%20S.%2039%26%23x2013%3B47.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1093%5C%2Fcid%5C%2Fciac759%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1093%5C%2Fcid%5C%2Fciac759%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Same-Day%20Antiretroviral%20Therapy%20Initiation%20as%20a%20Predictor%20of%20Loss%20to%20Follow-up%20and%20Viral%20Suppression%20Among%20People%20With%20Human%20Immunodeficiency%20Virus%20in%20Sub-Saharan%20Africa%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J.%22%2C%22lastName%22%3A%22Ross%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22E.%22%2C%22lastName%22%3A%22Brazier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22G.%22%2C%22lastName%22%3A%22Fatti%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22A.%22%2C%22lastName%22%3A%22Jaquet%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22A.%22%2C%22lastName%22%3A%22Tanon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22A.%20D.%22%2C%22lastName%22%3A%22Haas%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22L.%22%2C%22lastName%22%3A%22Diero%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22B.%22%2C%22lastName%22%3A%22Castelnuovo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22C.%20T.%22%2C%22lastName%22%3A%22Yiannoutsos%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22D.%22%2C%22lastName%22%3A%22Nash%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22K.%20M.%22%2C%22lastName%22%3A%22Anastos%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M.%22%2C%22lastName%22%3A%22Yotebieng%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20Treat-All%20guidelines%20recommend%20initiation%20of%20antiretroviral%20therapy%20%28ART%29%20for%20all%20people%20with%20HIV%20%28PWH%29%20on%20the%20day%20of%20diagnosis%20when%20possible%2C%20yet%20uncertainty%20exists%20about%20the%20impact%20of%20same-day%20ART%20initiation%20on%20subsequent%20care%20engagement.%20We%20examined%20the%20association%20of%20same-day%20ART%20initiation%20with%20loss%20to%20follow-up%20and%20viral%20suppression%20among%20patients%20in%2011%20sub-Saharan%20African%20countries.%20METHODS%3A%20We%20included%20ART-naive%20adult%20PWH%20from%20sites%20participating%20in%20the%20International%20epidemiology%20Databases%20to%20Evaluate%20AIDS%20%28IeDEA%29%20consortium%20who%20enrolled%20in%20care%20after%20Treat-All%20implementation%20and%20prior%20to%20January%202019.%20We%20used%20multivariable%20Cox%20regression%20to%20estimate%20the%20association%20between%20same-day%20ART%20initiation%20and%20loss%20to%20follow-up%20and%20Poisson%20regression%20to%20estimate%20the%20association%20between%20same-day%20ART%20initiation%20and%206-month%20viral%20suppression.%20RESULTS%3A%20Among%2029%20017%20patients%20from%2063%20sites%2C%2018%20584%20%2864.0%25%29%20initiated%20ART%20on%20the%20day%20of%20enrollment.%20Same-day%20ART%20initiation%20was%20less%20likely%20among%20those%20with%20advanced%20HIV%20disease%20versus%20early-stage%20disease.%20Loss%20to%20follow-up%20was%20significantly%20lower%20among%20those%20initiating%20ART%20%26gt%3B%5C%2F%3D1%20day%20of%20enrollment%2C%20compared%20with%20same-day%20ART%20initiators%20%2820.6%25%20vs%2027.7%25%3B%20adjusted%20hazard%20ratio%3A%20.66%3B%2095%25%20CI%20.57-.76%29.%20No%20difference%20in%20viral%20suppression%20was%20observed%20by%20time%20to%20ART%20initiation%20%28adjusted%20rate%20ratio%3A%201.00%3B%2095%25%20CI%3A%20.98-1.02%29.%20CONCLUSIONS%3A%20Patients%20initiating%20ART%20on%20the%20day%20of%20enrollment%20were%20more%20frequently%20lost%20to%20follow-up%20than%20those%20initiating%20later%20but%20were%20equally%20likely%20to%20be%20virally%20suppressed.%20Our%20findings%20support%20recent%20World%20Health%20Organization%20recommendations%20for%20providing%20tailored%20counseling%20and%20support%20to%20patients%20who%20accept%20an%20offer%20of%20same-day%20ART.%22%2C%22date%22%3A%22Jan%206%202023%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1093%5C%2Fcid%5C%2Fciac759%22%2C%22ISSN%22%3A%221537-6591%20%28Electronic%29%201058-4838%20%28Print%29%201058-4838%20%28Linking%29%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22GXCKG69T%22%2C%22ZVWK2Q45%22%2C%22D9WC3N3V%22%2C%22TCMBXKKM%22%2C%228IRGNQWZ%22%2C%22F2Y6PLUL%22%2C%22ZBJI578D%22%2C%22YAE5EUBI%22%2C%223FNU2D64%22%5D%2C%22dateModified%22%3A%222025-03-20T13%3A10%3A50Z%22%7D%7D%2C%7B%22key%22%3A%226YLLHW7Q%22%2C%22library%22%3A%7B%22id%22%3A2775998%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Brazier%20et%20al.%22%2C%22parsedDate%22%3A%222023%22%2C%22numChildren%22%3A16%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BBrazier%2C%20E.%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BMaruri%2C%20F.%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BWester%2C%20C.%20W.%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BMusick%2C%20B.%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BFreeman%2C%20A.%26lt%3B%5C%2Fspan%26gt%3B%20et%20al.%26lt%3B%5C%2Fspan%26gt%3B%20%282023%29.%20Design%20and%20implementation%20of%20a%20global%20site%20assessment%20survey%20among%20HIV%20clinics%20participating%20in%20the%20International%20epidemiology%20Databases%20to%20Evaluate%20AIDS%20%28IeDEA%29%20research%20consortium.%20%26lt%3Bi%26gt%3BPLoS%20One%26lt%3B%5C%2Fi%26gt%3B%2C%20%26lt%3Bi%26gt%3B18%26lt%3B%5C%2Fi%26gt%3B%20%283%29%2C%20S.%20e0268167.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1371%5C%2Fjournal.pone.0268167%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1371%5C%2Fjournal.pone.0268167%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Design%20and%20implementation%20of%20a%20global%20site%20assessment%20survey%20among%20HIV%20clinics%20participating%20in%20the%20International%20epidemiology%20Databases%20to%20Evaluate%20AIDS%20%28IeDEA%29%20research%20consortium%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22E.%22%2C%22lastName%22%3A%22Brazier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22F.%22%2C%22lastName%22%3A%22Maruri%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22C.%20W.%22%2C%22lastName%22%3A%22Wester%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22B.%22%2C%22lastName%22%3A%22Musick%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22A.%22%2C%22lastName%22%3A%22Freeman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22A.%22%2C%22lastName%22%3A%22Parcesepe%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22S.%22%2C%22lastName%22%3A%22Hossmann%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22B.%22%2C%22lastName%22%3A%22Christ%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22A.%22%2C%22lastName%22%3A%22Kimmel%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J.%22%2C%22lastName%22%3A%22Humphrey%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22E.%22%2C%22lastName%22%3A%22Freeman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22L.%20A.%22%2C%22lastName%22%3A%22Enane%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22K.%20E.%22%2C%22lastName%22%3A%22Lancaster%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M.%22%2C%22lastName%22%3A%22Ballif%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J.%20E.%22%2C%22lastName%22%3A%22Golub%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22D.%22%2C%22lastName%22%3A%22Nash%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22S.%20N.%22%2C%22lastName%22%3A%22Duda%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Aids%20consortium%22%2C%22lastName%22%3A%22International%20epidemiology%20Databases%20to%20Evaluate%22%7D%5D%2C%22abstractNote%22%3A%22INTRODUCTION%3A%20Timely%20descriptions%20of%20HIV%20service%20characteristics%20and%20their%20evolution%20over%20time%20across%20diverse%20settings%20are%20important%20for%20monitoring%20the%20scale-up%20of%20evidence-based%20program%20strategies%2C%20understanding%20the%20implementation%20landscape%2C%20and%20examining%20service%20delivery%20factors%20that%20influence%20HIV%20care%20outcomes.%20METHODS%3A%20The%20International%20epidemiology%20Databases%20to%20Evaluate%20AIDS%20%28IeDEA%29%20consortium%20undertakes%20periodic%20cross-sectional%20surveys%20on%20service%20availability%20and%20care%20at%20participating%20HIV%20treatment%20sites%20to%20characterize%20trends%20and%20inform%20the%20scientific%20agenda%20for%20HIV%20care%20and%20implementation%20science%20communities.%20IeDEA%26%23039%3Bs%202020%20general%20site%20assessment%20survey%20was%20developed%20through%20a%20consultative%2C%2018-month%20process%20that%20engaged%20diverse%20researchers%20in%20identifying%20content%20from%20previous%20surveys%20that%20should%20be%20retained%20for%20longitudinal%20analyses%20and%20in%20developing%20expanded%20and%20new%20content%20to%20address%20gaps%20in%20the%20literature.%20An%20iterative%20review%20process%20was%20undertaken%20to%20standardize%20the%20format%20of%20new%20survey%20questions%20and%20align%20them%20with%20best%20practices%20in%20survey%20design%20and%20measurement%20and%20lessons%20learned%20through%20prior%20IeDEA%20site%20assessment%20surveys.%20RESULTS%3A%20The%20survey%20questionnaire%20developed%20through%20this%20process%20included%20eight%20content%20domains%20covered%20in%20prior%20surveys%20%28patient%20population%2C%20staffing%20and%20community%20linkages%2C%20HIV%20testing%20and%20diagnosis%2C%20new%20patient%20care%2C%20treatment%20monitoring%20and%20retention%2C%20routine%20HIV%20care%20and%20screening%2C%20pharmacy%2C%20record-keeping%20and%20patient%20tracing%29%2C%20along%20with%20expanded%20content%20related%20to%20antiretroviral%20therapy%20%28differentiated%20service%20delivery%20and%20roll-out%20of%20dolutegravir-based%20regimens%29%3B%20mental%20health%20and%20substance%20use%20disorders%3B%20care%20for%20pregnant%5C%2Fpostpartum%20women%20and%20HIV-exposed%20infants%3B%20tuberculosis%20preventive%20therapy%3B%20and%20pediatric%5C%2Fadolescent%20tuberculosis%20care%3B%20and%20new%20content%20related%20to%20Kaposi%26%23039%3Bs%20sarcoma%20diagnostics%2C%20the%20impact%20of%20COVID-19%20on%20service%20delivery%2C%20and%20structural%20barriers%20to%20HIV%20care.%20The%20survey%20was%20distributed%20to%20238%20HIV%20treatment%20sites%20in%20late%202020%2C%20with%20a%2095%25%20response%20rate.%20CONCLUSION%3A%20IeDEA%26%23039%3Bs%20approach%20for%20site%20survey%20development%20has%20broad%20relevance%20for%20HIV%20research%20networks%20and%20other%20priority%20health%20conditions.%22%2C%22date%22%3A%222023%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1371%5C%2Fjournal.pone.0268167%22%2C%22ISSN%22%3A%221932-6203%20%28Electronic%29%201932-6203%20%28Linking%29%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22GXCKG69T%22%2C%22ZVWK2Q45%22%2C%22D9WC3N3V%22%2C%22TCMBXKKM%22%2C%228IRGNQWZ%22%2C%22F2Y6PLUL%22%2C%22ZBJI578D%22%2C%22YAE5EUBI%22%2C%223FNU2D64%22%5D%2C%22dateModified%22%3A%222025-03-20T13%3A19%3A41Z%22%7D%7D%2C%7B%22key%22%3A%224NICZCI6%22%2C%22library%22%3A%7B%22id%22%3A2775998%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Zachek%20et%20al.%22%2C%22parsedDate%22%3A%222023%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BZachek%2C%20Christine%20M.%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BCoelho%2C%20Lara%20E.%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BClark%2C%20Jesse%20L.%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BDomingues%2C%20Rosa%20M.%20S.%20M.%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BLuz%2C%20Paula%20M.%26lt%3B%5C%2Fspan%26gt%3B%20et%20al.%26lt%3B%5C%2Fspan%26gt%3B%20%282023%29.%20Reproductive%20health%20syndemics%20impact%20retention%20in%20care%20among%20women%20living%20with%20HIV%20in%20Rio%20de%20Janeiro%2C%20Brazil.%20%26lt%3Bi%26gt%3BThe%20Brazilian%20Journal%20of%20Infectious%20Diseases%3A%20An%20Official%20Publication%20of%20the%20Brazilian%20Society%20of%20Infectious%20Diseases%26lt%3B%5C%2Fi%26gt%3B%2C%20%26lt%3Bi%26gt%3B27%26lt%3B%5C%2Fi%26gt%3B%20%284%29%2C%20S.%20102779.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.bjid.2023.102779%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.bjid.2023.102779%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Reproductive%20health%20syndemics%20impact%20retention%20in%20care%20among%20women%20living%20with%20HIV%20in%20Rio%20de%20Janeiro%2C%20Brazil%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christine%20M.%22%2C%22lastName%22%3A%22Zachek%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lara%20E.%22%2C%22lastName%22%3A%22Coelho%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jesse%20L.%22%2C%22lastName%22%3A%22Clark%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rosa%20M.%20S.%20M.%22%2C%22lastName%22%3A%22Domingues%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Paula%20M.%22%2C%22lastName%22%3A%22Luz%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ruth%20K.%22%2C%22lastName%22%3A%22Friedman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22%5Cu00c2ngela%20C.%20Vasconcelos%22%2C%22lastName%22%3A%22de%20Andrade%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Valdilea%20G.%22%2C%22lastName%22%3A%22Veloso%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jordan%20E.%22%2C%22lastName%22%3A%22Lake%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Beatriz%22%2C%22lastName%22%3A%22Grinsztejn%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Raquel%20B.%22%2C%22lastName%22%3A%22De%20Boni%22%7D%5D%2C%22abstractNote%22%3A%22Syndemic%20psychosocial%20and%20reproductive%20factors%20affecting%20women%26%23039%3Bs%20retention%20in%20HIV%20care%20remain%20understudied.%20We%20analyzed%20correlates%20of%20non-retention%20in%20a%20cohort%20of%20women%20with%20HIV%20in%20Brazil%20from%5Cu00a02000%5Cu20122015.%20Participants%20self-reported%20exposure%20to%20physical%5C%2Fsexual%20violence%2C%20illicit%20drug%20use%2C%20adolescent%20pregnancy%2C%20or%20induced%20abortion.%20Lifetime%20history%20of%20these%20psychosocial%20stressors%20were%20used%20to%20create%20a%20syndemic%20score%20based%20on%20the%20presence%20or%20absence%20of%20these%20conditions.%20All%20dichotomous%20variables%20were%20summed%20%28range%5Cu00a00%5Cu00a0to%5Cu00a04%29%2C%20with%20greater%20scores%20indicating%20more%20syndemic%20factors%20experienced.%20Logistic%20regression%20models%20identified%20predictors%20of%20non-retention%2C%20defined%20as%5Cu00a0%26lt%3B%202%5Cu00a0HIV%20viral%20load%20or%20CD4%20results%20within%20the%20first%20year%20of%20enrollment.%20Of%5Cu00a0915%5Cu00a0women%2C%20non-retention%20was%20observed%20for%5Cu00a018%25.%20Prevalence%20of%20syndemic%20factors%20was%20adolescent%20pregnancy%5Cu00a0%2853.2%25%29%2C%20physical%5C%2Fsexual%20violence%5Cu00a0%2838.3%25%29%2C%20induced%20abortion%5Cu00a0%2827.3%25%29%2C%20and%20illicit%20drug%20use%5Cu00a0%2817.2%25%29%3B%2041.2%25%5Cu00a0experienced%20%5Cu2265%202%5Cu00a0syndemic%20conditions.%20Syndemic%20scores%20of%5Cu00a02%5Cu00a0and%5Cu00a03%5Cu00a0were%20associated%20with%20non-retention%2C%20as%20well%20as%20low%20education%2C%20years%20with%20HIV%20and%20seroprevalent%20syphilis.%20Psychosocial%20and%20reproductive%20syndemics%20can%20limit%20women%26%23039%3Bs%20retention%20in%20HIV%20care.%20Syphilis%20infection%20predicted%20non-retention%20and%20could%20be%20explored%20as%20a%20syndemic%20factor%20in%20future%20studies.%22%2C%22date%22%3A%222023%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.bjid.2023.102779%22%2C%22ISSN%22%3A%221678-4391%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22GXCKG69T%22%2C%22F2Y6PLUL%22%5D%2C%22dateModified%22%3A%222025-03-11T12%3A08%3A03Z%22%7D%7D%2C%7B%22key%22%3A%22MKFX37ZD%22%2C%22library%22%3A%7B%22id%22%3A2775998%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Lotspeich%20et%20al.%22%2C%22parsedDate%22%3A%222023%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BLotspeich%2C%20Sarah%20C.%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BShepherd%2C%20Bryan%20E.%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BKariuki%2C%20Marion%20Achieng%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BWools-Kaloustian%2C%20Kara%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BMcGowan%2C%20Catherine%20C.%26lt%3B%5C%2Fspan%26gt%3B%20et%20al.%26lt%3B%5C%2Fspan%26gt%3B%20%282023%29.%20Lessons%20learned%20from%20over%20a%20decade%20of%20data%20audits%20in%20international%20observational%20HIV%20cohorts%20in%20Latin%20America%20and%20East%20Africa.%20%26lt%3Bi%26gt%3BJournal%20of%20Clinical%20and%20Translational%20Science%26lt%3B%5C%2Fi%26gt%3B%2C%20%26lt%3Bi%26gt%3B7%26lt%3B%5C%2Fi%26gt%3B%20%281%29%2C%20S.%20e245.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1017%5C%2Fcts.2023.659%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1017%5C%2Fcts.2023.659%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Lessons%20learned%20from%20over%20a%20decade%20of%20data%20audits%20in%20international%20observational%20HIV%20cohorts%20in%20Latin%20America%20and%20East%20Africa%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sarah%20C.%22%2C%22lastName%22%3A%22Lotspeich%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bryan%20E.%22%2C%22lastName%22%3A%22Shepherd%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marion%20Achieng%22%2C%22lastName%22%3A%22Kariuki%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kara%22%2C%22lastName%22%3A%22Wools-Kaloustian%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Catherine%20C.%22%2C%22lastName%22%3A%22McGowan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Beverly%22%2C%22lastName%22%3A%22Musick%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Aggrey%22%2C%22lastName%22%3A%22Semeere%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Brenda%20E.%22%2C%22lastName%22%3A%22Crabtree%20Ram%5Cu00edrez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Denna%20M.%22%2C%22lastName%22%3A%22Mkwashapi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Carina%22%2C%22lastName%22%3A%22Cesar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Matthew%22%2C%22lastName%22%3A%22Ssemakadde%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Daisy%20Maria%22%2C%22lastName%22%3A%22Machado%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Antony%22%2C%22lastName%22%3A%22Ngeresa%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fl%5Cu00e1via%20Faleiro%22%2C%22lastName%22%3A%22Ferreira%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jerome%22%2C%22lastName%22%3A%22Lwali%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Adias%22%2C%22lastName%22%3A%22Marcelin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sandra%20Wagner%22%2C%22lastName%22%3A%22Cardoso%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marco%20Tulio%22%2C%22lastName%22%3A%22Luque%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Larissa%22%2C%22lastName%22%3A%22Otero%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Claudia%20P.%22%2C%22lastName%22%3A%22Cort%5Cu00e9s%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Stephany%20N.%22%2C%22lastName%22%3A%22Duda%22%7D%5D%2C%22abstractNote%22%3A%22INTRODUCTION%3A%20Routine%20patient%20care%20data%20are%20increasingly%20used%20for%20biomedical%20research%2C%20but%20such%20%26quot%3Bsecondary%20use%26quot%3B%20data%20have%20known%20limitations%2C%20including%20their%20quality.%20When%20leveraging%20routine%20care%20data%20for%20observational%20research%2C%20developing%20audit%20protocols%20that%20can%20maximize%20informational%20return%20and%20minimize%20costs%20is%20paramount.%5CnMETHODS%3A%20For%20more%20than%20a%20decade%2C%20the%20Latin%20America%20and%20East%20Africa%20regions%20of%20the%20International%20epidemiology%20Databases%20to%20Evaluate%20AIDS%20%28IeDEA%29%20consortium%20have%20been%20auditing%20the%20observational%20data%20drawn%20from%20participating%20human%20immunodeficiency%20virus%20clinics.%20Since%20our%20earliest%20audits%2C%20where%20external%20auditors%20used%20paper%20forms%20to%20record%20audit%20findings%20from%20paper%20medical%20records%2C%20we%20have%20streamlined%20our%20protocols%20to%20obtain%20more%20efficient%20and%20informative%20audits%20that%20keep%20up%20with%20advancing%20technology%20while%20reducing%20travel%20obligations%20and%20associated%20costs.%5CnRESULTS%3A%20We%20present%20five%20key%20lessons%20learned%20from%20conducting%20data%20audits%20of%20secondary-use%20data%20from%20resource-limited%20settings%20for%20more%20than%2010%20years%20and%20share%20eight%20recommendations%20for%20other%20consortia%20looking%20to%20implement%20data%20quality%20initiatives.%5CnCONCLUSION%3A%20After%20completing%20multiple%20audit%20cycles%20in%20both%20the%20Latin%20America%20and%20East%20Africa%20regions%20of%20the%20IeDEA%20consortium%2C%20we%20have%20established%20a%20rich%20reference%20for%20data%20quality%20in%20our%20cohorts%2C%20as%20well%20as%20large%2C%20audited%20analytical%20datasets%20that%20can%20be%20used%20to%20answer%20important%20clinical%20questions%20with%20confidence.%20By%20sharing%20our%20audit%20processes%20and%20how%20they%20have%20been%20adapted%20over%20time%2C%20we%20hope%20that%20others%20can%20develop%20protocols%20informed%20by%20our%20lessons%20learned%20from%20more%20than%20a%20decade%20of%20experience%20in%20these%20large%2C%20diverse%20cohorts.%22%2C%22date%22%3A%222023%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1017%5C%2Fcts.2023.659%22%2C%22ISSN%22%3A%222059-8661%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22GXCKG69T%22%2C%22F2Y6PLUL%22%2C%22ZBJI578D%22%5D%2C%22dateModified%22%3A%222025-03-11T11%3A54%3A32Z%22%7D%7D%2C%7B%22key%22%3A%22URS9BIA7%22%2C%22library%22%3A%7B%22id%22%3A2775998%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Humphrey%20et%20al.%22%2C%22parsedDate%22%3A%222023%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BHumphrey%2C%20John%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BNagel%2C%20Elizabeth%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BCarlucci%2C%20James%20G.%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BEdmonds%2C%20Andrew%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BKinikar%2C%20Aarti%26lt%3B%5C%2Fspan%26gt%3B%20et%20al.%26lt%3B%5C%2Fspan%26gt%3B%20%282023%29.%20Integration%20of%20HIV%20care%20into%20maternal%20and%20child%20health%20services%20in%20the%20global%20IeDEA%20consortium.%20%26lt%3Bi%26gt%3BFrontiers%20in%20Global%20Women%26%23x2019%3Bs%20Health%26lt%3B%5C%2Fi%26gt%3B%2C%20%26lt%3Bi%26gt%3B4%26lt%3B%5C%2Fi%26gt%3B%2C%20S.%201066297.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.3389%5C%2Ffgwh.2023.1066297%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.3389%5C%2Ffgwh.2023.1066297%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Integration%20of%20HIV%20care%20into%20maternal%20and%20child%20health%20services%20in%20the%20global%20IeDEA%20consortium%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22John%22%2C%22lastName%22%3A%22Humphrey%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Elizabeth%22%2C%22lastName%22%3A%22Nagel%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22James%20G.%22%2C%22lastName%22%3A%22Carlucci%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Andrew%22%2C%22lastName%22%3A%22Edmonds%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Aarti%22%2C%22lastName%22%3A%22Kinikar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kim%22%2C%22lastName%22%3A%22Anderson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Val%5Cu00e9riane%22%2C%22lastName%22%3A%22Leroy%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Daisy%22%2C%22lastName%22%3A%22Machado%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dwight%20E.%22%2C%22lastName%22%3A%22Yin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marco%22%2C%22lastName%22%3A%22Tulio%20Luque%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Madeleine%22%2C%22lastName%22%3A%22Amorissani-Folquet%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Safari%22%2C%22lastName%22%3A%22Mbewe%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tulathip%22%2C%22lastName%22%3A%22Suwanlerk%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Athanase%22%2C%22lastName%22%3A%22Munyaneza%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rena%20C.%22%2C%22lastName%22%3A%22Patel%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Beverly%22%2C%22lastName%22%3A%22Musick%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lisa%22%2C%22lastName%22%3A%22Abuogi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kara%22%2C%22lastName%22%3A%22Wools-Kaloustian%22%7D%5D%2C%22abstractNote%22%3A%22The%20WHO%20recommends%20the%20integration%20of%20routine%20HIV%20services%20within%20maternal%20and%20child%20health%20%28MCH%29%20services%20to%20reduce%20the%20fragmentation%20of%20and%20to%20promote%20retention%20in%20care%20for%20pregnant%20and%20postpartum%20women%20living%20with%20HIV%20%28WWH%29%20and%20their%20infants%20and%20children%20exposed%20to%20HIV%20%28ICEH%29.%20During%202020-2021%2C%20we%20surveyed%20202%20HIV%20treatment%20sites%20across%2040%20low-%20and%20middle-income%20countries%20within%20the%20global%20International%20epidemiology%20Databases%20to%20Evaluate%20AIDS%20%28IeDEA%29%20consortium.%20We%20determined%20the%20proportion%20of%20sites%20providing%20HIV%20services%20integrated%20within%20MCH%20clinics%2C%20defined%20as%20full%20%5BHIV%20care%20and%20antiretroviral%20treatment%20%28ART%29%20initiation%20in%20MCH%20clinic%5D%2C%20partial%20%28HIV%20care%20or%20ART%20initiation%20in%20MCH%20clinic%29%2C%20or%20no%20integration.%20Among%20sites%20serving%20pregnant%20WWH%2C%2054%25%20were%20fully%20and%2021%25%20partially%20integrated%2C%20with%20the%20highest%20proportions%20of%20fully%20integrated%20sites%20in%20Southern%20Africa%20%2880%25%29%20and%20East%20Africa%20%2876%25%29%20compared%20to%2014%25-40%25%20in%20other%20regions%20%28i.e.%2C%20Asia-Pacific%3B%20the%20Caribbean%2C%20Central%20and%20South%20America%20Network%20for%20HIV%20Epidemiology%3B%20Central%20Africa%3B%20West%20Africa%29.%20Among%20sites%20serving%20postpartum%20WWH%2C%2051%25%20were%20fully%20and%2010%25%20partially%20integrated%2C%20with%20a%20similar%20regional%20integration%20pattern%20to%20sites%20serving%20pregnant%20WWH.%20Among%20sites%20serving%20ICEH%2C%2056%25%20were%20fully%20and%209%25%20were%20partially%20integrated%2C%20with%20the%20highest%20proportions%20of%20fully%20integrated%20sites%20in%20East%20Africa%20%2876%25%29%2C%20West%20Africa%20%2858%25%29%20and%20Southern%20Africa%20%2854%25%29%20compared%20to%20%5Cu226433%25%20in%20the%20other%20regions.%20Integration%20was%20heterogenous%20across%20IeDEA%20regions%20and%20most%20prevalent%20in%20East%20and%20Southern%20Africa.%20More%20research%20is%20needed%20to%20understand%20this%20heterogeneity%20and%20the%20impacts%20of%20integration%20on%20MCH%20outcomes%20globally.%22%2C%22date%22%3A%222023%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.3389%5C%2Ffgwh.2023.1066297%22%2C%22ISSN%22%3A%222673-5059%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22GXCKG69T%22%2C%22ZVWK2Q45%22%2C%22D9WC3N3V%22%2C%22TCMBXKKM%22%2C%228IRGNQWZ%22%2C%22F2Y6PLUL%22%2C%22ZBJI578D%22%2C%22YAE5EUBI%22%2C%223FNU2D64%22%5D%2C%22dateModified%22%3A%222023-12-01T11%3A00%3A35Z%22%7D%7D%2C%7B%22key%22%3A%22V938TV5R%22%2C%22library%22%3A%7B%22id%22%3A2775998%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Arriaga%20et%20al.%22%2C%22parsedDate%22%3A%222023%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BArriaga%2C%20Mar%26%23xED%3Ba%20B.%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BAra%26%23xFA%3Bjo-Pereira%2C%20Mariana%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BAndrade%2C%20Vanessa%20M.%20B.%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BQueiroz%2C%20Artur%20T.%20L.%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BFernandes%2C%20Catarina%20D.%26lt%3B%5C%2Fspan%26gt%3B%20et%20al.%26lt%3B%5C%2Fspan%26gt%3B%20%282023%29.%20Influence%20of%20dietary%20pattern%20on%20anti-tuberculosis%20treatment%20outcomes%20in%20persons%20with%20dysglycemia%3A%20a%20Peruvian%20prospective%20cohort%20study.%20%26lt%3Bi%26gt%3BFrontiers%20in%20Nutrition%26lt%3B%5C%2Fi%26gt%3B%2C%20%26lt%3Bi%26gt%3B10%26lt%3B%5C%2Fi%26gt%3B%2C%20S.%201254983.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.3389%5C%2Ffnut.2023.1254983%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.3389%5C%2Ffnut.2023.1254983%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Influence%20of%20dietary%20pattern%20on%20anti-tuberculosis%20treatment%20outcomes%20in%20persons%20with%20dysglycemia%3A%20a%20Peruvian%20prospective%20cohort%20study%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mar%5Cu00eda%20B.%22%2C%22lastName%22%3A%22Arriaga%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mariana%22%2C%22lastName%22%3A%22Ara%5Cu00fajo-Pereira%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vanessa%20M.%20B.%22%2C%22lastName%22%3A%22Andrade%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Artur%20T.%20L.%22%2C%22lastName%22%3A%22Queiroz%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Catarina%20D.%22%2C%22lastName%22%3A%22Fernandes%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Caio%22%2C%22lastName%22%3A%22Sales%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Juan%20Gonzalo%22%2C%22lastName%22%3A%22Aliaga%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rupak%22%2C%22lastName%22%3A%22Shivakoti%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Leonid%22%2C%22lastName%22%3A%22Lecca%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Roger%20I.%22%2C%22lastName%22%3A%22Calderon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bruno%20B.%22%2C%22lastName%22%3A%22Andrade%22%7D%5D%2C%22abstractNote%22%3A%22INTRODUCTION%3A%20Dietary%20patterns%20%28DPs%29%20are%20associated%20with%20overall%20nutritional%20status%20and%20may%20alter%20the%20clinical%20prognosis%20of%20tuberculosis.%20This%20interaction%20can%20be%20further%20intricated%20by%20dysglycemia%20%28i.e.%2C%20diabetes%20or%20prediabetes%29.%20Here%2C%20we%20identified%20DPs%20that%20are%20more%20common%20with%20tuberculosis-dysglycemia%20and%20depicted%20their%20association%20with%20tuberculosis%20treatment%20outcomes.%5CnMETHODS%3A%20A%20prospective%20cohort%20study%20of%20persons%20with%20tuberculosis%20and%20their%20contacts%20was%20conducted%20in%20Peru.%20A%20food%20frequency%20questionnaire%20and%20a%20multidimensional%20systems%20biology-based%20analytical%20approach%20were%20employed%20to%20identify%20DPs%20associated%20with%20these%20clinical%20groups.%20Potential%20independent%20associations%20between%20clinical%20features%20and%20DPs%20were%20analyzed.%5CnRESULTS%3A%20Three%20major%20DPs%20were%20identified.%20TB-dysglycemia%20cases%20more%20often%20had%20a%20high%20intake%20of%20carbohydrates%20%28DP1%29.%20Furthermore%2C%20DP1%20was%20found%20to%20be%20associated%20with%20an%20increased%20risk%20of%20unfavorable%20TB%20outcomes%20independent%20of%20other%20factors%2C%20including%20dysglycemia.%5CnCONCLUSION%3A%20Our%20findings%20suggest%20that%20the%20evaluation%20of%20nutritional%20status%20through%20DPs%20in%20comorbidities%20such%20as%20dysglycemia%20is%20a%20fundamental%20action%20to%20predict%20TB%20treatment%20outcomes.%20The%20mechanisms%20underlying%20the%20association%20between%20high%20intake%20of%20carbohydrates%2C%20dysglycemia%2C%20and%20unfavorable%20tuberculosis%20treatment%20outcomes%20warrant%20further%20investigation.%22%2C%22date%22%3A%222023%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.3389%5C%2Ffnut.2023.1254983%22%2C%22ISSN%22%3A%222296-861X%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22GXCKG69T%22%2C%22F2Y6PLUL%22%5D%2C%22dateModified%22%3A%222024-04-12T12%3A41%3A10Z%22%7D%7D%5D%7D
Rodrigues, Moreno M. S.; Barreto-Duarte, Beatriz; Vinhaes, Caian L.; Araújo-Pereira, Mariana; Fukutani, Eduardo R. et al. (2023). Machine learning algorithms using national registry data to predict loss to follow- up during tuberculosis treatment. Research Square, S. rs.3.rs-3706875. http://doi.org/10.21203/rs.3.rs-3706875/v1.
Grinsztejn, Eduarda; Cardoso, Sandra Wagner; Velasque, Luciane; Hoagland, Brenda; Dos Santos, Desiree Gomes et al. (2023). Impact of Latent M. tuberculosis Infection Treatment on Time to CD4/CD8 Recovery in Acute, Recent, and Chronic HIV Infection. Journal of Acquired Immune Deficiency Syndromes (1999), 94 (4), S. 355–363. http://doi.org/10.1097/QAI.0000000000003284.
Meireles, Glaucia; Nobre, Aline A.; Cardoso, Sandra W.; Velasque, Luciane; Veloso, Valdilea G. et al. (2023). Real-world effectiveness of WHO recommended first-line antiretroviral therapies: a cohort study from a middle-income country. AIDS Care, 35 (12), S. 1891–1903. http://doi.org/10.1080/09540121.2023.2190954.
Eden, Svetlana K.; Li, Chun & Shepherd, Bryan E. (2023). Spearman-like correlation measure adjusting for covariates in bivariate survival data. Biometrical Journal. Biometrische Zeitschrift, S. e2200137. http://doi.org/10.1002/bimj.202200137.
Bocage, A. E.; Coelho, L. E.; Lake, J. E.; Clark, J. L.; Torres, T. S. et al. (2023). The Impact of COVID-19 on HIV Care in Rio de Janeiro, Brazil 2019-2021: Disparities by Age and Gender. AIDS Behav, 27 (8), S. 2629–2641. http://doi.org/10.1007/s10461-023-03988-3.
Parcesepe, Angela M.; Stockton, Melissa; Remch, Molly; Wester, C. William; Bernard, Charlotte et al. (2023). Availability of screening and treatment for common mental disorders in HIV clinic settings: data from the global International epidemiology Databases to Evaluate AIDS (IeDEA) Consortium, 2016-2017 and 2020. Journal of the International AIDS Society, 26 (8), S. e26147. http://doi.org/10.1002/jia2.26147.
Person, Anna K.; Crabtree-Ramirez, Brenda; Kim, Ahra; Veloso, Valdiléa; Maruri, Fernanda et al. (2023). Cryptococcal Meningitis and Clinical Outcomes in Persons With Human Immunodeficiency Virus: A Global View. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America, 76 (12), S. 2116–2125. http://doi.org/10.1093/cid/ciad076.
Araújo-Pereira, Mariana; Nogueira, Betânia M. F.; Spener-Gomes, Renata; Carvalho, Anna C. C.; Sant’Anna, Flávia Marinho et al. (2023). Anemia and anti-tuberculosis treatment outcome in persons with pulmonary tuberculosis: A multi-center prospective cohort study. Journal of Infection and Public Health, 16 (6), S. 974–980. http://doi.org/10.1016/j.jiph.2023.04.009.
Queiroz, Artur T. L.; Vinhaes, Caian L.; Fukutani, Eduardo R.; Gupte, Akshay N.; Kumar, Nathella Pavan et al. (2023). A multi-center, prospective cohort study of whole blood gene expression in the tuberculosis-diabetes interaction. Scientific Reports, 13 (1), S. 7769. http://doi.org/10.1038/s41598-023-34847-9.
Vreeman, R. C.; Yiannoutsos, C. T.; Yusoff, N. K. N.; Wester, C. W.; Edmonds, A. et al. (2023). Global HIV prevention, care and treatment services for children: a cross-sectional survey from the International Epidemiology Databases to Evaluate AIDS (IeDEA) consortium. BMJ Open, 13 (3), S. e069399. http://doi.org/10.1136/bmjopen-2022-069399.
Ridolfi, F.; Peetluk, L.; Amorim, G.; Turner, M.; Figueiredo, M. et al. (2023). Tuberculosis Treatment Outcomes in Brazil: Different Predictors for Each Type of Unsuccessful Outcome. Clin Infect Dis, 76 (3), S. e930–e937. http://doi.org/10.1093/cid/ciac541.
Ross, J.; Brazier, E.; Fatti, G.; Jaquet, A.; Tanon, A. et al. (2023). Same-Day Antiretroviral Therapy Initiation as a Predictor of Loss to Follow-up and Viral Suppression Among People With Human Immunodeficiency Virus in Sub-Saharan Africa. Clin Infect Dis, 76 (1), S. 39–47. http://doi.org/10.1093/cid/ciac759.
Brazier, E.; Maruri, F.; Wester, C. W.; Musick, B.; Freeman, A. et al. (2023). Design and implementation of a global site assessment survey among HIV clinics participating in the International epidemiology Databases to Evaluate AIDS (IeDEA) research consortium. PLoS One, 18 (3), S. e0268167. http://doi.org/10.1371/journal.pone.0268167.
Zachek, Christine M.; Coelho, Lara E.; Clark, Jesse L.; Domingues, Rosa M. S. M.; Luz, Paula M. et al. (2023). Reproductive health syndemics impact retention in care among women living with HIV in Rio de Janeiro, Brazil. The Brazilian Journal of Infectious Diseases: An Official Publication of the Brazilian Society of Infectious Diseases, 27 (4), S. 102779. http://doi.org/10.1016/j.bjid.2023.102779.
Lotspeich, Sarah C.; Shepherd, Bryan E.; Kariuki, Marion Achieng; Wools-Kaloustian, Kara; McGowan, Catherine C. et al. (2023). Lessons learned from over a decade of data audits in international observational HIV cohorts in Latin America and East Africa. Journal of Clinical and Translational Science, 7 (1), S. e245. http://doi.org/10.1017/cts.2023.659.
Humphrey, John; Nagel, Elizabeth; Carlucci, James G.; Edmonds, Andrew; Kinikar, Aarti et al. (2023). Integration of HIV care into maternal and child health services in the global IeDEA consortium. Frontiers in Global Women’s Health, 4, S. 1066297. http://doi.org/10.3389/fgwh.2023.1066297.
Arriaga, María B.; Araújo-Pereira, Mariana; Andrade, Vanessa M. B.; Queiroz, Artur T. L.; Fernandes, Catarina D. et al. (2023). Influence of dietary pattern on anti-tuberculosis treatment outcomes in persons with dysglycemia: a Peruvian prospective cohort study. Frontiers in Nutrition, 10, S. 1254983. http://doi.org/10.3389/fnut.2023.1254983.
2022
Romo, M. L.; Patel, R. C.; Edwards, J. K.; Humphrey, J. M.; Musick, B. S. et al. (2022). Disparities in Dolutegravir Uptake Affecting Females of Reproductive Age With HIV in Low- and Middle-Income Countries After Initial Concerns About Teratogenicity : An Observational Study. Ann Intern Med, 175 (1), S. 84–94. http://doi.org/10.7326/M21-3037.
Arriaga, M. B.; Araujo-Pereira, M.; Barreto-Duarte, B.; Nogueira, B.; Freire, Mvcns et al. (2022). The Effect of Diabetes and Prediabetes on Antituberculosis Treatment Outcomes: A Multicenter Prospective Cohort Study. J Infect Dis, 225 (4), S. 617–626. http://doi.org/10.1093/infdis/jiab427.
Peetluk, L. S.; Rebeiro, P. F.; Ridolfi, F. M.; Andrade, B. B.; Cordeiro-Santos, M. et al. (2022). A Clinical Prediction Model for Unsuccessful Pulmonary Tuberculosis Treatment Outcomes. Clin Infect Dis, 74 (6), S. 973–982. http://doi.org/10.1093/cid/ciab598.
Collaborative Initiative for Paediatric, H. I. V. Education; Research Global Cohort, Collaboration; Jesson, J.; Crichton, S.; Quartagno, M. et al. (2022). Growth and CD4 patterns of adolescents living with perinatally acquired HIV worldwide, a CIPHER cohort collaboration analysis. J Int AIDS Soc, 25 (3), S. e25871. http://doi.org/10.1002/jia2.25871.
Hovhannisyan, L.; Coelho, L. E.; Velasque, L.; De Boni, R. B.; Clark, J. et al. (2022). Multilevel Analysis of Individual and Neighborhood Characteristics Associated with Viral Suppression Among Adults with HIV in Rio de Janeiro, Brazil. AIDS Behav, 26 (3), S. 947–962. http://doi.org/10.1007/s10461-021-03450-2.
Crabtree-Ramirez, B.; Jenkins, C. A.; Shepherd, B. E.; Jayathilake, K.; Veloso, V. G. et al. (2022). Tuberculosis treatment intermittency in the continuation phase and mortality in HIV-positive persons receiving antiretroviral therapy. BMC Infect Dis, 22 (1), S. 341. http://doi.org/10.1186/s12879-022-07330-5.
Antimycobacterial Susceptibility Testing, Group (2022). Updating the approaches to define susceptibility and resistance to anti-tuberculosis agents: implications for diagnosis and treatment. Eur Respir J, 59 (4), S. 2200166. http://doi.org/10.1183/13993003.00166-2022.
Caro-Vega, Y.; Rebeiro, P. F.; Shepherd, B. E.; Belaunzaran-Zamudio, P. F.; Crabtree-Ramirez, B. et al. (2022). Clinical effects of durability of immunosuppression in virologically suppressed ART-initiating persons with HIV in Latin America. A retrospective cohort study. Lancet Reg Health Am, 8, S. 100175. http://doi.org/10.1016/j.lana.2021.100175.
Coelho, L. E.; Jenkins, C. A.; Shepherd, B. E.; Pape, J. W.; Mejia Cordero, F. et al. (2022). Weight gain post-ART in HIV+ Latinos/as differs in the USA, Haiti, and Latin America. Lancet Reg Health Am, 8, S. 100173. http://doi.org/10.1016/j.lana.2021.100173.
Justice, A. C.; Goetz, M. B.; Stewart, C. N.; Hogan, B. C.; Humes, E. et al. (2022). Delayed presentation of HIV among older individuals: a growing problem. Lancet HIV, 9 (4), S. e269–e280. http://doi.org/10.1016/S2352-3018(22)00003-0.
Leite, Phac; Coelho, L. E.; Cardoso, S. W.; Moreira, R. I.; Veloso, V. G. et al. (2022). Early mortality in a cohort of people living with HIV in Rio de Janeiro, Brazil, 2004-2015: a persisting problem. BMC Infect Dis, 22 (1), S. 475. http://doi.org/10.1186/s12879-022-07451-x.
Giraldo, L.; Fink, V.; Cahn, F.; Aristegui, I.; Caceres, B. et al. (2022). Design and Development of an Electronic Health Record According to Argentine Gender Identity Law. Stud Health Technol Inform, 290, S. 995–996. http://doi.org/10.3233/SHTI220235.
Giraldo, L.; Fink, V.; Cahn, F.; Caceres, B.; Sued, O. et al. (2022). Redesigning an Electronic Health Record in Argentina to Improve Comprehensive Health Care and Clinical Research. Stud Health Technol Inform, 290, S. 993–994. http://doi.org/10.3233/SHTI220234.
Eden, S. K.; Li, C. & Shepherd, B. E. (2022). Nonparametric estimation of Spearman’s rank correlation with bivariate survival data. Biometrics, 78 (2), S. 421–434. http://doi.org/10.1111/biom.13453.
Lewis, J. T.; Stephens, J.; Musick, B.; Brown, S.; Malateste, K. et al. (2022). The IeDEA harmonist data toolkit: A data quality and data sharing solution for a global HIV research consortium. J Biomed Inform, 131, S. 104110. http://doi.org/10.1016/j.jbi.2022.104110.
Villalva-Serra, K.; Barreto-Duarte, B.; Nunes, V. M.; Menezes, R. C.; Rodrigues, M. M. S. et al. (2022). Tuberculosis treatment outcomes of diabetic and non-diabetic TB/HIV co-infected patients: A nationwide observational study in Brazil. Front Med (Lausanne), 9, S. 972145. http://doi.org/10.3389/fmed.2022.972145.
Edmonds, A.; Brazier, E.; Musick, B. S.; Yotebieng, M.; Humphrey, J. et al. (2022). Clinical and programmatic outcomes of HIV-exposed infants enrolled in care at geographically diverse clinics, 1997-2021: A cohort study. PLoS Med, 19 (9), S. e1004089. http://doi.org/10.1371/journal.pmed.1004089.
Nunez, I.; Crabtree-Ramirez, B.; Shepherd, B. E.; Sterling, T. R.; Cahn, P. et al. (2022). Late-onset opportunistic infections while receiving anti-retroviral therapy in Latin America: burden and risk factors. Int J Infect Dis, 122, S. 469–475. http://doi.org/10.1016/j.ijid.2022.06.041.
Sobral, L.; Arriaga, M. B.; Souza, A. B.; Araujo-Pereira, M.; Barreto-Duarte, B. et al. (2022). Determinants of losses in the tuberculosis infection cascade of care among children and adolescent contacts of pulmonary tuberculosis cases: A Brazilian multi-centre longitudinal study. Lancet Reg Health Am, 15, S. 100358. http://doi.org/10.1016/j.lana.2022.100358.
Brazier, E.; Ajeh, R.; Maruri, F.; Musick, B.; Freeman, A. et al. (2022). Service delivery challenges in HIV care during the first year of the COVID-19 pandemic: results from a site assessment survey across the global IeDEA consortium. J Int AIDS Soc, 25 (12), S. e26036. http://doi.org/10.1002/jia2.26036.
Lotspeich, S. C.; Shepherd, B. E.; Amorim, G. G. C.; Shaw, P. A. & Tao, R. (2022). Efficient odds ratio estimation under two-phase sampling using error-prone data from a multi-national HIV research cohort. Biometrics, 78 (4), S. 1674–1685. http://doi.org/10.1111/biom.13512.
Araujo-Pereira, M.; Barreto-Duarte, B.; Arriaga, M. B.; Musselwhite, L. W.; Vinhaes, C. L. et al. (2022). Relationship Between Anemia and Systemic Inflammation in People Living With HIV and Tuberculosis: A Sub-Analysis of the CADIRIS Clinical Trial. Front Immunol, 13, S. 916216. http://doi.org/10.3389/fimmu.2022.916216.
Arriaga, M. B.; Karim, F.; Queiroz, A. T. L.; Araujo-Pereira, M.; Barreto-Duarte, B. et al. (2022). Effect of Dysglycemia on Urinary Lipid Mediator Profiles in Persons With Pulmonary Tuberculosis. Front Immunol, 13, S. 919802. http://doi.org/10.3389/fimmu.2022.919802.
Zurcher, K.; Cox, S. R.; Ballif, M.; Enane, L. A.; Marcy, O. et al. (2022). Integrating services for HIV and multidrug-resistant tuberculosis: A global cross-sectional survey among ART clinics in low- and middle-income countries. PLOS Glob Public Health, 2 (3), S. e0000180. http://doi.org/10.1371/journal.pgph.0000180.
2021
Castilho, Jessica L.; Kim, Ahra; Jenkins, Cathy A.; Grinsztejn, Beatriz; Gotuzzo, Eduardo et al. (2021). Antiretroviral therapy and Kaposi’s sarcoma trends and outcomes among adults with HIV in Latin America. Journal of the International AIDS Society, 24 (1). http://doi.org/10.1002/jia2.25658.
Pereira, Gerson Fernando Mendes; Kim, Ahra; Jalil, Emilia M.; Fernandes Fonseca, Fernanda; Shepherd, Bryan E. et al. (2021). Dolutegravir and pregnancy outcomes in women on antiretroviral therapy in Brazil: a retrospective national cohort study. The Lancet. HIV, 8 (1), S. e33–e41. http://doi.org/10.1016/S2352-3018(20)30268-X.
Tsondai, Priscilla Ruvimbo; Davies, Mary-Ann; Singtoroj, Thida; Maxwell, Nicola; McGowan, Catherine C. et al. (2021). Improving Methods to Classify Perinatal versus Nonperinatal HIV Acquisition in Young Adolescents 10-14 Years of Age. The Pediatric Infectious Disease Journal. http://doi.org/10.1097/INF.0000000000003059.
Rodrigues, Amanda; Struchiner, Claudio J.; Coelho, Lara E.; Veloso, Valdilea G.; Grinsztejn, Beatriz et al. (2021). Late initiation of antiretroviral therapy: inequalities by educational level despite universal access to care and treatment. BMC Public Health, 21 (1), S. 389. http://doi.org/10.1186/s12889-021-10421-8.
Peetluk, Lauren S.; Ridolfi, Felipe M.; Rebeiro, Peter F.; Liu, Dandan; Rolla, Valeria C. et al. (2021). Systematic review of prediction models for pulmonary tuberculosis treatment outcomes in adults. BMJ Open, 11 (3), S. e044687. http://doi.org/10.1136/bmjopen-2020-044687.
Brazier, Ellen; Tymejczyk, Olga; Zaniewski, Elizabeth; Egger, Matthias; Wools-Kaloustian, Kara et al. (2021). Effects of national adoption of Treat-All guidelines on pre-ART CD4 testing and viral load monitoring after ART initiation: A regression discontinuity analysis. Clinical Infectious Diseases, S. ciab222. http://doi.org/10.1093/cid/ciab222.
Eden, Svetlana K.; Li, Chun & Shepherd, Bryan E. (2021). Nonparametric estimation of Spearman’s rank correlation with bivariate survival data. Biometrics. http://doi.org/10.1111/biom.13453.
Oh, Eric J.; Shepherd, Bryan E.; Lumley, Thomas & Shaw, Pamela A. (2021). Improved generalized raking estimators to address dependent covariate and failure-time outcome error. Biometrical Journal. Biometrische Zeitschrift. http://doi.org/10.1002/bimj.202000187.
McMahon, Devon E.; Semeere, Aggrey; Laker-Oketta, Miriam; Byakwaga, Helen; Mugglin, Catrina et al. (2021). Global disparities in skin cancer services at HIV treatment centers across 29 countries. The Journal of Investigative Dermatology. http://doi.org/10.1016/j.jid.2021.02.758.
Smiley, Casey L.; Rebeiro, Peter F.; Cesar, Carina; Belaunzaran-Zamudio, Pablo F.; Crabtree-Ramirez, Brenda et al. (2021). Estimated life expectancy gains with antiretroviral therapy among adults with HIV in Latin America and the Caribbean: a multisite retrospective cohort study. The Lancet. HIV, 8 (5), S. e266–e273. http://doi.org/10.1016/S2352-3018(20)30358-1.
Yohannes, Nathaniel T.; Jenkins, Cathy A.; Clouse, Kate; Cortés, Claudia P.; Mejía Cordero, Fernando et al. (2021). Timing of HIV diagnosis relative to pregnancy and postpartum HIV care continuum outcomes among Latin American women, 2000 to 2017. Journal of the International AIDS Society, 24 (5), S. e25740. http://doi.org/10.1002/jia2.25740.
Somerville, Kayla; Jenkins, Cathy A.; Carlucci, James G.; Person, Anna K.; Machado, Daisy M. et al. (2021). Outcomes After Second-Line Antiretroviral Therapy in Children Living With HIV in Latin America. Journal of Acquired Immune Deficiency Syndromes (1999), 87 (3), S. 993–1001. http://doi.org/10.1097/QAI.0000000000002678.
Lotspeich, Sarah C.; Shepherd, Bryan E.; Amorim, Gustavo G. C.; Shaw, Pamela A. & Tao, Ran (2021). Efficient odds ratio estimation under two-phase sampling using error-prone data from a multi-national HIV research cohort. Biometrics. http://doi.org/10.1111/biom.13512.
Peetluk, Lauren S.; Rebeiro, Peter F.; Ridolfi, Felipe M.; Andrade, Bruno B.; Cordeiro-Santos, Marcelo et al. (2021). A clinical prediction model for unsuccessful pulmonary tuberculosis treatment outcomes. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America, S. ciab598. http://doi.org/10.1093/cid/ciab598.
Hovhannisyan, Lyolya; Coelho, Lara E.; Velasque, Luciane; De Boni, Raquel B.; Clark, Jesse et al. (2021). Multilevel Analysis of Individual and Neighborhood Characteristics Associated with Viral Suppression Among Adults with HIV in Rio de Janeiro, Brazil. AIDS and Behavior. http://doi.org/10.1007/s10461-021-03450-2.
Johnson, Leigh F.; Kariminia, Azar; Trickey, Adam; Yiannoutsos, Constantin T.; Ekouevi, Didier K. et al. (2021). Achieving consistency in measures of HIV-1 viral suppression across countries: derivation of an adjustment based on international antiretroviral treatment cohort data. Journal of the International AIDS Society, 24 Suppl 5, S. e25776. http://doi.org/10.1002/jia2.25776.
Souza, Alexandra Brito; Arriaga, María B.; Amorim, Gustavo; Araújo-Pereira, Mariana; Nogueira, Betânia M. F. et al. (2021). Determinants of losses in the latent tuberculosis infection cascade of care in Brazil. BMJ Global Health, 6 (9), S. e005969. http://doi.org/10.1136/bmjgh-2021-005969.
Arriaga, María B.; Araújo-Pereira, Mariana; Barreto-Duarte, Beatriz; Nogueira, Betânia; Freire, Maria Vitória C. N. S. et al. (2021). The Effect of Diabetes and Prediabetes on Anti-tuberculosis Treatment Outcomes: A Multi-center Prospective Cohort Study. The Journal of Infectious Diseases, S. jiab427. http://doi.org/10.1093/infdis/jiab427.
Costa, Allyson G.; Carvalho, Brenda K. S.; Araújo-Pereira, Mariana; Ibiapina, Hiochelson N. S.; Spener-Gomes, Renata et al. (2021). Lessons Learned from Implementation of an Interferon Gamma Release Assay to Screen for Latent Tuberculosis Infection in a Large Multicenter Observational Cohort Study in Brazil. Microbiology Spectrum, S. e0116321. http://doi.org/10.1128/Spectrum.01163-21.
Carvalho, Anna Cristina C.; Amorim, Gustavo; Melo, Mayla G. M.; Silveira, Ana Karla A.; Vargas, Pedro H. L. et al. (2021). Pre-Treatment Neutrophil Count as a Predictor of Antituberculosis Therapy Outcomes: A Multicenter Prospective Cohort Study. Frontiers in Immunology, 12, S. 661934. http://doi.org/10.3389/fimmu.2021.661934.
Han, Win Min; Law, Matthew G.; Egger, Matthias; Wools-Kaloustian, Kara; Moore, Richard et al. (2021). Global estimates of viral suppression in children and adolescents and adults on antiretroviral therapy adjusted for missing viral load measurements: a multiregional, retrospective cohort study in 31 countries. The Lancet HIV, 8 (12), S. e766–e775. http://doi.org/10.1016/S2352-3018(21)00265-4.
Joseph, Yvetot; Yao, Zhiwen; Dua, Akanksha; Severe, Patrice; Collins, Sean E. et al. (2021). Long‐term mortality after tuberculosis treatment among persons living with HIV in Haiti. Journal of the International AIDS Society, 24 (7). http://doi.org/10.1002/jia2.25721.
Kassanjee, Reshma; Johnson, Leigh F.; Zaniewski, Elizabeth; Ballif, Marie; Christ, Benedikt et al. (2021). Global HIV mortality trends among children on antiretroviral treatment corrected for under‐reported deaths: an updated analysis of the International epidemiology Databases to Evaluate AIDS collaboration. Journal of the International AIDS Society, 24 (S5). http://doi.org/10.1002/jia2.25780.
Zürcher, Kathrin; Reichmuth, Martina L.; Ballif, Marie; Loiseau, Chloé; Borrell, Sonia et al. (2021). Mortality from drug-resistant tuberculosis in high-burden countries comparing routine drug susceptibility testing with whole-genome sequencing: a multicentre cohort study. The Lancet Microbe, 2 (7), S. e320–e330. http://doi.org/10.1016/S2666-5247(21)00044-6.
2020
Humphrey, John M.; Mpofu, Philani; Pettit, April C.; Musick, Beverly; Carter, E. Jane et al. (2020). Mortality Among People With HIV Treated for Tuberculosis Based on Positive, Negative, or No Bacteriologic Test Results for Tuberculosis: The IeDEA Consortium. Open Forum Infectious Diseases, 7 (1), S. ofaa006–ofaa006. http://doi.org/10.1093/ofid/ofaa006.
IeDEA and COHERE in EuroCoord Cohort Collaboration (2020). All-cause mortality after antiretroviral therapy initiation in HIV-positive women from Europe, Sub-Saharan Africa and the Americas. AIDS, 34 (2), S. 277–289. http://doi.org/10.1097/QAD.0000000000002399.
Rohner, Eliane; Bütikofer, Lukas; Schmidlin, Kurt; Sengayi, Mazvita; Maskew, Mhairi et al. (2020). Cervical cancer risk in women living with HIV across four continents: A multicohort study. International Journal of Cancer, 146 (3), S. 601–609. http://doi.org/10.1002/ijc.32260.
Lotspeich, Sarah C.; Giganti, Mark J.; Maia, Marcelle; Vieira, Renalice; Machado, Daisy Maria et al. (2020). Self-audits as alternatives to travel-audits for improving data quality in the Caribbean, Central and South America network for HIV epidemiology. Journal of Clinical and Translational Science, 4 (2), S. 125–132. http://doi.org/10.1017/cts.2019.442.
Patel, Kunjal; Smith, Colette; Collins, Intira Jeannie; Goodall, Ruth; Abrams, Elaine J. et al. (2020). Outcomes of second-line antiretroviral therapy among children living with HIV: a global cohort analysis. Journal of the International AIDS Society, 23 (4). http://doi.org/10.1002/jia2.25477.
Jesson, Julie; Desmonde, Sophie; Yiannoutsos, Constantin T.; Patten, Gabriela; Malateste, Karen et al. (2020). Weight-for-age distributions among children with HIV on antiretroviral therapy in the International epidemiology Databases to Evaluate AIDS (IeDEA) multiregional consortium. BMC Research Notes, 13 (1), S. 249–249. http://doi.org/10.1186/s13104-020-05081-7.
Rebeiro, Peter F.; Cohen, Mollie J.; Ewing, Heather M.; Figueiredo, Marina Cruvinel; Peetluk, Lauren Saag et al. (2020). Knowledge and stigma of latent tuberculosis infection in Brazil: implications for tuberculosis prevention strategies. BMC Public Health, 20 (1), S. 897–897. http://doi.org/10.1186/s12889-020-09053-1.
Duda, Stephany N.; Musick, Beverly S.; Davies, Mary-Ann; Sohn, Annette H.; Ledergerber, Bruno et al. (2020). The IeDEA Data Exchange Standard: a common data model for global HIV cohort collaboration (preprint). Health Informatics. https://doi.org/10.1101/2020.07.22.20159921
Loiseau, Chloé; Brites, Daniela; Reinhard, Miriam; Zürcher, Kathrin; Borrell, Sonia et al. (2020). HIV coinfection is associated with low fitness rpoB variants in rifampicin-resistant Mycobacterium tuberculosis. Antimicrobial Agents and Chemotherapy. http://doi.org/10.1128/AAC.00782-20.
Patten, Gabriela; Puthanakit, Thanyawee; McGowan, Catherine C.; Wools-Kaloustian, Kara; Hazra, Rohan et al. (2020). Raltegravir use and outcomes among children and adolescents living with HIV in the IeDEA global consortium. Journal of the International AIDS Society, 23 (7). http://doi.org/10.1002/jia2.25580.
Parcesepe, Angela M.; Lancaster, Kathryn; Edelman, E. Jennifer; DeBoni, Raquel; Ross, Jeremy et al. (2020). Substance use service availability in HIV treatment programs: Data from the global IeDEA consortium, 2014-2015 and 2017. PLoS ONE, 15 (8 August), S. e0237772–e0237772. http://doi.org/10.1371/journal.pone.0237772.
Demitto, Fernanda O.; Araújo-Pereira, Mariana; Schmaltz, Carolina A.; Sant’Anna, Flávia M.; Arriaga, María B. et al. (2020). Impact of Persistent Anemia on Systemic Inflammation and Tuberculosis Outcomes in Persons Living With HIV. Frontiers in Immunology, 11. http://doi.org/10.3389/fimmu.2020.588405.
Desmonde, Sophie; Neilan, Anne M.; Musick, Beverly; Patten, Gabriela; Chokephaibulkit, Kulkanya et al. (2020). Time-varying age- and CD4-stratified rates of mortality and WHO stage 3 and stage 4 events in children, adolescents and youth 0 to 24 years living with perinatally acquired HIV, before and after antiretroviral therapy initiation in the paediatric IeDEA Gl. Journal of the International AIDS Society, 23 (10), S. e25617–e25617. http://doi.org/10.1002/jia2.25617.
Rebeiro, Peter F.; Duda, Stephany N.; Wools-Kaloustian, Kara K.; Nash, Denis & Althoff, Keri N. (2020). Implications of COVID-19 for HIV Research: data sources, indicators and longitudinal analyses. Journal of the International AIDS Society, 23 (10), S. e25627–e25627. http://doi.org/10.1002/jia2.25627.
Reichmuth, Martina L.; Hömke, Rico; Zürcher, Kathrin; Sander, Peter; Avihingsanon, Anchalee et al. (2020). Natural Polymorphisms in Mycobacterium tuberculosis Conferring Resistance to Delamanid in Drug-Naive Patients. Antimicrobial Agents and Chemotherapy, 64 (11). http://doi.org/10.1128/AAC.00513-20.
Tao, Ran; Lotspeich, Sarah C.; Amorim, Gustavo; Shaw, Pamela A. & Shepherd, Bryan E. (2020). Efficient semiparametric inference for two-phase studies with outcome and covariate measurement errors. Statistics in Medicine, S. sim.8799-sim.8799. http://doi.org/10.1002/sim.8799.
Giganti, Mark J. & Shepherd, Bryan E. (2020). Multiple-Imputation Variance Estimation in Studies With Missing or Misclassified Inclusion Criteria. American Journal of Epidemiology, 189 (12), S. 1628–1632. http://doi.org/10.1093/aje/kwaa153.
Oliveira-de-Souza, Deivide; Vinhaes, Caian L.; Arriaga, María B.; Kumar, Nathella Pavan; Queiroz, Artur T. L. et al. (2020). Aging increases the systemic molecular degree of inflammatory perturbation in patients with tuberculosis. Scientific Reports, 10 (1). http://doi.org/10.1038/s41598-020-68255-0.
Penn-Nicholson, Adam; Mbandi, Stanley Kimbung; Thompson, Ethan; Mendelsohn, Simon C.; Suliman, Sara et al. (2020). RISK6, a 6-gene transcriptomic signature of TB disease risk, diagnosis and treatment response. Scientific Reports, 10 (1). http://doi.org/10.1038/s41598-020-65043-8.
Barreto-Duarte, Beatriz; Sterling, Timothy R.; Fiske, Christina T.; Almeida, Alexandre; Nochowicz, Cynthia H. et al. (2020). Increased Frequency of Memory CD4+ T-Cell Responses in Individuals With Previously Treated Extrapulmonary Tuberculosis. Frontiers in Immunology, 11, S. 605338. http://doi.org/10.3389/fimmu.2020.605338.
Belaunzaran-Zamudio, Pablo F.; Caro-Vega, Yanink; Giganti, Mark J.; Castilho, Jessica L.; Crabtree-Ramirez, Brenda E. et al. (2020). Frequency of non-communicable diseases in people 50 years of age and older receiving HIV care in Latin America. PloS One, 15 (6), S. e0233965–e0233965. http://doi.org/10.1371/journal.pone.0233965.
Boettiger, David C.; Escuder, Maria Mercedes; Law, Matthew G.; Veloso, Valdiléa; Souza, Rosa A. et al. (2020). Cardiovascular disease among people living with HIV in Brazil. Tropical Medicine and International Health. http://doi.org/10.1111/tmi.13405.
Giganti, Mark J.; Shaw, Pamela A.; Chen, Guanhua; Bebawy, Sally S.; Turner, Megan M. et al. (2020). Accounting for dependent errors in predictors and time-to-event outcomes using electronic health records, validation samples and multiple imputation. Annals of Applied Statistics, 14 (2), S. 1045–1061. http://doi.org/10.1214/20-AOAS1343.
Musayón-Oblitas, Flor Yesenia; Cárcamo, Cesar Paul; Gimbel, Sarah; Zarate, Juan Ignacio Echevarria & Espinoza, Ana Beatriz Graña (2020). Validation of a counseling guide for adherence to antiretroviral therapy using implementation science. Revista Latino-Americana de Enfermagem, 28, S. e3228–e3228. http://doi.org/10.1590/1518-8345.3117.3228.
Oh, Eric J.; Shepherd, Bryan E.; Lumley, Thomas & Shaw, Pamela A. (2020). Raking and regression calibration: Methods to address bias from correlated covariate and time-to-event error. Statistics in Medicine. http://doi.org/10.1002/sim.8793.
Safe, Izabella P.; Amaral, Eduardo P.; Araújo-Pereira, Mariana; Lacerda, Marcus V. G.; Printes, Vitoria S. et al. (2020). Adjunct N-Acetylcysteine Treatment in Hospitalized Patients With HIV-Associated Tuberculosis Dampens the Oxidative Stress in Peripheral Blood: Results From the RIPENACTB Study Trial. Frontiers in Immunology, 11, S. 602589. http://doi.org/10.3389/fimmu.2020.602589.
2019
Castilho, Jessica L.; Escuder, Maria M.; Veloso, Valdiléa; Gomes, Jackeline O.; Jayathilake, Karu et al. (2019). Trends and predictors of non‐communicable disease multimorbidity among adults living with HIV and receiving antiretroviral therapy in Brazil. Journal of the International AIDS Society, 22 (1), S. e25233–e25233. http://doi.org/10.1002/jia2.25233.
Crabtree-Ramírez, B.; Jenkins, C.; Jayathilake, K.; Carriquiry, G.; Veloso, V. et al. (2019). HIV-related tuberculosis: mortality risk in persons without vs. with culture-confirmed disease. The International Journal of Tuberculosis and Lung Disease, 23 (3), S. 306–314. http://doi.org/10.5588/ijtld.18.0111.
Gygli, Sebastian M.; Keller, Peter M.; Ballif, Marie; Blöchliger, Nicolas; Hömke, Rico et al. (2019). Whole-Genome Sequencing for Drug Resistance Profile Prediction in Mycobacterium tuberculosis. Antimicrobial Agents and Chemotherapy, 63 (4). http://doi.org/10.1128/AAC.02175-18.
Oliveira-de-Souza, Deivide; Vinhaes, Caian L.; Arriaga, Maria B.; Kumar, Nathella Pavan; Cubillos-Angulo, Juan M. et al. (2019). Molecular degree of perturbation of plasma inflammatory markers associated with tuberculosis reveals distinct disease profiles between Indian and Chinese populations. Scientific Reports, 9 (1), S. 8002–8002. http://doi.org/10.1038/s41598-019-44513-8.
Perez-Patrigeon, S.; Camiro-Zúñiga, A.; Jaramillo-Jante, M. R.; Belaunzarán-Zamudio, P. F.; Crabtree-Ramírez, B. et al. (2019). Immediate treatment of acute HIV in a tertiary healthcare center: bridging gaps in communication using smartphones. HIV Medicine, 20 (5), S. 308–316. http://doi.org/10.1111/hiv.12713.
Brazier, Ellen; Maruri, Fernanda; Duda, Stephany N.; Tymejczyk, Olga; Wester, C. William et al. (2019). Implementation of “Treat-all” at adult HIV care and treatment sites in the Global IeDEA Consortium: results from the Site Assessment Survey. Journal of the International AIDS Society, 22 (7), S. e25331–e25331. http://doi.org/10.1002/jia2.25331.
Cubillos-Angulo, Juan Manuel; Arriaga, María B.; Silva, Elisângela C.; Müller, Beatriz L. A.; Ramalho, Daniela M. P. et al. (2019). Polymorphisms in TLR4 and TNFA and Risk of Mycobacterium tuberculosis Infection and Development of Active Disease in Contacts of Tuberculosis Cases in Brazil: A Prospective Cohort Study. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America, 69 (6), S. 1027–1035. http://doi.org/10.1093/cid/ciy1001.
Zürcher, Kathrin; Ballif, Marie; Kiertiburanakul, Sasisopin; Chenal, Henri; Yotebieng, Marcel et al. (2019). Diagnosis and clinical outcomes of extrapulmonary tuberculosis in antiretroviral therapy programmes in low- and middle-income countries: a multicohort study. Journal of the International AIDS Society, 22 (9), S. e25392–e25392. http://doi.org/10.1002/jia2.25392.
Belaunzarán-Zamudio, Pablo F.; Caro-Vega, Yanink N.; Shepherd, Bryan E.; Rebeiro, Peter F.; Crabtree-Ramírez, Brenda E. et al. (2019). The Population Impact of Late Presentation with Advanced HIV Disease and Delayed Antiretroviral Therapy in Adults Receiving HIV Care in Latin America. American Journal of Epidemiology. http://doi.org/10.1093/aje/kwz252.
Koenig, Serena P.; Kim, Ahra; Shepherd, Bryan E.; Cesar, Carina; Veloso, Valdilea et al. (2019). Increased Mortality after Tuberculosis Treatment Completion in Persons with HIV in Latin America. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. http://doi.org/10.1093/cid/ciz1032.
Silveira-Mattos, Paulo S.; Barreto-Duarte, Beatriz; Vasconcelos, Beatriz; Fukutani, Kiyoshi F.; Vinhaes, Caian L. et al. (2019). Differential expression of activation markers by Mycobacterium tuberculosis-specific CD4+ T-cell distinguishes extrapulmonary from pulmonary tuberculosis and latent infection. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. http://doi.org/10.1093/cid/ciz1070.
Jesson, Julie; Schomaker, Michael; Malasteste, Karen; Wati, Dewi K.; Kariminia, Azar et al. (2019). Stunting and growth velocity of adolescents with perinatally acquired HIV: differential evolution for males and females. A multiregional analysis from the IeDEA global paediatric collaboration. Journal of the International AIDS Society, 22 (11), S. e25412–e25412. http://doi.org/10.1002/jia2.25412.
Peetluk, Lauren S.; Rebeiro, Peter F.; Cordeiro-Santos, Marcelo; Kritski, Afranio; Andrade, Bruno B. et al. (2019). Lack of Weight Gain During the First 2 Months of Treatment and Human Immunodeficiency Virus Independently Predict Unsuccessful Treatment Outcomes in Tuberculosis. The Journal of Infectious Diseases. http://doi.org/10.1093/infdis/jiz595.
Vinhaes, Caian L.; Oliveira-de-Souza, Deivide; Silveira-Mattos, Paulo S.; Nogueira, Betania; Shi, Ruiru et al. (2019). Changes in inflammatory protein and lipid mediator profiles persist after antitubercular treatment of pulmonary and extrapulmonary tuberculosis: A prospective cohort study. Cytokine, 123, S. 154759–154759. http://doi.org/10.1016/j.cyto.2019.154759.
Crabtree-Ramírez, Brenda E.; Caro-Vega, Yanink; Belaunzarán-Zamudio, Pablo F.; Shepherd, Bryan E.; Rebeiro, Peter F. et al. (2019). Temporal changes in ART initiation in adults with high CD4 counts in Latin America: a cohort study. Journal of the International AIDS Society, 22 (12), S. e25413–e25413. http://doi.org/10.1002/jia2.25413.
Giganti, Mark J.; Shepherd, Bryan E.; Caro-Vega, Yanink; Luz, Paula M.; Rebeiro, Peter F. et al. (2019). The impact of data quality and source data verification on epidemiologic inference: a practical application using HIV observational data. BMC Public Health, 19 (1), S. 1748–1748. http://doi.org/10.1186/s12889-019-8105-2.
Johnson, Leigh F.; Anderegg, Nanina; Zaniewski, Elizabeth; Eaton, Jeffrey W.; Rebeiro, Peter F. et al. (2019). Global variations in mortality in adults after initiating antiretroviral treatment: an updated analysis of the International epidemiology Databases to Evaluate AIDS cohort collaboration. AIDS (London, England), 33 Suppl 3, S. S283–S294. http://doi.org/10.1097/QAD.0000000000002358.
Pettit, April C.; Jenkins, Cathy A.; Blevins Peratikos, Meridith; Yotebieng, Marcel; Diero, Lameck et al. (2019). Directly observed therapy and risk of unfavourable tuberculosis treatment outcomes among an international cohort of people living with HIV in low- and middle-income countries. Journal of the International AIDS Society, 22 (12), S. e25423–e25423. http://doi.org/10.1002/jia2.25423.
Stover, John; Glaubius, Robert; Mofenson, Lynne; Dugdale, Caitlin M.; Davies, Mary Ann et al. (2019). Updates to the Spectrum/AIM model for estimating key HIV indicators at national and subnational levels. AIDS, 33, S. S227–S234. http://doi.org/10.1097/QAD.0000000000002357.
Rivera, V. R.; Lu, L.; Ocheretina, O.; Jean Juste, M. A.; Julma, P. et al. (2019). Diagnostic yield of active case finding for tuberculosis at human immunodeficiency virus testing in Haiti. The International Journal of Tuberculosis and Lung Disease : The Official Journal of the International Union against Tuberculosis and Lung Disease, 23 (11), S. 1217–1222. http://doi.org/10.5588/ijtld.18.0835.
Tymejczyk, Olga; Brazier, Ellen; Yiannoutsos, Constantin T.; Vinikoor, Michael; van Lettow, Monique et al. (2019). Changes in rapid HIV treatment initiation after national “treat all” policy adoption in 6 sub-Saharan African countries: Regression discontinuity analysis. PLoS Medicine, 16 (6), S. e1002822–e1002822. http://doi.org/10.1371/journal.pmed.1002822.
2018
IeDEA and COHERE Cohort Collaborations (2018). Global Trends in CD4 Cell Count at the Start of Antiretroviral Therapy: Collaborative Study of Treatment Programs. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. http://doi.org/10.1093/cid/cix915.
Wolff, Marcelo J.; Cortes, Claudia P.; Mejìa, Fernando A.; Padgett, Denis; Belaunzarán-Zamudio, Pablo et al. (2018). Evaluating the care cascade after antiretroviral therapy initiation in Latin America. International Journal of STD & AIDS, 29 (1), S. 4–12. http://doi.org/10.1177/0956462417714094.
Caro-Vega, Yanink; Belaunzarán-Zamudio, Pablo F.; Crabtree-Ramírez, Brenda E.; Shepherd, Bryan E.; Grinsztejn, Beatriz et al. (2018). Durability of Efavirenz Compared With Boosted Protease Inhibitor-Based Regimens in Antiretroviral-Naïve Patients in the Caribbean and Central and South America. Open Forum Infectious Diseases, 5 (3), S. ofy004–ofy004. http://doi.org/10.1093/ofid/ofy004.
Carriquiry, Gabriela; Giganti, Mark J.; Castilho, Jessica L.; Jayathilake, Karu; Cahn, Pedro et al. (2018). Virologic failure and mortality in older ART initiators in a multisite Latin American and Caribbean Cohort. Journal of the International AIDS Society, 21 (3), S. e25088–e25088. http://doi.org/10.1002/jia2.25088.
Collaborative Initiative for Paediatric HIV Education and Research (CIPHER) Global Cohort Collaboration, CIPHER; Slogrove, Amy L.; Schomaker, Michael; Davies, Mary-Ann; Williams, Paige et al. (2018). The epidemiology of adolescents living with perinatally acquired HIV: A cross-region global cohort analysis. PLoS Medicine, 15 (3), S. e1002514–e1002514. http://doi.org/10.1371/journal.pmed.1002514.
De Boni, Raquel B.; Peratikos, Meridith B.; Shepherd, Bryan E.; Grinsztejn, Beatriz; Cortés, Claudia et al. (2018). Is substance use associated with HIV cascade outcomes in Latin America? PloS One, 13 (3), S. e0194228–e0194228. http://doi.org/10.1371/journal.pone.0194228.
Parcesepe, Angela M.; Mugglin, Catrina; Nalugoda, Fred; Bernard, Charlotte; Yunihastuti, Evy et al. (2018). Screening and management of mental health and substance use disorders in HIV treatment settings in low- and middle-income countries within the global IeDEA consortium. Journal of the International AIDS Society, 21 (3), S. e25101–e25101. http://doi.org/10.1002/jia2.25101.
Tymejczyk, Olga; Brazier, Ellen; Yiannoutsos, Constantin; Wools-Kaloustian, Kara; Althoff, Keri et al. (2018). HIV treatment eligibility expansion and timely antiretroviral treatment initiation following enrollment in HIV care: A metaregression analysis of programmatic data from 22 countries. PLoS Medicine, 15 (3), S. e1002534–e1002534. http://doi.org/10.1371/journal.pmed.1002534.
Prochazka, Mateo; Otero, Larissa; Konda, Kelika A.; González-Lagos, Elsa; Echevarría, Juan et al. (2018). Patient-nominated supporters as facilitators for engagement in HIV care in a referral hospital in Peru: A retrospective cohort study. PloS One, 13 (4), S. e0195389–e0195389. http://doi.org/10.1371/journal.pone.0195389.
Caro-Vega, Y.; Belaunzarán-Zamudio, P. F.; Crabtree-Ramírez, B.; Shepherd, B. E.; Mejia, F. et al. (2018). Trends in proportion of older HIV-infected people in care in Latin America and the Caribbean: a growing challenge. Epidemiology and Infection, S. 1–4. http://doi.org/10.1017/S0950268818001346.
Desmonde, Sophie; Tanser, Franck; Vreeman, Rachel; Takassi, Elom; Edmonds, Andrew et al. (2018). Access to antiretroviral therapy in HIV-infected children aged 0-19 years in the International Epidemiology Databases to Evaluate AIDS (IeDEA) Global Cohort Consortium, 2004-2015: A prospective cohort study. PLoS Medicine, 15 (5), S. e1002565–e1002565. http://doi.org/10.1371/journal.pmed.1002565.
Zamudio-Rodríguez, Alfonso; Belaunzarán-Zamudio, Pablo F.; Sierra-Madero, Juan G.; Cuellar-Rodríguez, Jennifer; Crabtree-Ramírez, Brenda E. et al. (2018). Association Between Frailty and HIV-Associated Neurodegenerative Disorders Among Older Adults Living with HIV. AIDS Research and Human Retroviruses, 34 (5), S. 449–455. http://doi.org/10.1089/aid.2017.0100.
Giles, Michelle L.; Achhra, Amit C.; Abraham, Alison G.; Haas, Andreas D.; Gill, Michael John et al. (2018). Sex-based differences in antiretroviral therapy initiation, switching and treatment interruptions: global overview from the International Epidemiologic Databases to Evaluate AIDS (IeDEA). Journal of the International AIDS Society, 21 (6), S. e25149–e25149. http://doi.org/10.1002/jia2.25149.
Arrivé, Elise; Ayaya, Samuel; Davies, Mary-Ann; Chimbetete, Cleophas; Edmonds, Andrew et al. (2018). Models of support for disclosure of HIV status to HIV-infected children and adolescents in resource-limited settings. Journal of the International AIDS Society, 21 (7), S. e25157–e25157. http://doi.org/10.1002/jia2.25157.
Bakal, David R.; Coelho, Lara E.; Luz, Paula M.; Clark, Jesse L.; De Boni, Raquel B. et al. (2018). Obesity following ART initiation is common and influenced by both traditional and HIV-/ART-specific risk factors. Journal of Antimicrobial Chemotherapy, 73 (8), S. 2177–2185. http://doi.org/10.1093/jac/dky145.
Coelho, Lara; Rebeiro, Peter F.; Castilho, Jessica L.; Caro-Veja, Yanink; Mejia, Fernando A. et al. (2018). Early Retention in Care Neither Mediates Nor Modifies the Effect of Sex and Sexual Mode of HIV Acquisition on HIV Survival in the Americas. AIDS Patient Care and STDs, 32 (8), S. 306–313. http://doi.org/10.1089/apc.2018.0028.
Guiteau Moise, Colette; Rivera, Vanessa R.; Hennessey, Kelly A.; Bellot, Clovy; Nicholas, Chris et al. (2018). A Successful Model of Expedited Antiretroviral Therapy for Clinically Stable Patients Living With HIV in Haiti. Journal of Acquired Immune Deficiency Syndromes (1999), 79 (1), S. 70–76. http://doi.org/10.1097/QAI.0000000000001725.
Rohner, Eliane & AIDS-defining Cancer Project Working Group of IeDEA, COHERE in EuroCoord (2018). Non-Hodgkin lymphoma risk in adults living with HIV across five continents: a multicohort study. AIDS (London, England). http://doi.org/10.1097/QAD.0000000000002003.
Panayidou, Klea; Davies, Mary-Ann; Anderegg, Nanina; Egger, Matthias & IeDEA, COHERE, PHACS and IMPAACT 219C Collaborations Writing Group (2018). Global temporal changes in the proportion of children with advanced disease at the start of combination antiretroviral therapy in an era of changing criteria for treatment initiation. Journal of the International AIDS Society, 21 (11), S. e25200–e25200. http://doi.org/10.1002/jia2.25200.
Rebeiro, Peter F.; Howe, Chanelle J.; Rogers, William B.; Bebawy, Sally S.; Turner, Megan et al. (2018). The relationship between adverse neighborhood socioeconomic context and HIV continuum of care outcomes in a diverse HIV clinic cohort in the Southern United States. AIDS Care, 30 (11), S. 1426–1434. http://doi.org/10.1080/09540121.2018.1465526.
Zaniewski, Elizabeth; Tymejczyk, Olga; Kariminia, Azar; Desmonde, Sophie; Leroy, Valériane et al. (2018). IeDEA-WHO Research-Policy Collaboration: contributing real-world evidence to HIV progress reporting and guideline development. Journal of Virus Eradication, 4 (Suppl 2), S. 9–15. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/30515309
Caro-Vega, Yanink; Schultze, Anna; W. Efsen, Anne Marie; Post, Frank A.; Panteleev, Alexander et al. (2018). Differences in response to antiretroviral therapy in HIV-positive patients being treated for tuberculosis in Eastern Europe, Western Europe and Latin America. BMC Infectious Diseases, 18 (1), S. 191–191. http://doi.org/10.1186/s12879-018-3077-x.
Fink, Valeria I.; Jenkins, Cathy A.; Castilho, Jessica L.; Person, Anna K.; Shepherd, Bryan E. et al. (2018). Survival after cancer diagnosis in a cohort of HIV-positive individuals in Latin America. Infectious Agents and Cancer, 13 (1), S. 16–16. http://doi.org/10.1186/s13027-018-0188-3.
Kariminia, Azar; Law, Matthew; Davies, Mary‐Ann; Vinikoor, Michael; Wools‐Kaloustian, Kara et al. (2018). Mortality and losses to follow‐up among adolescents living with HIV in the Ie DEA global cohort collaboration. Journal of the International AIDS Society, 21 (12), S. e25215–e25215. http://doi.org/10.1002/jia2.25215.
Ford, Nathan; Penazzato, Martina; Vitoria, Marco; Doherty, Meg; Davies, Mary Ann et al. (2018). The contribution of observational studies in supporting the WHO “treat all” recommendation for HIV/AIDS. Journal of Virus Eradication, 4 (Suppl 2), S. 5–8. http://doi.org/10.1016/S2055-6640(20)30346-0.
2017
Fritz, Cristin Q.; Blevins, Meridith; Lindegren, Mary Lou; Wools-Kaloutsian, Kara; Musick, Beverly S. et al. (2017). Comprehensiveness of HIV care provided at global HIV treatment sites in the IeDEA consortium: 2009 and 2014. Journal of the International AIDS Society, 20 (1), S. 1–14. http://doi.org/10.7448/IAS.20.1.20933.
Machado, Iona K.; Luz, Paula M.; Lake, Jordan E.; Castro, Rodolfo; Velasque, Luciane et al. (2017). Self-rated health and substance use among individuals in HIV care in Rio de Janeiro, Brazil: a cross-sectional study. International Journal of STD & AIDS, S. 956462417692278–956462417692278. http://doi.org/10.1177/0956462417692278.
Clouse, Kate; Blevins, Meridith; Lindegren, Mary Lou; Yotebieng, Marcel; Nguyen, Dung Thi et al. (2017). Low implementation of Xpert MTB/RIF among HIV/TB co-infected adults in the International epidemiologic Databases to Evaluate AIDS (IeDEA) program. PloS One, 12 (2), S. e0171384–e0171384. http://doi.org/10.1371/journal.pone.0171384.
Teixeira da Silva, Daniel S.; Luz, Paula M.; Lake, Jordan E.; Cardoso, Sandra W.; Ribeiro, Sayonara et al. (2017). Poor retention in early care increases risk of mortality in a Brazilian HIV-infected clinical cohort. AIDS Care, 29 (2), S. 263–267. http://doi.org/10.1080/09540121.2016.1211610.
Coelho, Lara E.; Ribeiro, Sayonara R.; Japiassu, Andre M.; Moreira, Ronaldo I.; Lara, Priscila C. et al. (2017). 30-day readmission rates in an HIV-infected cohort from Rio de Janeiro, Brazil. Journal of Acquired Immune Deficiency Syndromes (1999), S. 1–1. http://doi.org/10.1097/QAI.0000000000001352.
Coelho, Lara E.; Ribeiro, Sayonara R.; Veloso, Valdilea G.; Grinsztejn, Beatriz & Luz, Paula M. (2017). Hospitalization rates, length of stay and in-hospital mortality in a cohort of HIV infected patients from Rio de Janeiro, Brazil. The Brazilian Journal of Infectious Diseases : An Official Publication of the Brazilian Society of Infectious Diseases, 21 (2), S. 190–195. http://doi.org/10.1016/j.bjid.2016.10.007.
Luque, Marco T.; Jenkins, Cathy A.; Shepherd, Bryan E.; Padgett, Denis; Rouzier, Vanessa et al. (2017). Mortality in Children with Human Immunodeficiency Virus Initiating Treatment: A Six-Cohort Study in Latin America. The Journal of Pediatrics, 182, S. 245- 252.e1. http://doi.org/10.1016/j.jpeds.2016.12.034.
Shepherd, Bryan E.; Rebeiro, Peter F. & Caribbean, Central and South America network for HIV epidemiology (2017). Brief Report: Assessing and Interpreting the Association Between Continuous Covariates and Outcomes in Observational Studies of HIV Using Splines. Journal of Acquired Immune Deficiency Syndromes (1999), 74 (3), S. e60–e63. http://doi.org/10.1097/QAI.0000000000001221.
Anderegg, Nanina; Johnson, Leigh F.; Zaniewski, Elizabeth; Althoff, Keri N.; Balestre, Eric et al. (2017). All-cause mortality in HIV-positive adults starting combination antiretroviral therapy: correcting for loss to follow-up. AIDS (London, England), 31 Suppl 1, S. S31–S40. http://doi.org/10.1097/QAD.0000000000001321.
Oh, Eric J.; Shepherd, Bryan E.; Lumley, Thomas & Shaw, Pamela A. (2017). Considerations for analysis of time-to-event outcomes measured with error: Bias and correction with SIMEX. Statistics in Medicine, 37 (8), S. 1276–1289. http://doi.org/10.1002/sim.7554.
Wolff, Marcelo J.; Giganti, Mark J.; Cortes, Claudia P.; Cahn, Pedro; Grinsztejn, Beatriz et al. (2017). A decade of HAART in Latin America: Long term outcomes among the first wave of HIV patients to receive combination therapy. PloS One, 12 (6), S. e0179769–e0179769. http://doi.org/10.1371/journal.pone.0179769.
Jiamsakul, Awachana; Kariminia, Azar; Althoff, Keri N.; Cesar, Carina; Cortes, Claudia P. et al. (2017). HIV viral load suppression in adults and children receiving antiretroviral therapy – results from the IeDEA collaboration. Journal of Acquired Immune Deficiency Syndromes (1999), S. 1–1. http://doi.org/10.1097/QAI.0000000000001499.
Rebeiro, Peter Francis; Ivey, Kelsey Sunderland; Craig, Kaylin Smith; Hulgan, Todd; Huaman, Moises Arturo et al. (2017). New Faces of HIV Infection: Age, Race, and Timing of Entry into HIV Care in the Southeastern United States. Journal of the International Association of Providers of AIDS Care, 16 (4), S. 347–352. http://doi.org/10.1177/2325957417710719.
Shepherd, Bryan E.; Blevins Peratikos, Meridith; Rebeiro, Peter F.; Duda, Stephany N. & McGowan, Catherine C. (2017). A Pragmatic Approach for Reproducible Research With Sensitive Data. American Journal of Epidemiology, 186 (4), S. 387–392. http://doi.org/10.1093/aje/kwx066.
Brown, Steven A.; Abbas, Salma; Davies, Mary-Ann; Bunupuradah, Torsak; Sohn, Annette H. et al. (2017). Brief Report: Pediatric Cancer Burden and Treatment Resources Within the Pediatric IeDEA Consortium. JAIDS Journal of Acquired Immune Deficiency Syndromes, 76 (1), S. 60–64. http://doi.org/10.1097/QAI.0000000000001453.
Machado, Iona K.; Luz, Paula M.; Lake, Jordan E.; Castro, Rodolfo; Velasque, Luciane et al. (2017). Substance use among HIV-infected patients in Rio de Janeiro, Brazil: Agreement between medical records and the ASSIST questionnaire. Drug and Alcohol Dependence, 178, S. 115–118. http://doi.org/10.1016/j.drugalcdep.2017.04.033.
AIDS-defining Cancer Project Working Group for IeDEA and COHERE in EuroCoord & AIDS-defining Cancer Project Working Group for IeDEA and COHERE in EuroCoord (2017). Comparison of Kaposi Sarcoma Risk in Human Immunodeficiency Virus-Positive Adults Across 5 Continents: A Multiregional Multicohort Study. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America, 65 (8), S. 1316–1326. http://doi.org/10.1093/cid/cix480.
Crabtree Ramírez, B.; Caro Vega, Y.; Shepherd, B. E.; Le, C.; Turner, M. et al. (2017). Outcomes of HIV-positive patients with cryptococcal meningitis in the Americas. International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases, 63, S. 57–63. http://doi.org/10.1016/j.ijid.2017.08.004.
Rebeiro, Peter F.; Bakoyannis, Giorgos; Musick, Beverly S.; Braithwaite, Ronald S.; Wools-Kaloustian, Kara K. et al. (2017). Observational Study of the Effect of Patient Outreach on Return to Care: The Earlier the Better. Journal of Acquired Immune Deficiency Syndromes (1999), 76 (2), S. 141–148. http://doi.org/10.1097/QAI.0000000000001474.
Liu, Qi; Shepherd, Bryan E.; Li, Chun & Harrell, Frank E. (2017). Modeling continuous response variables using ordinal regression. Statistics in Medicine, 36 (27), S. 4316–4335. http://doi.org/10.1002/sim.7433.
Lamas, Cristiane C.; Coelho, Lara E.; Grinsztejn, Beatriz J. & Veloso, Valdilea G. (2017). Community-acquired lower respiratory tract infections in HIV-infected patients on antiretroviral therapy: predictors in a contemporary cohort study. Infection, 45 (6), S. 801–809. http://doi.org/10.1007/s15010-017-1041-0.
2016
Wolff, Marcelo; Shepherd, Bryan E.; Cortés, Claudia; Rebeiro, Peter; Cesar, Carina et al. (2016). Clinical and Virologic Outcomes After Changes in First Antiretroviral Regimen at 7 Sites in the Caribbean, Central and South America Network. Journal of Acquired Immune Deficiency Syndromes (1999), 71 (1), S. 102–110. http://doi.org/10.1097/QAI.0000000000000817.
Blevins, Meridith; Wehbe, Firas H.; Rebeiro, Peter F.; Caro-Vega, Yanink; McGowan, Catherine C. et al. (2016). Interactive Data Visualization for HIV Cohorts: Leveraging Data Exchange Standards to Share and Reuse Research Tools. PloS One, 11 (3), S. e0151201–e0151201. http://doi.org/10.1371/journal.pone.0151201.
Cesar, Carina; Koethe, John R.; Giganti, Mark J.; Rebeiro, Peter; Althoff, Keri N. et al. (2016). Health outcomes among HIV-positive Latinos initiating antiretroviral therapy in North America versus Central and South America. Journal of the International AIDS Society, 19 (1). http://doi.org/10.7448/IAS.19.1.20684.
Coelho, Lara E.; Cardoso, Sandra W.; Amancio, Rodrigo T.; Moreira, Ronaldo I.; Ribeiro, Sayonara R. et al. (2016). Predictors of opportunistic illnesses incidence in post combination antiretroviral therapy era in an urban cohort from Rio de Janeiro, Brazil. BMC Infectious Diseases, 16 (1), S. 134–134. http://doi.org/10.1186/s12879-016-1462-x.
Charles, M. Katherine; Lindegren, Mary Lou; Wester, C. William; Blevins, Meridith; Sterling, Timothy R. et al. (2016). Implementation of Tuberculosis Intensive Case Finding, Isoniazid Preventive Therapy, and Infection Control (“Three I’s”) and HIV-Tuberculosis Service Integration in Lower Income Countries. PloS One, 11 (4), S. e0153243–e0153243. http://doi.org/10.1371/journal.pone.0153243.
Rebeiro, Peter F.; Cesar, Carina; Shepherd, Bryan E.; De Boni, Raquel B.; Cort?s, Claudia P. et al. (2016). Assessing the HIV Care Continuum in Latin America: progress in clinical retention, cART use and viral suppression. Journal of the International AIDS Society, 19 (1), S. 20636–20636. http://doi.org/10.7448/IAS.19.1.20636.
Crabtree-Ramírez, Brenda; Caro-Vega, Yanink; Shepherd, Bryan E.; Grinsztejn, Beatriz; Wolff, Marcelo et al. (2016). Time to HAART Initiation after Diagnosis and Treatment of Opportunistic Infections in Patients with AIDS in Latin America. PloS One, 11 (6), S. e0153921–e0153921. http://doi.org/10.1371/journal.pone.0153921.
Diaz, Chanelle M.; Segura, Eddy R.; Luz, Paula M.; Clark, Jesse L.; Ribeiro, Sayonara R. et al. (2016). Traditional and HIV-specific risk factors for cardiovascular morbidity and mortality among HIV-infected adults in Brazil: a retrospective cohort study. BMC Infectious Diseases, 16 (1), S. 376–376. http://doi.org/10.1186/s12879-016-1735-4.
Coelho, Lara; Grinsztejn, Beatriz; Castilho, Jessica L.; De Boni, Raquel; Quintana, Marcel S. B. et al. (2016). Mortality in HIV-infected women, heterosexual men, and men who have sex with men in Rio de Janeiro, Brazil: an observational cohort study. The Lancet. HIV, 3 (10), S. e490-8. http://doi.org/10.1016/S2352-3018(16)30052-2.
Rachlis, Beth; Karwa, Rakhi; Chema, Celia; Pastakia, Sonak; Olsson, Sten et al. (2016). Targeted Spontaneous Reporting: Assessing Opportunities to Conduct Routine Pharmacovigilance for Antiretroviral Treatment on an International Scale. Drug Safety, 39 (10), S. 959–976. http://doi.org/10.1007/s40264-016-0434-9.
De Boni, Raquel B.; Shepherd, Bryan E.; Grinsztejn, Beatriz; Cesar, Carina; Cortés, Claudia et al. (2016). Substance Use and Adherence Among People Living with HIV/AIDS Receiving cART in Latin America. AIDS and Behavior, 20 (11), S. 2692–2699. http://doi.org/10.1007/s10461-016-1398-6.
Cesar, Carina; Blugerman, Gabriela; Valiente, José Antonio; Rebeiro, Peter; Sued, Omar et al. (2016). The HIV care cascade in Buenos Aires, Argentina: results in a tertiary referral hospital. Revista Panamericana de Salud Publica = Pan American Journal of Public Health, 40 (6), S. 448–454. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/28718494
Shepherd, Bryan E.; Li, Chun & Liu, Qi (2016). Probability-scale residuals for continuous, discrete, and censored data. The Canadian Journal of Statistics = Revue Canadienne de Statistique, 44 (4), S. 463–479. http://doi.org/10.1002/cjs.11302.
Althoff, Keri N.; Rebeiro, Peter F.; Hanna, David B.; Padgett, Denis; Horberg, Michael A. et al. (2016). A picture is worth a thousand words: maps of HIV indicators to inform research, programs, and policy from NA-ACCORD and CCASAnet clinical cohorts. Journal of the International AIDS Society, 19 (1), S. 20707–20707. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/27049052
2015
Ballif, Marie; Renner, Lorna; Dusingize, Jean Claude; Leroy, Valeriane; Ayaya, Samuel et al. (2015). Tuberculosis in Pediatric Antiretroviral Therapy Programs in Low- and Middle-Income Countries: Diagnosis and Screening Practices. Journal of the Pediatric Infectious Diseases Society, 4 (1), S. 30–38. http://doi.org/10.1093/jpids/piu020.
Luz, Paula M.; Belaunzarán-Zamudio, Pablo F.; Crabtree-Ramírez, Brenda; Caro-Vega, Yanink; Hoces, Daniel et al. (2015). CD4 Response Up to 5 Years After Combination Antiretroviral Therapy in Human Immunodeficiency Virus-Infected Patients in Latin America and the Caribbean. Open Forum Infectious Diseases, 2 (2), S. ofv079–ofv079. http://doi.org/10.1093/ofid/ofv079.
Giganti, Mark J.; Luz, Paula M.; Caro-Vega, Yanink; Cesar, Carina; Padgett, Denis et al. (2015). A Comparison of Seven Cox Regression-Based Models to Account for Heterogeneity Across Multiple HIV Treatment Cohorts in Latin America and the Caribbean. AIDS Research and Human Retroviruses, 31 (5), S. 496–503. http://doi.org/10.1089/aid.2014.0241.
Castilho, Jessica L.; Levi, José Eduardo; Luz, Paula M.; Cambou, Mary Catherine; Vanni, Tazio et al. (2015). A cross-sectional study of high-risk human papillomavirus clustering and cervical outcomes in HIV-infected women in Rio de Janeiro, Brazil. BMC Cancer, 15 (1), S. 478–478. http://doi.org/10.1186/s12885-015-1486-4.
Belaunzarán-Zamudio, Pablo F.; Caro-Vega, Yanink N.; Shepherd, Bryan E.; Crabtree-Ramírez, Brenda E.; Luz, Paula M. et al. (2015). Monitoring of HIV treatment in seven countries in the WHO Region of the Americas. Bulletin of the World Health Organization, 93 (8), S. 529–539. http://doi.org/10.2471/BLT.14.147447.
Caro-Vega, Yanink; del Rio, Carlos; Dias Lima, Viviane; Lopez-Cervantes, Malaquias; Crabtree-Ramirez, Brenda et al. (2015). Estimating the Impact of Earlier ART Initiation and Increased Testing Coverage on HIV Transmission among Men Who Have Sex with Men in Mexico using a Mathematical Model. PLOS ONE, 10 (8), S. e0136534–e0136534. http://doi.org/10.1371/journal.pone.0136534.
Crabtree-Ramírez, Brenda; Vega, Yanink Neried Caro; Shepherd, Bryan E.; Turner, Megan; Carriquiry, Gabriela et al. (2015). Temporal Trends in Age at HIV Diagnosis in Cohorts in the United States, the Caribbean, and Central and South America. AIDS and Behavior, 19 (9), S. 1599–1608. http://doi.org/10.1007/s10461-014-0974-x.
Hamilton, Carol D.; Swaminathan, Soumya; Christopher, Devasahayam J.; Ellner, Jerrold; Gupta, Amita et al. (2015). RePORT International: Advancing Tuberculosis Biomarker Research Through Global Collaboration. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America, 61Suppl 3 (suppl 3), S. S155-9. http://doi.org/10.1093/cid/civ611.
Cesar, Carina; Jenkins, Cathy A.; Shepherd, Bryan E.; Padgett, Denis; Mejía, Fernando et al. (2015). Incidence of virological failure and major regimen change of initial combination antiretroviral therapy in the Latin America and the Caribbean: an observational cohort study. The Lancet. HIV, 2 (11), S. e492-500. http://doi.org/10.1016/S2352-3018(15)00183-6.
Castilho, Jessica L.; Luz, Paula M.; Shepherd, Bryan E.; Turner, Megan; Ribeiro, Sayonara R. et al. (2015). HIV and cancer: a comparative retrospective study of Brazilian and U.S. clinical cohorts. Infectious Agents and Cancer, 10 (1), S. 4–4. http://doi.org/10.1186/1750-9378-10-4.
Carriquiry, Gabriela; Fink, Valeria; Koethe, John Robert; Giganti, Mark Joseph; Jayathilake, Karu et al. (2015). Mortality and loss to follow-up among HIV-infected persons on long-term antiretroviral therapy in Latin America and the Caribbean. Journal of the International AIDS Society, 18, S. 20016–20016. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/26165322
Duda, Stephany N.; McGowan, Catherine C. & Gadd, Cynthia S. (2015). Perceived Reasons for High and Low Quality Observational HIV Research Data. Studies in Health Technology and Informatics, 216, S. 994–994. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/26262296
Marcelin, A.; Perodin, C.; Baja, C.; Bright, A.; Duperval, J. et al. (2015). Developing an Electronic Medical Record for Interlinked Care Services in Haiti. Studies in Health Technology and Informatics, 216, S. 883–883. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/26262185
2014
IeDEA and ART Cohort Collaborations, Matthias; Avila, Dorita; Althoff, Keri N.; Mugglin, Catrina; Wools-Kaloustian, Kara et al. (2014). Immunodeficiency at the start of combination antiretroviral therapy in low-, middle-, and high-income countries. Journal of Acquired Immune Deficiency Syndromes (1999), 65 (1), S. e8-16. http://doi.org/10.1097/QAI.0b013e3182a39979.
Cesar, Carina; Shepherd, Bryan E.; Jenkins, Cathy A.; Ghidinelli, Massimo; Castro, Jose Luis et al. (2014). Use of third line antiretroviral therapy in Latin America. PloS One, 9 (9), S. e106887–e106887. http://doi.org/10.1371/journal.pone.0106887.
Ballif, M.; Nhandu, V.; Wood, R.; Dusingize, J. C.; Carter, E. J. et al. (2014). Detection and management of drug-resistant tuberculosis in HIV-infected patients in lower-income countries. The International Journal of Tuberculosis and Lung Disease : The Official Journal of the International Union against Tuberculosis and Lung Disease, 18 (11), S. 1327–36. http://doi.org/10.5588/ijtld.14.0106.
Duda, Stephany N.; Farr, Amanda M.; Lindegren, Mary Lou; Blevins, Meridith; Wester, C. William et al. (2014). Characteristics and comprehensiveness of adult HIV care and treatment programmes in Asia-Pacific, sub-Saharan Africa and the Americas: results of a site assessment conducted by the International epidemiologic Databases to Evaluate AIDS (IeDEA) Collaborati. Journal of the International AIDS Society, 17 (1), S. 19045–19045. http://doi.org/10.7448/IAS.17.1.19045.
2013
Cortes, Claudia P.; Wehbe, Firas H.; McGowan, Catherine C.; Shepherd, Bryan E.; Duda, Stephany N. et al. (2013). Duration of anti-tuberculosis therapy and timing of antiretroviral therapy initiation: association with mortality in HIV-related tuberculosis. PloS One, 8 (9), S. e74057–e74057. http://doi.org/10.1371/journal.pone.0074057.
Fenner, Lukas; Ballif, Marie; Graber, Claire; Nhandu, Venerandah; Dusingize, Jean Claude et al. (2013). Tuberculosis in antiretroviral treatment programs in lower income countries: availability and use of diagnostics and screening. PloS One, 8 (10), S. e77697–e77697. http://doi.org/10.1371/journal.pone.0077697.
2012
Zhou, Jialun; Jaquet, Antoine; Bissagnene, Emmanuel; Musick, Beverly; Wools-Kaloustian, Kara et al. (2012). Short-term risk of anaemia following initiation of combination antiretroviral treatment in HIV-infected patients in countries in sub-Saharan Africa, Asia-Pacific, and central and South America. Journal of the International AIDS Society, 15 (1), S. 5. http://doi.org/10.1186/1758-2652-15-5.
Duda, Stephany N.; Shepherd, Bryan E.; Gadd, Cynthia S.; Masys, Daniel R. & McGowan, Catherine C. (2012). Measuring the quality of observational study data in an international HIV research network. PloS One, 7 (4), S. e33908–e33908. http://doi.org/10.1371/journal.pone.0033908.
Shepherd, Bryan E.; Shaw, Pamela A. & Dodd, Lori E. (2012). Using audit information to adjust parameter estimates for data errors in clinical trials. Clinical Trials (London, England), 9 (6), S. 721–729. http://doi.org/10.1177/1740774512450100.
Yiannoutsos, Constantin Theodore; Johnson, Leigh Francis; Boulle, Andrew; Musick, Beverly Sue; Gsponer, Thomas et al. (2012). Estimated mortality of adult HIV-infected patients starting treatment with combination antiretroviral therapy. Sexually Transmitted Infections, 88 Suppl 2 (Suppl 2), S. i33-43. http://doi.org/10.1136/sextrans-2012-050658.
2011
Fink, Valeria I.; Shepherd, Bryan E.; Cesar, Carina; Krolewiecki, Alejandro; Wehbe, Firas et al. (2011). Cancer in HIV-Infected Persons From the Caribbean, Central and South America. JAIDS Journal of Acquired Immune Deficiency Syndromes, 56 (5), S. 467–473. http://doi.org/10.1097/QAI.0b013e31820bb1c3.
Crabtree-Ramírez, Brenda; Caro-Vega, Yanink; Shepherd, Bryan E.; Wehbe, Firas; Cesar, Carina et al. (2011). Cross-sectional analysis of late HAART initiation in Latin America and the Caribbean: late testers and late presenters. PloS One, 6 (5), S. e20272–e20272. http://doi.org/10.1371/journal.pone.0020272.
Hoyo-Ulloa, Irma; Belaunzarán-Zamudio, Pablo F.; Crabtree-Ramirez, Brenda; Galindo-Fraga, Arturo; Pérez-Aguinaga, María Eugenia et al. (2011). Impact of the immune reconstitution inflammatory syndrome (IRIS) on mortality and morbidity in HIV-infected patients in Mexico. International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases, 15 (6), S. e408-14. http://doi.org/10.1016/j.ijid.2011.02.007.
Shepherd, Bryan E. & Yu, Chang (2011). Accounting for Data Errors Discovered from an Audit in Multiple Linear Regression. Biometrics, 67 (3), S. 1083–1091. http://doi.org/10.1111/j.1541-0420.2010.01543.x.
Chi, Benjamin H.; Yiannoutsos, Constantin T.; Westfall, Andrew O.; Newman, Jamie E.; Zhou, Jialun et al. (2011). Universal Definition of Loss to Follow-Up in HIV Treatment Programs: A Statistical Analysis of 111 Facilities in Africa, Asia, and Latin America. PLoS Medicine, 8 (10), S. e1001111. http://doi.org/10.1371/journal.pmed.1001111.
2010
Tuboi, Suely Hiromi; Pacheco, Antonio Guilherme; Harrison, Lee H.; Stone, Roslyn A.; May, Margaret et al. (2010). Mortality Associated With Discordant Responses to Antiretroviral Therapy in Resource-Constrained Settings. JAIDS Journal of Acquired Immune Deficiency Syndromes, 53 (1), S. 70–77. http://doi.org/10.1097/QAI.0b013e3181c22d19.
Cesar, Carina; Shepherd, Bryan E.; Krolewiecki, Alejandro J.; Fink, Valeria I.; Schechter, Mauro et al. (2010). Rates and Reasons for Early Change of First HAART in HIV-1-Infected Patients in 7 Sites throughout the Caribbean and Latin America. PLoS ONE, 5 (6), S. e10490–e10490. http://doi.org/10.1371/journal.pone.0010490.
Duda, Stephany N.; Wehbe, Firas H. & Gadd, Cynthia S. (2010). Desiderata for a computer-assisted audit tool for clinical data source verification audits. Studies in Health Technology and Informatics, 160 (Pt 2), S. 894–898. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/20841814
2009
Tuboi, Suely H.; Schechter, Mauro; McGowan, Catherine C.; Cesar, Carina; Krolewiecki, Alejandro et al. (2009). Mortality During the First Year of Potent Antiretroviral Therapy in HIV-1-Infected Patients in 7 Sites Throughout Latin America and the Caribbean. JAIDS Journal of Acquired Immune Deficiency Syndromes, 51 (5), S. 615–623. http://doi.org/10.1097/QAI.0b013e3181a44f0a.
Dorjgochoo, Tsogzolmaa; Noel, Francine; Deschamps, Marie Marcelle; Theodore, Harry; Dupont, William et al. (2009). Risk Factors for HIV Infection Among Haitian Adolescents and Young Adults Seeking Counseling and Testing in Port-au-Prince. JAIDS Journal of Acquired Immune Deficiency Syndromes, 52 (4), S. 498–508. http://doi.org/10.1097/QAI.0b013e3181ac12a8.
2008
Pacheco, A. G.; Saraceni, V.; Tuboi, S. H.; Moulton, L. H.; Chaisson, R. E. et al. (2008). Validation of a Hierarchical Deterministic Record-Linkage Algorithm Using Data From 2 Different Cohorts of Human Immunodeficiency Virus-Infected Persons and Mortality Databases in Brazil. American Journal of Epidemiology, 168 (11), S. 1326–1332. http://doi.org/10.1093/aje/kwn249.
Noel, Francine; Mehta, Sapna; Zhu, Yuwei; Rouzier, Patricia De Matteis; Marcelin, Abdias et al. (2008). Improving Outcomes in Infants of HIV-Infected Women in a Developing Country Setting. PLoS ONE, 3 (11), S. e3723–e3723. http://doi.org/10.1371/journal.pone.0003723.
2007
McGowan, Catherine C.; Cahn, Pedro; Gotuzzo, Eduardo; Padgett, Denis; Pape, Jean W. et al. (2007). Cohort Profile: Caribbean, Central and South America Network for HIV research (CCASAnet) collaboration within the International Epidemiologic Databases to Evaluate AIDS (IeDEA) programme. International Journal of Epidemiology, 36 (5), S. 969–976. http://doi.org/10.1093/ije/dym073.
Duda, Stephany N.; Cushman, Clint & Masys, Daniel R. (2007). An XML model of an enhanced data dictionary to facilitate the exchange of pre-existing clinical research data in international studies. Studies in Health Technology and Informatics, 129 (Pt 1), S. 449–453. Retrieved from https://pubmed.ncbi.nlm.nih.gov/17911757/